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ABSTRACT 
 
Light-emitting electrochemical cells (LEECs) are a promising class of solid state lighting 
devices. Their working mechanism is based on the presence of mobile ionic species within the 
device, making them independent of the work function of the electrodes and layer thickness. 
Compared to multilayer organic light emitting diodes (OLEDs), the architecture and assembly 
is much simpler, resulting in reduced manufacturing costs. 
 Cationic iridium(III) complexes of the type [Ir(C^N)2(N^N)]
+
, where C^N is a 
cyclometallating ligand (e.g. 2-phenylpyridine (ppy)) and N^N is an ancillary ligand (e.g. 
2,2'-bipyridine (bpy)), have been extensively used in LEECs due to their excellent properties. 
High quantum yields and stability make them well suited for application in light emitting 
devices. Furthermore, the emission colour can be tuned easily, spanning the whole visible 
region. The frontier orbitals are spatially separated in this type of complex and by careful 
design of the ligands, desired blue- or red-shifts in the emission maximum are possible. 
 In this thesis, the synthesis, characterization and LEEC performance of iridium(III) 
complexes containing sulfur-functionalized ligands are described. Thioether- and sulfone-
based cyclometallating ligands are introduced in Chapter I, resulting in complexes with 
yellow to green emission. In Chapter II, the influence on photophysical, electrochemical and 
device properties of iridium complexes with regioisomeric cyclometallating ligands 
containing a methylsulfonyl group is investigated. Based on the results of the previous 
chapters, the combination of sulfone-substituted cyclometallating ligands with electron-rich 
ancillary ligands to obtain blue emitting complexes is described in Chapter III. Chapter IV 
summarizes a series of iridium complexes with benzothiazole-based ancillary ligands, 
yielding red emitters with exceptionally long LEEC lifetimes. Ongoing work in the field of 
glycosylated iridium complexes is reported in Chapter V. 
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MATERIALS AND METHODS 
 
Starting materials were obtained in reagent grade from Sigma-Aldrich, Alfa Aesar, Acros 
Organics, Fluorochem, Strem, Apollo Scientific, Oxkem or TCI and used as received. For 
boronic acids, the purity was determined by 
1
H NMR spectroscopy. Dry solvents (crown cap 
or AcroSeal®) were purchased from Sigma-Aldrich or Acros Organics and used for reactions 
carried out under inert atmosphere. For all other reactions, solvents used were of reagent 
grade or distilled. HPLC grade solvents were used for analyses. Column chromatography was 
performed using Fluka silica gel 60 (0.040–0.063 mm) or Merck aluminium oxide 90 
standardized. Microwave-assisted syntheses were carried out on a Biotage Initiator 8 reactor. 
 
1
H, 
13
C, 
19
F, 
11
B and 
31
P NMR spectra were measured on Bruker Avance III-250 
(250 MHz), III-400 (400 MHz) or III-500 (500 MHz) spectrometers. 2D experiments (COSY, 
NOESY, HMQC and HMBC) were used for complete assignment and carried out on a Bruker 
Avance III-500 spectrometer. Chemical shifts are referenced to residual solvent peaks with 
δ(TMS) = 0 ppm. Variable temperature experiments were performed by PD Dr. Daniel 
Häußinger and Yann Baumgartner on a Bruker Avance III-600 (600 MHz) spectrometer. 
Electrospray ionization mass spectra were recorded by Dr. Gabriel Schneider, Dr. 
Collin Morris or Frederik Malzner on a Bruker esquire 3000
plus
 spectrometer. LC-ESI mass 
spectra were obtained by Dr. Collin Morris on a combination of Shimadzu (LC) and Bruker 
AmaZon X instruments. MALDI-TOF mass spectrometry was carried out on a Bruker 
Daltonics microflex instrument by Dr. Steffen Müller and Dr. Srboljub Vujović. Elemental 
analysis was performed by Sylvie Mittelheisser on an Elementar Vario Micro Cube 
instrument. High resolution ESI mass spectra were acquired on a Bruker maXis 4G QTOF 
spectrometer by Heinz Nadig. 
FT-IR spectra were recorded on a Perkin Elmer Spectrum Two UATR instrument. 
Absorption spectra were measured on an Agilent 8453 spectrophotometer and solution 
emission spectra on a Shimadzu 5301PC spectrofluorophotometer. Solution and powder 
photoluminescence quantum yields were recorded on a Hamamatsu absolute PL quantum 
yield spectrometer C11347 Quantaurus QY. Emission spectra of powder samples as well as 
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solution and powder excited state lifetime measurements were carried out on a Hamamatsu 
Compact Fluorescence lifetime spectrometer C11367 Quantaurus Tau. 
Electrochemical measurements were performed using cyclic and square wave 
voltammetry on a CH Instruments 900B potentiostat with glassy carbon or platinum working 
and platinum auxiliary electrodes; a silver wire was used as a pseudo-reference electrode. 
Dry, purified CH3CN or CH2Cl2 was used as solvent and 0.1 M TBAPF6 as supporting 
electrolyte. Ferrocene as internal reference was added at the end of each experiment. 
Single crystal structure determination was carried out by Dr. Jennifer Zampese, Dr. 
Markus Neuburger and Dr. Alessandro Prescimone on a Bruker-Nonius KappaAPEX or a 
Bruker APEX-II diffractometer. Data reduction, solution and refinement used the programs 
APEX
1
 and SHELXL97.
2
 Structure analysis was done using Mercury v. 3.6.
3
 
Density functional theory (DFT) calculations were performed by Prof. Dr. Enrique 
Ortí and his team at the University of Valencia with the D.01 revision of the Gaussian 09 
program package
4
 using Becke's three-parameter B3LYP exchange-correlation functional
5,6
 
together with the 6-31G** basis set for C, H, N, S and O
7
 and the “double-ζ” quality 
LANL2DZ basis set for iridium.
8
 The singlet ground state (S0) and lowest-energy triplet state 
(T1) geometries were fully optimized without any symmetry restriction. The T1 geometry was 
calculated at the spin-unrestricted UB3LYP level with a spin multiplicity of three. Emission 
energies were assumed as the vertical difference between the energy minimum of T1 and the 
energy of S0. All calculations were carried out in the presence of acetonitrile solvent, 
considering the self-consistent reaction field theory using the polarized continuum model 
approach.
9–11
 The 15 lowest lying triplets were estimated with time-dependent DFT (TD-
DFT)
12–14
 calculations at the minimum-energy geometry optimized for S0 in the presence of 
acetonitrile. 
Light emitting electrochemical cells were assembled and investigated by Dr. Henk 
Bolink and his team at the University of Valencia as follows: glass substrates with ITO 
contact layers (Naranjo Substrates) were washed and sonicated with soap, deionized water 
and isopropanol. They were further cleaned under a UV-O3 lamp (Jelight 42-220) for 20 min. 
In order to increase the reproducibility and to avoid the formation of pinholes, an 80 nm thick 
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layer of poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS) (CLEVIOS™ 
P VP AI 4083, aqueous dispersion, 1.3–1.7% solid content, Heraeus) was spin-coated on the 
ITO substrates. Iridium complex and 1-butyl-3-methylimidazolium hexfluoridophosphate 
([Bmim][PF6]) (>98.5%, Sigma-Aldrich) were mixed in a 4:1 molar ratio in acetonitrile 
solution (20 mg mL
−1
) and spin-coated onto the PEDOT:PSS layer to form a 100 nm 
transparent film. Thermal vapour deposition of the Al electrode (70 nm) was done using a 
shadow mask under vacuum (<1 × 10
−6
 mbar) with an Edwards Auto500 evaporator 
integrated in the glovebox (<0.1 ppm O2 and H2O, M. Braun). The device performance was 
investigated using pulsed current conditions (average current density 100 A m
−2
, 50% duty 
cycle, 1 kHz, block wave). Current and luminance were measured over time using a True 
Colour Sensor MAZeT (MTCSiCT Sensor) with a Botest OLT OLED Lifetime-Test System. 
Electroluminescence spectra were obtained from an Avantes AvaSpec-2048 Fiber Optic 
spectrometer.
  
 
 
INTRODUCTION 
 
 
 
 
 - 1 -  
 
INTRODUCTION 
 
1. A Story about Light 
2015 was declared the “International Year of Light and Light-Based Technologies” by the 
United Nations to “raise awareness of how optical technologies promote sustainable 
development and provide solutions to worldwide challenges in energy, education, agriculture, 
communications and health”.15 But what is light and why is it so essential and fascinating to 
us? Physically speaking light is an electromagnetic wave of a certain wavelength (λ) and 
frequency (ν). At the same time it consists of particles, called photons (photon = quantum of 
light). This wave–particle duality of light was first described at the beginning of the 20th 
century by Max Planck and Albert Einstein.
16,17
 
 For humans, it is only possible to perceive light with wavelengths between 380 and 
700 nm, thus called visible light (Fig. 1). Adjacent to the visible region lie the ultraviolet (UV, 
below 380 nm) and the infrared (IR, above 700 nm) regions.
17
 The Sun’s spectrum is at its 
most intense in the visible region and tails into the UV and IR range.
18
 Sunlight is the source 
of all life on Earth. Through the mechanism of photosynthesis, plants are capable of using 
light to produce energy-rich carbohydrates from carbon dioxide with oxygen as by-product. 
This carbon dioxide fixation by photosynthesis is basically the storage of solar energy and is 
therefore extremely beneficial for mankind as energy source (e.g. wood and fossil fuels).
15
 
Indeed, animals or humans are not capable to perform photosynthesis but also need sunlight 
irradiation for some vital processes in the body, for example the production of vitamin D by a 
photochemical reaction.
19
 Furthermore, light has a not negligible cultural aspect. For 
thousands of years, mankind was dependent on the daily light–dark cycle: when the sun went 
down, human activity stopped. This is why the development of artificial lighting became so 
crucial to mankind. First, fire was used not only as a light, but also as a heat source. Later, 
candles and simple lamps based on natural resources, such as fish oil and later petroleum, 
appeared. Due to the low energy conversion and poor sustainability, alternatives were needed. 
With the development of the incandescent light bulb by the work of Thomas Edison and 
Joseph Swan in 1879, the rise of electrical light sources began. The tungsten lamp was 
introduced in 1906, followed by the sodium vapour lamp in the 1930s, which is still used 
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today as street lighting in its high pressure form. Fluorescent tubes were developed in the 
1940s, halogen lamps in the 1960s and compact fluorescent lamps in the 1980s. All of these 
light sources are still being applied nowadays.
20,21 
 
 
Fig. 1 The electromagnetic spectrum, highlighting the part visible to humans between 380 and 
700 nm.
22
 
 
The impressive power of electric light sources can be illustrated by the example of the 
“Centennial Bulb”: In 1901, when Thomas Edison was still alive, a hand-blown light bulb 
based on a carbon filament was installed in the Fire Station in Livermore, California (Fig. 2a). 
It has since been shining with only short interruptions for 114 years – corresponding to an 
incredible lifetime of over one million hours – making it the longest lasting light bulb known. 
It is noteworthy to mention that its power has dropped significantly from an initial 60 W to 
today’s 4 W during the 114 years.23 Due to its outstanding stability, the “Centennial Bulb” 
became a problem for the industry at that time. To overcome this problem, the industrial 
leaders of the light industry started with the planned obsolescence of light bulbs in the 
1920s.
24
 Planned obsolescence describes the strategy of companies to design a product with 
limited lifetime in order to increase consumption. The lifetime reduction of light bulbs is one 
of the earliest examples of planned obsolescence. It was carried out by the Phoebus Cartel, an 
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association of the worldwide largest light bulb producers at the time, including for example 
Philips, Osram and General Electric. Before the agreement, light bulbs existed which could 
last around 2500 hours, but the Phoebus Cartel limited the lifetime to 1000 hours. The light 
bulbs of all member companies were regularly tested and in case that they lasted for more 
than 1000 hours, the manufacturing company had to pay a fine (Fig. 2b). This means that 
instead of conducting research focused on making the bulbs more stable and efficient, the goal 
was to create a product that was more fragile and had to be replaced more often than 
necessary.
24
 
 Planned obsolescence is now part of our consumer society; however, it is in no way 
compatible with sustainability. Therefore, it is of great importance that research is focused on 
creating the best, most stable and most efficient products possible. 
 
a) 
 
b) 
 
Fig. 2 a) Photograph of the “Centennial Bulb” at the Livermore Fire Station, 17 th November 
2013.
25
 b) A Philips testing facility used to ensure standardized light bulb lifetimes of 1000 
hours according to the Phoebus Cartel.
24
 Copyright (2014) IEEE. 
 
2. A Short History of Solid State Lighting 
Nowadays, artificial lighting amounts to 14% of the total electricity consumption in the 
European Union and an even higher percentage of 19% worldwide.
26
 In a time of expeditious 
climate change, the reduction of energy consumption accompanied with sustainable, 
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renewable energy sources is of ever growing importance. The potential of artificial lighting as 
an energy saver was therefore noted by the European Union
27
 and many other countries, 
including Switzerland
28
 and Canada.
29
 They have already put a ban on the most inefficient 
incandescent light bulbs. This has paved the way for a shift towards more efficient and thus 
energy-saving lamps, e.g. compact fluorescent lamps (CFLs) or light emitting diodes (LEDs). 
 Since the first reports of red LEDs in 1962,
30,31
 solid state lighting techniques have 
emerged as the promising new class of efficient lighting devices. LEDs consist of inorganic 
semiconductor materials and are now used for traffic lights, Christmas decorations, 
automotive lighting, display backlighting and in home illumination.
31
 In 2014, the Nobel Prize 
in Physics was awarded to Isamu Akasaki, Hiroshi Amano and Shuji Nakamura “for the 
invention of efficient blue light-emitting diodes which has enabled bright and energy-saving 
white light sources”.32–35 This highlights the impact that LEDs have had on mankind since 
their first development. More recently, organic light emitting diodes (OLEDs) and light 
emitting electrochemical cells (LEECs) have attracted attention. The active layer in OLEDs 
and LEECs contains either polymers or small molecules as emissive materials. OLEDs 
already have made it into the market applied in displays of mobile phones, media players, 
digital cameras and televisions, to note just a few examples.
21
 
 
 
Fig. 3 Schematic representation of the principle of electroluminescence.  
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In comparison to traditional light sources, where light is only a by-product of discharging or 
heating processes, the principal output in solid state lighting applications is light itself, posing 
a huge advantage.
21
 In all solid state lighting devices, light is generated by the mechanism of 
electroluminescence, shown schematically in Fig. 3. Upon applying a bias to the device, 
electrons are injected from the cathode into the active layer of the device, while electrons are 
abstracted at the anode (hole injection). In LEDs, electron injection takes place into the 
conduction band of the inorganic semiconductor material and electrons are abstracted from 
the valence band. In both OLEDs and LEECs, electrons are injected into the lowest 
unoccupied molecular orbital (LUMO) of the emissive material and electrons are abstracted 
from the highest occupied molecular orbital (HOMO), creating reduced and oxidized 
molecules within the active layer (Fig. 3). The electrons continue to travel through the device, 
from cathode to anode, until the recombination of an electron-hole pair yields an exciton. This 
excited state can then relax back to the ground state via emission of a photon, as happens for 
photoluminescence.
36–38
 
 
 
Fig. 4 Schematic representation of a multilayer OLED architecture.  
 
The emissive material in an OLED consists either of a polymer, a fluorescent organic 
molecule or a phosphorescent transition metal complex. To avoid quenching effects, 
recombination should take place in the middle of the device. Therefore, multiple layers are 
required between the electrodes and the active layer to get a balanced charge injection. These 
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additional layers include finely tuned electron and hole injection and transport layers based on 
organic materials. Indium tin oxide (ITO) is widely used as transparent anode material and the 
cathode consists of air-sensitive, low work-function metals (e.g. Ca, Ba). The schematic 
device structure of a typical multilayer OLED is shown in Fig. 4. As a result of their complex 
architecture, the assembly of OLEDs involves many different steps. Layer after layer has to 
be vacuum-deposited, requiring materials that are stable under these conditions. In addition, 
the final device needs to be rigorously encapsulated, resulting in a costly manufacturing 
process.
21,36,37 
 
3. Light-Emitting Electrochemical Cells – the Future? 
1995 marked the birth year of a new type of solid state lighting device, the light-emitting 
electrochemical cell (LEEC). While OLEDs typically contain uncharged emitters, LEECs are 
built up of ionic species. The first reported LEEC consisted of a fluorescent polymer as the 
emissive material, mixed with a conductive polymer to improve the ionic mobility and lithium 
trifluoromethanesulfonate as the ion source.
39
 By choosing the appropriate emissive polymer, 
orange, green and blue LEECs were prepared. 
 One year later, the first LEECs based on ionic transition metal complexes (iTMCs) 
were described by Maness et al.
40
 and Lee et al.
41
 In both cases, the emissive material was a 
charged ruthenium(II) complex (compounds A and B in Scheme 1), resulting in orange-red 
electroluminescence. The first iTMC-LEECs were mostly based on ruthenium
42–48
 with some 
examples of osmium complexes.
49,50
 This changed completely with the introduction of an 
ionic biscyclometallated iridium(III) complex as the emissive material in a yellow LEEC in 
2004 (compound C in Scheme 1).
51
 Since then, the number of iridium emitters has 
continuously risen, replacing ruthenium complexes as the most used active materials. 
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A  
B 
 
C 
Scheme 1 Structures of the first iTMCs used in LEECs (ruthenium complexes A and B) and 
structure of the first charged iridium complex (C) used as emissive material.
 
 
The typical architecture of an iTMC-LEEC is shown in Fig. 5. ITO is commonly used as 
transparent anode material on a glass substrate. The anode is covered with a hole injection 
layer consisting of poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) in 
order to smoothen the ITO surface, therefore enhancing the reproducibility of device 
preparation. A layer of the emissive material (e.g. an ionic biscyclometallated iridium 
complex), often diluted with ionic liquid, is spin-coated onto the polymer layer. Finally, the 
metal cathode (usually Au, Ag or Al) is thermally evaporated onto the active layer, yielding 
the finished device.
21
 
Due to the presence of ionic species in the device, the working principle of a LEEC is 
different to that of an OLED. When a bias is applied to the device, the ions start to migrate to 
either the anode or cathode, leading to the build-up of electric double layers at the electrodes. 
The separation of cations and anions results in a facilitated charge injection from the 
electrodes. Two models exist to describe the operation mechanism of a LEEC, the 
electrodynamical (ED) and the electrochemical doping (ECD) model. Until now, it was not 
possible to exclude the occurrence of either one of these models. The ED model suggests that 
a large potential drop takes place at the electrodes, due to the formation of electric double 
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layers, but in the bulk material, the ions are not separated and emission occurs from there. In 
the ECD model, it is assumed that rearrangement of the ions leads to p- and n-doped regions 
(p = positive, n = negative) at the anode and cathode, respectively. These doped regions widen 
over time, giving rise to a p–i–n junction (i = intrinsic, undoped). Light emission is believed 
to take place in the undoped region in the middle of the device, where a continuous potential 
drop occurs.
21,52
 
 
 
Fig. 5 Schematic representation of the typical architecture of an iTMC-LEEC. The active layer 
contains an emissive iridium complex mixed with ionic liquid, sandwiched between an ITO 
anode coated with PEDOT:PSS and an aluminium cathode. 
 
As a result of their distinctive working mechanism based on the mobility of ionic species 
within the device, LEECs have several advantages with respect to OLEDs. Operation is 
independent of the thickness of the active layer and the work function of the electrodes; 
therefore, air-stable metals can be used as cathode material. There is also no need for a multi-
layer structure, making solution processing possible. Rigorous encapsulation of the final 
device is not necessary either. All of these benefits lead to simple and cost-efficient device 
preparation.
21,52
 
 There are, however, still some intrinsic issues of LEECs which have to be addressed 
before commercialization becomes possible. Turn-on times (ton, Fig. 6), defined as the time 
until reaching maximum luminance, are typically long and can range from a few seconds to 
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hundreds of hours. This feature is related to the ion separation taking place upon biasing the 
device, until charge injection starts. In contrast to OLEDs, which may be stable over 
thousands of hours, the lifetimes of LEECs are generally much shorter, ranging from a few 
minutes to several days.
21
 The lifetime (t1/2, Fig. 6) of a device is defined as the time to reach 
half of the maximum luminance. The poor stability of most LEECs is explained by both 
chemical degradation of the emissive material and the increase of the doped zones with time, 
leading to luminescence quenching effects. A correlation between turn-on time and lifetime is 
often observed for LEECs and can be traced back to the operation mechanism (formation of 
electric double layers and subsequent growth of the p- and n-doped regions).
21
 Therefore, 
many of the improvements carried out in order to reduce the turn-on time generally lead to a 
decreased lifetime and vice versa.
 
 In addition to turn-on time (ton) and lifetime (t1/2), there are several other important 
parameters used to determine the performance of a LEEC.
21
 The luminance (black solid line 
in Fig. 6) is defined as the flux of light emitted by the device, measured in candela per surface 
unit (cd m
−2
). In general, the maximum luminance (Lummax) level reached is described for a 
LEEC. The current density corresponds to the flux of current through the device, determined 
in ampere per surface unit (A m
−2
). The efficacy or current efficiency is the emitted light per 
electric flux, given in candela per ampere (cd A
−1
). The flux of light per electric power input 
defines the power efficiency or power conversion efficiency (PCE), measured in lumen per 
watt (lm W
−1
). The external quantum efficiency (EQE) is determined by the ratio of photons 
released from the device per electrons injected and given as percentage. For all efficiency 
measures, the maximum reached by the device is reported. Fig. 6 shows the typical evolution 
of luminance (black solid line) and average voltage (open red squares) over time of a LEEC 
driven under pulsed current conditions. When the average current density is kept constant, an 
initial high voltage is necessary, which quickly drops when the injection barriers are reduced 
due to rearrangement of the ionic species and then remains basically constant over time. The 
luminance shows a fast increase at the start until the maximum is reached (turn-on time), then 
slowly decreases due to quenching effects and chemical degradation.
21
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Fig. 6 Typical performance of a LEEC operated under pulsed driving conditions: Luminance 
(black solid line) and average voltage (open red squares) plotted against time. ton = turn-on time, 
t1/2 = lifetime, Lummax = maximum luminance. 
 
Chemical modifications employed to improve LEEC performance will be discussed in the 
following section, together with the properties of iridium-based emitters. An enhancement of 
the device performance can also be achieved by physical measures. For ruthenium-based 
LEECs, the beneficial effect of a high initial voltage
45
 as well as a pulsed driving method
46
 
was reported. Combining these approaches and applying them to LEECs containing iridium 
complexes resulted in both drastically reduced turn-on times and increased stability.
53
 Until 
the introduction of pulsed driving conditions at a constant current density, LEECs were run at 
a constant voltage. Another means of improving turn-on time, luminance and efficiency is the 
addition of ionic liquid, usually 3-butyl-1-methylimidazolium hexafluoridophosphate 
([Bmim][PF6]) to the active layer. The dilution of an emitter with ionic liquid leads to reduced 
intermolecular interactions and thus less self-quenching, thereby enhancing luminance and 
efficiency of a device. The turn-on time is reduced as a consequence of the increased number 
of small ionic species present.
21
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4. Why Iridium? 
While mostly ruthenium(II) and a few osmium(II) complexes have been the used materials in 
the early days of iTMC-LEECs, biscyclometallated iridium(III) complexes have become 
popular choices. Few reports exist on LEECs using complexes based on other metal centres, 
such as rhenium(I),
54
 silver(I)
55
 and copper(I).
56–61
 Recently, there have been two examples of 
charged organic small molecules used as fluorescent emitters in LEECs.
62,63
 
 Considering the price and scarcity of iridium, why are iridium-based complexes so 
extensively used as emissive material in both OLEDs and LEECs? Cyclometallated iridium 
compounds have excellent properties, well suited for the use in light emitting devices, such as 
high stability, high quantum yields and easy emission colour tunability. With this class of 
complexes, it is possible to obtain luminescence colours from blue to red, spanning the whole 
visible region.
21,64–67
 
 
a) 
 
b) 
 
Fig. 7 Energy diagrams of iridium(III) complexes. a) Metal-centred (MC), ligand-centred (LC), 
metal-to-ligand charge transfer (MLCT) and ligand-to-ligand charge transfer (LLCT) 
transitions. Adapted with permission from Angew. Chem. Int. Ed., 2012, 51, 8178–8211.21 
Copyright (2012) Wiley-VCH. b) Absorption, luminescence and non-radiative relaxation 
mechanisms (dashed lines) occurring in iridium complexes. GS = ground state. Adapted with 
permission from Top. Curr. Chem., 2007, 281, 143–203.68 Copyright (2007) Springer. 
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Iridium(III) is a 5d
6
 metal centre and in cyclometallated complexes of the type 
[Ir(C^N)2(N^N)]
+
 (C^N = cyclometallating ligand, e.g. the conjugate base of 2-
phenylpyridine (Hppy), N^N = ancillary ligand, e.g. 2,2'-bipyridine (bpy)) the electron 
configuration is always low-spin, resulting in three filled t2g and two empty eg orbitals. Due to 
the strong ligand field splitting, the metal-centred (MC) states are high in energy, reducing the 
probability of degradation or non-radiative relaxation from these states (Fig. 7b).
21,68
 Photon 
absorption leads to the electronic transitions shown in Fig. 7; these include mainly ligand-
centred (LC), metal-to-ligand charge transfer (MLCT) and ligand-to-ligand charge transfer 
(LLCT) transitions.
21
 As a result of the high spin-orbit coupling constant of iridium (ζ = 
3909 cm
−1
), direct excitation to the triplet excited states becomes possible, in addition to fast 
intersystem crossing (ISC) from the excited singlet to triplet states.
21,68
 Emission takes place 
from a mixed triplet state of 
3
LC, 
3
MLCT and 
3
LLCT transitions (Fig. 7). The extent of 
contribution from each of these states on the emission depends on the ligands in any 
individual iridium complex.
21 
 
 
 
HOMO 
 
LUMO 
Fig. 8 a) Structure of the archetypal iridium complex [Ir(ppy)2(bpy)]
+
, indicating the typical 
position of the frontier orbitals. b) Electron density contours showing the location of the HOMO 
and LUMO in [Ir(ppy)2(bpy)]
+
. Adapted with permission from Angew. Chem. Int. Ed., 2012, 51, 
8178–8211.21 Copyright (2012) Wiley-VCH.  
 
Typically, the frontier orbitals are spatially separated in [Ir(C^N)2(N^N)]
+
 complexes. The 
HOMO (red) usually resides on the iridium centre and the phenyl rings of the 
a) b) 
INTRODUCTION 
 
 
 
 
 - 13 -  
 
cyclometallating ligands, whereas the LUMO (blue) is located on the ancillary ligand (shown 
in Fig. 8a for the simple complex [Ir(ppy)2(bpy)]
+
).
21,64,66,68
 This is supported by density 
functional theory (DFT) calculations (see Fig. 8b) and corroborated by electrochemical 
measurements.
21,64
 Because of the separation of the frontier orbitals, iridium complexes are 
such versatile materials in terms of emission colour tuning. Blue-shifts in the emission colour 
are possible by attaching electron-withdrawing groups (EWG) on the cyclometallating ligands 
and electron-donating groups (EDG) on the ancillary ligand. This leads to an enhanced 
HOMO-LUMO energy gap by stabilization of the HOMO and destabilization of the LUMO. 
Another possibility is the replacement of the standard 2,2'-bipyridine (bpy) ancillary ligand by 
more electron-rich ligands, for example 2-(1H-pyrazol-1-yl)pyridine (pzpy). Strong-field 
ancillary ligands such as CO, isocyanides or carbenes are also effective in shifting the 
emission towards the blue. Emission red-shifts can be achieved by using electron-releasing 
cyclometallating and electron-deficient ancillary ligands. Due to a destabilization of the 
HOMO and stabilization of the LUMO, the energy gap is reduced, resulting in a red-shifted 
emission. Another strategy is an increased delocalization of the π-system, using for example 
quinoline- or isoquinoline-based ligands, also leading to a red-shift in the emission 
maximum.
21,66
 
 
 
D 
 
E 
 
F 
 
G 
Scheme 2 Structure of iridium complexes designed to enhance LEEC performance: charged 
substituents (compound D), bulky groups (compound E) and one to three π-stacking interactions 
(compounds F and G, respectively). π-stacking occurs between rings of the same colour.
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Not only can iridium complexes be chemically modified to tune the emission colour, but also 
to improve LEEC performance. The turn-on time of a device is reduced by changing the 
widely used [PF6]
–
 anion to a smaller counterion, for example [BF4]
–
 or [ClO4]
–
. However, 
this usually results also in a reduced lifetime of the device.
21
 The addition of extra charge on 
the emissive compound has the same effect, as shown by Zysman-Colman et al.
69
 for the 
introduction of triethylammonium hexafluoridophosphate substituents on the ancillary ligand 
(compound D, Scheme 2). It is possible to enhance the stability of LEECs by designing robust 
and hydrophobic iridium complexes. For that, bulky substituents such as tert-butyl groups can 
be introduced to the ligands (compound E, Scheme 2). This approach does not only exert a 
positive effect on the lifetime, but also the efficiency of a device by reducing the 
intermolecular interactions, resulting in less luminescence quenching.
21,66
 Another strategy to 
increase the stability of a LEEC is the design of intramolecular π-stacking interactions, 
leading to robust iridium complexes and diminishing the probability of chemical degradation 
in the device. This was first demonstrated by adding a pendant phenyl ring to the bpy 
ancillary ligand which enables π-stacking with the phenyl ring of one of the cyclometallating 
ligands (compound F, Scheme 2).
70–72
 The concept has since been extended to multiple 
intramolecular π-stacking interactions by careful design of the cyclometallating and ancillary 
ligands, leading to complexes with up to three of such π-π interactions (compound G, Scheme 
2).
73,74
 Interestingly, increasing the number of intramolecular interactions does not further 
enhance the LEEC lifetime. 
 While great progress has been made in the field of iTMC-LEECs since their first 
report in 2004, some issues still need to be resolved. Up to today, there is a lack of stable blue 
and green LEECs. In addition, there are no reports of efficient and stable red emitters for 
LEECs.
21,66
 These drawbacks greatly limit practical application, as devices of all colours are 
required; e.g. for display applications, as well as for the development of white LEECs, which 
are commonly based on a mixture of active materials with different emission colours.
75–77
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CHAPTER I: YELLOW & GREEN EMITTERS – THIOETHER- AND 
SULFONE-SUBSTITUTED CYCLOMETALLATING LIGANDS 
 
1. Introduction 
Fluoro-substituted cyclometallating ligands have been extensively used in iridium complexes 
of the type [Ir(C^N)2(N^N)]
+
 in order to tune the emission colour to the blue region.
78–80
 
Introduction of electron-withdrawing fluorine substituents leads to a stabilization of the 
HOMO in [Ir(C^N)2(N^N)]
+
 complexes, which is located on the C^N ligands and the iridium 
metal centre. However, it has been shown that increasing the number of fluorine atoms leads 
to a decrease in device stability in both OLEDs
81
 and LEECs.
82
 The cause of this effect is 
assumed to be a hydrodehalogenation reaction occurring on the iridium complexes when 
operated in a device.
81
 As a result, the design of fluorine-free blue emitting iridium complexes 
has become a challenging goal in recent years. Considering the Hammett parameters (σm = 
0.60 and σp = 0.72 for SO2Me; σm = 0.34 and σp = 0.06 for F
83,84
), sulfonyl moieties appear to 
be an interesting choice for the design of green and blue emitting iridium complexes: the 
higher the Hammett parameter, the larger the electron-withdrawing effect. Few examples of 
sulfone-substituted cyclometallating ligands in iridium complexes exist; most of them are 
used in neutral emitters, suited for OLEDs. These include 3-(pyridin-2-
yl)dibenzo[b,d]thiophene 5,5-dioxide (H),
85
 2-(4-(phenylsulfonyl)phenyl)pyridine (I),
86–88
 
fluorinated 2-(4-(phenylsulfonyl)phenyl)pyridine (J),
89
 regioisomeric benzylsulfonyl-
substituted 2-phenylpyridine and fluorinated 2-(4-(benzylsulfonyl)phenyl)pyridine (K),
90
 2-
(2,4-difluoro-3-tosylphenyl)pyridine (L)
91
 and sulfonyl-functionalized 2-(4-
methoxyphenyl)pyridine (M)
92
 cyclometallating ligands (Scheme 3). 
 Our group has recently reported the use of 1-(4-(methylsulfonyl)phenyl)-1H-pyrazole 
(compound N in Scheme 3) as a cyclometallating ligand in iridium complexes for highly 
efficient green light emitting electrochemical cells.
93
 Due to the promising device 
performances, the investigation of  iridium complexes with sulfone-substituted 
phenylpyridines was started.
94
 In this chapter, the synthesis and characterization of a series of 
sulfone- and thioether-substituted iridium complexes is presented. The influence of the 
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sulfone and thioether groups is investigated with respect to the reference compound 
containing 2-(4-fluorophenyl)pyridine as cyclometallating ligands. By comparing pairs of 
thioether and sulfonyl-substituted complexes, it is possible to study the influence of the sulfur 
oxidation state on photophysical and electrochemical properties. Furthermore, different alkyl 
groups bound to the sulfur atom were examined: from simple methyl to bulky tert-butyl and 
long-chain dodecyl substituents. Judging by their photophysical properties, the most 
promising candidates have been tested in LEECs.
95
 
 
   
 
 
 
 
H I J K L M N 
Scheme 3 Structures of sulfonyl-substituted cyclometallating ligands used in the literature for 
iridium complexes.
 
 
2. Synthesis and NMR Spectroscopic Characterization 
2.1. Ligand synthesis 
The synthetic route to ligands H1–H7 is summarized in Scheme 4. Fluoro ligand H1 was 
synthesized by a room temperature Suzuki coupling of 4-fluorophenylboronic acid and 2-
bromopyridine in EtOH/H2O with PdCl2 as catalyst.
96
 H1 acts as a precursor for thioether 
compounds H2, H4 and H6, which were formed via a nucleophilic substitution reaction with 
the appropriate thiolate. In the case of H2, commercially available NaSMe was reacted with 
H1 in N-methyl-2-pyrrolidone (NMP) under microwave conditions, leading to a superior yield 
of 93% with respect to the Ullmann coupling reported in the literature.
97
 For H4 and H6, a 
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literature procedure was adapted:
98
 The corresponding thiol (2-methyl-2-propanethiol and 1-
dodecanethiol, respectively) was deprotonated in situ with sodium hydride before the fluoro 
precursor was added. Compounds H4 and H6 were obtained in quantitative and good yield, 
respectively. The desired sulfone ligands H3, H5 and H7 were prepared in excellent yields 
from the corresponding thioether compounds, using H2O2/Na2WO4·2H2O as oxidizing 
agent.
99
 
Previous to the synthesis of mono-sulfone cyclometallating ligands, the preparation of 
bis-sulfonyl phenylpyridines was investigated. Several conditions and reagents (H2O2, 
MCPBA, KMnO4, oxone, NaIO4, H2O2/(NH4)6Mo7O24·4H2O) were tested for the oxidation of 
2-(2,4-bis(methylthio)phenyl)pyridine to the bis-sulfone compound. The combination of 
H2O2/Na2WO4·2H2O in MeOH at room temperature proved to be the most effective and 
selective: the least side products (mixed sulfone-sulfoxide or pyridine N-oxide) were observed 
with this method. Therefore, this synthetic protocol was adapted for the oxidation of the 
mono-sulfone ligands. 
 
 
Scheme 4 Synthetic route to ligands H1 and H3–H7. Reaction conditions: a) PdCl2, K2CO3, 
EtOH/H2O 1:1, room temperature, 3 d; b) for H2: NaSMe, NMP, MW, 80 °C, 1 h; for H4 and 
H6: 2-methyl-2-propanethiol or 1-dodecanethiol, NaH (60%), DMF, 120 °C, 24 or 4 h, N2; c) 
Na2WO4·2H2O, H2O2, MeOH, room temperature, overnight.
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Compounds H2–H7 were characterized by NMR and IR spectroscopies, mass spectrometry, 
elemental analysis and melting point analysis. 
1
H and 
13
C{
1
H} NMR signals were fully 
assigned using 2D methods (COSY, HMQC, HMBC). For each of H2–H5 and H7, the base 
peak in the ESI mass spectrum corresponds to the [M+H]
+
 ion. No ESI peak was observed in 
the case of H6, however, [M]
+
 could be detected at m/z 355.7 in the MALDI-TOF mass 
spectrum. 
 
2.2. Synthesis of [Ir(C^N)2Cl]2 dimers 
Chlorido-bridged dimers of the type [Ir(C^N)2Cl]2 are typically synthesized from iridium 
trichloride and the corresponding cyclometallating ligand under reflux conditions in a mixture 
of 2-ethoxyethanol and water.
100,101
 This method was used in the case of ligands H1, H5 and 
H7 to obtain the iridium dimers in moderate to good yields (Scheme 5). For the preparation of 
[Ir(C^N)2Cl]2 dimers with C^N = 3 and 4, however, the standard procedure did not prove 
successful as no product could be isolated. Reaction of H3 and H4 with [Ir(cod)Cl]2 in 2-
ethoxyethanol
102
 either under reflux or microwave conditions as an alternative route finally 
gave the desired iridium dimers. Compounds [Ir(C^N)2Cl]2 with C^N = 3–5 and 7 were 
characterized by NMR spectroscopic methods and LC-ESI or MALDI-TOF mass 
spectrometry. Proton and 
13
C NMR signals were fully assigned with the support of 2D 
experiments (COSY, HMQC, HMBC), except for [Ir(4)2Cl]2, where low solubility prevented 
the recording of a sufficiently resolved 
13
C{
1
H} NMR spectrum. For [Ir(C^N)2Cl]2 (C^N = 3–
5), observed peaks in the LC-ESI mass spectra correspond to [Ir(C^N)2]
+
, 
[Ir(C^N)2(CH3CN)]
+
 and [Ir(C^N)2(CH3CN)2]
+
. The coordinating CH3CN arises from the 
eluent of the LC column. [Ir(7)2Cl]2 did not give any peaks in the LC-ESI mass spectrum, 
however, the base peak in the MALDI-TOF mass spectrum is attributed to [Ir(7)2]
+
. 
 Complexation reactions with H2 under different conditions did not yield the desired 
iridium dimer. A yellow insoluble solid was obtained which could not be characterized and 
gave only trace amounts of [Ir(2)2(bpy)]
+
 when treated with 2,2'-bipyridine under standard 
conditions. Treatment of [Ir(cod)Cl]2 with H6 to give [Ir(6)2Cl]2 was not successful either, 
only unreacted ligand could be isolated after the reaction. 
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Scheme 5 Synthetic pathway to [Ir(C^N)2Cl]2 dimers with C^N = 1, 3–5 and 7. Reaction 
conditions: a) IrCl3·xH2O, 2-ethoxyethanol/H2O 3:1, reflux, overnight, N2; b) [Ir(cod)Cl]2, 2-
ethoxyethanol, reflux, overnight, Ar (for H3) or MW, 110 °C, 1.5 h, N2 (for H4).
 
 
2.3. Synthesis of [Ir(C^N)2(bpy)][PF6] complexes 
To obtain the desired [Ir(C^N)2(bpy)][PF6] complexes, dimers [Ir(C^N)2Cl]2 with C^N = 1, 
3–5 and 7 were treated with bpy according to standard literature procedures (Scheme 
6).
93,103,104
 The reactions proceeded smoothly in MeOH under reflux or microwave conditions, 
followed by anion exchange with an excess of solid NH4PF6. The complexes were obtained as 
yellow to dark yellow solids in moderate to good yields. 
Since the iridium dimer [Ir(6)2Cl]2 could not be synthesized, an alternative route to 
[Ir(6)2(bpy)][PF6] was developed. 1-Dodecanethiol was deprotonated with sodium hydride in 
DMF to produce the thiolate nucleophile which was subsequently reacted with fluoro-
subtituted complex [Ir(1)2(bpy)][PF6] in a nucleophilic aromatic substitution reaction, leading 
to the desired complex in good yield (Scheme 6). The base peak in the ESI mass spectrum of 
each complex corresponds to the [M–PF6]
+
 ion, exhibiting the typical iridium isotope pattern. 
1
H and 
13
C{
1
H} signals were assigned for all complexes using 2D NMR spectroscopic 
measurements (COSY, HMQC, HMBC). 
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Scheme 6 Synthetic route to complexes [Ir(C^N)2(bpy)][PF6] with C^N = 1, 3–7. Structures 
include numbering scheme used for NMR assignment. Reaction conditions: a) 2,2'-bipyridine, 
MeOH, MW, 120 °C, 1 h (for C^N = 3) or reflux, overnight (for C^N = 1, 4, 5 and 7); then 
NH4PF6; b) 1-dodecanethiol, NaH (60%), DMF, 120 °C, 1.5 h, N2.
 
 
The aromatic region of the 
1
H NMR spectra of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 
1, 3–7 is shown in Fig. 9 (numbering according to Scheme 6). Proton HA6 shows a range of 
chemical shift from δ 5.89 to 6.70 ppm and is affected the most by changing the substituent 
on the cyclometallating ligand. The second-largest chemical shift differences are seen for H
A4
 
(ranges from δ 6.81 to 7.58 ppm) and to a lesser extent for HA3 and the B ring protons. 
Negligible shifts are observed for protons on the bpy ancillary ligand (E ring). In 
[Ir(1)2(bpy)][PF6], protons H
A4
 (δ 6.81 ppm) and HA6 (δ 5.89 ppm) are observed at the lowest 
frequency within this series. Comparing the thioether and sulfone complexes, all A ring 
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protons are shifted downfield on going from the thioether to the sulfone compounds. These 
shifts are attributed to the de-shielding effect of the electron-withdrawing sulfone group. 
Chemical shifts of protons H
tBu
 move from δ 1.00 ppm in the thioether complex 
[Ir(4)2(bpy)][PF6] to δ 0.93 ppm in the sulfone complex [Ir(5)2(bpy)][PF6]. CH2 protons of the 
dodecyl chains next to the thioether and sulfone moieties are shifted downfield on going from 
[Ir(6)2(bpy)][PF6] (δ 2.63 ppm) to [Ir(7)2(bpy)][PF6] (δ 2.87 ppm). 
 
 
Fig. 9 Aromatic region of the 500 MHz 
1
H NMR spectra of [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–
7) in CD3CN solution with assignments. Scale: δ/ppm. 
 
3. Crystal Structures 
X-ray quality single crystals of H3 and H5 were grown by overlaying CHCl3 or CH2Cl2 
solutions of the compounds, respectively, with n-hexane. Structures of both ligands are shown 
in Fig. 10, with selected bond lengths and angles given in the figure caption. Both H3 and H5 
crystallize in the monoclinic space group C2/c. As observed in several aryl-aryl
105,106
 and 
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aryl-alkyl sulfones,
105
 the sulfone group is twisted with respect to the attached aromatic ring, 
leading to intramolecular CH···OS contacts. The dihedral angles O1–S1–C9–C10 and O2–
S1–C9–C8 in H3 are −25.0 and 28.2°, respectively, resulting in intramolecular interactions 
with distances of 2.60 (O1···H10A) and 2.64 Å (O2···H8A). In H5, the corresponding angles 
are −23.1 (O1–S1–C9–C8) and 24.6° (O2–S1–C9–C10), giving short intramolecular CH···OS 
contacts of 2.57 (O1···H8A) and 2.64 Å (O2···H10A). The phenyl and pyridine rings are 
twisted with respect to each other in both structures, with angles between the ring planes of 
17.7° in H3 and 37.7° in H5. 
 
a) b) 
 
 
Fig. 10 Structures of ligands a) H3 and b) H5, H atoms omitted and ellipsoids plotted at 40% 
probability level. Selected bond parameters: a) S1–O1 = 1.4434(10), S1–O2 = 1.4411(9), S1–C9 
= 1.7575(11), S1–C12 = 1.7569(14) Å; O1–S1–O2 = 118.19(6), O1–S1–C9 = 108.45(6), O1–
S1–C12 = 108.11(6), O2–S1–C9 = 109.20(6), O2–S1–C12 = 108.03(7), C9–S1–C12 = 
103.93(6)°; b) S1–O1 = 1.4402(12), S1–O2 = 1.4378(12), S1–C9 = 1.7727(15), S1–C12 = 
1.8190(16) Å; O1–S1–O2 = 118.85(8), O1–S1–C9 = 107.03(7), O1–S1–C12 = 107.50(8), O2–
S1–C9 = 107.48(7), O2–S1–C12 = 108.05(8), C9–S1–C12 = 107.46(7)°. 
 
Single crystals of [Ir(3)2Cl]2·2CH2Cl2 were grown from a CH2Cl2 solution of the iridium 
dimer overlaid with Et2O. The structure is shown in Fig. 11 with important bond lengths and 
angles stated in the figure caption. The compound crystallizes in the orthorhombic space 
group Pbca and the asymmetric unit contains the Λ,Λ-enantiomer; both Λ,Λ- and Δ,Δ-
enantiomers are present in the lattice. One CH2Cl2 solvent molecule is disordered and has 
been modelled over two positions with fractional occupancies of 0.62 and 0.38. Two of the 
sulfone groups are again twisted with respect to the phenyl rings with dihedral angles O2–S2–
C9–C10 = −20.5, O1–S2–C9–C8 = 30.9, O6–S3–C33–C34 = −17.4 and O5–S3–C33–C32 = 
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31.4°. These torsions give rise to short CH···OS contacts ranging from 2.56 to 2.66 Å. In the 
remaining two sulfone groups, torsion angles are −1.3 (O8–S4–C45–C44) and −53.8 (O7–S4–
C45–C46) and −3.3 (O4–S1–C21–C20) and −58.1° (O3–S1–C21–C22). This leads to two 
shorter (2.47 and 2.49 Å) and two longer (2.96 and 2.99 Å) CH···OS interactions. 
 
 
Fig. 11 Structure of [Ir(3)2Cl]2 in [Ir(3)2Cl]2·2CH2Cl2; H atoms and solvent molecules omitted 
and ellipsoids plotted at 40% probability level. Selected bond parameters: Ir1–Cl1 = 2.486(2), 
Ir1–Cl2 = 2.512(2), Ir1–N1 = 2.050(7), Ir1–N2 = 2.057(7), Ir1–C7 = 1.988(8), Ir1–C19 = 
1.984(8), S1–O3 = 1.404(9), S1–O4 = 1.441(8), S2–O1 = 1.422(8), S2–O2 = 1.439(7), Ir2–Cl1 
= 2.504(2), Ir2–Cl2 = 2.503(2), Ir2–N3 = 2.053(7), Ir2–N4 = 2.043(7), Ir2–C31 = 2.015(9), Ir2–
C43 = 1.995(8), S3–O5 = 1.427(8), S3–O6 = 1.423(8), S4–O7 = 1.435(9), S4–O8 = 1.443(8) Å; 
N1–Ir1–C19 = 80.2(3), N2–Ir1–C7 = 80.9(3), Cl1–Ir1–Cl2 = 84.46(7), O1–S2–O2 = 117.0(5), 
O3–S1–O4 = 117.5(5), N3–Ir2–C31 = 80.7(3), N4–Ir2–C43 = 80.4(3), Cl1–Ir2–Cl2 = 84.30(6), 
O5–S3–O6 = 119.7(5), O7–S4–O8 = 117.1(6)°. 
 
Crystals of [Ir(1)2(bpy)][PF6] were grown from CH3CN or CH2Cl2 solutions of the complex 
layered with Et2O and resulted in the resolution of two different structures, namely Δ-
[Ir(1)2(bpy)][PF6] (Fig. 12) and rac-4{[Ir(1)2(bpy)][PF6]}·Et2O·2CH2Cl2 (Fig. 13a). Important 
bond lengths and angles are similar in both structures and are given in the figure captions. 
Enantiomerically pure Δ-[Ir(1)2(bpy)][PF6] crystallizes in the trigonal space group P3121. In 
rac-4{[Ir(1)2(bpy)][PF6]}·Et2O·2CH2Cl2, two independent cations (Δ- and Λ-enantiomer) are 
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present in the asymmetric unit and the compound crystallizes in the triclinic space group P−1. 
The Et2O solvent molecule in the asymmetric unit is half occupancy and the CH2Cl2 molecule 
is ordered. π-stacking interactions are observed between the two independent cations in the 
asymmetric unit and are displayed in Fig. 13b. Face-to-face π-stacking occurs between the 
bpy pyridyl ring containing N1B and the cyclometallating phenyl ring containing C28A with 
a distance of 4.24 Å between the two centroids and an angle of 12.4° between the ring planes. 
In addition, CH···π contacts are observed between proton H3BA and the phenyl ring 
containing C17A (H···centroid distance = 2.59 Å) and between H31A and the pyridyl ring 
with N4B (3.03 Å). No π-stacking is observed in Δ-[Ir(1)2(bpy)][PF6], where dominant 
packing motifs are CH···F interactions between aromatic protons and F from both [PF6]
−
 
anions and cyclometallating ligands. 
 
 
Fig. 12 Structure of the Δ-[Ir(1)2(bpy)]
+
 cation of Δ-[Ir(1)2(bpy)][PF6]; H atoms omitted for 
clarity and ellipsoids plotted at 40% probability level. Selected bond parameters: Ir1–N1 = 
2.130(3), Ir1–N2 = 2.141(3), Ir1–N3 = 2.048(3), Ir1–N4 = 2.054(3), Ir1–C17 = 2.008(4), Ir1–
C28 = 2.008(4), F1–C19 = 1.374(5), F2–C30 = 1.370(5) Å; N1–Ir1–N2 = 76.95(12), N3–Ir1–
C17 = 80.17(14), N4–Ir1–C28 = 80.77(14), N1–Ir1–C17 = 170.94(13), N2–Ir1–C28 = 
172.58(13), N3–Ir1–N4 = 172.38(12)°. 
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a) b) 
  
Fig. 13 Structures of the two independent Δ- and Λ-[Ir(1)2(bpy)]
+
 cations in rac-
4{[Ir(1)2(bpy)][PF6]}·Et2O·2CH2Cl2. a) H atoms and solvent molecules omitted and ellipsoids 
plotted at 40% probability level. Selected bond parameters: Ir1A–N1A = 2.136(4), Ir1A–N2A = 
2.136(4), Ir1A–N3A = 2.050(4), Ir1A–N4A = 2.058(4), Ir1A–C17A = 2.007(5), Ir1A–C28A = 
2.013(5), F1A–C19A = 1.356(8), F2A–C30A = 1.360(8), Ir1B–N1B = 2.144(4), Ir1B–N2B = 
2.141(5), Ir1B–N3B = 2.044(4), Ir1B–N4B = 2.050(4), Ir1B–C17B = 2.011(5), Ir1B–C28B = 
2.009(5), F1B–C19B = 1.367(7), F2B–C30B = 1.364(7) Å; N1A–Ir1A–N2A = 76.45(16), N3A–
Ir1A–C17A = 80.2(2), N4A–Ir1A–C28A = 80.8(2), N1A–Ir1A–C17A = 173.29(17), N2A–
Ir1A–C28A = 175.01(18), N3A–Ir1A–N4A = 173.46(18), N1B–Ir1B–N2B = 76.88(19), N3B–
Ir1B–C17B = 80.0(2), N4B–Ir1B–C28B = 80.4(2), N1B–Ir1B–C17B = 175.15(17), N2B–Ir1B–
C28B = 173.20(18), N3B–Ir1B–N4B = 173.52(16)°. b) Space-fill model showing the face-to-
face and edge-to-face π-stacking interactions between the two independent cations.  
 
4. Photophysical Properties 
UV-Vis absorption spectra are similar for complexes [Ir(C^N)2(bpy)][PF6] with C^N = 1, 3–5 
and 7 and are pictured in Fig. 14. [Ir(6)2(bpy)][PF6] (brown line) exhibits a slightly different 
absorption spectrum with a less intense maximum in the UV region and more intense 
absorption bands above 320 nm compared to the other complexes in this series. Ligand-
centred, spin-allowed π*←π transitions lead to the intense absorption maxima observed in the 
UV region, around 250–265 nm. Less intense absorption bands between 350 and 450 nm are 
attributed to spin-allowed charge transfer transitions (
1
MLCT and 
1
LLCT), whereas the very 
weak tails above 450 nm arise from spin-forbidden direct excitation to the triplet state 
(
3
MLCT, 
3
LLCT and 
3
LC).
21
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Fig. 14 UV-Vis absorption spectra in CH3CN solution (1.0 × 10
−5
 M) of [Ir(C^N)2(bpy)][PF6] 
complexes with C^N = 1, 3–7. 
 
Excitation of CH3CN solutions of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 1, 3–7 leads to 
the photoluminescence spectra shown in Fig. 15. Emission profiles are independent of the 
excitation wavelength for all complexes. With respect to unsubstituted parent compound 
[Ir(ppy)2(bpy)][PF6],
103
 the emission maximum of fluoro complex [Ir(1)2(bpy)][PF6] is blue-
shifted by 28 nm in CH3CN solution. This shift from 585 to 557 nm is attributed to the 
electron-withdrawing nature of the fluorine substituents, leading to a stabilization of the 
HOMO localized on the iridium centre and the phenyl rings of the cyclometallating ligands. 
Introduction of a strongly electron-withdrawing sulfone group shifts the emission 
maximum significantly to the blue region, by 64 or even 92 nm when compared to reference 
compounds [Ir(1)2(bpy)][PF6] and [Ir(ppy)2(bpy)][PF6],
103
 respectively. All three complexes 
containing a sulfone substituent are therefore green emitters and exhibit vibrational structure 
in their emission bands. No influence on the photoluminescence position was observed by 
changing the alkyl substituent on the sulfone group from methyl in [Ir(3)2(bpy)][PF6] to 
sterically hindered tert-butyl in [Ir(5)2(bpy)][PF6] and long-chain dodecyl in 
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[Ir(7)2(bpy)][PF6]. Only the relative intensities of the vibrational bands are affected slightly by 
changing the alkyl group (cf. Fig. 15). 
 
 
Fig. 15 Emission spectra of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 1, 3–7 in CH3CN 
solution (1.0 × 10
−5
 M). λexc = 300 nm for [Ir(1)2(bpy)][PF6], 400 nm for [Ir(C^N)2(bpy)][PF6] 
(C^N = 3–7). * = Harmonic (600 nm) of the excitation. 
 
Replacing the fluoro- by thioether-substituents in [Ir(4)2(bpy)][PF6] and 
[Ir(6)2(bpy)][PF6] leads to small red-shifts in the emission maximum of 11 and 20 nm for tert-
butyl- and dodecylthio-groups, respectively. Compared to [Ir(ppy)2(bpy)][PF6],
103
 the 
emission is blue-shifted by 8–17 nm for both complexes, resulting from a weak electron-
accepting nature of the thioether substituents. In contrast to the sulfone complexes, all three 
yellow emitters [Ir(C^N)2(bpy)][PF6] (C^N = 1, 4 and 6) have broad, unstructured emission 
bands. Such broad emission spectra indicate larger charge transfer contributions to the triplet 
emissive state, which is a mix of 
3
MLCT, 
3
LLCT and 
3
LC excited states in this type of 
iridium complexes. Vibrational structure, however, as observed for sulfone complexes 
[Ir(C^N)2(bpy)][PF6] with C^N = 3, 5 and 7, suggests a larger ligand-centred character of the 
emissive state.
21
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Sulfone complexes [Ir(3)2(bpy)][PF6], [Ir(5)2(bpy)][PF6] and [Ir(7)2(bpy)][PF6] exhibit 
high quantum yields in de-aerated CH3CN solution of 64 and 74%, together with long excited 
state lifetimes in the range 2.33 to 3.36 µs (Table 1). These τ values are an order of magnitude 
longer than for the fluoro- and thioether-substituted analogues (0.224 to 0.528 µs). PLQYs are 
also substantially lower for [Ir(C^N)2(bpy)][PF6] (C^N = 1, 4 and 6) with respect to the 
sulfone compounds, ranging from 15 to 36%. When solutions are not de-aerated, both 
quantum yield and excited state lifetime values are considerably lower due to strong oxygen 
quenching of the excited state. 
 
 
Fig. 16 Solid state emission spectra of powder samples of complexes [Ir(C^N) 2(bpy)][PF6] with 
C^N = 1, 3–7. λexc = 405 nm. 
 
Solid state photoluminescence spectra shown in Fig. 16 were obtained upon excitation of 
powder samples of complexes [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–7). Emission maxima and 
quantum yields are given in Table 1. In the solid state, all complexes are yellow emitters, with 
maxima ranging from 532 to 558 nm and broad, unstructured emission profiles. Small blue-
shifts of 10 to 19 nm are observed on going from solution to powder samples for compounds 
with fluoro and thioether groups. The three sulfone complexes exhibit more pronounced 
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bathochromic shifts of roughly 40 nm, which can be attributed to strong intermolecular 
interactions, together with the loss of vibrational structure. Quantum yields are much lower in 
powder samples for most of the complexes (2.6 to 6.6%), suggesting strong quenching in the 
solid state. With 15 and 23%, [Ir(5)2(bpy)][PF6] and [Ir(1)2(bpy)][PF6] show significantly 
higher PLQYs than the other complexes. In the case of [Ir(5)2(bpy)][PF6], this observation can 
be assigned to a beneficial effect of the bulky tert-butyl substituents, leading to less excited 
state quenching due to intermolecular interactions. 
 
Table 1 Photophysical properties of complexes [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–7) in CH3CN 
solution and as powder samples. 
Compound 
CH3CN solution Powder 
λexc 
[nm] 
λem
max 
[nm] 
PLQY 
[%]
a
 
τ [µs] 
(χ)a,b 
λem
max 
[nm]
c
 
PLQY 
[%] 
[Ir(1)2(bpy)][PF6] 269 557 36 0.224 (1.0) 547 23 
[Ir(3)2(bpy)][PF6] 262 493, 525 74 2.33 (1.3) 532 6.6 
[Ir(4)2(bpy)][PF6] 260 568 24 0.528 (1.0) 553 4.9 
[Ir(5)2(bpy)][PF6] 262 493, 523 64 3.36 (1.3) 535 15 
[Ir(6)2(bpy)][PF6] 252 577 15 0.369 (1.1) 558 2.6 
[Ir(7)2(bpy)][PF6] 262 493, 524 64 3.21 (1.4) 537 4.2 
a
 Measured in de-aerated solution. 
b
 λexc = 280 nm for [Ir(C^N)2(bpy)][PF6] with C^N = 3, 5 and 7; 
340 nm for [Ir(C^N)2(bpy)][PF6] with C^N = 1, 4 and 6. 
c
 λexc = 405 nm. 
 
5. Electrochemical Properties 
Table 2 Cyclic voltammetric data of [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–7) measured in de-
aerated CH3CN solution with glassy carbon working, Pt counter and Ag pseudo-reference 
electrode, 0.1 M TBAPF6 supporting electrolyte and a scan rate of 0.1 V s
−1
. Referenced to 
Fc/Fc
+
. qr = quasi-reversible, ir = irreversible. 
Compound E1/2
ox  [V] E1/2
red [V] ΔE1/2 [V] 
[Ir(1)2(bpy)][PF6] +1.07
qr
 −1.74, −2.41ir, −2.54 2.81 
[Ir(3)2(bpy)][PF6] +1.18 −1.72, −2.16, −2.61
ir
 2.90 
[Ir(4)2(bpy)][PF6] +1.04
ir
 −1.75, −2.48ir, −2.57ir 2.79 
[Ir(5)2(bpy)][PF6] +1.19 −1.73, −2.18, −2.43 2.92 
[Ir(6)2(bpy)][PF6] +0.82
ir
, +0.98
ir
 −1.76, −2.55ir 2.58 
[Ir(7)2(bpy)][PF6] +1.25 −1.71, −2.16, −2.39 2.96 
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Cyclic voltammetric data for [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–7) in CH3CN solution with 
respect to Fc/Fc
+
 are summarized in Table 2 and cyclic voltammograms showing the 
oxidation and first reduction waves are given in Fig. 17. With values between −1.71 and 
−1.76 V, the first reduction potentials are similar for all complexes. This observation is in 
accordance with the assumption that the LUMO is localized on the ancillary ligand in 
[Ir(C^N)2(N^N)]
+
 complexes, which is the 2,2'-bipyridine ligand for all compounds in this 
series. The first reductions of all complexes are reversible and comparable to that of the 
parent complex [Ir(ppy)2(bpy)][PF6] (−1.77 V vs. Fc/Fc
+
 in DMF).
103
 One or two more 
reduction waves are seen within the accessible solvent window for all complexes, but have 
not been investigated in detail. 
 
 
Fig. 17 Cyclic voltammograms of [Ir(C^N)2(bpy)][PF6] (C^N = 1, 3–7) with respect to Fc/Fc
+
 in 
de-aerated CH3CN solution with glassy carbon working, Pt counter and Ag pseudo-reference 
electrode, 0.1 M TBAPF6 supporting electrolyte, scan rate = 0.1 V s
−1
. 
 
Quasi-reversible to reversible oxidation waves are observed for complexes with strongly 
electron-withdrawing groups (fluoro and sulfonyl) and occur at higher potential than for 
unsubstituted [Ir(ppy)2(bpy)][PF6] (+0.84 V). [Ir(4)2(bpy)][PF6] (+1.04 V) and 
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[Ir(6)2(bpy)][PF6] (+0.82 and 0.98 V) exhibit irreversible oxidation waves at lower potentials 
than the remaining four complexes, in agreement with the introduction of weakly accepting 
thioether moieties on the cyclometallating ligands. The electrochemical HOMO-LUMO gap 
values, ΔE1/2, follow the same trend as the solution emission maxima (vide supra). With 
respect to [Ir(1)2(bpy)][PF6], the three sulfone-substituted complexes [Ir(C^N)2(bpy)][PF6] 
(C^N = 3, 5, 7) exhibit a larger ΔE1/2, consistent with a blue-shifted emission. 
[Ir(4)2(bpy)][PF6] and [Ir(6)2(bpy)][PF6] have both a smaller electrochemical band gap and a 
photoluminescence maximum that is slightly red-shifted compared to [Ir(1)2(bpy)][PF6]. 
 
6. Electroluminescence and Device Data 
Due to their promising photophysical properties in solution and powder, sulfone complexes 
[Ir(3)2(bpy)][PF6] and [Ir(5)2(bpy)][PF6] were tested in light emitting electrochemical cells by 
Dr. Henk Bolink and co-workers at the University of Valencia. Devices composed of 
ITO/PEDOT:PSS/[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al were measured under block-
wave pulsed current conditions
21,93,107
 with a frequency of 1 kHz, average current density of 
100 A m
−2
 and 50% duty cycles. Both complexes show yellow-green electroluminescence in 
LEEC configuration (see Fig. 18 and Table 3) with electroluminescence maxima around 
550 nm and a shoulder at 495 nm. 
 
Table 3 Device parameters for LEECs containing complexes [Ir(3)2(bpy)][PF6] and 
[Ir(5)2(bpy)][PF6]. Configuration: ITO/PEDOT:PSS/[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al. 
Measured by applying a block-wave pulsed current of 100 A m
−2
 at a frequency of 1 kHz and 
duty cycles of 50%.
21,93,107
 
Compound 
ton 
[min] 
Lummax 
[cd m
–2
] 
t1/2 
[min] 
PCE 
[lm W
–1
] 
EQE 
[%] 
λEL
max 
[nm] 
[Ir(3)2(bpy)][PF6] 19 182 69 0.9 0.5 495 sh, 553 
[Ir(5)2(bpy)][PF6] 17 71 25 0.3 0.2 495 sh, 548 
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Fig. 18 Normalized electroluminescence spectra of sulfone complexes [Ir(3)2(bpy)][PF6] and 
[Ir(5)2(bpy)][PF6] applied in LEEC devices. 
 
Performance parameters of LEEC devices with complexes [Ir(3)2(bpy)][PF6] and 
[Ir(5)2(bpy)][PF6] are given in Table 3. Luminance and average voltage curves vs. time are 
depicted in Fig. 19. Complex [Ir(3)2(bpy)][PF6] reaches a significantly higher maximum 
luminance level of 182 cd m
−2
 compared to [Ir(5)2(bpy)][PF6] (71 cd m
−2
). Similarly, power 
conversion efficiency and external quantum efficiency values are more than two times higher 
for [Ir(3)2(bpy)][PF6] (0.9 lm W
−1
 and 0.5%) than for [Ir(5)2(bpy)][PF6] (0.3 lm W
−1
 and 
0.2%). The turn-on time (defined as the time needed to reach maximum luminance) does not 
change considerably from methyl-substituted [Ir(3)2(bpy)][PF6] (19 min) to tert-butyl-
substituted [Ir(5)2(bpy)][PF6] (17 min) and is relatively long in relation to the half lifetime 
exhibited by the LEECs. Turn-on times reported in the literature for green light emitting 
electrochemical cells range from less than five seconds
80,82,93,107
 to several minutes
80,108
 and 
more than one hour.
80,109
 Device lifetimes (t1/2, time to reach half of the luminance maximum) 
amount to 25 and 69 min, with [Ir(3)2(bpy)][PF6] exhibiting better device stability. These 
observed half lifetimes are relatively short, but similar to green LEECs reported in the 
literature, where lifetimes range from several minutes to a few hours.
80,93,107–110
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 In general, methylsulfonyl-substituted complex [Ir(3)2(bpy)][PF6] shows superior 
device performance with respect to [Ir(5)2(bpy)][PF6]. Apparently, in this case, the bulky tert-
butyl groups do not enhance LEEC performance. This observation is in contrast to the 
frequently reported improvement of device parameters such as efficiency, turn-on time, 
luminance and stability by the introduction of sterically hindered substituents.
21
 
 
 
Fig. 19 Luminance and average voltage curves vs. time of LEECs containing [Ir(3)2(bpy)][PF6] 
(black) and [Ir(5)2(bpy)][PF6] (green). Device configuration: ITO/PEDOT:PSS/ 
[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al. Measured by applying a block-wave pulsed current 
of 100 A m
−2
 at a frequency of 1 kHz and duty cycles of 50%.
21,93,107
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7. Conclusions 
Iridium complexes with thioether- and sulfone-substituted cyclometallating ligands have been 
prepared in order to investigate the influence of these groups on the photophysical and 
electrochemical properties. As expected, the strongly electron-withdrawing sulfone moieties 
lead to blue-shifted emission maxima. With respect to unsubstituted parent complex 
[Ir(ppy)2(bpy)]
+
, λem
max
 is hypsochromically shifted by 92 nm in CH3CN solution, indicating the 
potential of the sulfone group to act as an alternative to the commonly used fluoro substituents 
for green and blue emission. Emission bands show vibrational structure, suggesting a 
pronounced ligand-centred (
3
LC) character of the emissive triplet state. Only a negligible 
effect was observed upon changing the alkyl group on the sulfone from methyl to sterically 
hindered tert-butyl and long-chain dodecyl. All three sulfone-based iridium complexes are 
green emitters with high quantum yields of 64 and 74% in solution and excited state lifetimes 
an order of magnitude longer than those of the remaining complexes in this series. 
 Complexes with fluoro-, tert-butylthio- and dodecylthio-substituted cyclometallating 
ligands are yellow emitters with maxima between 557 and 577 nm. They exhibit lower 
PLQYs than the sulfone complexes ranging from 15 to 36% and emission profiles are broad 
and unstructured. Compared to [Ir(ppy)2(bpy)]
+
, emission maxima of the thioether complexes 
are slightly blue-shifted, attributed to the weakly electron accepting character of the thioether 
groups. Alkyl substituents have a small influence on the emission bands, leading to a 9 nm 
red-shift on going from tert-butyl to dodecyl. 
 As powder samples, all complexes in this series are yellow emitters with λem
max
 between 
532 and 558 nm and broad emission bands. Solid state quantum yields are substantially lower, 
with the highest value found for fluoro complex [Ir(1)2(bpy)][PF6] (23%). Electrochemical 
data obtained from CH3CN solutions of the complexes support the trends observed from 
photoluminescence measurements. 
 Complexes with methylsulfonyl and tert-butylsulfonyl substituents on the 
cyclometallating ligands were tested in light emitting electrochemical cells. Both complexes 
exhibited yellow-green electroluminescence in device configuration. Unfortunately, they 
showed relatively low maximum luminance levels, together with low efficiencies and short 
device lifetimes (<69 min). In conclusion, the introduction of a bulky substituent does not 
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have a beneficial effect in this case; superior device performance is observed for complex 
[Ir(3)2(bpy)][PF6] with methylsulfone-containing cyclometallating ligands. 
 The results from this series of complexes support the possibility of using sulfone 
groups in the search of fluorine-free blue emitting iridium complexes. However, all 
complexes are substituted in 5-position of the cyclometallating ligands (meta to the Ir-C 
bond). Investigating the influence of the substitution position of the sulfonyl moiety (in 3- and 
4-position) on the photophysical and electrochemical properties would be interesting. The 
investigation of regioisomerism in iridium complexes and its consequences on structural, 
photophysical, electrochemical and device properties will be reported in the following 
chapter. 
 
8. Experimental 
The following experimental procedures have been written by the author of this thesis and 
have been published in Dalton Transactions.
95
 
8.1. General 
2-(4-Fluorophenyl)pyridine (H1) was synthesized according to a literature protocol and 
1
H 
NMR spectroscopic data matched those reported.
96
 [Ir(cod)Cl]2
111
 and [Ir(1)2Cl]2
112
 were 
prepared as reported. 
8.2. 2-(4-(Methylthio)phenyl)pyridine (H2) 
2-(4-(Methylthio)phenyl)pyridine (H2) has been synthesized previously,
97
 
but the following procedure gives a higher yield. 2-(4-
Fluorophenyl)pyridine (H1) (617 mg, 3.56 mmol, 1.0 eq.) and an excess 
of NaSMe (1.06 g, 14.3 mmol, 4.0 eq.) were added to NMP (18 mL) in a microwave vial. The 
violet reaction mixture was heated at 80 °C for 1 h in a microwave reactor to give a dark 
brown suspension. This was poured into a mixture of H2O and brine (3:1, 100 mL). The 
resulting yellow precipitate was separated by filtration, dissolved in CH2Cl2 and dried over 
Na2SO4. The solvent was removed under reduced pressure to yield 2-(4-
(methylthio)phenyl)pyridine (H2) as a yellow solid (665 mg, 3.30 mmol, 92.7%). M.p. 
CHAPTER I: YELLOW & GREEN EMITTERS – THIOETHER- AND SULFONE-SUBSTITUTED 
CYCLOMETALLATING LIGANDS 
 
 
 
 - 36 -  
 
59.5 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 8.67 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H, H
B6
), 7.93 
(m, 2H, H
A2
), 7.76–7.67 (overlapping m, 2H, HB3+B4), 7.34 (m, 2H, HA3), 7.21 (ddd, J = 7.3, 
4.8, 1.4 Hz, 1H, H
B5
), 2.53 (s, 3H, H
Me
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 157.0 
(C
B2
), 149.8 (C
B6
), 139.9 (C
A4
), 136.9 (C
B4
), 136.2 (C
A1
), 127.3 (C
A2
), 126.5 (C
A3
), 122.1 
(C
B5
), 120.2 (C
B3
), 15.7 (C
Me
). IR (solid, ṽ/cm−1) 3086 (w), 3046 (w), 3002 (w), 2981 (w), 
2919 (w), 1982 (w), 1910 (w), 1767 (w), 1661 (w), 1605 (w), 1583 (s), 1569 (s), 1552 (m), 
1498 (w), 1458 (s), 1431 (s), 1399 (m), 1322 (w), 1296 (w), 1256 (w), 1227 (w), 1190 (m), 
1154 (w), 1121 (w), 1098 (m), 1089 (m), 1057 (w), 1008 (m), 988 (m), 969 (w), 958 (m), 884 
(w), 830 (m), 772 (s), 738 (s), 725 (m), 708 (m), 675 (w), 636 (w), 616 (w), 569 (w), 544 (w), 
484 (m), 461 (m). ESI-MS m/z 202.0 [M+H]
+
 (calc. 202.1). Found C 71.43, H 5.57, N 6.75; 
C12H11NS requires C 71.60, H 5.51, N 6.96%. 
8.3. 2-(4-(Methylsulfonyl)phenyl)pyridine (H3) 
2-(4-(Methylthio)phenyl)pyridine (H2) (1.00 g, 4.97 mmol, 1.0 eq.) and 
sodium tungstate dihydrate (819 mg, 2.48 mmol, 0.50 eq.) were dissolved 
in MeOH (35 mL). H2O2 (30%, 1.20 mL, 1.36 g, 12.0 mmol, 2.4 eq.) was 
added and the mixture was stirred overnight at room temperature. The 
suspension was poured into a mixture of H2O and brine (3:1, 200 mL) and extracted with 
CH2Cl2 (3 × 100 mL). The combined organic layers were dried over Na2SO4 and the solvent 
was removed under reduced pressure to yield 2-(4-(methylsulfonyl)phenyl)pyridine (H3) as a 
white powder (1.14 g, 4.89 mmol, 98.4%). M.p. 134.5 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 
8.75 (ddd, J = 4.7, 1.8, 1.0 Hz, 1H, H
B6
), 8.21 (m, 2H, H
A2
), 8.10–7.99 (m, 2H, HA3), 7.87–
7.75 (m, 2H, H
B3+B4
), 7.34 (ddd, J = 7.0, 4.8, 1.6 Hz, 1H, H
B5
), 3.09 (s, 3H, H
Me
). 
13
C{
1
H} 
NMR (126 MHz, CDCl3) δ/ppm 155.4 (C
B2
), 150.2 (C
B6
), 144.7 (C
A1
), 140.7 (C
A4
), 137.3 
(C
B4
), 128.0 (C
A3
), 127.9 (C
A2
), 123.5 (C
B5
), 121.3 (C
B3
), 44.7 (C
Me
). IR (solid, ṽ/cm−1) 3000 
(w), 2921 (w), 1586 (m), 1563 (w), 1465 (m), 1435 (m), 1392 (w), 1314 (w), 1292 (s), 1185 
(w), 1146 (s), 1087 (m), 1030 (w), 1013 (w), 988 (w), 964 (m), 848 (m), 789 (m), 776 (s), 750 
(s), 677 (m), 636 (w), 616 (m), 562 (m), 548 (s), 514 (s). ESI-MS m/z 234.0 [M+H]
+
 (calc. 
234.1). Found C 62.03, H 4.95, N 6.29; C12H11NO2S requires C 61.78, H 4.75, N 6.00%. 
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8.4. 2-(4-(tert-Butylthio)phenyl)pyridine (H4) 
NaH (60% suspension in mineral oil, 235 mg, 5.88 mmol, 2.0 eq.) was 
suspended in DMF (8 mL) under N2. 2-Methyl-2-propanethiol 
(0.660 mL, 528 mg, 5.80 mmol, 2.0 eq.) was added, leading to gas 
evolution and white foam. After the reaction mixture had been stirred for 10 min at room 
temperature, 2-(4-fluorophenyl)pyridine (H1) (501 mg, 2.89 mmol, 1.0 eq.) was added 
dissolved in DMF (2 mL). The mixture was heated at 120 °C for 24 h. The yellow-orange 
solution was allowed to cool to room temperature and was then poured into a mixture of H2O 
and brine (3:1, 50 mL). The resulting suspension was stirred for 5 min. The precipitate was 
separated by filtration, washed with H2O and dried under vacuum. 2-(4-(tert-
Butylthio)phenyl)pyridine (H4) was isolated as a pale brown solid (704 mg, 2.89 mmol, 
quant.). M.p. 90.7 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 8.70 (ddd, J = 4.8, 1.9, 1.1 Hz, 1H, 
H
B6
), 7.95 (m, 2H, H
A2
), 7.82–7.70 (overlapping m, 2H, HB3+B4), 7.64 (m, 2H, HA3), 7.26 (m, 
1H, H
B5
), 1.32 (s, 9H, H
tBu
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 157.0 (C
B2
), 149.9 
(C
B6
), 139.8 (C
A1
), 137.9 (C
A3
), 137.0 (C
B4
), 133.9 (C
A4
), 127.0 (C
A2
), 122.5 (C
B5
), 120.8 
(C
B3
), 46.4 (C
CtBu
), 31.2 (C
tBu
). IR (solid, ṽ/cm−1) 1462 (m), 1429 (m), 1391 (w), 1366 (m), 
1305 (w), 1289 (w), 1259 (w), 1168 (m), 1152 (m), 1098 (m), 1059 (w), 1031 (w), 1014 (m), 
989 (m), 934 (w), 899 (w), 844 (s), 780 (s), 748 (s), 725 (m), 682 (w), 633 (w), 618 (w), 579 
(w), 560 (m), 520 (m), 491 (m). ESI-MS m/z 244.0 [M+H]
+
 (calc. 244.1). Found C 74.04, 
H 7.01, N 5.64; C15H17NS requires C 74.03, H 7.04, N 5.76%. 
8.5. 2-(4-(tert-Butylsulfonyl)phenyl)pyridine (H5) 
2-(4-(tert-Butylthio)phenyl)pyridine (H4) (501 mg, 2.06 mmol, 1.0 eq.) 
and sodium tungstate dihydrate (352 mg, 1.07 mmol, 0.52 eq.) were 
dissolved in MeOH (13 mL). H2O2 (30%, 0.500 mL, 568 mg, 
5.01 mmol, 2.4 eq.) was added and the suspension was stirred at room 
temperature for 20 h. CH2Cl2 (100 mL) was then added and the white precipitate was 
separated by filtration. The filtrate was washed with H2O (50 mL), the aqueous layer 
extracted with CH2Cl2 (100 mL) and the combined organic layers dried over Na2SO4. The 
solvent was removed under reduced pressure and the residue was purified by column 
chromatography (silica, CH2Cl2–1% MeOH). 2-(4-(tert-Butylsulfonyl)phenyl)pyridine (H5) 
was isolated as a white powder (473 mg, 1.72 mmol, 83.5%). M.p. 174.4 °C. 
1
H NMR 
(500 MHz, CDCl3) δ/ppm 8.75 (ddd, J = 4.7, 1.8, 1.1 Hz, 1H, H
B6
), 8.17 (m, 2H, H
A2
), 7.98 
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(m, 2H, H
A3
), 7.88–7.75 (overlapping m, 2H, HB3+B4), 7.33 (ddd, J = 6.7, 4.8, 1.7 Hz, 1H, 
H
B5
), 1.37 (s, 9H, H
tBu
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 155.7 (C
B2
), 150.2 (C
B6
), 
144.5 (C
A1
), 137.3 (C
B4
), 135.5 (C
A4
), 131.1 (C
A3
), 127.3 (C
A2
), 123.5 (C
B5
), 121.3 (C
B3
), 60.1 
(C
CtBu
), 23.8 (C
tBu
). IR (solid, ṽ/cm–1) 2970 (w), 1586 (m), 1561 (w), 1463 (m), 1436 (w), 
1395 (w), 1314 (w), 1287 (s), 1192 (w), 1159 (w), 1131 (s), 1113 (m), 1079 (s), 1011 (m), 
990 (w), 853 (m), 801 (w), 778 (s), 752 (w), 741 (w), 722 (m), 694 (s), 646 (s), 616 (m), 579 
(s), 555 (m), 517 (m), 505 (m). ESI-MS m/z 276.0 [M+H]
+
 (calc. 276.1). Found C 65.41, 
H 6.31, N 5.14; C15H17NO2S requires C 65.43, H 6.22, N 5.09%. 
8.6. 2-(4-(Dodecylthio)phenyl)pyridine (H6) 
NaH (60% suspension in mineral oil, 187 mg, 
4.67 mmol, 2.0 eq.) was suspended in DMF 
(6 mL) under N2. 1-Dodecanethiol (1.14 mL, 
956 mg, 4.63 mmol, 2.0 eq.) and then DMF (4 mL) were added and the mixture was stirred 
for 10 min. 2-(4-Fluorophenyl)pyridine (H1) (400 mg, 2.31 mmol, 1.0 eq.) was added 
dissolved in DMF (2 mL) and the mixture was heated at 120 °C for 4 h. The yellow mixture 
was allowed to cool to room temperature and was then poured into a mixture of H2O and 
brine (3:1, 50 mL). The resulting suspension was stirred for 5 min and the precipitate was 
removed by filtration, washed with H2O, dried under vacuum and purified by column 
chromatography (silica, n-hexane/EtOAc 6:1 changing to 2:1). 2-(4-
(Dodecylthio)phenyl)pyridine (H6) was isolated as a white solid (542 mg, 1.52 mmol, 
65.8%). M.p. 65.3 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 8.67 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H, 
H
B6
), 7.91 (m, 2H, H
A2
), 7.78–7.63 (overlapping m, 2H, HB3+B4), 7.39 (m, 2H, HA3), 7.21 
(ddd, J = 7.2, 4.8, 1.4 Hz, 1H, H
B5
), 2.97 (m, 2H, H
SCH2
), 1.68 (m, 2H, H
SCH2CH2
), 1.43 (m, 
2H, H
SCH2CH2CH2
), 1.35–1.12 (overlapping m, 16H, HCH2), 0.88 (t, J = 6.9 Hz, 3H, HCH3). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 157.0 (C
B2
), 149.8 (C
B6
), 138.7 (C
A4
), 136.9 (C
B4
), 
136.7 (C
A1
), 128.6 (C
A3
), 127.3 (C
A2
), 122.1 (C
B5
), 120.3 (C
B3
), 33.3 (C
SCH2
), 32.1 (C
CH2
), 
29.8 (C
CH2
), 29.8 (C
CH2
), 29.7 (C
CH2
), 29.7 (C
CH2
), 29.5 (C
CH2
), 29.3 (C
CH2
), 29.2 (C
SCH2CH2
), 
29.0 (C
SCH2CH2CH2
), 22.8 (C
CH2
), 14.3 (C
CH3
). IR (solid, ṽ/cm–1) 3059 (w), 3003 (w), 2954 (m), 
2917 (s), 2872 (m), 2850 (s), 1585 (s), 1571 (m), 1554 (w), 1496 (w), 1463 (s), 1432 (s), 1398 
(w), 1379 (m), 1297 (m), 1259 (w), 1242 (w), 1191 (w), 1153 (w), 1122 (w), 1100 (m), 1056 
(w), 1009 (m), 988 (w), 834 (m), 768 (s), 734 (m), 720 (m), 708 (m), 636 (w), 616 (w), 548 
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(w), 513 (w), 488 (w), 462 (m). MALDI-TOF MS (no matrix) m/z 355.7 [M]
+
 (calc. 355.2). 
Found C 77.75, H 9.76, N 4.05; C23H33NS requires C 77.69, H 9.35, N 3.94%. 
8.7. 2-(4-(Dodecylsulfonyl)phenyl)pyridine (H7) 
2-(4-(Dodecylthio)phenyl)pyridine (H6) (212 mg, 
0.597 mmol, 1.0 eq.) and sodium tungstate 
dihydrate (98.4 mg, 0.298 mmol, 0.50 eq.) were 
suspended in MeOH (15 mL). H2O2 (35%, 
0.120 mL, 136 mg, 1.40 mmol, 2.3 eq.) was added and the mixture was stirred at room 
temperature overnight. H2O (50 mL) was added and the suspension was stirred for 15 min, 
after which time the precipitate was separated by filtration, washed with H2O and dried under 
vacuum. 2-(4-(Dodecylsulfonyl)phenyl)pyridine (H7) was isolated as a white solid (207 mg, 
0.534 mmol, 89.4%). M.p. 84.4 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 8.74 (ddd, J = 5.0, 1.3 
Hz, 1H, H
B6
), 8.19 (m, 2H, H
A2
), 8.00 (m, 2H, H
A3
), 7.81 (m, 2H, H
B3+B4
), 7.33 (ddd, J = 6.7, 
4.7, 1.6 Hz, 1H, H
B5
), 3.11 (m, 2H, H
SO2CH2
), 1.71 (m, 2H, H
SO2CH2CH2
), 1.35 (m, 2H, 
H
SO2CH2CH2CH2
), 1.31–1.18 (overlapping m, 16H, HCH2), 0.87 (t, J = 7.0 Hz, 3H, HCH3). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 155.5 (C
B2
), 150.2 (C
B6
), 144.6 (C
A1
), 139.3 (C
A4
), 
137.2 (C
B4
), 128.7 (C
A3
), 127.8 (C
A2
), 123.5 (C
B5
), 121.3 (C
B3
), 56.6 (C
SO2CH2
), 32.0 (C
CH2
), 
29.72 (C
CH2
), 29.69 (C
CH2
), 29.6 (C
CH2
), 29.5 (C
CH2
), 29.4 (C
CH2
), 29.2 (C
CH2
), 28.4 
(C
SO2CH2CH2CH2
), 22.9 (C
SO2CH2CH2
), 22.8 (C
CH2
), 14.3 (C
CH3
). IR (solid, ṽ/cm–1) 2915 (m), 
2848 (m), 1586 (w), 1562 (w), 1468 (m), 1436 (w), 1399 (w), 1301 (m), 1285 (m), 1271 (m), 
1144 (s), 1099 (w), 1086 (m), 1027 (w), 1009 (w), 991 (w), 853 (w), 776 (s), 758 (m), 739 
(m), 722 (w), 691 (s), 635 (w), 621 (m), 606 (s), 557 (m), 528 (s), 496 (m). ESI-MS m/z 388.2 
[M+H]
+ 
(calc. 388.2). Found C 71.30, H 8.79, N 3.77; C23H33NO2S requires C 71.27, H 8.58, 
N 3.61%. 
8.8. [Ir(3)2Cl]2 
[Ir(cod)Cl]2 (285 mg, 0.424 mmol, 1.0 eq.) and 2-
(4-(methylsulfonyl)phenyl)pyridine (H3) (395 mg, 
1.69 mmol, 4.0 eq.) were suspended in degassed 2-
ethoxyethanol (10 mL) and the mixture was purged 
with argon. The suspension was heated at reflux 
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overnight and was then allowed to cool to room temperature. The yellow precipitate was 
separated by filtration, washed with H2O and EtOH and dried under vacuum. [Ir(3)2Cl]2 was 
isolated as a yellow powder (516 mg, 0.373 mmol, 88.0%). 
1
H NMR (500 MHz, CDCl3) 
δ/ppm 9.21 (ddd, J = 5.8, 1.6, 0.7 Hz, 4H, HB6), 8.06 (ddd, J = 8.4, 1.4, 0.7 Hz, 4H, HB3), 7.95 
(ddd, J = 8.1, 7.5, 1.6 Hz, 4H, H
B4
), 7.68 (d, J = 8.2 Hz, 4H, H
A3
), 7.36 (dd, J = 8.1, 1.9 Hz, 
4H, H
A4
), 7.01 (ddd, J = 7.3, 5.7, 1.4 Hz, 4H, H
B5
), 6.36 (d, J = 1.9 Hz, 4H, H
A6
), 2.75 (s, 
12H, H
Me
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 166.5 (C
B2
), 151.8 (C
B6
), 149.2 (C
A2
), 
144.8 (C
A1/A5
), 139.8 (C
A1/A5
), 138.0 (C
B4
), 128.1 (C
A6
), 124.4 (C
B5
), 124.3 (C
A3
), 121.0 (C
A4
), 
120.6 (C
B3
), 44.3 (C
Me
). LC-ESI-MS m/z 657.1 [Ir(3)2]
+
 (calc. 657.1), 698.2 [Ir(3)2(CH3CN)]
+
 
(calc. 698.1). 
8.9. [Ir(4)2Cl]2 
2-(4-(tert-Butylthio)phenyl)pyridine (H4) 
(401 mg, 1.65 mmol, 4.0 eq.) was dissolved in 2-
ethoxyethanol (18 mL) in a microwave vial and 
the solution purged with N2. [Ir(cod)Cl]2 
(280 mg, 0.417 mmol, 1.0 eq.) was added and the 
mixture heated at 110 °C for 1.5 h in a 
microwave reactor. The yellow precipitate was separated by filtration, washed with H2O and 
EtOH and dried under vacuum to yield [Ir(4)2Cl]2 as a yellow solid (383 mg, 0.269 mmol, 
64.5%). 
1
H NMR (500 MHz, CDCl3) δ/ppm 9.29 (d, J = 5.5 Hz, 4H, H
B6
), 7.89 (d, J = 8.0 Hz, 
4H, H
B3
), 7.76 (pseudo-td, J = 7.8, 1.6 Hz, 4H, H
B4
), 7.42 (d, J = 8.0 Hz, 4H, H
A3
), 6.92 (dd, 
J = 7.9, 1.7 Hz, 4H, H
A4
), 6.78 (ddd, J = 7.3, 5.7, 1.5 Hz, 4H, H
B5
), 5.96 (d, J = 1.6 Hz, 4H, 
H
A6
), 0.98 (s, 36H, H
tBu
). LC-ESI-MS m/z 677.2 [Ir(4)2]
+
 (calc. 677.2), 718.3 
[Ir(4)2(CH3CN)]
+
 (calc. 718.2). 
8.10. [Ir(5)2Cl]2 
2-(4-(tert-Butylsulfonyl)phenyl)pyridine (H5) 
(151 mg, 0.548 mmol, 2.0 eq.) was suspended in 
2-ethoxyethanol (3 mL) and H2O (1 mL) under 
N2 atmosphere. IrCl3·xH2O (ca. 82% IrCl3, 
99.2 mg, 0.272 mmol, 1.0 eq.) was added and the 
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suspension was heated at reflux for 21 h. The mixture was allowed to cool to room 
temperature and then H2O was added. The precipitate was removed by filtration and was 
washed with H2O to give [Ir(5)2Cl]2 as a yellow powder (101 mg, 65.0 µmol, 47.8%). 
1
H 
NMR (500 MHz, CDCl3) δ/ppm 9.30 (ddd, J = 5.8, 1.5, 0.6 Hz, 4H, H
B6
), 8.03 (ddd, J = 8.3, 
1.3, 0.6 Hz, 4H, H
B3
), 7.93 (td, J = 7.8, 1.5 Hz, 4H, H
B4
), 7.64 (d, J = 8.2 Hz, 4H, H
A3
), 7.30 
(dd, J = 8.1, 1.7 Hz, 4H, H
A4
), 6.98 (ddd, J = 7.3, 5.7, 1.5 Hz, 4H, H
B5
), 6.21 (d, J = 1.8 Hz, 
4H, H
A6
), 1.00 (s, 36H, H
tBu
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 166.7 (C
B2
), 151.8 
(C
B6
), 148.9 (C
A2
), 143.8 (C
A1/A5
), 137.9 (C
B4
), 134.4 (C
A5/A1
), 131.6 (C
A6
), 124.13 (C
B5
), 
124.07 (C
A4
), 123.5 (C
A3
), 120.5 (C
B3
), 59.7 (C
CtBu
), 23.5 (C
tBu
). LC-ESI-MS m/z 741.2 
[Ir(5)2]
+
 (calc. 741.1), 782.1 [Ir(5)2(CH3CN)]
+
 (calc. 782.2), 823.1 [Ir(5)2(CH3CN)2]
+
 (calc. 
823.2). 
8.11. [Ir(7)2Cl]2 
IrCl3·xH2O (ca. 82% IrCl3, 
93.5 mg, 0.257 mmol, 1.0 eq.) 
was added to a suspension of 2-
(4-(dodecylsulfonyl)phenyl)-
pyridine (H7) (200 mg, 
0.516 mmol, 2.0 eq.) in 2-
ethoxyethanol (3 mL) and H2O (1 mL) under N2 atmosphere. The mixture was heated at 
reflux for 22 h. After cooling to room temperature, the mixture was poured into H2O (50 mL) 
and stirred at room temperature for a few minutes. The resulting suspension was poured into 
brine (40 mL) and stirred again at room temperature. The precipitate was removed by 
filtration, washed with H2O, EtOH and Et2O and dried under vacuum. [Ir(7)2Cl]2 was isolated 
as a yellow powder (216 mg, 0.108 mmol, 84.0%). 
1
H NMR (500 MHz, CDCl3) δ/ppm 9.23 
(ddd, J = 5.7, 1.5, 0.6 Hz, 4H, H
B6
), 8.04 (pseudo-dt, J = 8.4, 1.0 Hz, 4H, H
B3
), 7.94 (pseudo-
td, J = 7.8, 1.6 Hz, 4H, H
B4
), 7.66 (d, J = 8.2 Hz, 4H, H
A3
), 7.31 (dd, J = 8.1, 1.8 Hz, 4H, 
H
A4
), 6.99 (ddd, J = 7.3, 5.7, 1.5 Hz, 4H, H
B5
), 6.30 (d, J = 1.8 Hz, 4H, H
A6
), 2.74 (m, 8H, 
H
SO2CH2
), 1.43 (m, 8H, H
SO2CH2CH2
), 1.33–1.05 (overlapping m, 72H, HCH2), 0.88 (t, J = 7.0 
Hz, 12H, H
Me
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 166.6 (C
B2
), 151.8 (C
B6
), 149.0 
(C
A2
), 144.7 (C
A1/A5
), 138.6 (C
A5/A1
), 137.9 (C
B4
), 128.9 (C
A6
), 124.3 (C
B5
), 124.2 (C
A3
), 121.6 
(C
A4
), 120.5 (C
B3
), 56.2 (C
SO2CH2
), 32.1 (C
CH2
), 29.73 (C
CH2
), 29.72 (C
CH2
), 29.6 (C
CH2
), 29.5 
(C
CH2
), 29.4 (C
CH2
), 29.2 (C
CH2
), 28.3 (C
CH2
), 22.8 (C
CH2
), 22.5 (C
SO2CH2CH2
), 14.3  (C
Me
). 
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MALDI-TOF MS (no matrix) m/z 965.9 [Ir(7)2]
+
 (calc. 965.4). 
8.12. [Ir(1)2(bpy)][PF6] 
[Ir(1)2Cl]2 (350 mg, 0.306 mmol, 1.0 eq.) and bpy (150 mg, 
0.960 mmol, 3.1 eq.) were suspended in MeOH (45 mL). 
The mixture was heated at reflux overnight and then 
allowed to cool to room temperature. After filtration, an 
excess of solid NH4PF6 was added to the filtrate and the 
mixture was stirred for 1 h at room temperature. The yellow 
precipitate was separated by filtration, washed with H2O and redissolved in CH2Cl2. The 
solution was dried over Na2SO4 and the solvent removed under reduced pressure. The yellow 
residue was purified by column chromatography (silica, CH2Cl2 changing to CH2Cl2–2% 
MeOH). [Ir(1)2(bpy)][PF6] was isolated as a yellow solid (405 mg, 0.483 mmol, 78.9%). 
1
H NMR (500 MHz, CD3CN) δ/ppm 8.53 (pseudo-dt, J = 8.3, 1.0 Hz, 2H, H
E3
), 8.14 (pseudo-
td, J = 8.0, 1.6 Hz, 2H, H
E4
), 8.06–7.95 (overlapping m, 4H, HB3+E6), 7.90–7.79 (overlapping 
m, 4H, H
A3+B4
), 7.57 (ddd, J = 5.8, 1.5, 0.8 Hz, 2H, H
B6
), 7.51 (ddd, J = 7.7, 5.5, 1.2 Hz, 2H, 
H
E5
), 7.04 (ddd, J = 7.3, 5.8, 1.4 Hz, 2H, H
B5
), 6.81 (m, 2H, H
A4
), 5.89 (dd, JHF = 9.6 Hz, 
JHH = 2.6 Hz, 2H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 167.1 (C
B2
), 164.6 (d, 
JCF = 253 Hz, C
A5
), 156.6 (C
E2
), 154.3 (d, JCF = 5.8 Hz, C
A1
), 151.8 (C
E6
), 150.1 (C
B6
), 141.4 
(d, JCF = 2.1 Hz, C
A2
), 140.5 (C
E4
), 139.8 (C
B4
), 129.4 (C
E5
), 128.1 (dCF, J = 9.4 Hz, C
A3
), 
125.7 (C
E3
), 124.5 (C
B5
), 121.0 (C
B3
), 118.3 (dCF, J = 17.7 Hz, C
A6
), 110.5 (d, J = 23.3 Hz, 
C
A4
). IR (solid, ṽ/cm–1) 1594 (m), 1568 (m), 1555 (m), 1482 (w), 1447 (m), 1434 (m), 1314 
(w), 1262 (w), 1245 (w), 1187 (m), 1163 (w), 1032 (w), 833 (s), 766 (s), 733 (m), 675 (w), 
576 (m), 556 (s). UV/Vis (CH3CN, 1.1 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 251 
(62 000), 264 (60 000), 295 sh (33 000), 310 sh (2000), 395 sh (4300). Emission (CH3CN, 
1.1 × 10
–5
 mol dm
–3
, λexc = 269 nm) λem
max
 = 557 nm. ESI-MS m/z 693.2 [M–PF6]
+
 (calc. 693.1). 
Found C 45.95, H 2.84, N 6.74; C32H22F8IrN4P requires C 45.88, H 2.65, N 6.69%. 
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8.13. [Ir(3)2(bpy)][PF6] 
[Ir(3)2Cl]2 (109 mg, 57.4 µmol, 1.0 eq.) and bpy (26.9 mg, 
0.172 mmol, 3.0 eq.) were suspended in MeOH (10 mL) 
and the mixture was heated at 120 °C in a microwave 
reactor for 1 h (15 bar). After cooling, an excess of solid 
NH4PF6 was added to the yellow solution and the 
resulting suspension was stirred for 15 min at room 
temperature. The yellow precipitate that formed was separated by filtration, washed with 
MeOH and redissolved in CH2Cl2. The solvent was removed under reduced pressure and the 
product was purified by column chromatography (silica, CH2Cl2 changing to CH2Cl2–4% 
MeOH). The major fraction was collected and solvent removed under reduced pressure. The 
residue was suspended in CH2Cl2 and the mixture sonicated and then filtered. 
[Ir(3)2(bpy)][PF6] was isolated as a yellow solid (92.3 mg, 96.4 µmol, 84.0%). 
1
H NMR 
(500 MHz, CD3CN) δ/ppm 8.54 (pseudo-dt, J = 8.3, 1.1 Hz, 2H, H
E3
), 8.23 (pseudo-dt, J = 
8.2, 1.1 Hz, 2H, H
B3
), 8.15 (pseudo-td, J = 8.0, 1.6 Hz, 2H, H
E4
), 8.02 (d, J = 8.3 Hz, 2H, 
H
A3
), 7.98 (ddd, J = 8.0, 7.7, 1.5 Hz, 2H, H
B4
), 7.95 (ddd, J = 5.4, 1.6, 0.8 Hz, 2H, H
E6
), 7.72 
(ddd, J = 5.8, 1.5, 0.7 Hz, 2H, H
B6
), 7.58 (dd, J = 8.3, 1.9 Hz, 2H, H
A4
), 7.51 (ddd, J = 7.7, 
5.5, 1.2 Hz, 2H, H
E5
), 7.21 (ddd, J = 7.4, 5.8, 1.4 Hz, 2H, H
B5
), 6.70 (d, J = 1.9 Hz, 2H, H
A6
), 
2.89 (s, 6H, H
Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.2 (C
B2
), 156.6 (C
E2
), 152.0 
(C
E6
), 151.2 (C
A1
), 150.9 (C
B6
), 150.2 (C
A2
), 142.3 (C
A5
), 140.7 (C
E4
), 140.3 (C
B4
), 129.6 
(C
A6+E5
), 126.31 (C
A3
), 126.29 (C
B5
), 125.8 (C
E3
), 122.60 (C
A4
), 122.58 (C
B3
), 44.3 (C
Me
). IR 
(solid, ṽ/cm–1) 2927 (w), 1608 (w), 1575 (w), 1475 (m), 1447 (w), 1430 (w), 1375 (w), 1294 
(m), 1267 (w), 1144 (s), 1091 (m), 1062 (m), 1030 (w), 957 (m), 892 (w), 838 (s), 808 (m), 
782 (m), 753 (s), 733 (m), 699 (m), 666 (w), 651 (w), 600 (w), 592 (w), 557 (s), 546 (s), 524 
(m), 487 (s). UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 256 (58 000), 
300 sh (30 000), 350 sh (7500), 390 (4900), 425 sh (3200). Emission (CH3CN, 1.0 × 10
–5
 mol 
dm
–3
, λexc = 262 nm) λem
max
 = 493, 525 nm. ESI-MS m/z 813.1 [M–PF6]
+
 (calc. 813.1). Found  
C 41.74, H 3.33, N 5.90; C34H28F6IrN4O4PS2·H2O requires C 41.84, H 3.10, N 5.74%. 
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8.14. [Ir(4)2(bpy)][PF6] 
[Ir(4)2Cl]2 (144 mg, 0.101 mmol, 1.0 eq.) and bpy 
(66.0 mg, 0.423 mmol, 4.2 eq.) were suspended in 
MeOH (15 mL) and the mixture was heated at reflux for 
16 h. The orange solution was allowed to cool to room 
temperature. An excess of solid NH4PF6 was added 
followed by enough H2O to precipitate the product, and 
the resulting suspension was stirred for 10 min. The yellow precipitate was separated by 
filtration, washed with H2O and MeOH and then redissolved in CH2Cl2. The solution was 
dried over Na2SO4 and the solvent was removed under reduced pressure. The residue was 
purified twice by column chromatography (silica, CH2Cl2 changing to CH2Cl2–1% MeOH; 
alumina, CH2Cl2 changing to CH2Cl2–5% MeOH). The residue was dissolved in MeOH and 
an excess of solid NH4PF6 followed by H2O were added. The resulting suspension was stirred 
for 5 min, and the yellow precipitate was collected by filtration and redissolved in CH2Cl2. 
The solution was dried over Na2SO4 and the solvent was removed under reduced pressure. 
[Ir(4)2(bpy)][PF6] was isolated as a yellow solid (139 mg, 0.142 mmol, 70.3%). 
1
H NMR 
(500 MHz, CD3CN) δ/ppm 8.54 (pseudo-dt, J = 8.2, 1.0 Hz, 2H, H
E3
), 8.15 (pseudo-td, J = 
7.9, 1.6 Hz, 2H, H
E4
), 8.10–8.04 (overlapping m, 4H, HB3+E6), 7.86 (ddd, J = 8.2, 7.6, 1.5 Hz, 
2H, H
B4
), 7.72 (d, J = 8.0 Hz, 2H, H
A3
), 7.61 (pseudo-dt, J = 5.8, 1.2 Hz, 2H, H
B6
), 7.51 (ddd, 
J = 7.5, 5.3, 1.2 Hz, 2H, H
E5
), 7.13 (dd, J = 8.0, 1.7 Hz, 2H, H
A4
), 7.05 (ddd, J = 7.4, 5.8, 
1.4 Hz, 2H, H
B5
), 6.30 (d, J = 1.7 Hz, 2H, H
A6
), 1.00 (s, 18H, H
tBu
). 
13
C{
1
H} NMR (126 MHz, 
CD3CN) δ/ppm 167.7 (C
B2
), 156.7 (C
E2
), 151.8 (C
E6
), 150.9 (C
A5
), 150.3 (C
B6
), 145.2 (C
B6
), 
140.4 (C
A2
), 140.3 (C
E4
), 139.7 (C
A6
), 136.0 (C
B4
), 131.6 (C
A1
), 129.4 (C
A4
), 125.7 (C
E3
), 
125.5 (C
A3
), 124.8 (C
B5
), 121.3 (C
B3
), 46.8 (C
CtBu
), 31.1 (C
tBu
). IR (solid, ṽ/cm–1) 2970 (w), 
1607 (m), 1569 (m), 1472 (m), 1447 (m), 1425 (m), 1366 (m), 1313 (w), 1258 (w), 1162 (m), 
1099 (w), 1062 (w), 875 (w), 834 (s), 778 (s), 765 (s), 733 (m), 650 (w), 600 (w), 557 (s). 
UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 261 (57 000), 305 sh 
(35 000), 415 sh (4800). Emission (CH3CN, 1.0 × 10
–5
 mol dm
–3
, λexc = 260 nm) λem
max
 = 
568 nm. ESI-MS m/z 833.5 [M–PF6]
+
 (calc. 833.2). Found C 48.96, H 4.35, N 5.70; 
C40H40F6IrN4PS2 requires C 49.12, H 4.12, N 5.73%. 
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8.15. [Ir(5)2(bpy)][PF6] 
[Ir(5)2Cl]2 (101 mg, 65.0 µmol, 1.0 eq.) and bpy 
(44.3 mg, 0.284 mmol, 4.4 eq.) were suspended in 
MeOH (10 mL) and the mixture was heated at reflux for 
14 h. The solution was left to cool to room temperature, 
and an excess of solid NH4PF6 was then added followed 
by enough H2O to precipitate the product. The resulting 
suspension was stirred for 30 min. The yellow precipitate was separated by filtration, washed 
with H2O and redissolved in CH2Cl2. After removal of the solvent under reduced pressure, the 
residue was purified by column chromatography (silica, CH2Cl2 changing to CH2Cl2–2% 
MeOH). [Ir(5)2(bpy)][PF6] was isolated as a yellow solid (119 mg, 0.114 mmol, 87.7%). 
1
H NMR (500 MHz, CD3CN) δ/ppm 8.58 (dd, J = 8.2, 1.1 Hz, 2H, H
E3
), 8.22 (d, J = 8.0 Hz, 
2H, H
B3
), 8.17 (pseudo-td, J = 8.0, 1.5 Hz, 2H, H
E4
), 8.09 (d, J = 4.9 Hz, 2H, H
E6
), 8.02–7.93 
(overlapping m, 4H, H
A3+B4
), 7.71 (pseudo-dt, J = 5.6, 1.1 Hz, 2H, H
B6
), 7.51 (ddd, 
J = 6.9, 5.5, 1.2 Hz, 2H, H
E5
), 7.45 (dd, J = 8.2, 1.8 Hz, 2H, H
A4
), 7.20 (ddd, J = 7.4, 5.8, 
1.4 Hz, 2H, H
B5
), 6.50 (d, J = 1.8 Hz, 2H, H
A6
), 0.93 (s, 18H, H
tBu
). 
13
C{
1
H} NMR (126 MHz, 
CD3CN) δ/ppm 166.2 (C
B2
), 156.6 (C
E2
), 152.3 (C
E6
), 150.9 (C
B6
), 150.6 (C
A1/A5
), 
150.1 (C
A2
), 140.8 (C
E4
), 140.4 (C
B4
), 135.9 (C
A5/A1
), 133.2 (C
A6
), 129.6 (C
E5
), 126.3 (C
B5
), 
125.9 (C
E3
), 125.5 (C
A4
), 125.4 (C
A3
), 122.5 (C
B3
), 60.3 (C
CtBu
), 23.5 (C
tBu
). IR (solid, ṽ/cm–1) 
2979 (w), 1607 (w), 1575 (w), 1475 (m), 1448 (w), 1430 (w), 1373 (w), 1285 
(m), 1193 (w), 1129 (s), 1082 (m), 836 (s), 806 (m), 781 (m), 764 (m), 730 (w), 710 (m), 672 
(m), 658 (m), 648 (m), 585 (m), 569 (m), 556 (s), 492 (m). UV/Vis (CH3CN, 0.99 × 10
–5
 mol 
dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 257 (59 000), 295 sh (35 000), 391 (4700), 420 sh (3400). 
Emission (CH3CN, 0.99 × 10
–5
 mol dm
–3
, λexc = 262 nm) λem
max
 = 493, 523 nm. ESI-MS m/z 
897.2 [M–PF6]
+
 (calc. 897.2). Found C 45.51, H 4.05, N 5.56; C40H40F6IrN4O4PS2·H2O 
requires C 45.32, H 3.99, N 5.29%. 
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8.16. [Ir(6)2(bpy)][PF6] 
1-Dodecanethiol (60.0 µL, 50.4 mg, 
0.249 mmol, 3.9 eq.) was added to a suspension 
of NaH (60% in mineral oil, 10.0 mg, 
0.250 mmol, 3.9 eq.) in DMF (2 mL) under N2 
atmosphere. The mixture was stirred at room 
temperature for 10 min. [Ir(1)2(bpy)][PF6] 
(53.0 mg, 63.3 mmol, 1.0 eq.) was added to the reaction mixture; this was heated at 120 °C 
for 1.5 h. The dark brown mixture was allowed to cool to room temperature and was then 
poured into a mixture of H2O and brine (3:1, 20 mL). The resulting suspension was stirred for 
30 min at room temperature. The brown-yellow precipitate was separated by filtration and 
was washed with H2O. The solid was redissolved in CH2Cl2 and the solution dried over 
Na2SO4. Solvent was removed under reduced pressure and the product was purified by 
column chromatography (silica, CH2Cl2 changing to CH2Cl2–2% MeOH). [Ir(6)2(bpy)][PF6] 
was isolated as an orange solid (56.1 mg, 46.7 µmol, 73.8%). 
1
H NMR (500 MHz, CD3CN) 
δ/ppm 8.54 (pseudo-dt, J = 8.3, 1.0 Hz, 2H, HE3), 8.15 (pseudo-td, J = 7.9, 1.6 Hz, 2H, HE4), 
8.06 (ddd, J = 5.4, 1.5, 0.7 Hz, 2H, H
E6
), 8.00 (pseudo-dt, J = 8.4, 1.1 Hz, 2H, H
B3
), 7.83 
(ddd, J = 8.2, 7.4, 1.5 Hz, 2H, H
B4
), 7.68 (d, J = 8.3 Hz, 2H, H
A3
), 7.58 (pseudo-dt, J = 5.9, 
1.1 Hz, 2H, H
B6
), 7.53 (ddd, J = 7.7, 5.4, 1.2 Hz, 2H, H
E5
), 7.00 (ddd, J = 7.3, 5.8, 1.4 Hz, 2H, 
H
B5
), 6.94 (dd, J = 8.2, 1.9 Hz, 2H, H
A4
), 6.09 (d, J = 1.9 Hz, 2H, H
A6
), 2.63 (m, 4H, H
SCH2
), 
1.40 (m, 4H, H
SCH2CH2
), 1.35–1.16 (overlapping m, 36H, HCH2), 0.89 (t, J = 7.0 Hz, 6H, HCH3). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 168.0 (C
B2
), 156.7 (C
E2
), 151.8 (C
A1+E6
), 150.1 
(C
B6
), 141.6 (C
A2
), 141.5 (C
A5
), 140.3 (C
E4
), 139.4 (C
B4
), 129.4 (C
E5
), 128.7 (C
A6
), 126.1 
(C
A3
), 125.6 (C
E3
), 123.9 (C
B5
), 122.0 (C
A4
), 120.5 (C
B3
), 32.6 (C
CH2
), 32.0 (C
SCH2
), 30.3 
(C
CH2
), 30.3 (C
CH2
), 30.2 (C
CH2
), 30.1 (C
CH2
), 29.9 (C
CH2
), 29.7 (C
SCH2CH2
), 29.4 (C
CH2
), 23.4 
(C
CH2
), 14.4 (S
CH3
). IR (solid, ṽ/cm–1) 2922 (m), 2852 (m), 1606 (m), 1567 (m), 1537 (w), 
1472 (m), 1446 (m), 1423 (m), 1373 (w), 1315 (w), 1261 (w), 1244 (w), 1164 (w), 1095 (m), 
1062 (w), 1030 (w), 876 (w), 835 (s), 791 (m), 769 (s), 732 (m), 650 (w), 639 (w), 556 (s), 
520 (w). UV/Vis (CH3CN, 0.99 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 251 (41 000), 310 
(36 000), 400 sh (8200). Emission (CH3CN, 0.99 × 10
–5
 mol dm
–3
, λexc = 252 nm) λem
max
  = 
583 nm. ESI-MS m/z 1058.1 [M–PF6]
+
 (calc. 1057.5). Found C 56.02, H 6.00, N 4.73; 
C56H72F6IrN4PS2 requires C 55.93, H 6.04, N 4.66%. 
CHAPTER I: YELLOW & GREEN EMITTERS – THIOETHER- AND SULFONE-SUBSTITUTED 
CYCLOMETALLATING LIGANDS 
 
 
 
 - 47 -  
 
8.17. [Ir(7)2(bpy)][PF6] 
[Ir(7)2Cl]2 (214 mg, 0.107 mmol, 1.0 eq.) and 
bpy (50.1 mg, 0.321 mmol, 3.0 eq.) were 
suspended in MeOH (15 mL) and the mixture 
was heated at reflux for 2 d. After cooling to 
room temperature, the mixture was filtered. An 
excess of NH4PF6 followed by H2O were added 
to the orange filtrate and the resulting suspension was stirred for 5 min. The precipitate was 
collected by filtration, washed with H2O and redissolved in CH2Cl2. Solvent was removed 
under reduced pressure and the residue was purified twice by column chromatography (silica, 
CH2Cl2 changing to CH2Cl2–1% MeOH; silica, CH2Cl2–1% MeOH). [Ir(7)2(bpy)][PF6] was 
isolated as a yellow solid (81.1 mg, 64.0 µmol, 30.0%). 
1
H NMR (500 MHz, CD3CN) δ/ppm 
8.56 (pseudo-dt, J = 8.4, 1.0 Hz, 2H, H
E3
), 8.23 (pseudo-dt, J = 8.1, 0.9 Hz, 2H, H
B3
), 8.17 
(pseudo-td, J = 7.9, 1.5 Hz, 2H, H
E4
), 8.04–7.96 (overlapping m, 6H, HA3+B4+E6), 7.71 (ddd, 
J = 5.8, 1.5, 0.7 Hz, 2H, H
B6
), 7.55–7.47 (m, 4H, HA4+E5), 7.21 (ddd, J = 7.5, 5.8, 1.4 Hz, 2H, 
H
B5
), 6.58 (d, J = 1.8 Hz, 2H, H
A6
), 2.87 (m, 4H, H
SO2CH2
), 1.40–1.01 (overlapping m, 40H, 
H
CH2
), 0.88 (t, J = 7.1 Hz, 6H, H
CH3
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.2 (C
B2
), 
156.6 (C
E2
), 152.1 (C
E6
), 151.1 (C
A1/A5
), 150.9 (C
B6
), 150.1 (C
A2
), 140.8 (C
E4
), 140.4 (C
B4
), 
140.3 (C
A5/A1
), 130.8 (C
A6
), 129.6 (C
E5
), 126.3 (C
B5
), 126.2 (C
A3
), 125.9 (C
E3
), 123.2 (C
A4
), 
122.5 (C
B3
), 56.3 (C
SO2CH2
), 32.6 (C
CH2
), 30.33 (C
CH2
), 30.32 (C
CH2
), 30.2 (C
CH2
), 30.1 (C
CH2
), 
30.0 (C
CH2
), 29.7 (C
CH2
), 28.6 (C
CH2
), 23.8 (C
CH2
), 23.4 (C
CH2
), 14.4 (C
CH3
). IR (solid, ṽ/cm–1) 
2923 (m), 2853 (w), 1608 (w), 1576 (w), 1476 (m), 1448 (w), 1430 (w), 1375 (w), 1294 (m), 
1140 (s), 1090 (m), 1063 (w), 836 (s), 762 (s), 728 (m), 667 (m), 652 (w), 606 (m), 582 (w), 
556 (s), 500 (m). UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 256 
(58 000), 310 sh (25 000), 350 sh (7900), 390 (5000), 420 sh (3700). Emission (CH3CN, 
1.0 × 10
–5
 mol dm
–3
, λexc = 262 nm) λem
max
 = 493, 524 nm. ESI-MS m/z 1121.6 [M–PF6]
+
 (calc. 
1121.5). Found C 53.38, H 5.57, N 4.72; C56H72F6IrN4O4PS2 requires C 53.11, H 5.73, 
N 4.42%. 
8.18. Crystallography 
2-(4-(Methylsulfonyl)phenyl)pyridine (H3). C12H11NO2S, M = 233.29, colourless block, 
monoclinic, space group C2/c, a = 23.4437(15), b = 7.1763(5), c = 16.5008(11) Å, β = 
129.026(3)
o
, U = 2156.6(2) Å
3
, Z = 8, Dc = 1.437 Mg m
–3
, µ(Mo-Kα) = 0.282 mm−1, T = 
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123 K. Total 30251 reflections, 3021 unique, Rint = 0.0269. Refinement of 2681 reflections 
(146 parameters) with I>2σ (I) converged at final R1 = 0.0323 (R1 all data = 0.0376), wR2 = 
0.0913 (wR2 all data = 0.0962), gof = 1.057. CCDC 972690. 
2-(4-(tert-Butylsulfonyl)phenyl)pyridine (H5). C15H17NO2S, M = 275.37, colourless block, 
monoclinic, space group C2/c, a = 22.2664(12), b = 6.1121(4), c = 22.0876(11) Å, β = 
110.398(2)
o
, U = 2817.5(3) Å
3
, Z = 8, Dc = 1.298 Mg m
–3
, µ(Mo-K) = 2.019 mm−1, T = 
296 K. Total 7450 reflections, 2523 unique, Rint = 0.0275. Refinement of 2228 reflections 
(175 parameters) with I>2σ (I) converged at final R1 = 0.0378 (R1 all data = 0.0420), wR2 = 
0.1024 (wR2 all data = 0.1068), gof = 1.080. CCDC 972692. 
[Ir(3)2Cl]2·2CH2Cl2. C50H44Cl6Ir2N4O8S4, M = 1554.31, yellow plate, orthorhombic, space 
group Pbca, a = 22.0732(12), b = 21.3598(11), c = 23.0604(12) Å, U = 10872.5(10) Å
3
, Z = 
8, Dc = 1.899 Mg m
–3
, µ(Cu-Kα) = 13.963 mm−1, T = 123 K. Total 59052 reflections, 9726 
unique, Rint = 0.1107. Refinement of 6764 reflections (699 parameters) with I>2σ (I) 
converged at final R1 = 0.0470 (R1 all data = 0.0820), wR2 = 0.1111 (wR2 all data = 0.1295), 
gof = 1.008. CCDC 972691. 
-[Ir(1)2(bpy)][PF6]. C32H22F2IrN4P, M = 837.73, yellow block, trigonal, space group 
P3121, a = b = 13.9523(9), c = 26.0654(17) Å, U = 4394.3(6) Å
3
, Z = 6, Dc = 1.899 Mg m
–3
, 
µ(Cu-Kα) = 10.083 mm−1, T = 123 K. Total 67974 reflections, 5359 unique, Rint = 0.0341. 
Refinement of 5311 reflections (415 parameters) with I>2σ (I) converged at final R1 = 0.0170 
(R1 all data = 0.0172), wR2 = 0.0436 (wR2 all data = 0.0437), gof = 1.098, Flack parameter = 
0.007(2). CCDC 972693. 
rac-4{[Ir(1)2(bpy)][PF6]}·Et2O·2CH2Cl2. C134H102Cl4F32Ir4N16OP4, M = 3594.88, yellow 
block, triclinic, space group P–1, a = 14.2353(6), b = 16.2890(7), c = 17.6451(7) Å, α = 
66.1650(10), β = 81.642(2), γ = 67.3900(10)o, U = 3454.7(3) Å3, Z = 1, Dc = 1.728 Mg m
–3
, 
µ(Cu-Kα) = 9.298 mm−1, T = 296 K. Total 23674 reflections, 11699 unique, Rint = 0.0287. 
Refinement of 10552 reflections (906 parameters) with I>2σ (I) converged at final R1 = 
0.0368 (R1 all data = 0.0399), wR2 = 0.1120 (wR2 all data = 0.1168), gof = 1.036. CCDC 
972694. 
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CHAPTER II: GREEN EMITTERS – REGIOISOMERISM IN 
SULFONYL-FUNCTIONALIZED COMPLEXES 
 
1. Introduction 
The majority of iridium complexes used in OLEDs and LEECs contain substituents in 5-
position of the cyclometallated phenyl ring (see Scheme 7 for numbering). Complexes with 
functional groups in 4-position are less well represented,
113,114
 and even fewer examples are 
known with substitution in 3-position.
82
 Furthermore, only a few reports exist in which a 
specific substituent was placed subsequently in each of the three positions and the influence 
of the substitution pattern was investigated. In the literature, series of regioisomeric iridium 
complexes that were examined include functionalization with diphenylamino,
115
 fluoro,
116
 
methyl,
117
 trifluoromethyl,
118,119
 methylpyridinium,
120
 bromo and fluorenyl
121
 and 
benzylsulfonyl
90
 groups. The largest influence on the emission colour was found to be exerted 
by a substituent in 4-position (para to the Ir–C bond). This finding was supported by DFT 
calculations.
117
 Only in the study by Bronstein et al.
121
 investigating bromo and fluorenyl 
substituents on the phenyl ring of the cyclometallating phenylisoquinoline ligands, differing 
results were obtained. They showed that the largest red-shift in the emission maximum is 
obtained by substitution in the 3-position (bromo) or 5-position (fluorenyl). In both cases, the 
functional group is placed meta to the Ir–C bond. 
 
 
Scheme 7 Chemical structure of [Ir(ppy)2(bpy)]
+
 as a representative example including 
numbering of the phenyl ring of the cyclometallating ligand. 5- and 3-positions: meta with 
respect to Ir–C bond; 4-position: para to Ir–C bond.
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In this chapter, the synthesis of a series of regioisomeric iridium complexes with 
methylsulfonyl groups in 3-, 4- and 5-position of the cyclometallating phenyl ring is 
described. Photophysical and electrochemical properties are compared with respect to the 
substitution pattern. Finally, the influence on device properties of light emitting 
electrochemical cells containing the prepared complexes is investigated. 
 
2. Synthesis and NMR Spectroscopic Characterization 
2.1. Ligand synthesis 
 
 
Scheme 8 Synthetic route to cyclometallating ligand H8. Reaction conditions: a) PdCl2, K2CO3, 
EtOH/H2O 1:1, reflux, overnight; b) NaSMe, NMP, MW, 120 °C, 1 h, N2; c) Na2WO4·2H2O, 
H2O2, MeOH, room temperature, overnight.
 
 
2-(3-Methylsulfonylphenyl)pyridine (H8) was synthesized in a similar manner to ligand H3, 
described in Chapter I. The synthetic route is shown in Scheme 8. 2-(3-Fluorophenyl)pyridine 
is prepared via a Suzuki coupling reaction from 2-bromopyridine and 3-fluorophenylboronic 
acid, catalysed by PdCl2. In the next step, the fluorine is replaced by a methylthiolate in a 
nucleophilic aromatic substitution reaction to yield 2-(3-methylthiophenyl)pyridine, which is 
subsequently oxidized with sodium tungstate dihydrate–hydrogen peroxide in methanolic 
solution to yield the desired ligand H8 in 54% yield over three steps. 2-(3-
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Methylsulfonylphenyl)pyridine (H8) was fully characterized by NMR and IR spectroscopies, 
LC-ESI mass spectrometry, melting point and elemental analysis. 
The synthesis of the ligand 2-(2-methylsulfonylphenyl)pyridine (H9) was achieved 
using a different approach, according to a procedure described in the literature (Scheme 
10).
122,123
 The intermediate 2-(2-dibromoborylphenyl)pyridine was obtained in good yield via 
an electrophilic aromatic borylation reaction using 2-phenylpyridine and boron tribromide. 
The nitrogen atom of the pyridine ring acts as a directing group in this case. Ishida et al.
122
 
have proposed a probable mechanism for the borylation of 2-phenylpyridine, shown in 
Scheme 9. In the first step, coordination occurs from the Lewis basic pyridine nitrogen to the 
Lewis acidic boron atom of BBr3. Next, a second BBr3 molecule abstracts a bromide from 
intermediate O, leading to the formation of salt P. Subsequent electrophilic attack of the 
coordinated boron atom on the neighbouring phenyl ring and rearomatization by 
deprotonation with N,N-diisopropylethylamine leads to final product R. 
 
 
Scheme 9 Reaction mechanism for the borylation of 2-phenylpyridine, as proposed by Ishida et 
al.
122
 
 
Treatment of the pyridine–dibromoborane intermediate with sodium methanesulfinate in a 
copper-catalysed aerobic oxidative coupling reaction yielded the desired ligand 2-(2-
methylsulfonylphenyl)pyridine (H9).
123
 Cu2O/NH3 was used as the catalyst in ethanolic 
solution at 45 °C under air to give H9 in good yield (Scheme 10). 
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Scheme 10 Synthetic pathway to ligand H9. Reaction conditions: a) BBr3, 
i
Pr2NEt, CH2Cl2, 
room temperature, 24 h; b) NaSO2Me, Cu2O, aq. NH3, 45 °C, overnight.
 
 
2.2. Synthesis of [Ir(C^N)2Cl]2 dimers 
The synthetic pathway to chlorido-bridged dimers [Ir(C^N)2Cl]2 with C^N = 3, 8 and 9 is 
shown in Scheme 11. [Ir(3)2Cl]2 (cf. Chapter I) and [Ir(8)2Cl]2 were prepared in excellent 
yields by reaction of [Ir(cod)Cl]2 with the appropriate cyclometallating ligand (H3 or H8) in 
2-ethoxyethanol under reflux conditions. For [Ir(9)2Cl]2, different reaction conditions were 
tested: Starting from IrCl3·xH2O, [Ir(cod)Cl]2 and Ir(tht)3Cl3, both under reflux and in a 
microwave reactor. The most successful route proved to be a microwave-assisted 
complexation using IrCl3·xH2O in a mixture of 2-ethoxyethanol and H2O (3:1). With this 
method, the desired iridium dimer was obtained in good yield. For both reactions with 
Ir(tht)3Cl3, only unreacted ligand was observed, as well as for the microwave reaction starting 
with [Ir(cod)Cl]2. In the case of the reflux reactions with both IrCl3·xH2O and [Ir(cod)Cl]2, the 
desired product was obtained containing undefined impurities. 
 Dimers [Ir(C^N)2Cl]2 with C^N = 8 and 9 were characterized by 
1
H NMR and IR 
spectroscopies, LC-ESI mass spectrometry and, in the case of [Ir(9)2Cl]2, elemental analysis. 
The base peaks at m/z 657 in the LC-ESI mass spectra correspond to the [Ir(C^N)2]
+
 ions; 
further peaks at m/z 698 and 739 were observed for [Ir(C^N)2(CH3CN)]
+
 and 
[Ir(C^N)2(CH3CN)2]
+
, respectively. The coordinating acetonitrile stems from the eluent of the 
LC column. 
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Scheme 11 Synthetic route to iridium dimers [Ir(C^N)2Cl]2 (C^N = 3, 8, 9). Reaction 
conditions: a) [Ir(cod)Cl]2, 2-ethoxyethanol, reflux, overnight, N2; b) IrCl3·xH2O, 2-
ethoxyethanol/H2O 3:1, MW, 110 °C, 1.5 h, N2.
 
 
2.3. Synthesis of [Ir(C^N)2(bpy)][PF6] complexes 
 
 
Scheme 12 Synthesis of iridium complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9. 
Reaction conditions: a) 2,2'-bipyridine, MeOH, MW, 120 °C, 1 h; then NH4PF6.
 
 
Dimers were cleaved using the 2,2'-bipyridine ancillary ligand in MeOH under microwave 
conditions (Scheme 12). Subsequent anion exchange with an excess of solid NH4PF6 added to 
the chloride salts dissolved in a small amount of MeOH gave the desired complexes in 45 to 
84% yield. The complexes were separated by filtration after ion metathesis; the low yield of 
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[Ir(8)2(bpy)][PF6] can be explained by the better solubility in MeOH of this complex with 
respect to [Ir(3)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6]. 
Complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 were fully characterized using 
NMR and IR spectroscopies, ESI mass spectrometry and elemental analysis. The base peak in 
the ESI mass spectrum of each complex was assigned to the [Ir(C^N)2(bpy)
+
 ion; the 
characteristic iridium isotope pattern was observed for all three complexes. 
1
H and 
13
C NMR 
signals were assigned using 2D experiments (COSY, HMQC and HMBC). The 
1
H NMR 
spectra including full assignment are shown in Fig. 20; for numbering see Scheme 12. By 
changing the substitution position from 5- to 4- and 3-position, the methyl group signal is 
shifted downfield from δ 2.89 to 3.04 to 3.25 ppm (Δδ = 0.36 ppm). The largest shift is 
observed for signal H
B3
 (on the C^N pyridyl ring), which moves from δ 8.23 and 8.26 ppm for 
[Ir(3)2(bpy)][PF6] and [Ir(8)2(bpy)][PF6], respectively, to δ 9.30 ppm for [Ir(9)2(bpy)][PF6], 
corresponding to a chemical shift difference Δδ of over 1 ppm. This significant shift can be 
explained by intramolecular interactions between the sulfone oxygen atoms and proton H
B3
 in 
[Ir(9)2(bpy)][PF6], supported by crystal structure data (vide infra). For phenyl proton H
A6
, it is 
possible to see the distance influence of the sulfonyl group: H
A6
 resonates at highest 
frequency with the sulfone group ortho (5-position, δ 6.70 ppm), followed by meta (4-
position, δ 6.54 ppm) and para (3-position, δ 6.47 ppm). Chemical shift differences of the 
remaining A ring protons (H
A3
, H
A4
 and H
A5
) are in the range Δδ 0.28 to 0.32 ppm. No or 
negligible shifts are observed for bipyridyl proton signals (E ring) and H
B4
, H
B5
 and H
B6
, with 
Δδ ≤ 0.1 ppm. All of these protons are remote from the strongly electron-withdrawing sulfone 
group and the substitution position therefore does not exert a large influence on the chemical 
shift. 
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Fig. 20 500 MHz 
1
H NMR spectra of complexes [Ir(C^N)2(bpy)][PF6] (C^N = 3, 8, 9) in CD3CN 
solution including assignments. For numbering, see Scheme 12. Scale: δ/ppm. 
 
3. Crystal Structures 
X-ray quality single crystals of 2{[Ir(3)2(bpy)][PF6]}·7CH2Cl2, 2{[Ir(8)2(bpy)][PF6]}·5.5H2O 
and [Ir(9)2(bpy)][PF6] were grown by layering a CH2Cl2 solution of the complex with Et2O, 
an CH3CN solution of the complex with tert-butyl methyl ether (t-BME) and an CH3CN 
solution of the complex with Et2O, respectively. Structures of the [Ir(C^N)2(bpy)]
+
 cations are 
shown in Fig. 21 to Fig. 23; selected bond lengths and angles are given in the figure captions. 
2{[Ir(3)2(bpy)][PF6]}·7CH2Cl2 crystallizes in the orthorhombic space group Pbca; 
2{[Ir(8)2(bpy)][PF6]}·5.5H2O and [Ir(9)2(bpy)][PF6] crystallize in the monoclinic space 
groups P21/c and C2/c, respectively. 
 Solvent molecules are heavily disordered in 2{[Ir(1)2(bpy)][PF6]}·7CH2Cl2 and have 
been modelled over four sites with fractional occupancies. The asymmetric unit of 
2{[Ir(8)2(bpy)][PF6]}·5.5H2O contains two independent Λ-cations and two ordered [PF6]
−
 
anions, one of which is half occupancy. Furthermore, the P atom of the third [PF6]
−
 anion lies 
on a special position and is shared equally between two unit cells. In [Ir(9)2(bpy)][PF6], half a 
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cation and half an anion are present in the asymmetric unit. The second half is generated by a 
C2 axis through the central iridium atom, parallel to the b axis of the unit cell. All complexes 
crystallize in achiral space groups; both enantiomers are therefore present in the unit cell. 
 
 
Fig. 21 Structure of the Λ-[Ir(3)2(bpy)]
+
 cation in 2{[Ir(3)2(bpy)][PF6]}·7CH2Cl2, H atoms and 
solvent molecules omitted and ellipsoids plotted at 40% probability level. Selected bond 
parameters: Ir1–N1 = 2.133(5), Ir1–N2 = 2.134(4), Ir1–N3 = 2.044(5), Ir1–N4 = 2.057(5), Ir1–
C17 = 2.029(5), Ir1–C29 = 2.009(5), C34–S2 = 1.757(7), S1–O1 = 1.435(5), S1–O2 = 1.440(5), 
S2–O3 = 1.437(6), S2–O4 = 1.451(6), C22–S1 = 1.748(7) Å; N1–Ir1–N2 = 77.53(19), N3–Ir1–
C17 = 80.70(19), N4–Ir1–C29 = 80.53(19), N3–Ir1–N4 = 174.41(18), N1–Ir1–C29 = 174.1(2), 
N2–Ir1–C17 = 174.4(2), O1–S1–O2 = 118.2(3), O3–S2–O4 = 118.2(4)°. 
 
By moving the methylsulfonyl group from the 5- to 4- and 3-position, the twist between the 
two pyridyl ring planes in the bpy ancillary ligand becomes substantially larger. The bpy is 
nearly planar in 2{[Ir(3)2(bpy)][PF6]}·7CH2Cl2, with an angle of 3.0° between the planes. 
Moving to 2{[Ir(8)2(bpy)][PF6]}·5.5H2O, the deviation from planarity becomes larger, as 
angles of 6.4 and 7.8° between the pyridyl ring planes are observed in the two independent 
cations. Due to the large steric hindrance introduced by substitution in the 3-position – as in 
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the case of [Ir(9)2(bpy)][PF6] – the two bpy pyridyl rings are significantly distorted from 
planarity, with an angle of 13.6° between the planes of the rings. 
 
 
Fig. 22 Structure of one of the independent Λ-[Ir(8)2(bpy)]
+
 cations in the asymmetric unit in 
2{[Ir(8)2(bpy)][PF6]}·5.5H2O, H atoms and solvent molecules omitted and ellipsoids plotted at 
40% probability level. Selected bond parameters: Ir1–N2 = 2.134(4), Ir1–N9 = 2.134(4), Ir1–
N14 = 2.045(4), Ir1–N29 = 2.045(4), Ir1–C21 = 2.000(4), Ir1–C32 = 2.006(4), S1–C13 = 
1.719(10), S1–O27 = 1.454(6), S1–O28 = 1.415(5), S2–O38 = 1.431(4), S2–O39 = 1.431(4), 
C40–S2 = 1.761(6) Å; N2–Ir1–N9 = 76.72(16), N14–Ir1–C21 = 80.67(16), N29–Ir1–C32 = 
80.61(16), N14–Ir1–N29 = 172.70(14), N2–Ir1–C21 = 175.99(16), N9–Ir1–C32 = 173.13(16), 
O27–S1–O28 = 114.8(4), O38–S2–O39 = 117.5(3)°. 
 
As described in the literature for series of aryl–aryl105,124 and aryl–alkyl105 sulfones, short 
intramolecular CH···OS contacts between the sulfonyl oxygen atoms and the aryl protons of 
the adjacent pyridyl ring were observed in ligands H3 and H5
95
 and dimer [Ir(3)2Cl]2
95
 
(Chapter I). Such interactions in the range 2.55–2.70 Å are also seen in [Ir(3)2(bpy)]
+
. These 
optimized contacts are due to twists of the sulfone groups with respect to the phenyl ring they 
are attached to, giving rise to torsion angles of 14.8 (O3–S2–C31–C30), –34.5 (O4–S2–C31–
C32), 20.8 (O1–S1–C19–C18) and –30.2° (O2–S1–C19–C20). Similar observations are made 
for [Ir(8)2(bpy)]
+
, leading to intramolecular CH···OS contacts ranging from 2.50 to 2.80 Å. In 
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[Ir(9)2(bpy)]
+
, however, steric hindrance induces a different arrangement of the sulfone 
substituents, resulting in short contacts between the sulfonyl oxygen and the adjacent pyridyl 
ring of 2.49 Å (O1···HC4) and 2.77 Å (O2···HC4). 
 Furthermore, the steric hindrance introduced in [Ir(9)2(bpy)]
+
 causes a significant 
distortion of the phenylpyridine cyclometallating ligand, as observed by an angle of 22.2° 
between the phenyl and pyridyl ring planes. In both [Ir(3)2(bpy)]
+
 and [Ir(8)2(bpy)]
+
, no such 
severe deviation from planarity is seen and the corresponding angles between the ring planes 
lie in the range 2.0–6.2°. 
 
 
Fig. 23 Structure of the Λ-[Ir(9)2(bpy)]
+
 cation in [Ir(9)2(bpy)][PF6], H atoms omitted for clarity 
and ellipsoids plotted at 40% probability level. Symmetry code: i = 1–x,y,½–z. Selected bond 
parameters: Ir1–N1 = 2.036(2), Ir1–N2 = 2.146(2), Ir1–C7 = 2.007(2), S1–O1 = 1.432(2), S1–
O2 = 1.433(2), C12–S1 = 1.763(3) Å; N1–Ir1–C7 = 80.08(9), N2–Ir1–N2i = 76.83(11), N2–Ir1–
C7
i
 = 173.07(9), N1–Ir1–N1i = 173.67(11), O1–S1–O2 = 118.38(18)°. 
 
4. Photophysical Properties 
UV-Vis absorption spectra of compounds [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 in 
CH3CN solution are given in Fig. 24. The spectra of the regioisomeric complexes are similar 
and show dominant absorption bands in the UV region (λmax = 253–259 nm), ascribed to spin-
allowed π*←π transitions based on the ligands. Between 350–450 nm, less intense absorption 
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bands correspond to spin-allowed 
1
MLCT and 
1
LLCT transitions. At even lower energy 
(<450 nm), very weak tails into the visible region are observable which arise from spin-
forbidden direct population of the triplet excited states (
3
MLCT, 
3
LLCT and 
3
LC).
21
 
 
 
Fig. 24 UV-Vis absorption spectra of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 in 
CH3CN solution (1.0 × 10
−5
 M). 
 
By excitation of CH3CN solutions of complexes [Ir(C^N)2(bpy)][PF6] (C^N = 3, 8, 9), the 
emission spectra shown in Fig. 25 were obtained. For all complexes, the emission maxima 
and profiles are independent of the excitation wavelength. All three complexes are green 
emitters in solution (cf. Fig. 26a); their emission maxima are blue-shifted by 68 to 92 nm with 
respect to unsubstituted parent complex [Ir(ppy)2(bpy)]
+
 (585 nm in CH3CN).
103
 The emission 
maximum blue-shift follows the trend 5-position > 3-position > 4-position. Comparison is 
difficult due to the different shapes of the emission bands, especially considering the broad 
and unstructured emission profile of [Ir(8)2(bpy)][PF6] in comparison to the vibrationally 
structured emission bands of [Ir(3)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6]. From the spectra it can 
be seen that the emissions of [Ir(8)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6] are in fact very similar, 
with the emission maximum of [Ir(8)2(bpy)][PF6] (517 nm) approximately halfway between 
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the two emission maxima of [Ir(9)2(bpy)][PF6] (506, 527 nm). [Ir(3)2(bpy)][PF6] (493, 
525 nm) exhibits definitely blue-shifted photoluminescence maxima compared to the other 
two complexes; however, the emission band of [Ir(8)2(bpy)][PF6] extends furthest into the 
shorter wavelength region of the spectrum. 
 As mentioned above, both [Ir(3)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6] exhibit vibrational 
structure in their photoluminescence bands. The emission of [Ir(8)2(bpy)][PF6] on the other 
hand is broad and unstructured. In general, a more structured emission profile indicates a 
larger ligand-centred (
3
LC) character of the emissive triplet state. Broad and unstructured 
emission bands – as observed for complex [Ir(8)2(bpy)][PF6] – suggest a more pronounced 
charge transfer character (
3
MLCT and 
3
LLCT).
21
 The trend in radiative decay rate constants 
(kr = PLQY/τ) further supports this assumption (Table 4): the higher kr, the larger the charge 
transfer character of the emissive triplet state.
21
 [Ir(8)2(bpy)][PF6] has a radiative decay rate 
constant of 7.2 × 10
5
 s
–1
 which is more than twice as high as those of the other two complexes 
(2.6 and 3.2 × 10
5
 s
–1
); the 
3
LC contribution is therefore the lowest in the compound where 
the methylsulfonyl substituent is placed para to the cyclometallated Ir–C bond. 
 In most of the series of regioisomeric iridium complexes reported in the literature, the 
largest influence on the emission maximum has been observed by the introduction of a 
substituent in 4-position of the cyclometallating ligand. This means that the strongest 
emission maximum blue-shift has been achieved by the introduction of an electron-
withdrawing moiety
90,113,116,118,120
 and the largest red-shift by an electron-donating group
115,117
 
para to the Ir–C bond. A different trend has been described by Bronstein et al.121 for their 
bromo- and fluorenyl-substituted regioisomers. In both of their series, a substituent in 5-
position (meta to the Ir–C bond) of the cyclometallating phenyl ring exerted the largest 
influence on the emission maximum. Their observation therefore fits well with the trend we 
have seen in our sulfonyl-substituted isomeric complexes. Regarding the nature of the 
emissive triplet state, our sulfone series can be compared to a series of sulfur pentafluoride-
functionalized iridium complexes.
113
 In both cases, moving the substituent from the 5- to 4-
position (from meta to para with respect to the Ir–C bond) increases the charge transfer and 
decreases the ligand-centred character of the emissive state. This is indicated by a broadening 
and loss of structure of the emission band as well as a shorter excited state lifetime. Due to 
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these different contributions of CT and 
3
LC states to the emissive triplet state, comparison 
within the series of methylsulfonyl iridium complexes is difficult. 
 
 
Fig. 25 Photoluminescence spectra in CH3CN solution (1.0 × 10
−5
 M) of complexes 
[Ir(C^N)2(bpy)][PF6] (C^N = 3, 8, 9). λexc = 400 nm. 
 
Table 4 Photophysical properties of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8, 9 in 
CH3CN solution. PLQYs measured in de-aerated solution, τ in de-aerated solution under Ar 
atmosphere. kr = PLQY/τ; knr = (1–PLQY)/τ. 
Compound 
λexc 
[nm] 
λem
max 
[nm] 
PLQY 
[%] 
τ [µs] 
(χ)a 
kr 
[10
5
 s
−1
] 
knr 
[10
5
 s
−1
] 
[Ir(3)2(bpy)][PF6] 262 493, 525 74 2.33 (1.3) 3.2 1.1 
[Ir(8)2(bpy)][PF6] 271 517 92 1.28 (1.1) 7.2 0.63 
[Ir(9)2(bpy)][PF6] 261 506, 527 77 2.97 (1.2) 2.6 0.77 
a
 λexc = 280 nm. 
High photoluminescence quantum yields between 74 and 92% were obtained for de-aerated 
CH3CN solutions of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 (Table 4). 
[Ir(8)2(bpy)][PF6], containing the methylsulfone substituent in 4-position of the 
cyclometallating ligand, exhibits a considerably higher quantum yield (92%) than the other 
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two complexes (74 and 77%). The same trend has been observed in the bromo- and fluorenyl-
functionalized isomeric complexes reported by Bronstein et al.
121
 In their series, substitution 
para to the Ir–C bond also resulted in the largest solution PLQY. 
 Excited state lifetimes are in the order of a few microseconds for [Ir(C^N)2(bpy)][PF6] 
(C^N = 3, 8, 9) in de-aerated CH3CN solution under argon atmosphere (Table 4). The τ values 
range from 1.28 µs for [Ir(8)2(bpy)][PF6] to 2.97 µs for [Ir(9)2(bpy)][PF6]. When solutions are 
not de-aerated, PLQYs are significantly lower (4.5 to 7.0%) and lifetimes significantly shorter 
(0.14 to 0.31 μs), suggesting strong excited state quenching effects due to oxygen present in 
the system. 
 
a) 
 
b) 
 
Fig. 26 Photographs of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 under 366 nm 
light excitation in a) CH3CN solution and b) the solid state (powder). 
 
Solid state emission spectra of powder samples of compounds [Ir(C^N)2(bpy)][PF6] with C^N 
= 3, 8 and 9 are depicted in Fig. 27. All three complexes are yellow emitters (cf. Fig. 26b) and 
the emission maxima lie in the range 535 to 542 nm. [Ir(3)2(bpy)][PF6] shows the largest 
emission maximum red-shift on going from solution to powder (42 nm), whereas 
[Ir(8)2(bpy)][PF6] has the smallest (25 nm). The vibrational structure observed in solution 
spectra of [Ir(3)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6] is almost completely lost in the solid state. 
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Fig. 27 Solid state emission spectra of powder samples of [Ir(C^N) 2(bpy)][PF6] with C^N = 3, 
8, 9. λexc = 340 nm. 
 
Table 5 Solid state photophysical properties of powder samples of [Ir(C^N) 2(bpy)][PF6] (C^N = 
3, 8 and 9). Biexponential fits were used for solid-state lifetime measurements, using the 
equation τave = ΣAiτi/ΣAi (Ai is the pre-exponential factor for the lifetime). 
Compound 
λem
max 
[nm]
a
 
PLQY 
[%]
b
 
τave [µs] 
(χ)c 
τ1 [µs] 
(A1)
c
 
τ2 [µs] 
(A2)
c
 
[Ir(3)2(bpy)][PF6] 535 6.6 0.475 (1.0) 0.299 (7035) 1.01 (691) 
[Ir(8)2(bpy)][PF6] 542 27 1.19 (1.1) 0.456 (2233) 1.58 (1201) 
[Ir(9)2(bpy)][PF6] 542 6.1 0.663 (1.0) 0.306 (4221) 1.41 (439) 
a
 λexc = 340 nm. 
b
 For λexc, see Table 4. 
c
 λexc = 280 nm. 
 
Photophysical properties of powder samples of complexes [Ir(C^N)2(bpy)][PF6] (C^N = 3, 8, 
9) are summarized in Table 5. Quantum yields are much lower in the solid state and range 
from 6.1 and 6.6% for [Ir(9)2(bpy)][PF6] and [Ir(3)2(bpy)][PF6], respectively, to 27% for 
[Ir(8)2(bpy)][PF6]. As in solution, [Ir(8)2(bpy)][PF6] (substituent para to Ir–C bond) again 
exhibits the highest quantum yield. Biexponential fits were used for the determination of 
excited state lifetimes of powder samples; τ values are shorter than for solution samples. 
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Strong photoluminescence quenching in the solid state due to intermolecular interactions is 
indicated by the loss of vibrational structure, lower quantum yields and shorter lifetimes.
78
 
 
5. Electrochemical Properties 
Electrochemical data of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 were obtained 
from cyclic voltammetry experiments in de-aerated CH3CN solution and are summarized in 
Table 6. In Fig. 28, the cyclic voltammogram of [Ir(8)2(bpy)][PF6] showing the oxidation and 
first reduction waves is depicted as a representative example. In complexes of the type 
[Ir(C^N)2(N^N)]
+
, the LUMO is located on the ancillary ligand. Since all three complexes 
contain a bpy ancillary ligand, the first reduction potentials should therefore be similar in 
[Ir(C^N)2(bpy)][PF6] (C^N = 3, 8 and 9). The first reduction waves are reversible and values 
are in the range −1.67 to −1.72 V; the numbers are comparable to unsubstituted reference 
compound [Ir(ppy)2(bpy)][PF6] (−1.77 V in DMF).
103
 Up to four more reduction waves in the 
case of [Ir(9)2(bpy)][PF6] are observed within the accessible solvent window. 
 
Table 6 Cyclic voltammetric data of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8, 9 vs. 
Fc/Fc
+
 in de-aerated CH3CN solution. Measured with glassy carbon working, Pt counter and Ag 
pseudo-reference electrode and 0.1 M TBAPF6 supporting electrolyte at a scan rate of 0.1 V s
−1
. 
qr = quasi-reversible, ir = irreversible. 
Compound E1/2
ox  [V] E1/2
red [V] ΔE1/2 [V] 
[Ir(3)2(bpy)][PF6] +1.18 –1.72, –2.16, –2.61
ir
 2.90 
[Ir(8)2(bpy)][PF6] +1.29 –1.67, –2.27
qr
, –2.52qr 2.96 
[Ir(9)2(bpy)][PF6] +1.20
qr
 –1.69, –2.06ir, –2.16ir, –2.34ir, –2.52ir 2.89 
 
One quasi-reversible or reversible oxidation wave is seen for complexes [Ir(C^N)2(bpy)][PF6] 
with C^N = 3, 8 and 9 in CH3CN solution. The oxidation is iridium-based with a considerable 
influence of the cyclometallating ligand. This is due to the location of the HOMO on the 
iridium centre and the phenyl rings of the C^N ligands. For the sulfone-substituted 
complexes, the oxidation potentials are in the range +1.18 to +1.29 V and are significantly 
shifted to higher potentials with respect to [Ir(ppy)2(bpy)]
+
 (+0.84 V in DMF).
103
 The 
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observed stabilization of the HOMO and thus larger oxidation potential is attributed to the 
strongly electron-withdrawing character of the sulfone substituent, removing electron density 
from the central iridium atom. The position of the methylsulfonyl group also plays a role in 
the degree of stabilization of the HOMO. Substitution para to the Ir–C bond leads to the 
highest oxidation potential (+1.29 V), whereas E1/2
ox  of the two complexes with sulfone 
substituents in meta position to the Ir–C bond are very similar (+1.18 and +1.20 V). As a 
consequence, compound [Ir(8)2(bpy)][PF6] has a slightly larger electrochemical HOMO-
LUMO gap than [Ir(3)2(bpy)][PF6] and [Ir(9)2(bpy)][PF6] (2.96 V vs. 2.90 and 2.89 V). 
 
 
Fig. 28 Cyclic voltammogram of [Ir(8)2(bpy)][PF6] in de-aerated CH3CN solution, showing the 
oxidation and the first reduction wave. The arrow indicates the initial scanning direction. 
 
6. Electroluminescence and Device Data 
Light-emitting electrochemical cells were assembled and measured by Dr. Henk Bolink and 
co-workers at the University of Valencia. Electroluminescence spectra were obtained for light 
emitting electrochemical cells containing complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 
and 9 and are given in Fig. 29. The device configuration used was 
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ITO/PEDOT:PSS/[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al and LEECs were measured using 
block-wave pulsed current with a frequency of 1 kHz, 50% duty cycles and an average current 
density of 100 A m
−2
.
21,80,82
 Electroluminescence maxima and device data are summarized in 
Table 7. 
All three regioisomeric methylsulfone complexes emit yellow-green 
electroluminescence with maxima in the range 549 to 560 nm. Electroluminescence maxima 
are therefore slightly red-shifted by 7–18 nm compared to solid state photoluminescence 
maxima of powder samples. 
 
 
Fig. 29 Electroluminescence spectra of complexes [Ir(C^N)2(bpy)][PF6] with C^N = 3, 8 and 9 
in device configuration: ITO/PEDOT:PSS/[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al. 
 
Maximum luminance levels (Lummax), power conversion efficiencies (PCE) and external 
quantum efficiencies (EQE) gained from measurements of LEECs containing 
[Ir(C^N)2(bpy)][PF6] with C^N = 3 and 9 are similar to each other (cf. Table 7, e.g. Lummax = 
182 and 206 cd m
−2
). For [Ir(8)2(bpy)][PF6], on the other hand, the values are roughly four to 
five times higher; the maximum luminance reaches 940 cd m
−2
 and maximum PCE and EQE 
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values are 4.4 lm W
−1
 and 2.6%, respectively. The significantly enhanced efficiency of a 
LEEC containing [Ir(8)2(bpy)][PF6], with respect to devices based on the other two 
regioisomers, may be rationalized by the significantly higher quantum yields of 
[Ir(8)2(bpy)][PF6] both in solution and powder. While maximum luminance levels and 
efficiency parameters of [Ir(C^N)2(bpy)][PF6] with C^N = 3 and 9 are poor, the values 
obtained from LEECs with [Ir(8)2(bpy)][PF6] are comparable to efficient green light emitting 
devices reported in the literature.
82,93,107,125
 
 
Table 7 Performance parameters of LEECs containing complexes [Ir(C^N) 2(bpy)][PF6] with 
C^N = 3, 8 and 9; measured under pulsed current conditions at an average current density of 
100 A m
−2
 (block wave, 1 kHz frequency, 50% duty cycle).
21,80,82
 
Compound 
ton 
[min] 
Lummax 
[cd m
–2
] 
t1/2 
[min] 
PCE 
[lm W
–1
] 
EQE 
[%] 
λEL
max 
[nm] 
[Ir(3)2(bpy)][PF6] 19 182 69 0.9 0.5 495 sh, 553 
[Ir(8)2(bpy)][PF6] 7 940 51 4.4 2.6 549 
[Ir(9)2(bpy)][PF6] 4 206 38 0.9 0.6 560 
 
Fig. 30 shows the performance of the different LEECs in terms of luminance and average 
voltage vs. time. One can see that turn-on times are reduced by moving the methylsulfone 
substituent from 5- to 4- and 3-position, resulting in a decrease from 19 minutes to seven and 
four minutes. In relation to the device lifetimes these values are still relatively high. The 
longest lifetime defined as t1/2 is observed for [Ir(3)2(bpy)][PF6] (5-SO2Me, 69 min), followed 
by [Ir(8)2(bpy)][PF6] (4-SO2Me, 51 min) and [Ir(9)2(bpy)][PF6] (3-SO2Me, 38 min). Device 
stability is therefore limited for LEECs containing our series of regioisomeric methylsulfonyl-
substituted iridium complexes; values obtained for both ton and t1/2 are however within the 
range of comparable green emitters used in light emitting electrochemical cells. Lifetimes 
reported in the literature lie between a few minutes
80,93,107,108
 and less than a hundred 
hours
80,82,93,107–110,125
 and turn-on times range from <5 s
80,82,93,107
 to several hours.
80,93,108,109,125
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Fig. 30 Luminance (solid lines) and average voltage curves (open squares) vs. time for 
[Ir(C^N)2(bpy)][PF6] (C^N = 3, 8, 9), measured under block-wave pulsed current conditions 
with a frequency of 1 kHz, 50% duty cycles and an average current density of 100 A m
−2
.
21,80,82
 
Device composition: ITO/PEDOT:PSS/[Ir(C^N)2(bpy)][PF6]:[Bmim][PF6] 4:1/Al. 
 
7. Conclusions 
A series of regioisomeric iridium complexes containing methylsulfonyl-functionalized 
cyclometallating ligands was prepared in order to study the effect of the substituent’s position 
on the photophysical, electrochemical and device properties. Single crystal data were obtained 
for all three complexes, showing the expected core structures and the influence of steric 
hindrance induced by the SO2Me group in the 3-position of the cyclometallating ligand, 
leading to ligand distortions. 
 All complexes are green emitters in solution and yellow emitters as powder samples. 
Vibrationally structured emission bands in CH3CN solution were observed for complexes 
with sulfone groups in the 3- and 5-position of the phenyl ring (meta to the Ir–C bond). The 
two complexes showed similar quantum yields and lifetimes. An enhanced PLQY of 92%, 
shorter excited state lifetime and a broad, unstructured emission profile were obtained for the 
4-substituted compound (substituent para to Ir–C bond). The lack of a vibrational emission 
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profile suggests a more pronounced charge transfer character of the emissive triplet state 
compared to the other two complexes. In the solid state (powder), emission maxima are red-
shifted, vibrational structure is lost and quantum yields and lifetimes are decreased, indicating 
excited state quenching due to intermolecular interactions. [Ir(8)2(bpy)][PF6] (4-SO2Me) 
again has the highest quantum yield of 27%. Electrochemical data parallel the 
photoluminescence trends and show that a methylsulfone substituent in para position to the 
Ir–C bond has the largest influence on the oxidation potential. 
 Yellow-green electroluminescence with maxima ranging from 549 to 560 nm is 
observed for LEECs with all complexes. Maximum luminance levels, power conversion 
efficiencies and EQEs are similar for complexes with the sulfone substituent meta to the Ir–C 
bond. For the complex containing the methylsulfonyl group in 4-position (para to the Ir–C 
bond), significantly higher luminance (940 cd m
−2
) and efficiencies (PCE = 4.4 lm W
−1
 and 
EQE = 2.6%) are obtained. The increased efficiency correlates with the higher solid state 
quantum yield. Lifetimes are unfortunately rather short and comparable for all devices, 
ranging from 38 to 69 min. 
 In order to achieve the desired blue emission, it is necessary to replace the 2,2'-
bipyridine by an electron-richer ancillary ligand which is capable of destabilizing the LUMO, 
leading to a larger HOMO-LUMO gap. As cyclometallating ligands, the methylsulfonyl-
functionalized phenylpyridines substituted in the 4- and 5-positions of the phenyl ring should 
be chosen, as they gave the most promising results concerning largest emission maximum 
blue-shift and highest quantum yield. In principle, it should then be possible to obtain 
fluorine-free blue emitting iridium complexes. Attempts to reach this goal are discussed in the 
next chapter of this thesis. 
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8. Experimental 
The following experimental procedures have been written by the author of this thesis and 
parts have been published in RSC Advances.
126
 
8.1. General 
The synthesis of [Ir(3)2(bpy)][PF6] was described in Chapter I.
127
 [Ir(cod)Cl]2
128
 and 2-(2-
methylsulfonylphenyl)pyridine (H9)
122,123
 were synthesized according to literature 
procedures. 3-Fluorophenylboronic acid was obtained from Fluorochem and purity was 
determined by 
1
H NMR spectroscopy to ca. 67%. 
8.2. 2-(3-Fluorophenyl)pyridine 
3-Fluorophenylboronic acid (67%, 1.67 g, 8.00 mmol, 1.5 eq.), 2-
bromopyridine (0.500 mL, 5.22 mmol, 1.0 eq.), PdCl2 (25.2 mg, 
0.142 mmol, 0.027 eq.) and K2CO3 (1.54 g, 11.1 mmol, 2.1 eq.) were 
suspended in EtOH and H2O (1:1, 40 mL). The mixture was heated at reflux overnight, then 
poured into brine (150 mL) and extracted with t-BME (3 × 150 mL). The combined organic 
layers were dried over Na2SO4 and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography (silica, toluene–ethyl acetate 5:1) to yield 2-
(3-fluorophenyl)pyridine as a colourless oil (764 mg, 4.41 mmol, 84.5%). 
1
H NMR (500 
MHz, CDCl3) δ/ppm 8.66 (pseudo-dt, J = 4.9, 1.3 Hz, 1H, H
B6
), 7.77–7.70 (overlapping m, 
2H, H
A2+A6
), 7.69–7.62 (overlapping m, 2H, HB3+B4), 7.41–7.35 (m, 1H, HA5), 7.18 (m, 1H, 
H
B5
), 7.07 (pseudo-td, J = 8.4, 2.3 Hz, 1H, H
A4
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 
163.3 (d, JCF = 245.3 Hz, C
A3
), 155.9 (d, JCF = 2.7 Hz, C
B2
), 149.7 (C
B6
), 141.7 (d, JCF = 7.6 
Hz, C
A1
), 136.8 (C
B4
), 130.2 (d, JCF = 8.2 Hz, C
A5
), 122.6 (C
B5
), 122.4 (d, JCF = 2.8 Hz, C
A6
), 
120.5 (C
B3
), 115.7 (d, JCF = 21.3 Hz, C
A4
), 113.8 (d, JCF = 22.8 Hz, C
A2
). LC-ESI-MS m/z 
174.0 [M+H]
+
 (calc. 174.1). Found C 75.95, H 4.87, N 8.25; C11H8FN requires C 76.29, 
H 4.66, N 8.09%. Spectroscopic data matched those reported in the literature.
129,130
 
8.3. 2-(3-Methylthiophenyl)pyridine 
A microwave vial was charged with 2-(3-fluorophenyl)pyridine (916 mg, 
5.29 mmol, 1.0 eq.) and N-methyl-2-pyrrolidone (18 mL) and purged with 
N2. Sodium thiomethoxide (1.51 g, 21.5 mmol, 4.1 eq.) was added and the 
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dark pink mixture was heated at 120 °C for 1 h in a microwave reactor. The resulting pale 
brown mixture was poured into H2O (150 mL) and brine (50 mL) and extracted with CH2Cl2 
(4 × 100 mL). The combined organic layers were washed with H2O (4 × 100 mL), dried over 
Na2SO4 and the solvent was removed under reduced pressure. The residue was purified by 
column chromatography (silica, toluene changing to toluene–ethyl acetate 1:1) to yield 2-(3-
methylthiophenyl)pyridine as a colourless liquid (826 mg, 4.10 mmol, 77.6%). 
1
H NMR 
(500 MHz, CDCl3) δ/ppm 8.70 (ddd, J = 4.8, 1.8, 1.0 Hz, 1H, H
B6
), 7.92 (pseudo-t, J = 
1.9 Hz, 1H, H
A2
), 7.79–7.69 (overlapping m, 3H, HA6+B3+B4), 7.39 (pseudo-t, J = 7.8 Hz, 1H, 
H
A5
), 7.31 (ddd, J = 7.8, 1.9, 1.1 Hz, 1H, H
A4
), 7.26–7.23 (m, 1H, HB5), 2.56 (s, 3H, HMe). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 157.1 (C
B2
), 149.8 (C
B6
), 140.2 (C
A1
), 139.3 (C
A3
), 
136.9 (C
B4
), 129.3 (C
A5
), 127.2 (C
A4
), 125.2 (C
A2
), 123.8 (C
A6
), 122.5 (C
B5
), 120.8 (C
B3
), 16.0 
(C
Me
). IR (solid, ṽ/cm–1) 3051 (w), 3006 (w), 2986 (w), 2920 (w), 2857 (w), 1722 (w), 1584 
(s), 1560 (s), 1457 (s), 1431 (s), 1400 (m), 1279 (m), 1261 (m), 1153 (m), 1096 (m), 1083 
(m), 1066 (m), 1041 (m), 990 (m), 966 (m), 902 (w), 882 (m), 800 (m), 764 (s), 742 (s), 687 
(s), 640 (m), 635 (m), 614 (m), 585 (m), 505 (w). LC-ESI-MS m/z 202.0 [M+H]
+
 (calc. 
202.1). Found C 71.15, H 5.88, N 6.78; C12H11NS requires C 71.60, H 5.51, N 6.96%. 
8.4. 2-(3-Methylsulfonylphenyl)pyridine (H8) 
2-(3-Methylthiophenyl)pyridine (826 mg, 4.10 mmol, 1.0 eq.) and 
sodium tungstate dihydrate (677 mg, 2.05 mmol, 0.50 eq.) were 
suspended in MeOH (25 mL). H2O2 (30%, 1.00 mL, 10.0 mmol, 2.4 eq.) 
was added and the suspension stirred at room temperature overnight. The mixture was poured 
into a mixture of H2O (150 mL) and saturated aqueous Na2CO3 solution (50 mL) and 
extracted with CH2Cl2 (3 × 100 mL). The combined organic layers were dried over Na2SO4 
and the solvent was removed under reduced pressure. The residue was purified by column 
chromatography (silica, CH2Cl2–1% MeOH changing to CH2Cl2–2% MeOH) to yield 2-(3-
methylsulfonylphenyl)pyridine (H8) as a white solid (786 mg, 3.37 mmol, 82.1%). M.p. 
94.3 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 8.74–8.68 (m, 1H, H
B6
), 8.57 (pseudo-t, J = 
1.9 Hz, 1H, H
A2
), 8.30 (m, 1H, H
A4
), 7.98 (pseudo-ddt, J = 7.7, 2.0, 1.0 Hz, 1H, H
A6
), 7.84–
7.75 (overlapping m, 2H, H
B3+B4
), 7.68 (pseudo-td, J = 7.8, 0.9 Hz, 1H, H
A5
), 7.30 (dddd, J = 
7.1, 4.9, 2.3, 0.8 Hz, 1H, H
B5
), 3.11 (s, 3H, H
Me
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 
155.2 (C
B2
), 150.1 (C
B6
), 141.3 (C
A3
), 141.0 (C
A1
), 137.2 (C
B4
), 132.1 (C
A4
), 130.0 (C
A5
), 
127.6 (C
A6
), 125.9 (C
A2
), 123.3 (C
B5
), 120.8 (C
B3
), 44.6 (C
Me
). IR (solid, ṽ/cm–1) 3080 (w), 
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2997 (w), 2916 (w), 1586 (m), 1565 (w), 1458 (m), 1444 (m), 1408 (w), 1323 (m), 1297 (s), 
1280 (m), 1145 (s), 1093 (m), 1066 (m), 992 (w), 975 (m), 916 (w), 886 (w), 818 (m), 780 
(m), 754 (s), 680 (m), 638 (w), 614 (m), 593 (m), 539 (s), 511 (s), 486 (m). LC-ESI-MS m/z 
234.0 [M+H]
+
 (calc. 234.1). Found C 61.53, H 4.98, N 6.22; C12H11NO2S requires C 61.78, 
H 4.75, N 6.00%. 
8.5. [Ir(8)2Cl]2 
2-(3-Methylsulfonylphenyl)pyridine (H8) (105 mg, 
0.450 mmol, 3.9 eq.) was dissolved in 2-
ethoxyethanol (3 mL). The solution was purged with 
N2, then [Ir(cod)Cl]2 (77.2 mg, 0.115 mmol, 1.0 eq.) 
was added. The mixture was heated at reflux 
overnight. After letting the mixture cool to room 
temperature, the precipitate was filtered off, washed with 2-ethoxyethanol, H2O and EtOH 
and dried under vacuum to yield [Ir(8)2Cl]2 as a yellow powder (131 mg, 94.6 µmol, 84.0%) 
which was used for subsequent reactions without further purification. 
1
H NMR (500 MHz, 
CDCl3) δ/ppm 9.19 (ddd, J = 5.7, 1.5, 0.7 Hz, 4H, H
B6
), 8.11 (ddd, J = 8.5, 1.4, 0.7 Hz, 4H, 
H
B3
), 8.05 (d, J = 2.0 Hz, 4H, H
A3
), 7.96 (ddd, J = 8.1, 7.6, 1.5 Hz, 4H, H
B4
), 7.09 (dd, J = 
8.3, 2.0 Hz, 4H, H
A5
), 6.98 (ddd, J = 7.3, 5.5, 1.4 Hz, 4H, H
B5
), 6.05 (d, J = 8.3 Hz, 4H, H
A6
), 
2.91 (s, 12H, H
Me
). IR (solid, ṽ/cm–1) 2922 (w), 1609 (m), 1577 (m), 1480 (m), 1423 (m), 
1401 (w), 1298 (s), 1224 (w), 1146 (s), 1096 (m), 1068 (m), 1054 (m), 1032 (m), 959 (s), 887 
(w), 827 (m), 784 (m), 761 (s), 728 (m), 703 (m), 639 (w), 593 (s), 558 (s), 522 (s), 486 (m), 
463 (m). LC-ESI-MS m/z 657.1 [Ir(C^N)2]
+
 (calc. 657.1), 698.1 [Ir(C^N)2(CH3CN)]
+
 (calc. 
698.1), 739.1 [Ir(C^N)2(CH3CN)2]
+
 (calc. 739.1). 
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8.6. [Ir(9)2Cl]2 
2-(2-Methylsulfonylphenyl)pyridine (H9) (354 mg, 
1.52 mmol, 1.8 eq.) was suspended in a mixture of 2-
ethoxyethanol and H2O (3:1, 4 mL) in a microwave vial and 
purged with N2. IrCl3·xH2O (ca. 82%, 307 mg, 0.842 mmol, 
1.0 eq.) was added and the mixture was heated at 110 °C for 
1.5 h in a microwave reactor (2 bar). The resulting precipitate 
was filtered off, washed with H2O and EtOH, redissolved in CH2Cl2 and the solvent was 
removed under reduced pressure. The orange precipitate which had formed in the filtrate was 
filtered off, washed with EtOH, redissolved with CH2Cl2 and the solvent removed. Both 
residues were combined to yield the product as a brownish-orange solid (424 mg, 
0.306 mmol, 80.5%). 
1
H NMR (500 MHz, CDCl3) δ/ppm 9.33 (pseudo-dt, J = 8.5, 1.1 Hz, 
4H, H
B3
), 9.14 (ddd, J = 5.8, 1.8, 0.8 Hz, 4H, H
B6
), 7.92 (ddd, J = 8.5, 7.4, 1.7 Hz, 4H, H
B4
), 
7.62 (dd, J = 7.7, 1.1 Hz, 4H, H
A4
), 6.90 (ddd, J = 7.3, 5.7, 1.4 Hz, 4H, H
B5
), 6.69 (pseudo-t, J 
= 7.8 Hz, 4H, H
A5
), 5.88 (dd, J = 7.9, 1.1 Hz, 4H, H
A5
), 3.22 (s, 12H, H
Me
). IR (solid, ṽ/cm–1) 
2928 (w), 1604 (w), 1561 (w), 1474 (m), 1422 (w), 1395 (w), 1290 (m), 1274 (m), 1256 (m), 
1154 (m), 1129 (s), 1067 (m), 961 (m), 786 (m), 755 (m), 736 (m), 722 (m), 709 (m), 646 (w), 
586 (w), 573 (w), 551 (w), 537 (s), 527 (s), 488 (s), 465 (m). LC-ESI-MS m/z 657.1 
[Ir(C^N)2]
+
 (calc. 657.1), 698.1 [Ir(C^N)2(CH3CN)]
+
 (calc. 698.1), 739.0 
[Ir(C^N)2(CH3CN)2]
+
 (calc. 739.1). Found C 40.62, H 3.28, N 4.08; 
C48H40Cl2Ir2N4O8S4·2H2O requires C 40.59, H 3.12, N 3.94%. 
8.7. General procedure for the synthesis of iridium(III) complexes 
The iridium dimer and ancillary ligand were suspended in MeOH (15 mL) in a microwave 
vial and heated at 120 °C for 1 h in a microwave reactor. The resulting yellow solution was 
filtered through cotton and concentrated under reduced pressure. The residue was dissolved in 
little MeOH, an excess of solid NH4PF6 was added and the resulting suspension was stirred 
for 5 min at room temperature. The yellow precipitate was filtered off and redissolved in 
CH2Cl2. The solvent was removed under reduced pressure and the crude product was purified 
by column chromatography (silica). Further purification was done by dissolving the residue in 
little CH2Cl2, precipitating with Et2O and leaving in the refrigerator overnight. The resulting 
precipitation was filtered off, washed with MeOH and Et2O and dried under vacuum. 
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8.8. [Ir(8)2(bpy)][PF6] 
[Ir(8)2Cl]2 (101 mg, 73.0 µmol, 1.0 eq.) and bpy (36.4 mg, 
0.233 mmol, 3.2 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–4% 
MeOH). [Ir(8)2(bpy)][PF6] was isolated as a pale yellow 
solid (63.2 mg, 0.146 mmol, 45.2%). 
1
H NMR (500 MHz, 
CD3CN) δ/ppm 8.53 (pseudo-dt, J = 8.3, 1.0 Hz, 2H, H
E3
), 
8.30 (d, J = 2.0 Hz, 2H, H
A3
), 8.26 (pseudo-dt, J = 8.2, 1.0 Hz, 2H, H
B3
), 8.16 (pseudo-td, J = 
8.0, 1.6 Hz, 2H, H
E4
), 7.96 (pseudo-td, J = 7.9, 1.5 Hz, 2H, H
B4
), 7.90 (ddd, J = 5.3, 1.5, 0.9 
Hz, 2H, H
E6
), 7.66 (pseudo-dt, J = 5.7, 1.2 Hz, 2H, H
B6
), 7.52 (ddd, J = 7.7, 5.5, 1.2 Hz, 2H, 
H
E5
), 7.39 (dd, J = 8.0, 2.0 Hz, 2H, H
A5
), 7.17 (ddd, J = 7.4, 5.8, 1.4 Hz, 2H, H
B5
), 6.54 (d, J = 
8.0 Hz, 2H, H
A6
), 3.04 (s, 6H, H
A4-SO2Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.3 
(C
B2
), 159.7 (C
A1
), 156.5 (C
E2
), 151.8 (C
E6
), 150.6 (C
B6
), 146.3 (C
A2
), 140.8 (C
E4
), 140.3 
(C
B4
), 136.7 (C
A4
), 133.4 (C
A6
), 129.6 (C
E5
), 129.0 (C
A5
), 125.9 (C
B5
), 125.8 (C
E3
), 124.1 
(C
A3
), 122.0 (C
B3
), 44.6 (C
A4-SO2Me
). IR (solid, ṽ/cm–1) 3041 (w), 1609 (w), 1579 (w), 1480 
(w), 1448 (w), 1426 (w), 1401 (w), 1300 (m), 1246 (w), 1225 (w), 1146 (s), 1096 (w), 1067 
(w), 1056 (w), 1032 (m), 960 (m), 840 (s), 784 (m), 760 (s), 734 (m), 703 (w), 640 (w), 594 
(m), 557 (s), 524 (m), 485 (m). UV/Vis (CH3CN, 1.0 × 10
−5
 mol dm
−3
) λ/nm 
(ε/dm3 mol−1 cm−1) 253 (62 000), 271 sh (48 000), 313 sh (19 000), 337 sh (9100), 406 sh 
(2800). Emission (CH3CN, 1.0 × 10
−5
 mol dm
−3
, λexc = 271 nm): λem
max
 = 517 nm. ESI-MS m/z 
813.4 [M–PF6]
+
 (calc. 813.1). Found C 41.62, H 3.10, N 6.03; C34H28F6IrN4O4PS2·H2O 
requires C 41.84, H 3.10, N 5.74%. 
8.9. [Ir(9)2(bpy)][PF6] 
[Ir(9)2Cl]2 (114 mg, 82.3 µmol, 1.0 eq.) and bpy (28.5 mg, 
0.182 mmol, 2.2 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–2% 
MeOH). [Ir(9)2(bpy)][PF6] was isolated as a dark yellow 
solid (97.5 mg, 0.102 mmol, 61.8%).  
1
H NMR (500 MHz, 
CD3CN) δ/ppm 9.30 (ddd, J = 8.6, 1.3, 0.8 Hz, 2H, H
B3
), 8.54 
(pseudo-dt, J = 8.3, 1.1 Hz, 2H, H
E3
), 8.16 (ddd, J = 7.7, 1.5 Hz, 2H, H
E4
), 7.98 (ddd, J = 8.7, 
7.5, 1.7 Hz, 2H, H
B4
), 7.89 (dd, J = 7.8, 1.2 Hz, 2H, H
A4
), 7.85 (ddd, J = 5.5, 1.6, 0.7 Hz, 2H, 
H
E6
), 7.76 (ddd, J = 5.8, 1.7, 0.7 Hz, 2H, H
B6
), 7.51 (ddd, J = 7.7, 5.5, 1.2 Hz, 2H, H
E5
), 7.14 
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(ddd, J = 7.3, 5.8, 1.3 Hz, 2H, H
B5
), 7.07 (pseudo-t, J = 7.7 Hz, 2H, H
A5
), 6.47 (dd, J = 7.7, 
1.2 Hz, 2H, H
A6
), 3.25 (s, 6H, H
A3-SO2Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 164.6 
(C
B2
), 156.5 (C
E2
), 155.6 (C
A1
), 151.5 (C
E6
), 151.2 (C
B6
), 141.1 (C
A2
), 140.8 (C
E4
), 140.6 
(C
A3
), 139.9 (C
B4
), 137.7 (C
A6
), 130.4 (C
A5
), 129.6 (C
E5
), 127.7 (C
B3
), 126.0 (C
B5
), 125.9 
(C
E3
), 125.5 (C
A4
), 43.5 (C
A3-SO2Me
). IR (solid, ṽ/cm–1) 3124 (w), 3039 (w), 2933 (w), 1609 
(w), 1563 (w), 1477 (m), 1449 (w), 1411 (w), 1396 (w), 1308 (m), 1278 (m), 1243 (w), 1200 
(w), 1170 (w), 1155 (m), 1131 (m), 1113 (m), 1070 (w), 1045 (w), 1031 (w), 1001 (w), 962 
(m), 904 (w), 876 (w), 835 (s), 803 (m), 792 (m), 760 (s), 752 (s), 735 (m), 724 (m), 716 (m), 
667 (w), 647 (w), 581 (w), 556 (s), 525 (s), 482 (s). UV/Vis (CH3CN, 1.0 × 10
−5
 mol dm
−3
) 
λ/nm (ε/dm3 mol−1 cm−1) 259 (46 000), 300 sh (28 000), 310 sh (25 000), 360 sh (8000), 397 
(5400), 437 sh (3300). Emission (CH3CN, 1.0 × 10
−5
 mol dm
−3
, λexc = 400 nm): λem
max
 = 506, 
527 nm. ESI-MS m/z 813.4 [M–PF6]
+ 
(calc. 813.1). Found C 42.49, H 3.24, N 6.08; 
C34H28F6IrN4O4PS2 requires C 42.63, H 2.95, N 5.85%. 
8.10. Crystallography 
2{[Ir(1)2(bpy)][PF6]}·7CH2Cl2. C75H70Cl14F12Ir2N8O8P2S4, M = 2510.39, needle, 
orthorhombic, space group Pbca, a = 18.1495(15), b = 22.5027(19), c = 23.189(2) Å, U = 
9470.7(8) Å
3
, Z = 4, Dc = 1.761 Mg m
–3
, µ(Mo-Kα) = 3.403 mm−1, T = 123 K. Total 72763 
reflections, 14677 unique, Rint = 0.045. Refinement of 14611 reflections (661 parameters) 
with I >2σ (I) converged at final R1 = 0.0524 (R1 all data = 0.0871), wR2 = 0.1260 (wR2 all 
data = 0.1539), gof = 1.0026. CCDC 1421913. 
2{[Ir(8)2(bpy)][PF6]}·5.5H2O. C68H67F12Ir2N8O13.50P2S4, M = 2014.95, yellow block, 
monoclinic, space group P21/c, a = 20.6753(13), b = 20.9141(13), c = 18.3265(12) Å, β = 
104.473(2)
o
, U = 7673.0(5) Å
3
, Z = 4, Dc = 1.744 Mg m
–3
, µ(Cu-Kα) = 8.865 mm−1, T = 
123 K. Total 105992 reflections, 13988 unique, Rint = 0.041. Refinement of 13925 reflections 
(959 parameters) with I >2σ (I) converged at final R1 = 0.0422 (R1 all data = 0.0458), wR2 = 
0.1120 (wR2 all data = 0.1143), gof = 0.9557. CCDC 1421914. 
[Ir(9)2(bpy)][PF6]. C34H28F6IrN4O4PS2, M = 957.93, yellow needle, monoclinic, space group 
C2/c, a = 15.6899(16), b = 28.163(3), c = 8.4211(9) Å, β = 115.797(3)o, U = 3350.3(4) Å3, 
Z = 4, Dc = 1.899 Mg m
–3
, µ(Cu-Kα) = 10.052 mm−1, T = 123 K. Total 18964 reflections, 
3003 unique, Rint = 0.029. Refinement of 3003 reflections (236 parameters) with I>2σ (I) 
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converged at final R1 = 0.0222 (R1 all data = 0.0223), wR2 = 0.0486 (wR2 all data = 0.0486), 
gof = 1.0000. CCDC 1421915. 
 
CHAPTER III: GREEN & BLUE EMITTERS – PYRAZOLYLPYRIDINE ANCILLARY LIGANDS 
 
 
 
 
- 77 - 
 
CHAPTER III: GREEN & BLUE EMITTERS – 
PYRAZOLYLPYRIDINE ANCILLARY LIGANDS 
 
1. Introduction 
The development of efficient and stable blue emitters remains desirable in the field of light-
emitting electrochemical cells. Up to date, most of the blue emitting iridium complexes used 
in LEECs comprise fluoro-substituted cyclometallating ligands, for example fluorine-
functionalized phenylpyridines,
82,131
 phenylpyrazoles
80,132,133
 or phenyltriazoles.
134
 The 
electron-withdrawing nature of fluorine leads to a stabilization of the HOMO, resulting in a 
larger HOMO-LUMO energy gap. Until now, not many alternative functional groups have 
been investigated, although fluorine substituents have been shown to lower device stability in 
both OLEDs
81
 and LEECs
82
 (cf. Chapter I). One of the main goals in the field of light emitting 
electrochemical cells is therefore the design of fluorine-free blue emitting iridium complexes. 
Mostly, this has been achieved by replacing the standard 2,2'-bipyridine by more electron-rich 
ancillary ligands. Examples include 4,4'-dimethylamino-2,2'-bipyridine,
134,135
 strong-field 
ancillary ligands (e.g. PPh3, CN
−
, CO, CH3CN),
136
 triazolylpyridines,
131,137
 
imidazolylpyridines
138
 and carbene-based ancillary ligands.
139,140
 Another strategy which has 
been less often pursued is the use of electron-deficient cyclometallating ligands. Emission 
blue-shifts were achieved with phenylpyrazoles,
141
 phenyltetrazoles,
142
 methoxy-substituted 
2,3'-bipyridines
107
 or sulfone-substituted phenylpyrazoles
93
 and phenylpyridines.
95
 
 Another ancillary ligand group which has been shown to efficiently tune the emission 
colour to the blue region is based on pyrazolylpyridines.
78,132,143–148
 These ancillary ligands 
have been combined with fluoro-substituted or unsubstituted phenylpyridine
78,143–146,148
 and 
phenylpyrazole
132,147
 cyclometallating ligands to yield green to blue emitting iridium 
complexes. 
 That the introduction of sulfone-functionalized phenylpyridine C^N ligands can 
efficiently shift the emission maximum to the green region was shown in Chapters I and II.
95
 
To further blue-shift the emission, it is necessary to replace the bpy ancillary ligand by a more 
electron-rich ligand. This should lead to a destabilization of the LUMO and therefore a larger 
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HOMO-LUMO energy gap. In this chapter, the synthesis, characterization and device 
performance of a series of four iridium complexes with cyclometallating ligands containing 
methylsulfonyl groups in 4- or 5-position and pyrazolylpyridine-based ancillary ligands (2-
(1H-pyrazol-1-yl)pyridine (pzpy) and 2-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine (dmpzpy)) 
are reported. 
 
2. Synthesis and NMR Spectroscopic Characterization 
2.1. Ligand synthesis 
The synthesis of cyclometallating ligands H3 and H8 was described in detail in Chapters I 
and II. Ancillary ligands 2-(1H-pyrazol-1-yl)pyridine (pzpy) and 2-(3,5-dimethyl-1H-pyrazol-
1-yl)pyridine (dmpzpy) were prepared according to a procedure described in the literature 
(Scheme 13). 2-Bromopyridine was reacted with 1H-pyrazole or 3,5-dimethyl-1H-pyrazole in 
an Ullmann-type coupling reaction using CuI as catalyst and L-proline as additive.
149
 The 
desired ligands were obtained in moderate to good yields and 
1
H NMR data matched those 
reported.
150,151
 
 
 
Scheme 13 Synthetic route to ancillary ligands 2-(1H-pyrazol-1-yl)pyridine (pzpy) and 2-(3,5-
dimethyl-1H-pyrazol-1-yl)pyridine (dmpzpy). Reaction conditions: a) CuI, L-proline, K2CO3, 
DMSO, 130 °C, 2–3 d, N2.
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2.2. Synthesis of [Ir(C^N)2Cl]2 dimers 
The synthetic routes followed to obtain chlorido-bridged iridium dimers [Ir(3)2Cl]2 and 
[Ir(8)2Cl]2 were reported in Chapters I and II. 
 
2.3. Synthesis of [Ir(C^N)2(N^N)][PF6] complexes 
The synthetic strategy leading to complexes [Ir(C^N)2(N^N)][PF6] with C^N = 3, 8 and N^N 
= pzpy, dmpzpy is shown in Scheme 14. Under microwave conditions, dimers [Ir(3)2Cl]2 and 
[Ir(8)2Cl]2 are treated with the appropriate ancillary ligand (pzpy or dmpzpy) in MeOH. 
Anion exchange is performed by addition of solid NH4PF6 to a methanolic solution of the 
chloride complexes, leading to precipitation of the [PF6]
−
 salts. Filtration and subsequent 
purification gave the desired compounds in yields ranging from 41 to 99%. 
 
 
Scheme 14 Synthesis of [Ir(C^N)2(N^N)][PF6] with C^N = 3 or 8 and N^N = pzpy or dmpzpy. 
Reaction conditions: a) pzpy or dmpzpy, MeOH, MW, 120 °C, 1 h; then NH4PF6.
 
 
Complexes [Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = pzpy and dmpzpy) were fully 
characterized using NMR and IR spectroscopies, ESI mass spectrometry and elemental 
analysis. In the ESI mass spectra, the base peaks correspond to the [Ir(C^N)2(N^N)]
+
 cations 
for all complexes, exhibiting the characteristic iridium isotope pattern. 
1
H and 
13
C signals 
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were assigned with the help of 2D experiments (COSY, NOESY, HMQC and HMBC). Due 
to the asymmetric ancillary ligand, the cyclometallating ligands are inequivalent and give rise 
to two sets of NMR signals; NOESY cross peaks are observed between protons H
E6
 and H
A6
, 
as well as between protons H
F5
/H
F5-Me
 and H
B6
 and/or H
C6
, making distinction between the 
two C^N ligands possible (see Scheme 14 for numbering). 
 
 
Fig. 31 Aromatic region of 500 MHz 
1
H NMR spectra of complexes [Ir(C^N)2(N^N)][PF6] with 
C^N = 3, 8 and N^N = pzpy, dmpzpy in CD3CN including assignment. See Scheme 14 for 
numbering scheme. Scale: δ/ppm. 
 
In Fig. 31, the aromatic regions of 
1
H NMR spectra of [Ir(C^N)2(N^N)][PF6] with C^N = 3 or 
8, N^N = pzpy or dmpzpy are shown. Comparison of chemical shifts is made difficult by the 
many overlapping signals observed for all complexes. Pyrazole protons (F ring) resonate at 
the same frequency for the pzpy and dmpzpy complexes, regardless of the cyclometallating 
ligands. E ring protons on the pyridine moiety of the ancillary ligands are slightly affected by 
both the pyrazole moiety (methyl-substituted or unsubstituted) and the coordinated C^N 
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ligands. Methyl substitution on the ancillary ligand has an observable effect on protons H
A6
 
and H
B6
, moving the signal upfield (Δδ = 0.12 ppm) or downfield (Δδ = ca. 0.2 ppm, 
overlapping signals make exact determination difficult), respectively. Of the aromatic protons, 
H
A6
, H
C6
 and H
F4
 appear at lowest frequency. Signals for H
F4
 are significantly shifted upfield 
by Δδ = 0.43 ppm in complexes [Ir(C^N)2(dmpzpy)][PF6] (δ = 6.34 ppm) with respect to 
[Ir(C^N)2(pzpy)][PF6] (δ = 6.77 ppm). The same effect, though less pronounced, is seen for 
H
A6
 (Δδ = 0.12 ppm) and HC6 (Δδ = 0.04–0.05 ppm). 
 
3. Crystal Structure 
Single crystals of [Ir(8)2(dmpzpy)][PF6]·CH3CN were grown from an CH3CN solution 
layered with Et2O. The structure of the cation is shown in Fig. 32; important bond lengths and 
angles are reported in the figure caption. The compound crystallizes in the monoclinic space 
group C2/c and both Δ- and Λ-enantiomers are therefore present in the unit cell; the 
asymmetric unit contains the Λ-enantiomer. Both the [PF6]
−
 anion and the CH3CN solvent 
molecule are ordered. 
 The methylsulfonyl groups are twisted with respect to the phenyl ring they are 
attached to with torsion angles of 27.4 (O1–S1–C18–C17), −22.4 (O2–S1–C18–C19), 15.0 
(O3–S2–C30–C31) and −35.1° (O4–S2–C30–C29). These orientations lead to short 
intramolecular CH···OS contacts with distances of O1···HC17 = 2.61, O2···HC19 = 2.59, 
O3···HC31 = 2.61 and O4···HC29 = 2.68 Å. This is comparable to intramolecular 
interactions observed in series of alkyl–aryl105 and aryl–aryl sulfones105,124 reported in the 
literature and our sulfone-substituted ligands H3 and H5,
95
 dimer [Ir(3)2Cl]2
95
 and complexes 
[Ir(C^N)2(bpy)][PF6] with C^N = 3 and 8 (cf. Chapters I and II). 
 The cyclometallating ligand containing N5 and C33 is nearly planar; the angle 
between the two ring planes amounts to 2.9°. The case is different for the dmpzpy ancillary 
ligand and the cyclometallating ligand containing N4 and C21: a considerable deviation from 
planarity is observed. Angles of 12.7 (C^N ligand) and 15.9° (N^N ligand) are the result of 
this distortion. 
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 A preliminary structure was obtained for [Ir(3)2(dmpzpy)][PF6] from crystals grown 
by layering an CH3CN solution of the complex with Et2O. The expected structure containing 
the octahedral iridium centre and the three chelating ligands was confirmed. 
 
 
Fig. 32 Structure of the Λ-[Ir(8)2(dmpzpy)]
+
 cation in [Ir(8)2(dmpzpy)][PF6]·CH3CN with 
ellipsoids plotted at 40% probability level and H atoms omitted. Selected bond parameters: Ir1 –
N1 = 2.144(2), Ir1–N3 = 2.126(2), Ir1–N4 = 2.050(2), Ir1–N5 = 2.044(2), Ir1–C21 = 1.998(2), 
Ir1–C33 = 2.012(3), N2–N3 = 1.385(3), S1–O1 = 1.435(2), S1–O2 = 1.441(2), S1–C22 = 
1.769(3), S2–O3 = 1.442(2), S2–O4 = 1.437(2), S2–C34 = 1.763(3) Å; N1–Ir1–N3 = 75.53(8), 
N4–Ir1–C21 = 80.34(9), N5–Ir1–C33 = 80.67(9), N1–Ir1–C21 = 178.07(9), N3–Ir1–C33 = 
171.26(9), N4–Ir1–N5 = 172.73(8), O1–S1–O2 = 119.32(14), O3–S2–O4 = 118.32(12)°. 
 
4. Photophysical Properties 
The UV-Vis absorption spectra in CH3CN solution are similar for complexes 
[Ir(C^N)2(N^N)][PF6] with C^N = 3 or 8 and N^N = pzpy or dmpzpy (Fig. 33). Strong 
absorption maxima occur in the UV region (λmax = 253–255 nm) correlating with spin-allowed 
ligand-centred π*←π transitions. Weaker bands are observed at higher wavelengths up to 
450 nm, corresponding to spin-allowed charge transfer transitions of the type 
1
MLCT and 
1
LLCT.
21
 Small differences are seen for the lower energy absorptions of complexes 
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[Ir(3)2(N^N)][PF6] compared to [Ir(8)2(N^N)][PF6]; the absorption tails of [Ir(3)2(N^N)][PF6] 
extend further into the visible region, comprising broad and weak maxima around 390 and 
420 nm. 
 
 
Fig. 33 UV-Vis absorption spectra in CH3CN solution of [Ir(C^N)2(N^N)][PF6] with C^N = 3 or 
8 and N^N = pzpy or dmpzpy (1.0 × 10
−5
 M). 
 
Photoluminescence spectra were measured in CH3CN solution at room temperature (Fig. 34) 
and at 77 K (Fig. 36); photophysical properties are reported in Table 8. Low temperature 
emission spectra were obtained by Dr. Henk Bolink and co-workers at the University of 
Valencia. The emission profiles are independent of the excitation wavelength. Vibrationally 
structured emission bands are observed for all complexes, with emission maxima at 491 and 
523 nm for [Ir(3)2(N^N)][PF6] and 463 and 493 nm for [Ir(8)2(N^N)][PF6] (N^N = pzpy and 
dmpzpy). Complexes [Ir(3)2(N^N)][PF6] containing the methylsulfonyl substituent in the 5-
position are therefore green emitters, while the emission of complexes [Ir(8)2(N^N)][PF6] 
(sulfone group in 4-position) is blue-shifted by approximately 30 nm, resulting in blue 
emission (cf. Fig. 35a). The structured emission profiles indicate a strong ligand-centred (
3
LC) 
contribution to the emissive triplet state.
21
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Fig. 34 Room temperature solution photoluminescence spectra of [Ir(C^N) 2(N^N)][PF6] 
complexes (C^N = 3 and 8, N^N = pzpy and dmpzpy) in CH3CN (1.0 × 10
−5
 M). λexc = 388 nm 
for [Ir(3)2(pzpy)][PF6], 350 nm for [Ir(3)2(dmpzpy)][PF6] and 370 nm for [Ir(8)2(N^N)][PF6]. 
 
a) 
 
b) 
 
Fig. 35 Photographs of complexes [Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = pzpy and 
dmpzpy) under 366 nm light excitation: a) CH3CN solution and b) powder samples. From left to 
right: [Ir(8)2(pzpy)][PF6], [Ir(8)2(dmpzpy)][PF6], [Ir(3)2(pzpy)][PF6] and [Ir(3)2(dmpzpy)][PF6]. 
 
Replacing the bpy ancillary ligand by electron-rich pzpy in [Ir(ppy)2(N^N)][PF6] leads to a 
considerable blue-shift in the emission maximum of 110 nm (from 585 nm
103
 to 475 nm
78
 in 
CH3CN solution). In contrast, going from [Ir(3)2(bpy)][PF6] to [Ir(3)2(N^N)][PF6] with N^N 
= pzpy and dmpzpy does not change the emission maxima (493, 525 nm
95
 vs. 491, 523 nm). 
This further supports the assumption that in both cases, emission occurs from a triplet state 
with large ligand-centred character involving the cyclometallating ligands, which is 
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independent of the ancillary ligand. The situation is different for [Ir(8)2(N^N)][PF6] 
complexes when N^N is changed from bpy to pzpy or dmpzpy; the result is a 54 nm blue-shift 
of the emission maximum from 517 nm to 463 nm. This is probably due to a different 
composition of the emissive state from a higher charge transfer contribution to a more 
pronounced ligand-centred character: [Ir(8)2(bpy)][PF6] exhibits a broad, unstructured 
emission profile, whereas complexes [Ir(8)2(N^N)][PF6] with N^N = pzpy and dmpzpy have 
vibrationally structured emission bands. Almost no rigidochromic shift is seen when cooling 
CH3CN solutions of all complexes within this series to 77 K (Fig. 36, Table 8), backing the 
theory that emission arises mainly from 
3
LC states.
78,152,153
 
 
 
Fig. 36 Photoluminescence spectra at 77 K of compounds [Ir(C^N)2(N^N)][PF6] with C^N = 3 
or 8 and N^N = pzpy or dmpzpy in CH3CN. λexc = 320 nm. 
Photoluminescence quantum yields obtained for de-aerated CH3CN solutions of the 
complexes are in the range 53–77%. These values are comparable to the PLQY of 
[Ir(3)2(bpy)][PF6] (74%) and are lower than that of [Ir(8)2(bpy)][PF6] (92%). Strong emission 
quenching in solution has been reported for a series of alkylated pyrazolylpyridine-based 
iridium complexes upon methyl substitution in 5-position of the pyrazole ring.
148
 Increased 
steric hindrance at the iridium metal centre was proposed by Shavaleev et al. as a possible 
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reason for this observation. The authors noted a three times higher non-radiative decay rate 
constant (knr = (1–PLQY)/τ) upon introduction of the 5-methyl group and attributed this to 
reversible dissociation of the sterically hindered Ir–N bond. This observation was made only 
in solution; powder samples of all their complexes showed visible emission. Within our series 
of pyrazolylpyridine complexes, no such significant decrease in the quantum yield is 
observed. PLQYs are only slightly lower for [Ir(C^N)2(dmpzpy)][PF6] with respect to 
unsubstituted [Ir(C^N)2(pzpy)][PF6]. Non-radiative decay rate constants (knr) are higher for 
complexes with dmpzpy than for those with pzpy, but not to such an extent as described by 
Shavaleev et al.
148
 PLQYs drop significantly to <5.1% when solutions of 
[Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = pzpy and dmpzpy) are not de-aerated. 
 
Table 8 Photophysical properties of complexes [Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = 
bpy, pzpy and dmpzpy) in CH3CN solution at room temperature and at 77 K. PLQYs were 
measured in de-aerated solution, excited state lifetimes in de-aerated solution under Ar 
atmosphere. kr = PLQY/τ, knr = (1–PLQY)/τ. 
Compound 
Room temperature 77 K 
λem
max 
[nm]
a
 
PLQY 
[%]
a
 
τ [µs] 
(χ)b 
kr 
[10
5
 s
−1
] 
knr 
[10
5
 s
−1
] 
λem
max 
[nm]
c
 
[Ir(3)2(bpy)][PF6] 493, 525 74 2.33 (1.3) 3.2 1.1 --- 
[Ir(3)2(pzpy)][PF6] 491, 523 77 4.47 (1.1) 1.7 0.52 488, 526, 563 
[Ir(3)2(dmpzpy)][PF6] 491, 523 66 5.12 (1.2) 1.3 0.66 489, 526, 564 
[Ir(8)2(bpy)][PF6] 517 92 1.28 (1.1) 7.2 0.63 --- 
[Ir(8)2(pzpy)][PF6] 463, 493 72 2.30 (1.2) 3.1 1.2 459, 492, 521 
[Ir(8)2(dmpzpy)][PF6] 463, 493 53 2.27 (1.1) 2.3 2.1 459, 494, 523 
a
 λexc = 262 for [Ir(3)2(bpy)][PF6], 261 nm for [Ir(3)2(N^N)][PF6] (N^N = pzpy, dmpzpy), 271 nm for 
[Ir(8)2(bpy)][PF6] and 259 nm for [Ir(8)2(N^N)][PF6] (N^N = pzpy, dmpzpy). 
b
 λexc = 280 nm. 
c
 λexc = 
320 nm. 
Excited state lifetimes were measured in de-aerated CH3CN solution under argon atmosphere 
and are in the microseconds region for complexes [Ir(C^N)2(N^N)][PF6] with C^N = 3 or 8 
and N^N = pzpy or dmpzpy (Table 8). τ is slightly higher for [Ir(3)2(N^N)][PF6] (4.5 and 
5.1 µs) with respect to [Ir(8)2(N^N)][PF6] (2.3 µs). Calculated radiative decay rate constants 
(kr = PLQY/τ) are in the range 1.3 to 3.1 × 10
5
 s
−1
. These numbers are comparable to kr values 
of [Ir(3)2(bpy)][PF6] (3.2 × 10
5
 s
−1
) and [Ir(ppy)2(pzpy)][PF6]
78
 (1.5 × 10
5
 s
−1
) and are 
significantly lower than kr of [Ir(8)2(bpy)][PF6] (7.2 × 10
5
 s
−1
). A lower kr correlates to a 
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higher 
3
LC contribution to the emissive triplet state;
21
 the obtained values are therefore in 
accordance with dominant ligand-centred character of the emission within the series reported 
in this chapter. Excited state lifetimes are considerably reduced when solutions are not de-
aerated (τ = 0.22–0.42 µs); this together with a decrease in PLQY indicates strong oxygen 
quenching of the emissive state. 
 
 
Fig. 37 Solid state photoluminescence spectra of powder samples of [Ir(C^N) 2(N^N)][PF6] 
(C^N = 3 and 8, N^N = pzpy and dmpzpy). λexc = 280 nm. 
 
The solid-state photophysical properties of [Ir(C^N)2(N^N)][PF6] were studied for powder 
samples and in thin films of the composition complex:[Bmim][PF6] 4:1. The thin films were 
spin-coated onto quartz substrates (Table 9) and evaluated by Dr. Henk Bolink and his team at 
the University of Valencia. Powder emission maxima (Fig. 37) are red-shifted by about 30 nm 
for all complexes with respect to solution maxima (Fig. 34). In fact, the position of the 
vibrational bands is not significantly different in powder and solution samples; the intensities 
differ considerably, however, leading to yellow emission from powder samples of 
[Ir(3)2(N^N)][PF6] and [Ir(8)2(pzpy)][PF6] (Fig. 35b). In contrast to [Ir(8)2(pzpy)][PF6], 
methyl-functionalized complex [Ir(8)2(dmpzpy)][PF6] exhibits less intense emission between 
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500 and 650 nm with respect to the emission maximum (Fig. 37, dotted blue line), resulting in 
sky-blue photoluminescence in powder (Fig. 35b). Photoluminescence quantum yields and 
excited state lifetimes are strongly reduced in powder samples compared to solution (PLQY ≤ 
11%, τave ≤ 0.977 µs); together with the red-shifted emission maxima and weaker vibrational 
structure, this suggests strong intermolecular interactions in the solid state.
78
 Lifetimes were 
determined using biexponential fits for all complexes; detailed data are given in Table 9. 
 
 
Fig. 38 Photoluminescence spectra of thin films of complexes [Ir(C^N)2(N^N)][PF6] with C^N 
= 3 or 8 and N^N = pzpy or dmpzpy. Complex:[Bmim][PF6] 4:1 on quartz plate. λexc = 320 nm. 
The emission profiles for the complexes in thin films are similar to those obtained in solution; 
again, the relative intensities of the vibrational bands differ from the solution intensities (Fig. 
38). Photoluminescence quantum yields range from 6.9 to 16.9% and are slightly higher than 
for powder samples, but significantly lower than for solution samples. This observation is due 
to the lower dilution of complex molecules in thin film, leading to excited state quenching 
mechanisms as a result of intermolecular interactions. 
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Table 9 Solid state photoluminescence properties of complexes [Ir(C^N)2(N^N)][PF6] with C^N 
= 3 or 8 and N^N = pzpy or dmpzpy as powder samples and in thin film (complex:[Bmim][PF 6] 
4:1). Biexponential fits were used for powder excited state lifetimes, according to the equation 
τave=∑Aiτi/∑Ai (Ai = pre-exponential factor of the lifetime). 
Compound 
Powder samples Thin film 
λem
max 
[nm]
a
 
PLQY 
[%]
b
 
τave [µs] 
(χ)a 
τ1 [µs] 
(A1) 
τ2 [µs] 
(A2) 
λem
max 
[nm]
c
 
PLQY 
[%]
c
 
[Ir(3)2(pzpy)][PF6] 524 7.5 
0.977 
(1.2) 
0.815 
(17639) 
2.48 
(624) 
499, 529, 564 13.2 
[Ir(3)2(dmpzpy)][PF6] 519 5.9 
0.537 
(1.3) 
0.398 
(27831) 
1.00 
(3295) 
496, 529, 564 16.9 
[Ir(8)2(pzpy)][PF6] 498 4.6 
0.659 
(1.2) 
0.346 
(8587) 
1.35 
(997) 
470, 500, 527 6.9 
[Ir(8)2(dmpzpy)][PF6] 491 11 
0.623 
(1.2) 
0.510 
(25612) 
1.33 
(1558) 
468, 499, 526 13.0 
a
 λexc = 280 nm. 
b
 λexc = 261 nm for [Ir(3)2(N^N)][PF6] and 259 nm for [Ir(8)2(N^N)][PF6]. 
c
 λexc = 
320 nm. 
 
5. Electrochemical Properties 
Electrochemical data gained from cyclic voltammetry measurements of complexes 
[Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = pzpy and dmpzpy) in de-aerated CH3CN 
solution are summarized in Table 10. The CV curves showing the oxidation and first 
reduction waves of [Ir(3)2(pzpy)][PF6] and [Ir(8)2(pzpy)][PF6] are given in Fig. 39. In 
[Ir(C^N)2(N^N)]
+
 type complexes, the HOMO is generally located on the iridium metal centre 
and the phenyl rings of the cyclometallating ligands; oxidation is therefore iridium-based with 
a strong influence of the C^N ligands. This assumption is reflected by the values obtained for 
the oxidation potentials, which are very similar when the cyclometallating ligands are the 
same; this is the case for [Ir(3)2(N^N)][PF6] with N^N = pzpy, dmpzpy and bpy (E1/2
ox  = +1.19, 
+1.20 and +1.18 V vs. Fc/Fc
+
, respectively), as well as [Ir(8)2(N^N)][PF6] with N^N = pzpy, 
dmpzpy and bpy (E1/2
ox  = +1.26, +1.27 and +1.29 V). Reversible oxidation waves are observed 
for all complexes. 
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Table 10 Electrochemical data vs. Fc/Fc
+
 for complexes [Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, 
N^N = bpy, pzpy and dmpzpy) obtained from cyclic voltammetry experiments in de-aerated 
CH3CN solution. Measured with glassy carbon working, Pt counter  and Ag pseudo-reference 
electrode, 0.1 M TBAPF6 supporting electrolyte and a scan rate of 0.1 V s
−1
. qr = quasi-
reversible, ir = irreversible. 
Compound E1/2
ox  [V] E1/2
red [V] ΔE1/2 [V] 
[Ir(3)2(bpy)][PF6] +1.18 –1.72, –2.16, –2.61
ir
 2.90 
[Ir(3)2(pzpy)][PF6] +1.19 –2.02, –2.26
ir
, –2.68ir 3.21 
[Ir(3)2(dmpzpy)][PF6] +1.20 –2.00, –2.27
ir
, –2.42ir, –2.63ir 3.20 
[Ir(8)2(bpy)][PF6] +1.29 –1.67, –2.27
qr
, –2.52qr 2.96 
[Ir(8)2(pzpy)][PF6] +1.26 –2.11
ir
, –2.37ir, –2.62ir 3.37 
[Ir(8)2(dmpzpy)][PF6] +1.27 –2.14
ir
, –2.37qr, –2.68ir 3.41 
 
Three to four reduction waves are detected within the accessible solvent window. The first 
reductions are reversible for complexes [Ir(3)2(N^N)][PF6] and irreversible for 
[Ir(8)2(N^N)][PF6] (N^N = pzpy, dmpzpy). With respect to [Ir(C^N)2(bpy)][PF6] (C^N = 3 
and 8), the reduction potentials of pyrazolylpyridine-based complexes are shifted to lower 
potential (from ca. −1.7 V to −2.0/−2.1 V). The LUMO is based almost exclusively on the 
ancillary ligand in [Ir(C^N)2(N^N)]
+
 complexes; replacing 2,2'-bipyridine by more electron-
rich pyrazolylpyridine ligands therefore leads to a destabilization of the LUMO. 
Electrochemical HOMO-LUMO energy gaps are increased on going from [Ir(3)2(N^N)][PF6] 
(ΔE1/2 = ca. 3.2 V) to [Ir(8)2(N^N)][PF6] (ΔE1/2 = ca. 3.4 V) with N^N = pzpy and dmpzpy, in 
accordance with the observed blue-shift in the emission maxima. 
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Fig. 39 Cyclic voltammetry curves of complexes [Ir(C^N)2(pzpy)][PF6] (C^N = 3 and 8) with 
respect to Fc/Fc
+
, showing the first oxidation and reduction waves. Measured in de-aerated 
CH3CN solution with glassy carbon working, Pt counter and Ag pseudo-reference electrodes, 
0.1 M TBAPF6 supporting electrolyte and a scan rate of 0.1 V s
−1
. The arrow indicates the 
initial scanning direction. 
 
6. Calculations 
In order to better understand the electrochemical and photophysical properties of complexes 
[Ir(C^N)2(N^N)][PF6] with C^N = 3 and 8, N^N = pzpy and dmpzpy, combined DFT/TD-
DFT calculations were carried out at the B3LYP/(6-31G**+LANL2DZ) level in the presence 
of CH3CN as the solvent.
126
 The calculations were performed by Prof. Enrique Ortí and co-
workers at the University of Valencia. [Ir(ppy)2(pzpy)]
+
 is included as a reference complex.
154
 
The calculated frontier orbitals (HOMO, LUMO and LUMO+1) for all complexes including 
the reference compound are shown in Fig. 40, together with calculated energy values. 
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Fig. 40 Schematic representation showing the electron density contours (±0.03 au) and 
calculated energy values for the HOMO, LUMO and LUMO+1 of [Ir(ppy) 2(pzpy)]
+
 and 
complexes [Ir(C^N)2(N^N)]
+
 with C^N = 3
 
and 8, N^N = pzpy and dmpzpy. Hydrogen atoms 
omitted for clarity. 
 
Introducing sulfone groups on the C^N ligands leads to a stabilization of the molecular 
orbitals localized on those ligands. A larger stabilization of the HOMO is observed when the 
sulfone substituent is placed in 4-position (para to the Ir–C bond) with respect to substitution 
in 5-position (meta to the Ir–C bond). A different observation is made for the LUMO or 
LUMO+1; a sulfone group in 5-position results in a larger stabilization in that case. For 
complexes [Ir(ppy)2(pzpy)]
+
 and [Ir(8)2(pzpy)]
+
, the LUMO is based on the ancillary ligand 
and the LUMO+1 is located on the cyclometallating ligands and the metal centre. For the 
remaining compounds, the orbitals are switched around and the LUMO is located on the C^N 
ligands and the iridium metal. Placing methyl substituents on the ancillary ligand leads to a 
destabilization of the molecular orbital of 0.1 eV compared to the unsubstituted analogues. 
The trends observed for the calculated HOMO and LUMO energies correlate well with the 
experimental oxidation and reduction potentials gained from electrochemical measurements 
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(Table 10). Calculated HOMO-LUMO energy gaps are in the order [Ir(ppy)2(pzpy)]
+
 
(3.66 eV) < [Ir(3)2(pzpy)]
+
 (3.86 eV) ≈ [Ir(3)2(dmpzpy)]
+
 (3.85 eV) < [Ir(8)2(pzpy)]
+
 
(4.02 eV) < [Ir(8)2(dmpzpy)]
+
 (4.08 eV). This trend is in accordance with the increase in the 
electrochemical energy gap determined experimentally (3.07 V
78
 < 3.21 V ≈ 3.20 V < 3.37 V 
< 3.41 V, Table 10). The blue-shift in the emission maxima on going from [Ir(ppy)2(pzpy)]
+
 
to [Ir(8)2(N^N)]
+
 (N^N = pzpy and dmpzpy) corresponds well to the calculated widening of 
the HOMO-LUMO gap. For complexes [Ir(3)2(N^N)]
+
 (N^N = pzpy, dmpzpy), a red-shift in 
the emission maximum is observed with respect to [Ir(ppy)2(pzpy)]
+
 which apparently 
contradicts the trend in the calculated energy values for the HOMO-LUMO gaps. 
In order to shed light on the aforementioned contradiction between experimental 
values and theoretical calculations, the geometry of the lowest-energy excited triplet state (T1) 
was optimized and emission energies calculated. In Fig. 41a, the adiabatic energy differences 
between S0 and T1 (ΔE) and the emission energies (Eem) are reported. Fig. 41b shows the 
calculated unpaired-electron spin density contours for the lowest-energy T1 states of 
complexes [Ir(C^N)2(N^N)]
+
. For all complexes, T1 is a ligand-centred state (
3
LC) mainly 
located on one of the cyclometallating ligands with a small contribution of the iridium centre 
(
3
MLCT). This result is in accordance with the experimental emission spectra obtained in 
CH3CN solution, showing structured emission bands. The trends in the calculated emission 
energies correlate well with the observed red-shifts in the emission maxima of [Ir(3)2(N^N)]
+
 
(491, 523 nm) with respect to [Ir(ppy)2(pzpy)]
+
 (475, 503 nm
78
) and the blue-shifts of 
[Ir(8)2(N^N)]
+
 (463, 493 nm). Time-dependent DFT calculations confirm the ligand-centred 
(
3
LC) nature of the emissive triplet state. The first and second excited states are ligand-centred 
states that arise from excitation to molecular orbitals located on the cyclometallating ligands. 
Calculations show that the first 
3
MLCT state lies higher in energy by 0.2 eV for 
[Ir(ppy)2(pzpy)]
+
 to 0.6 eV for [Ir(3)2(dmpzpy)]
+
. 
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Fig. 41 a) Schematic diagram showing the adiabatic energy difference between S 0 and T1 states 
(ΔE) and emission energy from the T1 state (Eem), together with calculated values for 
[Ir(ppy)2(pzpy)]
+
 and [Ir(C^N)2(N^N)]
+
 (C^N = 3, 8 and N^N = pzpy, dmpzpy). b) Unpaired-
electron spin density contours (0.002 au) calculated for the fully relaxed T1 states. 
 
7. Electroluminescence and Device Data 
Light emitting electrochemical cells were prepared with complexes [Ir(C^N)2(N^N)][PF6] 
with C^N = 3 or 8 and N^N = pzpy or dmpzpy using the device configuration 
ITO/PEDOT:PSS/[Ir(C^N)2(N^N)][PF6]:[Bmim][PF6] 4:1/Al. The devices were assembled 
and measured by Dr. Henk Bolink and co-workers at the University of Valencia. The LEECs 
were evaluated using block-wave pulsed current driving conditions with a frequency of 
1 kHz, 50% duty cycles and an average current density of 100 A m
−2
.
21,53,93,126
 The 
electroluminescence spectra obtained in that way are shown in Fig. 42. Structured 
electroluminescence spectra are observed for all complexes, indicating that 
electroluminescence also arises mainly from a 
3
LC emissive state. While the positions of the 
electroluminescence bands are similar to the solution photoluminescence bands, the relative 
intensities vary significantly (compare Fig. 34 with Fig. 42 and Table 8 with Table 11). As a 
result, all complexes exhibit green electroluminescence. 
 
a) 
b) 
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Fig. 42 Electroluminescence spectra of [Ir(C^N)2(N^N)][PF6] (C^N = 3 and 8, N^N = pzpy and 
dmpzpy) in LEEC devices. 
 
Table 11 Device parameters for LEECs containing complexes [Ir(C^N) 2(N^N)][PF6] (C^N = 3 
or 8, N^N = pzpy or dmpzpy). Composition: ITO/PEDOT:PSS/[Ir(C^N) 2(N^N)][PF6]: 
[Bmim][PF6] 4:1/Al. Measured by applying a block-wave pulsed current of 100 A m
−2
 at a 
frequency of 1 kHz and duty cycles of 50%.
21,53,93,126
 
Compound 
ton 
[s] 
Lummax 
[cd m
–2
] 
t1/2 
[min] 
PCE 
[lm W
–1
] 
EQE 
[%] 
λEL
max 
[nm] 
[Ir(3)2(pzpy)][PF6] 35 141 3.7 0.5 0.4 492, 530, 568 
[Ir(3)2(dmpzpy)][PF6] 78 125 6.2 0.6 0.4 492, 533, 568 
[Ir(8)2(pzpy)][PF6] 42 49 3.5 0.2 0.2 466, 496, 547 
[Ir(8)2(dmpzpy)][PF6] 30 129 2.4 0.5 0.4 466, 496, 547 
 
LEEC performance parameters are reported in Table 11; luminance and average voltage 
curves of complexes [Ir(C^N)2(N^N)][PF6] with C^N = 3, 8 and N^N = pzpy, dmpzpy are 
plotted vs. time in Fig. 43a–d. Fast turn-on times (ton, time to reach maximum luminance) in 
the range 30–78 s are observed together with short lifetimes (t1/2, defined as the time needed 
to drop to half of the maximum luminance) on the order of a few minutes. Although device 
stability is poor, the t1/2 values are not exceptionally low when compared to other blue and 
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green light emitting electrochemical cells reported in the literature, where lifetimes range 
from a few seconds to several hours.
80,107,131,140–142,145
 
 
 
 
Fig. 43 Luminance and average voltage vs. time for LEECs containing complexes 
[Ir(C^N)2(N^N)][PF6] with C^N = 3 or 8 and N^N = pzpy or dmpzpy, measured under a 
constant pulsed current (1 kHz, 50% duty cycle and block-wave) of 100 A m
–2
 (average current 
density).
21,53,93,126
 Device configuration: ITO/PEDOT:PSS/[Ir(C^N)2(N^N)][PF6]:[Bmim][PF6] 
4:1/Al. a) [Ir(3)2(pzpy)][PF6], b) [Ir(3)2(dmpzpy)][PF6], c) [Ir(8)2(pzpy)][PF6] and d) 
[Ir(8)2(dmpzpy)][PF6]. 
 
Low efficiencies were obtained for devices with [Ir(C^N)2(N^N)][PF6] (C^N = 3 or 8, N^N = 
pzpy or dmpzpy): power conversion efficiencies range from 0.2 to 0.6 lm W
−1
 and external 
quantum efficiencies lie between 0.2 and 0.4%. The trends in efficiency values are in line 
with the data obtained from PLQY measurements of thin films of the complexes mixed with 
ionic liquid; the lowest quantum yield and EQE values (6.9 and 0.2%, respectively) were 
obtained for [Ir(8)2(pzpy)][PF6], while the other complexes showed higher PLQYs (13.0 to 
16.9%), resulting in slightly higher EQEs (0.4%). Complex [Ir(8)2(pzpy)][PF6] also exhibits 
a) 
c) 
b) 
d) 
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the lowest maximum luminance level of 49 cd m
−2
; Lummax of compounds [Ir(3)2(N^N)][PF6] 
and [Ir(8)2(dmpzpy)][PF6] are significantly higher and range from 125 to 141 cd m
−2
. 
Maximum luminance values lie within the range observed for comparable blue and green 
iridium emitters used in light emitting electrochemical cells.
78,80,131,137,140–142
 
 
8. Conclusions 
A series of iridium complexes with phenylpyridine-based cyclometallating ligands containing 
sulfone substituents in 4- or 5-position of the phenyl ring and pyrazolylpyridine ancillary 
ligands was synthesized and characterized. The complexes were designed to induce a blue-
shifted emission as a consequence of the electron-deficient C^N and electron-rich N^N 
ligands. The combination of these effects should lead to an enlarged HOMO-LUMO energy 
gap. 
 The complexes are green or blue emitters in CH3CN solution; the emission colour 
depends on the substitution position of the methylsulfonyl moiety. Structured emission 
profiles are observed for all complexes, indicating a pronounced 
3
LC character of the 
emissive triplet state, which was confirmed by DFT and TD-DFT calculations. In the solid 
state (powder samples and thin films containing ionic liquid), the position of the emission 
bands is similar to solution samples; however, the relative intensities of the vibrational bands 
are different. This leads to yellow-green emission in the solid state. High photoluminescence 
quantum yields ranging from 53 to 77% are obtained in de-aerated solution, together with 
excited state lifetimes in the microseconds region. Both PLQYs and lifetime values are 
significantly reduced when solutions are not de-aerated; this suggests strong quenching of the 
excited state due to oxygen present in the system. 
 All complexes were tested in LEEC devices and showed green electroluminescence; 
turn-on times are short, ranging from 30 to 78 s. Unfortunately, poor performance was 
observed for the maximum luminance, efficiency and lifetime of the devices. The highest 
Lummax is observed for [Ir(3)2(pzpy)][PF6] (141 cd m
−2
), EQEs range from 0.2 to 0.4% and 
device lifetimes are in the order of a few minutes. Although the complexes in this series do 
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not show promising LEEC performance, the results obtained are comparable to other blue and 
green light-emitting electrochemical cells reported in the literature. 
 With the design strategy of combining sulfone-functionalized C^N and electron-rich 
N^N ligands, it was possible to achieve blue emission in solution with complexes that contain 
the electron-withdrawing sulfone group in para position to the Ir–C bond. This proves that 
sulfones are an alternative to the excessively used fluorine substituents in order to tune the 
emission colour to the blue. However, the electroluminescence maxima are red-shifted for all 
complexes in this series, leading to green light emitting electrochemical cells. Furthermore, 
device stability is not enhanced compared to complexes with fluoro-functionalized 
cyclometallating ligands. This leads to the conclusion that sulfone groups are either unstable 
when operated in LEECs (similar to fluorine substituents) or that instability is an inherent 
feature of iridium complexes with a large HOMO-LUMO energy gap. 
 
9. Experimental 
The following experimental procedures have been written by the author of this thesis and 
have been published in RSC Advances.
126
 
9.1. General 
2-(1H-pyrazol-1-yl)pyridine (pzpy) and 2-(3,5-dimethyl-1H-pyrazol-1-yl)pyridine (dmpzpy) 
were synthesized following a procedure described in the literature.
149
 
1
H NMR spectroscopic 
data matched those reported.
150,151
 
9.2. General procedure for the synthesis of iridium(III) complexes 
Iridium dimer and ancillary ligand were suspended in MeOH (15 mL) in a microwave vial 
and heated at 120 °C for 1 h in a microwave reactor. The resulting yellow solution was 
filtered through cotton and concentrated under reduced pressure. The residue was dissolved in 
little MeOH, an excess of solid NH4PF6 was added and the resulting suspension was stirred 
for 5 min at room temperature. The yellow precipitate was filtered off and redissolved in 
CH2Cl2/CH3CN. The solvent was removed under reduced pressure, the crude product was 
purified by column chromatography (silica) and solvent removed under reduced pressure. The 
CHAPTER III: GREEN & BLUE EMITTERS – PYRAZOLYLPYRIDINE ANCILLARY LIGANDS 
 
 
 
 
- 99 - 
 
residue was dissolved in little CH2Cl2 or CH3CN, precipitated with Et2O and left in the 
refrigerator overnight. The resulting precipitation was filtered off, washed with MeOH and 
Et2O and dried under vacuum. 
9.3. [Ir(3)2(pzpy)][PF6] 
[Ir(3)2Cl]2 (125 mg, 90.3 µmol, 1.0 eq.) and pzpy 
(27.0 mg, 0.186 mmol, 2.1 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–5% 
MeOH) and precipitation from an CH3CN solution. 
[Ir(3)2(pzpy)][PF6] was isolated as a yellow solid 
(169 mg, 0.179 mmol, 99.0%). 
1
H NMR (500 MHz, 
CD3CN) δ/ppm 8.70 (d, J = 3.1 Hz, 1H, H
F3
), 8.25–8.21 (overlapping m, 2H, HB3+D3), 8.19 
(ddd, J = 8.5, 7.6, 1.6 Hz, 1H, H
E4
), 8.10 (pseudo-dt, J = 8.5, 1.0 Hz, 1H, H
E3
), 8.05–7.97 
(overlapping m, 4H, H
A3+B4+C3+D4
), 7.85–7.82 (overlapping m, 2H, HB6+D6), 7.75 (ddd, J = 5.5, 
1.7, 0.7 Hz, 1H, H
E6
), 7.58 (dd, J = 8.2, 1.9 Hz, 1H, H
A4
), 7.56 (dd, J = 8.2, 1.9 Hz, 1H, H
C4
), 
7.36 (ddd, J = 7.6, 5.6, 1.1 Hz, 1H, H
E5
), 7.32 (d, J = 2.1 Hz, 1H, H
F5
), 7.30–7.22 
(overlapping m, 2H, H
B5+D5
), 6.77 (dd, J = 3.1, 2.1 Hz, 1H, H
F4
), 6.71 (d, J = 1.9 Hz, 1H, 
H
A6
), 6.70 (d, J = 1.9 Hz, 1H, H
C6
), 2.89 (s, 3H, H
A5-SO2Me
), 2.88 (s, 3H, H
C5-SO2Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.2 (C
D2
), 166.1 (C
B2
), 151.2 (C
D6
), 150.9 (C
B6
), 
150.5 (C
A2
), 150.40 (C
C2/E6
), 150.39 (C
C2/E6
), 150.2 (C
E2
), 149.9 (C
A1
), 146.8 (C
C1
), 145.0 
(C
F5
), 142.8 (C
E4
), 142.2 (C
A5
), 141.9 (C
C5
), 140.5 (C
B4
), 140.4 (C
D4
), 133.3 (C
F3
), 129.8 
(C
C6
), 129.7 (C
A6
), 126.34 (C
A3/B5
), 126.32 (C
A3/B5
), 126.21 (C
E5
), 126.17 (C
D5
), 126.0 (C
C3
), 
122.7 (C
A4
), 122.54 (C
C4
), 122.51 (C
B3/D3
), 122.48 (C
B3/D3
), 114.5 (C
E3
), 112.3 (C
F4
), 44.25 
(C
A5-SO2Me/C5-SO2Me
), 44.24 (C
A5-SO2Me/C5-SO2Me
). IR (solid, ṽ/cm–1) 3121 (w), 1724 (w), 1611 
(m), 1575 (w), 1524 (w), 1488 (m), 1477 (m), 1450 (w), 1430 (w), 1409 (w), 1375 (w), 1355 
(w), 1309 (m), 1292 (m), 1143 (s), 1092 (m), 1063 (m), 1047 (w), 959 (m), 915 (w), 878 (w), 
833 (s), 806 (m), 780 (m), 753 (s), 726 (m), 718 (m), 701 (m), 667 (m), 652 (m), 599 (m), 557 
(s), 546 (s), 526 (m), 488 (m), 481 (m). UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm 
(ε/dm3 mol–1 cm–1) 255 (61 000), 280 sh (39 000), 420 sh (3000). Emission (CH3CN, 
1.0 × 10
–5
 mol dm
–3
, λexc = 261 nm) λem
max
 = 491, 523 nm. ESI-MS m/z 802.4 [M−PF6]
+
 (calc. 
802.1). Found C 40.24, H 3.28, N 7.51; C32H27F6IrN5O4PS2·0.5H2O requires C 40.21, H 2.95, 
N 7.33%. 
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9.4. [Ir(3)2(dmpzpy)][PF6] 
[Ir(3)2Cl]2 (118 mg, 85.2 mmol, 1.0 eq.) and dmpzpy 
(49.4 mg, 0.285 mmol, 3.3 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–2% 
MeOH) and precipitation from an CH3CN solution. 
[Ir(3)2(dmpzpy)][PF6] was isolated as a yellow solid 
(133 mg, 0.136 mmol, 80.0%). 
1
H NMR (500 MHz, 
CD3CN) δ/ppm 8.26–8.20 (overlapping m, 2H, H
B3+D3
), 8.10 (ddd, J = 8.7, 7.0, 1.7 Hz, 1H, 
H
E4
), 8.07 (ddd, J = 8.7, 1.5, 0.9 Hz, 1H, H
E3
), 8.06–8.00 (overlapping m, 3H, HB4+B6+D4), 
7.99 (d, J = 8.3 Hz, 1H, H
A3
), 7.98 (d, J = 8.3 Hz, 1H, H
C3
), 7.81 (ddd, J = 5.8, 1.6, 0.7 Hz, 
1H, H
D6
), 7.72 (ddd, J = 5.6, 1.7, 0.9 Hz, 1H, H
E6
), 7.57 (dd, J = 8.2, 1.9 Hz, 1H, H
A4
), 7.51 
(dd, J = 8.2, 1.9 Hz, 1H, H
C4
), 7.35–7.28 (m, 1H, HB5), 7.29–7.25 (overlapping m, 2H, 
H
D5+E5
), 6.65 (d, J = 1.9 Hz, 1H, H
C6
), 6.59 (d, J = 1.9 Hz, 1H, H
A6
), 6.34 (s, 1H, H
F4
), 
2.87 (s, 3H, H
A5-SO2Me
), 2.84 (s, 3H, H
C5-SO2Me
), 2.83 (d, J = 0.8 Hz, 3H, H
F3-Me
), 1.58 (s, 3H, 
H
F5-Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.3 (C
D2
), 165.9 (C
B2
), 156.5 (C
F5
), 
151.4 (C
B6
), 151.3 (C
E2
), 151.0 (C
D6
), 150.6 (C
E6
), 150.3 (C
A2
), 150.15 (C
C2
), 150.12 (C
A1
), 
149.4 (C
C1
), 147.0 (C
F3
), 142.4 (C
E4
), 142.3 (C
A5
), 141.9 (C
C5
), 140.4 (C
B4
), 140.3 (C
D4
), 
129.9 (C
C6
), 129.1 (C
A6
), 126.5 (C
B5
), 126.4 (C
A3
), 126.3 (C
C3
), 126.1 (C
D5
), 125.1 
(C
E5
), 122.8 (C
A4
), 122.6 (C
B3/D3
), 122.5 (C
B3/D3
), 122.1 (C
C4
), 115.3 (C
E3
), 114.2 (C
F4
), 44.24 
(C
A5-SO2Me/C5-SO2Me
), 44.23 (C
A5-SO2Me/C5-SO2Me
), 15.6 (C
F3-Me
), 13.9 (C
F5-Me
). IR (solid, ṽ/cm–1) 
2924 (w), 1610 (m), 1578 (w), 1564 (w), 1475 (m), 1453 (m), 1431 (w), 1414 (w), 1392 (w), 
1373 (m), 1320 (m), 1295 (m), 1268 (m), 1148 (s), 1094 (m), 1062 (w), 1038 (w), 994 (w), 
957 (m), 874 (w), 836 (s), 805 (m), 782 (m), 756 (s), 749 (s), 701 (m), 666 (m), 652 (m), 593 
(m), 557 (m), 547 (s), 523 (m), 481 (m). UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm 
(ε/dm3 mol–1 cm–1) 255 (60 000), 285 sh (38 000), 420 sh (2900). Emission (CH3CN, 
1.0 × 10
–5
 mol dm
–3
, λexc = 261 nm) λem
max
 = 491, 523 nm. ESI-MS m/z 830.5 [M−PF6]
+
 (calc. 
830.1). Found C 42.25, H 3.51, N 7.47; C34H31F6IrN5O4PS2 requires C 41.89, H 3.20, 
N 7.18%. 
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9.5. [Ir(8)2(pzpy)][PF6] 
[Ir(8)2Cl]2 (142 mg, 0.103 mmol, 1.0 eq.) and pzpy 
(31.0 mg, 0.214 mmol, 2.1 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–10% 
MeOH) and precipitation from a CH2Cl2 solution. 
[Ir(8)2(pzpy)][PF6] was isolated as a pale yellow solid 
(79.5 mg, 84.0 µmol, 40.9%). 
1
H NMR (500 MHz, 
CD3CN) δ/ppm 8.69 (d, J = 3.1 Hz, 1H, H
F3
), 8.29 (d, J = 2.0 Hz, 1H, H
A3
), 8.30–8.23 
(overlapping m, 3H, H
B3+C3+D3
), 8.19 (ddd, J = 8.9, 7.5, 1.6 Hz, 1H, H
E4
), 8.10 (dd, J = 8.5, 
1.0 Hz, 1H, H
E3
), 8.03–7.94 (overlapping m, 2H, HB4+D4), 7.81–7.76 (overlapping m, 2H, 
H
B6+D6
), 7.71 (ddd, J = 5.6, 1.7, 0.7 Hz, 1H, H
E6
), 7.41–7.31 (overlapping m, 3H, HA5+C5+E5), 
7.31 (d, J = 2.1 Hz, 1H, H
F5
), 7.27–7.18 (overlapping m, 2H, HB5+D5), 6.77 (dd, J = 3.1, 
2.1 Hz, 1H, H
F4
), 6.55 (d, J = 8.0 Hz, 1H, H
A6
), 6.53 (d, J = 8.1 Hz, 1H, H
C6
), 3.03 (s, 3H, 
H
A4-SO2Me
), 3.02 (s, 3H, H
C4-SO2Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.3 (C
B2
), 
166.2 (C
D2
), 158.3 (C
A1
), 155.5 (C
C1
), 150.9 (C
D6
), 150.6 (C
B6
), 150.2 (C
E6
), 150.1 (C
E2
), 
146.6 (C
A2
), 146.5 (C
C2
), 144.8 (C
F5
), 142.9 (C
E4
), 140.5 (C
B4
), 140.4 (C
D4
), 136.8 (C
A4
), 
136.7 (C
C4
), 133.6 (C
C6
), 133.5 (C
A6
), 133.3 (C
F3
), 128.9 (C
A5
), 128.5 (C
C5
), 126.3 (C
E5
), 
125.9 (C
B5
), 125.8 (C
D5
), 124.1 (C
A3
), 123.7 (C
C3
), 121.89 (C
B3/D3
), 121.86 (C
B3/D3
), 114.5 
(C
E3
), 112.3 (C
F4
), 44.6 (C
A4-SO2Me+C4-SO2Me
). IR (solid, ṽ/cm–1) 3646 (w), 3133 (w), 1612 (m), 
1578 (w), 1524 (w), 1481 (m), 1451 (w), 1409 (w), 1355 (w), 1299 (m), 1224 (w), 1165 (w), 
1145 (s), 1111 (w), 1096 (w), 1067 (w), 1056 (m), 1033 (m), 960 (m), 837 (s), 781 (s), 
758 (s), 716 (w), 703 (w), 639 (w), 593 (m), 556 (s), 524 (s), 478 (m). UV/Vis (CH3CN, 
1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 253 (67 000), 280 sh (44 000), 375 sh (5000). 
Emission (CH3CN, 1.0 × 10
–5
 mol dm
–3
, λexc = 259 nm) λem
max
 = 463, 493 nm. ESI-MS m/z 
802.5 [M–PF6]
+
 (calc. 802.1). Found C 39.62, H 3.20, N 7.51; C32H27F6IrN5O4PS2·H2O 
requires C 39.83, H 3.03, N 7.26%. 
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9.6. [Ir(8)2(dmpzpy)][PF6] 
[Ir(8)2Cl]2 (143 mg, 0.103 mmol, 1.0 eq.) and dmpzpy 
(34.6 mg, 0.200 mmol, 1.9 eq.). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–10% 
MeOH) and precipitation from a CH2Cl2 solution. 
[Ir(8)2(dmpzpy)][PF6] was isolated as a pale yellow solid 
(151 mg, 0.155 mmol, 77.7%). 
1
H NMR (500 MHz, 
CD3CN) δ/ppm 8.30–8.22 (overlapping m, 4H, H
A3+B3+C3+D3
), 8.11 (ddd, J = 8.8, 7.2, 1.7 Hz, 
1H, H
E4
), 8.07 (pseudo-dt, J = 8.8, 1.1 Hz, 1H, H
E3
), 8.03–7.95 (overlapping m, 3H, 
H
B4+D4+B6
), 7.74 (ddd, J = 5.8, 1.4, 0.7 Hz, 1H, H
D6
), 7.66 (ddd, J = 5.5, 1.6, 0.8 Hz, 1H, H
E6
), 
7.36 (dd, J = 8.1, 2.0 Hz, 1H, H
A5
), 7.32–7.24 (overlapping m, 3H, HB5+C5+E5), 7.23 (ddd, J = 
7.4, 5.8, 1.4 Hz, 1H, H
D5
), 6.49 (d, J = 8.1 Hz, 1H, H
C6
), 6.43 (d, J = 8.1 Hz, 1H, H
A6
), 6.34 
(s, 1H, H
F4
), 3.03 (s, 3H, H
A4-SO2Me
), 3.00 (s, 3H, H
C4-SO2Me
), 2.83 (d, J = 0.8 Hz, 3H, H
F3-Me
), 
1.60 (s, 3H, H
F5-Me
). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 166.4 (C
D2
), 166.0 (C
B2
), 
158.6 (C
A1
), 158.1 (C
C1
), 156.6 (C
F5
), 151.2 (C
E2
), 151.1 (C
B6
), 150.7 (C
D6
), 150.4 (C
E6
), 
147.0 (C
F3
), 146.4 (C
A2
), 146.3 (C
C2
), 142.5 (C
E4
), 140.4 (C
B4
), 140.2 (C
D4
), 136.9 (C
A4
), 
136.3 (C
C4
), 133.6 (C
C6
), 133.0 (C
A6
), 129.1 (C
A5
), 128.4 (C
C5
), 126.0 (C
B5
), 125.7 (C
D5
), 
125.1 (C
E5
), 124.1 (C
A3
), 123.9 (C
C3
), 122.0 (C
B3
), 121.9 (C
D3
), 115.3 (C
E3
), 114.2 (C
F4
), 44.6 
(C
A4-SO2Me/C4-SO2Me
), 44.5 (C
A4-SO2Me/C4-SO2Me
), 15.6 (C
F3-Me
), 13.8 (C
F5-Me
). IR (solid, ṽ/cm–1) 
3086 (w), 2923 (w), 1609 (w), 1579 (w), 1538 (w), 1479 (m), 1451 (w), 1423 (w), 1396 (w), 
1372 (w), 1323 (w), 1297 (s), 1285 (m), 1274 (w), 1227 (w), 1169 (w), 1144 (s), 1094 (m), 
1077 (w), 1063 (w), 1055 (w), 1031 (w), 999 (w), 981 (w), 964 (m), 954 (m), 898 (w), 880 
(w), 833 (s), 823 (s), 795 (m), 783 (m), 761 (s), 741 (m), 701 (m), 651 (w), 639 (w), 595 
(m), 556 (s), 523 (m), 486 (m), 457 (w). UV/Vis (CH3CN, 1.0 × 10
–5
 mol dm
–3
) λ/nm 
(ε/dm3 mol–1 cm–1) 254 (66 000), 280 sh (41 000), 375 sh (4300). Emission (CH3CN, 
1.0 × 10
–5
 mol dm
–3
, λexc = 259 nm) λem
max
 = 463, 493 nm. ESI-MS m/z 830.5 [M−PF6]
+
 (calc. 
830.1). Found C 41.89, H 3.54, N 7.22; C34H31F6IrN5O4PS2 requires C 41.89, H 3.20, 
N 7.18%. 
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9.7. Crystallography 
[Ir(8)2(dmpzpy)][PF6]·CH3CN. C36H28F6IrN6O4PS2, M = 1009.97, yellow plate, monoclinic, 
space group C2/c, a = 25.335(3), b = 12.8383(13), c = 24.821(3) Å, β = 109.755(4)o, U = 
7598.2(8) Å
3
, Z = 8, Dc = 1.766 Mg m
–3
, µ(Cu-Kα) = 8.920 mm−1, T = 123 K. Total 50748 
reflections, 6985 unique, Rint = 0.049. Refinement of 6361 reflections (505 parameters) with 
I>2σ (I) converged at final R1 = 0.0239 (R1 all data = 0.0251), wR2 = 0.0257 (wR2 all data = 
0.0282), gof = 1.0886. CCDC 1055780. 
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CHAPTER IV: RED EMITTERS – BENZOTHIAZOLE-BASED 
ANCILLARY LIGANDS 
 
1. Introduction 
Despite the amount of research that has been conducted on light emitting electrochemical 
cells and Ir-iTMCs for LEECs in particular, there is still a lack of stable and efficient red 
emitters. Not only are they important for the production of red, but also of white light emitting 
electrochemical cells. From the first report of an iTMC-LEEC in 1996
40
 until the introduction 
of cationic iridium complexes in 2004,
51
 most light emitting electrochemical cells described in 
the literature were based on red and orange-red Ru(II)
41–48
 and Os(II)
49,50
 complexes. Later, 
more and more iridium-based red emitters started to appear alongside Ru(II) complexes with 
bipyridine and 2,2':6',2''-terpyridine (tpy) ligands.
69,155–160
 In Scheme 15, structures of the 
cationic iridium complexes which have been successfully implemented in host-free red 
emitting LEECs are shown. Among those are complexes with 2,2'-biquinoline (S),
133
 
imidazole-based (T),
76,147
 ester-substituted bpy (U),
161
 bis(diphenylamino)-9,9'-
spirobifluorene functionalized bpy (V),
162
 substituted tpy (W)
163
 and 1,3,4-oxadiazole-based 
(X)
164
 ancillary ligands and complexes containing methoxy-substituted cyclometallating 
ligands (Y).
165
 Complexes Z-Cbz and Z-B(Mes)2 combine more complicated 
cyclometallating ligands than the standard ppy- or ppz-based ligands with a carbazole-
substituted bpy ancillary ligand.
166
 Compound AA is a perylenediimide-iridium-complex 
dyad, exhibiting deep-red emission.
167,168
 Furthermore, red emitters [Ir(ppy)2(biq)]
+
 (biq = 
2,2'-biquinoline) and imidazole-based complex T have been used as dopants in host-guest 
red
147,169
 and white light emitting electrochemical cells.
75–77
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W  
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Z 
 
AA 
Scheme 15 Structures of red emitting iridium(III) complexes used in light emitting 
electrochemical cells.
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Table 12 and Table 13 summarize photophysical properties in solution and solid state as well 
as LEEC parameters of selected complexes shown in Scheme 15. All complexes exhibit 
photoluminescence maxima in the orange to red region and electroluminescence maxima in 
the red region of the visible spectrum. Functioning LEECs have been prepared with all 
complexes reported in Table 12 and Table 13; device performance varies significantly, 
however. Turn-on times range from under one minute for complex W containing phenol-
substituted tpy as the ancillary ligand to 27.8 h (1668 min) for complex Z-B(Mes)2 with a 
boron-substituted cyclometallating and a carbazole-functionalized bpy ligand. Compound S, 
containing a phenylpyrazole cyclometallating and biq ancillary ligand shows the highest 
maximum luminance of 7500 cd m
−2
 as well as the second-highest EQE value of 7.4%. The 
lowest luminance level (3 cd m
−2
) and EQE (0.02%) of the selected complexes is observed 
from LEECs using bis(diphenylamino)-9,9'-spirobifluorene functionalized complex V. 
LEECs incorporating complex Y (1,3,4-oxadiazole-based ancillary ligand) exhibit the highest 
EQE value of 9.51% so far reported for red light emitting electrochemical cells. While high 
maximum luminance levels and EQE values have been reached for red LEECs with Ir-
iTMCs, there remains room for improvement concerning the stability of these devices. For the 
complexes with reported device lifetimes, t1/2 generally lies in the range of 0.5 to 10 h. 
Lifetimes are slightly higher for complexes Z-Cbz and Z-B(Mes)2, but do not exceed 74 h to 
reach half of the maximum luminance. This poses a huge drawback regarding possible final 
application as artificial lighting or in displays. 
In this chapter, the synthesis and properties of a series of iridium complexes 
containing benzothiazole-based ancillary ligands are presented. In the literature, the 
benzothiazole moiety has mainly been used in the cyclometallating part of iridium 
complexes,
170–172
 for example as 2-phenylbenzo[d]thiazole (pbtz). Although coordination of 
other metal complexes by 2-(pyridin-2-yl)benzo[d]thiazole (btzpy) has been reported,
173,174
 
there is only one example of an iridium complex containing the related ligand 2-(pyridin-2-
yl)-4,5-dihydrothiazole for use as a photosensitizing complex.
175
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Table 12 Photoluminescence and electroluminescence properties of selected iridium complexes 
used as emissive materials in red light emitting electrochemical cells.  
Compound 
λem
max [nm] and 
PLQY (solution) 
λem
max [nm] and 
PLQY (film) 
EL [nm] 
CIE coord. 
(x, y) 
S
133
 
624, 
0.68% (2-MeTHF) 
622, 
--- (neat) 
635 0.67, 0.32 
T
76,147
 
627, 646, 
3% (CH3CN) 
631, 
--- (neat) 
650 0.66, 0.33 
U
161
 
687, 
2% (CH3CN) 
---, 
18% (in PMMA) 
630 0.71, 0.28 
V
162
 
595, 
0.1% (EtOH, 77 K) 
ca. 645, 
--- (neat) 
ca. 655 --- 
W (R = OH)
163
 
590, 
5.8% (CH2Cl2) 
593, 
11.3% (+IL) 
625 --- 
X (R1 = 3,4,5-
triOMe, R2 = 
t
Bu)
165
 
685, 
0.2% (CH3CN) 
ca. 625, 
9.0% (+IL) 
650 0.61, 0.38 
Y (R = H)
164
 
556, 
24.3% (CH2Cl2) 
627, 
20% (neat) 
616 0.59, 0.40 
Y (R = Me)
164
 
573, 
58.2% (CH2Cl2) 
625, 
17.8% (neat) 
624 0.50, 0.41 
Z-Cbz
166
 
559, 
9% (CH3CN) 
603, 
19% (in PMMA) 
633, 659 0.65, 0.36 
Z-B(Mes)2
166
 
583, 
49% (CH3CN) 
597, 
52% (in PMMA) 
604, 629, 651 0.62, 0.38 
AA
168
 
619, 
55% (CH3CN) 
--- 644 0.65, 0.34 
 
Table 13 Device performance of selected iridium complexes used as emissive materials in red 
light emitting electrochemical cells. 
Compound ton [min] t1/2 [h] 
Lummax 
[cd m
−2
] 
Efficacy 
[cd A
−1
] 
PCE 
[lm W
−1
] 
EQE [%] 
S
133
 70 --- 7500 --- 10 7.4 
T
76,147
 432 --- 70.3 1.6 --- 2.6 
U
161
 10 0.52 ca. 38 0.83 0.87 --- 
V
162
 --- ca. 1.3 3 0.013 0.017 0.02 
W (R = OH)
163
 <1 ca. 0.5 60 --- --- 0.4 
X (R1 = 3,4,5-
triOMe, R2 = 
t
Bu)
165
 
66 2 18 0.050 0.013 0.05 
Y (R = H)
164
 35 8.2 154 6.29 --- 9.51 
Y (R = Me)
164
 72 9.8 217 13.05 --- 2.74 
Z-Cbz
166
 516 40.0 8.4 0.10 --- 0.14 
Z-B(Mes)2
166
 1668 73.6 31.4 0.18 --- 0.13 
AA
168
 --- --- ca. 13 2.5 2.56 3.27 
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2. Synthesis and NMR Spectroscopic Characterization 
2.1. Ligand synthesis 
The chemical structures of all ligands used in this series are shown in Scheme 16, sorted by 
benzothiazole-based ancillary ligands (top row) and cyclometallating ligands (bottom row). 
To facilitate comparison, all ancillary ligands are combined with ppy as cyclometallating 
ligand and all cyclometallating ligands are combined with the simplest ancillary ligand 
(btzpy) in complexes. Ancillary ligands 2,2'-bibenzo[d]thiazole (bbtz)
176
 and 2,6-
bis(benzo[d]thiazol-2-yl)pyridine (btzpybtz)
177
 were synthesized following reported literature 
procedures by a condensation reaction of 2-aminothiophenol with oxalic acid or 2,6-
pyridinedicarboxaldehyde, respectively. 2-(pyridin-2-yl)benzo[d]thiazole (btzpy), 2-(4-(tert-
butyl)pyridin-2-yl)benzo[d]thiazole (tpybtz) and 2-(pyridin-2-yl)benzo[d]oxazole (bozpy) 
were prepared by adaptation of a copper-catalysed coupling reaction described in the 
literature,
178
 starting from the corresponding bromopyridines and benzothiazole or 
benzoxazole. 
 
 
    
 
btzpy bbtz ppybtz tpybtz btzpybtz bozpy 
   
  
ppy ppz piq tppy pbtz 
Scheme 16 Structures of ancillary (top row) and cyclometallating ligands (bottom row) used 
within this series of complexes.
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The synthesis of 2-(6-phenylpyridin-2-yl)benzo[d]thiazole (ppybtz) has not yet been reported. 
Bromination of 2-phenylpyridine with n-BuLi/LiDMAE and CBr4 gave 2-bromo-6-
phenylpyridine,
179
 which was then used in a Cu(I)-catalysed coupling reaction with 
benzothiazole
178
 to yield the desired product in moderate yield (Scheme 17). Ligand ppybtz 
was characterized by 1D and 2D NMR spectroscopy and all 
1
H and 
13
C signals were assigned. 
In the LC-ESI mass spectrum, the base peak at m/z 289.0 corresponds to the protonated ligand 
[M+H]
+
. 
 
 
Scheme 17 Synthesis of 2-(6-phenylpyridin-2-yl)benzo[d]thiazole (ppybtz). Reaction 
conditions: a) CuI, 1,10-phenanthroline monohydrate, K3PO4, DMF, 120 °C, overnight, N2.
 
 
Cyclometallating ligands 1-phenyl-1H-pyrazole (ppz),
149
 1-phenylisoquinoline (piq)
180
 and 2-
phenylbenzo[d]thiazole (pbtz)
178
 were prepared using literature procedures. The synthesis of 
2-(3-(tert-butyl)phenyl)pyridine (tppy) has been reported before, but the following procedure 
gives a higher yield. 1-bromo-3-(tert-butyl)benzene was transformed into 2-(3-(tert-
butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane via a microwave-assisted Miyaura 
borylation using bis(pinacolato)diboron and KOAc, catalysed by Pd(dppf)2Cl2·CH2Cl2.
181
 
Suzuki coupling with 2-bromopyridine gave the desired ligand in excellent yield (91.3% over 
two steps, Scheme 18). 
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Scheme 18 Synthesis of 2-(3-(tert-butyl)phenyl)pyridine (tppy). Reaction conditions: a) 
bis(pinacolato)diboron, KOAc, Pd(dppf)2Cl2·CH2Cl2, THF, MW, 90 °C, 1 h, N2; b) 2-
bromopyridine, Na2CO3, Pd(PPh3)2Cl2, THF/H2O 1:1, MW, 100 °C, 30 min.
 
 
2.2. Synthesis of [Ir(C^N)2Cl]2 dimers 
Iridium dimers [Ir(ppy)2Cl]2, [Ir(ppz)2Cl]2, [Ir(piq)2Cl]2, [Ir(tppy)2Cl]2 and [Ir(pbtz)2Cl]2 were 
synthesized according to the standard protocol.
100,101
 The cyclometallating ligand and 
IrCl3·xH2O were suspended in 2-ethoxyethanol and H2O (3:1) and heated at reflux overnight. 
The precipitated dimers were collected, washed with EtOH and Et2O and used for subsequent 
reactions without further purification. All of the dimers have been described before. For 
[Ir(ppy)2Cl]2
182
 and [Ir(piq)2Cl]2,
183
 
1
H NMR spectroscopic data matched those reported in the 
literature. For [Ir(ppz)2Cl]2, [Ir(tppy)2Cl]2 and [Ir(pbtz)2Cl]2, 
1
H NMR spectroscopy supported 
the expected structures. No characterization was reported in the literature. 
 
2.3. Synthesis of [Ir(C^N)2(N^N)][PF6] complexes 
Cationic iridium complexes of the type [Ir(C^N)2(N^N)]
+
 are typically synthesized by 
cleavage of the dimer with the desired N^N ligand in MeOH or CH2Cl2/MeOH.
93,103,104
 Using 
this method, however, traces of chloride ions can be carried through to the final product, 
despite using an excess of NH4PF6 for ion metathesis. We have recently shown that these 
chloride impurities are detrimental to device performance.
94
 Therefore, the complexes in this 
series were prepared via an intermediate solvento complex, formed by the reaction of the 
iridium dimer with AgPF6 in MeOH (Scheme 19 and Scheme 20). During the reaction, AgCl 
precipitates and is removed by filtration through Celite
®
. The filtrate is concentrated and the 
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solvento intermediate is used immediately without purification or characterization for 
subsequent transformations. As shown in a series of stable orange emitters, the purity 
obtained by this synthetic route can lead to excellent LEEC performance, decreasing the risk 
of chloride ion impurities in the final complexes.
73
 In Scheme 19, the synthetic strategy to the 
six complexes with ppy as cyclometallating ligand and different ancillary ligands is shown. 
Reaction of the [Ir(ppy)2(MeOH)2][PF6] intermediate with the corresponding benzothiazole-
based N^N ligands in MeOH at room temperature gave the desired iridium complexes in 
moderate to good yields based on the iridium dimer starting material. 
 
 
Scheme 19 Synthesis of [Ir(ppy)2(N^N)][PF6] complexes with different ancillary ligands. 
Reaction conditions: a) AgPF6, MeOH, room temperature, 2–3.5 h; b) N^N, MeOH, room 
temperature, overnight. Reported yields (over two steps) are calculated based on the dimer 
starting materials.
 
 
Similarly, four complexes with different cyclometallating ligands (ppz, piq, tppy and pbtz) 
and 2-(pyridin-2-yl)benzo[d]thiazole (btzpy) as ancillary ligand were synthesized. The 
corresponding iridium dimers were transformed to the solvento intermediates and 
subsequently reacted with btzpy, leading to the final products with yields ranging from 48.7 to 
80.0% over two steps (Scheme 20). All complexes in this series were fully characterized by 
1D and 2D NMR spectroscopy, IR spectroscopy, ESI-MS and elemental analysis. 
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Scheme 20 Synthesis of [Ir(C^N)2(btzpy)][PF6] complexes with different cyclometallating 
ligands. Reaction conditions: a) AgPF6, MeOH, room temperature, 2.5–4 h; b) btzpy, MeOH, 
room temperature, overnight. Reported yields (over two steps) are calculated based on the dimer 
starting materials.
 
 
2.3.1. Decomposition in acetonitrile solution 
The complexes reported in Chapters I–III have been characterized and analysed in acetonitrile 
solutions. During NMR spectroscopic characterization of the red emitter series it was found 
that four of the complexes, namely [Ir(ppy)2(bbtz)][PF6], [Ir(ppy)2(ppybtz)][PF6], 
[Ir(ppy)2(btzpybtz)][PF6] and [Ir(piq)2(btzpy)][PF6], are not stable in acetonitrile solution. 
Rates of decomposition vary between the four complexes; [Ir(ppy)2(btzpybtz)][PF6] shows 
degradation within a few minutes, whereas [Ir(ppy)2(bbtz)][PF6] is stable over the course of 
three days in acetonitrile solution and shows only slight decomposition after 20 days. For the 
remaining six complexes, no change is observed in the 
1
H NMR spectrum from immediately 
after preparation to 20 days in acetonitrile solution. A simple replacement of the ancillary 
ligand by solvent molecules is proposed as the decomposition process, shown in Scheme 21. 
This assumption is corroborated by the observation of free ppybtz ligand in the case of 
[Ir(ppy)2(ppybtz)][PF6] (see Fig. 44 for 
1
H NMR spectra). Furthermore, the appearance of the 
same species in the NMR spectra of [Ir(ppy)2(bbtz)][PF6], [Ir(ppy)2(ppybtz)][PF6] and 
[Ir(ppy)2(btzpybtz)][PF6] strongly suggests [Ir(ppy)2(CD3CN)2]
+
 to be the other dissociation 
product. The ligand displacement is accompanied by a colour change from an orange-red to a 
pale yellow solution, which is easily observed for complexes [Ir(ppy)2(btzpybtz)][PF6] and 
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[Ir(ppy)2(ppybtz)][PF6], where decomposition is complete within six hours or three days, 
respectively. A similar dissociation reaction has been observed for [Ir(dFphtl)2(btl)][PF6] 
(dFphtl = 1-benzyl-4-(2,4-difluorophenyl)-1H-1,2,3-triazole, btl = 1,1'-benzyl-4,4'-bi-1H-
1,2,3-triazole), in which ancillary ligand btl is replaced by acetonitrile molecules in 
solution.
184
 In this case, however, high energy irradiation (290/300 nm) is necessary for 
decomposition to take place which is not required in our case. 
 
 
Fig. 44 400 MHz 
1
H NMR spectra of [Ir(ppy)2(ppybtz)][PF6] immediately after dissolving in 
CD3CN, after 6 h and after 3 d, showing decomposition according to Scheme 21. The NMR 
spectrum of ligand ppybtz in CD3CN (bottom spectrum) is shown to confirm the dissociation 
reaction occurring in CD3CN solution. Scale: δ/ppm. 
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Scheme 21 Decomposition reaction of [Ir(ppy)2(ppybtz)][PF6] in CD3CN solution as a 
representative example.
 
 
2.3.2. Variable temperature NMR spectroscopy of [Ir(ppy)2(btzpybtz)][PF6] 
 
 
Scheme 22 Chemical structure of [Ir(ppy)2(btzpybtz)][PF6] including numbering scheme used 
for NMR assignment.
 
 
The 600 MHz 
1
H NMR spectra of [Ir(ppy)2(btzpybtz)][PF6] measured at elevated 
temperatures (298–350 K) in C2D2Cl4 solution are shown in Fig. 45. For comparison, the 
500 MHz room temperature 
1
H NMR spectrum in CD2Cl2 solution is added (top spectrum). 
The NMR experiments were performed by PD Dr. Daniel Häußinger and Yann Baumgartner 
at the University of Basel. At room temperature, significant broadening of the A ring proton 
signals as well as the signals for H
B6
 and H
D6
 is observed. These are the protons which are 
most affected by the proximity of the pendant benzothiazole moiety (G ring). Upon increasing 
the temperature, sharpening of the peaks occurs. Protons H
A5
, H
A6
 and H
B6
 are shifted 
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downfield by Δδ = 0.08 to 0.10 ppm from 298 to 350 K, while protons HA3 and HA4 retain 
their chemical shift. At 350 K, proton H
D6
 still shows a broad signal and overlaps with the 
signal of H
E3
. 
 
 
Fig. 45 Aromatic region of the NMR spectra of [Ir(ppy)2(btzpybtz)][PF6] at different 
temperatures, from room temperature to 350 K (top to bottom), including complete assignment 
for the room temperature CD2Cl2 and high temperature C2D2Cl4 spectra. Proton signals that 
sharpen significantly upon increasing temperature are shown in colour. See Scheme 22 for 
numbering. Scale: δ/ppm. 
 
2D NMR experiments (COSY, ROESY, HMQC and HMBC) were conducted at 345 K to 
allow for full assignment at elevated temperature in C2D2Cl4. In the ROESY spectrum (Fig. 
46), EXSY peaks are observed in addition to COSY and NOESY cross peaks. Exchange takes 
place between the proton signals of rings A and C (phenyl rings of C^N ligands), B and D 
(pyridyl rings of C^N ligands) and F and G (coordinated and non-coordinated benzothiazole 
rings). EXSY cross peaks are also observed between protons H
E3
 and H
E5
 of the pyridyl ring 
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of the N^N ligand. These observations lead to the assumption that a dynamic process occurs 
in solution. Since only one set of signals is observed in the 
1
H NMR spectrum, the two 
species which are transformed into each other must be equivalent in terms of NMR 
spectroscopy. 
 
 
Fig. 46 600 MHz high temperature (345 K) ROESY spectrum of [Ir(ppy)2(btzpybtz)][PF6] in 
C2D2Cl4 solution. EXSY cross peaks are shown in red with labels. See Scheme 22 for the 
numbering scheme used for signal assignment. Scale: δ/ppm. 
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Fig. 47 Schematic representation of the different possible Δ- to Λ- isomerization mechanisms 
for an octahedral metal complex with three equivalent symmetric bidentate ligands. Reprinted 
with permission from Inorg. Chem., 2010, 49, 4194–4211. Copyright (2010) American 
Chemical Society.
185
 
 
One possibility is an interconversion of the Δ- and Λ-enantiomers. This can occur in 
octahedral molecules via a non-bond breaking mechanism, for example the Bailar
186,187
 or 
Rây-Dutt twist.
187
 In both cases, the transition state is of trigonal prismatic geometry. 
Isomerization can also take place via the breaking of one coordination bond, leading to a 
trigonal-bipyramidal or a square-pyramidal transition state, and subsequently to a reformation 
of the bond.
185
 All these mechanisms are summarized in Fig. 47 for an octahedral metal 
complex with three equivalent symmetrical bidentate ligands. Another process which could 
explain the observed exchange mechanisms is a switching of the coordination sites of the 
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ancillary ligand. While the pyridyl ring of btzpybtz stays coordinated to the iridium metal, the 
second coordination bond can arise from either of the two benzothiazolyl units. 
 
3. Crystal Structures 
 
Fig. 48 Structure of the Λ-[Ir(ppy)2(btzpy)]
+
 cation in [Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2. H 
atoms omitted for clarity and ellipsoids plotted at 50% probability level. Selected bond 
parameters: Ir1–N1 = 2.172(2), Ir1–N2 = 2.050(2), Ir1–N3 = 2.143(2), Ir1–N4 = 2.041(2), Ir1–
C5 = 2.007(3), Ir1–C32 = 2.014(3), S1–C15 = 1.731(3), S1–C17 = 1.742(3) Å; N1–Ir1–N3 = 
76.15(9), N2–Ir1–C5 = 80.63(10), N4–Ir1–C32 = 80.65(10), N1–Ir1–C5 = 171.48(9), N2–Ir1–
N4 = 172.68(9), N3–Ir1–C32 = 175.40(10), C15–S1–C17 = 88.97(14)°. 
 
Single crystals of [Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2, [Ir(ppy)2(bbtz)][PF6] and 
[Ir(ppy)2(bozpy)][PF6]·CH2Cl2 were grown by layering CH2Cl2 solutions of the complexes 
with Et2O. Structures of the complex cations are shown in Fig. 48 to Fig. 50 and important 
bond lengths and angles are given in the figure captions. [Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2 
and [Ir(ppy)2(bozpy)][PF6]·CH2Cl2 crystallize in the monoclinic space groups P21/c and 
P21/n, respectively, whereas [Ir(ppy)2(bbtz)][PF6] crystallizes in the orthorhombic space 
group Fdd2. CH2Cl2 solvent molecules are heavily disordered in 
[Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2 and have been removed using the SQUEEZE
188
 method. In 
[Ir(ppy)2(bozpy)][PF6]·CH2Cl2, the CH2Cl2 solvent molecule is ordered. The asymmetric unit 
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of [Ir(ppy)2(bbtz)][PF6] contains half a cation and half an anion; in each case, the second half 
is generated by a C2 rotation axis which is parallel to the c axis of the unit cell and runs 
through the iridium or the phosphorus centre, respectively. 
 
 
Fig. 49 Structure of the Λ-[Ir(ppy)2(bbtz)]
+
 cation in [Ir(ppy)2(bbtz)][PF6], H atoms omitted and 
ellipsoids plotted at 50% probability level. Symmetry code: i = −x+½,−y+½,z+1. Selected bond 
parameters: Ir1–N1 = 2.176(3), Ir1–N3 = 2.048(2), Ir1–C20 = 2.004(3), S1–C6 = 1.730(4), S1–
C7 = 1.718(3) Å; N1–Ir1–N1i = 75.58(14), N3–Ir1–C20 = 80.75(12), N1–Ir1–C20 = 175.83(13), 
N3–Ir1–N3i = 168.96(15), C6–S1–C7 = 88.77(16)°. 
 
For [Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2 and [Ir(ppy)2(bozpy)][PF6]·CH2Cl2, the phenylpyridine 
ligand of which the coordinating C atom is trans to the benzothiazole/benzoxazole unit is 
nearly planar (angles between the ring planes are 3.3 and 2.7°, respectively). The other ppy 
cyclometallating ligand (coordinating carbon trans to the pyridine ring of the ancillary ligand) 
shows deviation from planarity, with angles between the ring planes of 8.2 and 10.9°. 
Whereas the btzpy ancillary ligand in [Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2 is distorted from 
planarity (angle between ring planes = 8.2°), the bozpy ligand in 
[Ir(ppy)2(bozpy)][PF6]·CH2Cl2 does not exhibit the same behaviour (angle between the ring 
planes = 2.2°). In [Ir(ppy)2(bbtz)][PF6], both the ppy and the bbtz ligands are twisted so that 
the angles between the ring planes amount to 7.1 and 7.5°, respectively. 
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Fig. 50 Structure of the Δ-[Ir(ppy)2(bozpy)]
+
 cation in [Ir(ppy)2(bozpy)][PF6]·CH2Cl2. H atoms 
omitted for clarity and ellipsoids plotted at 50% probability level. Selected bond parameters: 
Ir1–N1 = 2.044(2), Ir1–N2 = 2.055(2), Ir1–N3 = 2.173(2), Ir1–N4 = 2.140(2), Ir1–C11 = 
2.009(3), Ir1–C22 = 2.008(3), O1–C28 = 1.355(4), O1–C29 = 1.394(4) Å; N1–Ir1–C11 = 
80.60(11), N2–Ir1–C22 = 80.60(11), N3–Ir1–N4 = 76.33(9), N1–Ir1–N2 = 172.13(9), N3–Ir1–
C11 = 170.59(10), N4–Ir1–C22 = 173.90(10), C28–O1–C29 = 103.9(2)°. 
 
4. Photophysical Properties 
UV-Vis absorption spectra in CH2Cl2 solution are shown in Fig. 51 for complexes with ppy as 
cyclometallating and different ancillary ligands and in Fig. 52 for complexes with different 
cyclometallating ligands and btzpy as ancillary ligand. All complexes show intense absorption 
bands in the UV with maxima in the range 254–324 nm, which are ascribed to spin-allowed 
π*←π transitions of the ligands. Lower energy bands between 350 and 450 nm correspond to 
spin-allowed 
1
MLCT and 
1
LLCT excitations, whereas the low intensity tails above 450 nm 
arise from spin-forbidden 
3
MLCT, 
3
LLCT and 
3
LC transitions.
21
 
The UV-Vis absorption spectra of all complexes in this series are similar, with only 
three compounds showing significantly different spectra; these are [Ir(ppy)2(bbtz)][PF6], 
[Ir(piq)2(btzpy)][PF6] and [Ir(pbtz)2(btzpy)][PF6] and their absorption profiles will be 
discussed in more detail. [Ir(ppy)2(bbtz)][PF6] (orange line, Fig. 51) exhibits more intense 
absorption bands at wavelengths higher than 360 nm compared to the other complexes, with 
considerably stronger absorption bands extending into the visible region (around 450 nm). 
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This feature is attributed to the 2,2'-bibenzo[d]thiazole (bbtz) ancillary ligand. In the 
literature, there is only one example of a metal complex coordinated by the bbtz ligand, a 
cationic ruthenium complex of the formula [Ru(bpy)2(bbtz)][PF6]2.
174
 Unfortunately, neither 
an absorption curve nor any extinction coefficients are reported; the authors describe however 
red-shifted MLCT maxima on going from [Ru(bpy)3]
2+
 to [Ru(bpy)2(btzpy)]
2+
 to 
[Ru(bpy)2(bbtz)]
2+
. 
 
 
Fig. 51 UV-Vis absorption spectra in CH2Cl2 solution (1.0 × 10
−5
 mol dm
−3
) of complexes with 
ppy cyclometallating and different ancillary ligands. 
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Fig. 52 UV-Vis absorption spectra in CH2Cl2 solution (1.0 × 10
−5
 mol dm
−3
) of complexes with 
different cyclometallating ligands and btzpy ancillary ligand. 
 
Characteristic peaks at 293 (ε = 46 000 dm3 mol−1 cm−1) and 433 nm (ε = 
8900 dm
3
 mol
−1
 cm
−1
) are observed in the absorption spectrum of [Ir(piq)2(btzpy)][PF6] (blue 
line, Fig. 52) which arise due to the presence of the 1-phenylisoquinoline (piq) 
cyclometallating ligand. Those maxima are also observed for [Ir(piq)2(bpy)][PF6] at 290/291 
and 439/440 nm (in CH2Cl2), as described in the literature.
189–191
 Extinction coefficients are in 
the same range as those found for [Ir(piq)2(btzpy)][PF6]. The distinctive absorption band at 
324 nm (ε = 46 000 dm3 mol−1 cm−1) of [Ir(pbtz)2(btzpy)][PF6] (purple line, Fig. 52) is not 
present in [Ir(ppy)2(btzpy)][PF6] and must therefore be a characteristic of the 2-
phenylbenzo[d]thiazole (pbtz) cyclometallating ligand. Comparison with literature data of 
[Ir(pbtz)2(bpy)]
+
 shows the presence of an absorption band with two maxima in the same 
region (310–325 nm) in CH2Cl2,
192
 CH3CN,
192
 MeOH
193
 and THF
194
 solutions. The 
corresponding absorption intensities reported in the literature are lower, indicating the 
contribution of a transition involving the btzpy ancillary ligand in [Ir(pbtz)2(btzpy)][PF6] to 
the absorption band, thus leading to a higher extinction coefficient in this case. 
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Fig. 53 Emission spectra in CH2Cl2 solution (1.0 × 10
−5
 mol dm
−3
) of complexes with ppy 
cyclometallating and different ancillary ligands. λexc = 445 nm for [Ir(ppy)2(bbtz)][PF6], λexc = 
430 nm for the other compounds. 
 
Excitation of CH2Cl2 solutions of the complexes in this series gives the emission spectra 
shown in Fig. 53 and Fig. 54 with solution photophysical data summarized in Table 14. 
Emission maxima lie in the orange to deep-red region, ranging from 600 to 686 nm. For all 
complexes, the shapes and positions of the emission bands are independent of the excitation 
wavelength. 
Introduction of the btzpy ancillary ligand leads to a 49 nm red-shift of the emission 
maximum in CH2Cl2 when compared to the parent complex [Ir(ppy)2(bpy)][PF6] (595 nm).
195
 
This red-shift can be explained by the electron-deficient nature of the benzothiazole moiety, 
leading to stabilization of the LUMO and as a consequence a smaller energy gap. Replacing 
the pyridine ring of btzpy by another benzothiazole unit leads to a further 42 nm 
bathochromic shift of the emission maximum in [Ir(ppy)2(bbtz)][PF6] (orange line, Fig. 53). 
Substituting btzpy with a further benzothiazole group (btzpybtz ligand) does not have the 
same effect as bbtz; the pendant btz ring in [Ir(ppy)2(btzpybtz)][PF6] red-shifts the emission 
maximum by only 8 nm (light blue line, Fig. 53). Coordination of the benzothiazole to the 
iridium centre is therefore crucial for a substantial bathochromic shift. With the exception of 
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[Ir(ppy)2(bbtz)][PF6] (orange line, Fig. 53), [Ir(ppz)2(btzpy)][PF6] (dark green line, Fig. 54) 
and [Ir(pbtz)2(btzpy)][PF6] (purple line, Fig. 54), the emission maxima of all complexes in 
this series are found in a small 24 nm range between 636 and 660 nm, corresponding to red 
emission. Introduction of a pendant phenyl or benzothiazole ring (dark and light blue lines, 
Fig. 53) as well as substitution of ppy by piq (blue line, Fig. 54) exerts a negligible influence 
on the luminescence maximum. Whereas functionalization of ppy with a tert-butyl group red-
shifts the emission by 16 nm (light green line, Fig. 54), a blue-shift of the emission band is 
observed upon tert-butyl substitution on the pyridyl ring of btzpy (dark red line, Fig. 53). The 
same effect is observed by changing the benzothiazole to a benzoxazole unit in the ancillary 
ligand (light red line, Fig. 53). As for [Ir(ppz)2(btzpy)][PF6] and [Ir(pbtz)2(btzpy)][PF6], both 
ppz (dark green) and pbtz (purple line, Fig. 54) cyclometallating ligands stabilize the HOMO, 
thus increasing the HOMO-LUMO gap. Both complexes are therefore orange emitters, with 
blue-shifted λem
max
 of 607 and 600 nm, respectively. This observation is in accordance with the 
reported hypsochromic shifts of [Ir(ppz)2(bpy)][PF6]
133
 and [Ir(pbtz)2(bpy)][PF6]
192
 with 
respect to the archetypal [Ir(ppy)2(bpy)][PF6]. 
 The majority of complexes in this series show broad, unstructured emission profiles, 
indicating a large charge transfer character of the emissive state. Some vibrational structure is 
observed in the emission bands of [Ir(ppy)2(tpybtz)][PF6], [Ir(ppy)2(bozpy)][PF6] (dark and 
light red lines, Fig. 53), [Ir(ppz)2(btzpy)][PF6] and [Ir(pbtz)2(btzpy)][PF6] (dark green and 
purple lines, Fig. 54), suggesting that the 
3
LC contribution is more pronounced in the 
emissive state of these four complexes. 
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Fig. 54 Emission spectra in CH2Cl2 solution (1.0 × 10
−5
 mol dm
−3
) of complexes with different 
cyclometallating ligands and btzpy ancillary ligand. λexc = 430 nm for [Ir(ppy)2(btzpy)][PF6] and 
[Ir(ppz)2(btzpy)][PF6]; λexc = 435 nm for [Ir(tppy)2(btzpy)][PF6]; λexc = 437 nm for 
[Ir(piq)2(btzpy)][PF6] and [Ir(pbtz)2(btzpy)][PF6]. 
 
Photoluminescence quantum yields in solution are generally low (<10%) within this series of 
complexes (Table 14), but comparable to most of the red emitters reported in the literature 
(vide supra). A tert-butyl substituent on the ancillary ligand in [Ir(ppy)2(tpybtz)][PF6] and the 
exchange of ppy by ppz in [Ir(ppz)2(btzpy)][PF6] lead to slightly higher PLQYs of 14 and 
16%, respectively. With a substantially higher quantum yield of 41%, [Ir(pbtz)2(btzpy)][PF6] 
is an exception in this series. [Ir(pbtz)2(btzpy)][PF6] exhibits also a significantly longer 
excited state lifetime (1.2 µs) than the remaining nine complexes, which show lifetimes in the 
range 55–459 ns. Lifetimes were determined using biexponential fits in the case of 
[Ir(ppy)2(btzpybtz)][PF6], [Ir(ppy)2(bozpy)][PF6] and [Ir(piq)2(btzpy)][PF6]; data are given in 
Table 14. 
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Table 14 Photophysical properties in CH2Cl2 solution. 
Compound 
λexc 
[nm] 
λem
max 
[nm] 
PLQY 
[%]
a
 
τave [ns] 
(χ)a,b 
τ1 [ns] 
(A1) 
τ2 [ns] 
(A2) 
[Ir(ppy)2(bozpy)][PF6] 270 636 5.9 166 (1.2) 143 (6297) 237 (1185) 
[Ir(ppy)2(btzpybtz)][PF6] 265 652 4.1 169 (1.0) 139 (6306) 274 (917) 
[Ir(ppy)2(tpybtz)][PF6] 270 636 14 329 (1.0) --- --- 
[Ir(ppy)2(ppybtz)][PF6] 270 645 6.5 183 (1.1) --- --- 
[Ir(ppy)2(bbtz)][PF6] 259 686 3.6 126 (1.2) --- --- 
[Ir(ppy)2(btzpy)][PF6] 266 644 7.7 222 (1.1) --- --- 
[Ir(ppz)2(btzpy)][PF6] 261 607 16 459 (1.1) --- --- 
[Ir(piq)2(btzpy)][PF6] 293 642 8.7 380 (1.1) 251 (8009) 1349 (199) 
[Ir(tppy)2(btzpy)][PF6] 268 660 1.9 55 (1.1) --- --- 
[Ir(pbtz)2(btzpy)][PF6] 326 600 41 1200 (1.1) --- --- 
a
 Measured in de-aerated solution. 
b
 λexc = 280 nm; 340 nm for [Ir(pbtz)2(btzpy)][PF6]. Biexponential 
fits were used for the excited state lifetime determination of three of the complexes, according to the 
equation τave=∑Aiτi/∑Ai (Ai = pre-exponential factor of the lifetime). Monoexponential fits were used 
for the remaining complexes (no τ1 and τ2 reported). 
 
 
Fig. 55 Solid-state emission spectra of powder samples of complexes with ppy cyclometallating 
and different ancillary ligands. λexc = 280 nm. 
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Fig. 56 Solid-state emission spectra of powder samples of complexes with different 
cyclometallating ligands and btzpy ancillary ligand. λexc = 280 nm. 
 
Emission spectra of powder samples are depicted in Fig. 55 and Fig. 56; emission maxima, 
quantum yields and excited state lifetimes are summarized in Table 15. No shift of the 
emission maximum is observed for [Ir(piq)2(btzpy)][PF6] (blue line, Fig. 56) on going from 
CH2Cl2 solution to the solid state. [Ir(ppz)2(btzpy)][PF6] (dark green) and 
[Ir(pbtz)2(btzpy)][PF6] (purple line, Fig. 56) both show a slight red-shift of the emission 
maximum by 5 and 14 nm, respectively; all remaining complexes exhibit a blue-shift in the 
range 4–30 nm. The largest shift is seen for [Ir(ppy)2(bbtz)][PF6] (orange line, Fig. 55); this is 
also the only complex in this series which has a structured emission profile in the solid state. 
PLQYs vary from 2.3% for [Ir(piq)2(btzpy)][PF6] to 33% for [Ir(pbtz)2(btzpy)][PF6]. Solid 
state quantum yields are significantly higher with respect to solution quantum yields for 
[Ir(ppy)2(bbtz)][PF6] (17% in powder) and [Ir(tppy)2(btzpy)][PF6] (10%) and considerably 
lower for [Ir(ppz)2(btzpy)][PF6] (11%), [Ir(piq)2(btzpy)][PF6] (2.3%) and 
[Ir(pbtz)2(btzpy)][PF6] (33%). A decrease in quantum yields of solid samples compared to 
solution data is commonly observed in iridium complexes and suggests strong quenching of 
the excited state due to intermolecular interactions.
78
 A significant increase from solution to 
solid state PLQY – as seen for [Ir(ppy)2(bbtz)][PF6] and [Ir(tppy)2(btzpy)][PF6] – occurs less 
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frequently in this type of complex and can be attributed to the phenomenon of Aggregation-
Induced Emission (AIE),
196–199
 also called Enhanced Phosphorescence Emission in the Solid 
State (EPESS).
200
 Biexponential fits were used for solid state decay curves of all complexes. 
Average lifetimes lie in the range 142–730 ns, with [Ir(pbtz)2(btzpy)][PF6] exhibiting not only 
the highest quantum yield, but also the longest τave. 
 
 
Fig. 57 Thin film photoluminescence spectra of complexes with ppy as cyclometallating ligand 
and different ancillary ligands. Composition: [Ir(ppy)2(N^N)][PF6]:[Bmim][PF6] 4:1. For thin 
film with [Ir(ppy)2(tpybtz)][PF6], 2 wt-% PMMA was added. λexc = 320 nm. 
 
Thin films of the complexes combined with [Bmim][PF6] as ionic liquid (4:1 ratio) were spin-
coated onto quartz substrates and photophysical properties determined by Dr. Henk Bolink 
and co-workers at the University of Valencia. For [Ir(ppy)2(tpybtz)][PF6], 2 wt-% poly(methyl 
methacrylate) (PMMA) was added to facilitate film formation. Photoluminescence spectra are 
depicted in Fig. 57 for [Ir(ppy)2(N^N)][PF6] with different N^N ligands and Fig. 58 for 
[Ir(C^N)2(btzpy)][PF6] with different C^N ligands. Emission maxima and quantum yields are 
reported in Table 15. Red-shifts in the emission maxima are observed for all complexes on 
going from powder samples to thin films. A pronounced red-shift of 37 nm is seen for 
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[Ir(ppy)2(bbtz)][PF6] (orange line, Fig. 57), resulting in an emission maximum close to the 
near-infrared region (693 nm). All other complexes exhibit smaller bathochromic shifts in the 
range 9–18 nm. Interaction of the complexes with the ionic liquid in thin films apparently 
leads to a slight stabilization of the triplet emissive state and thus a smaller energy gap. In thin 
films, quantum yields of nearly all complexes stay the same or are slightly increased when 
compared to powder samples (Table 15). Only for [Ir(ppy)2(bbtz)][PF6] (6.7%) and 
[Ir(tppy)2(btzpy)][PF6] (5.1%), PLQYs are significantly lower in films than as powder 
samples (17 and 10%, respectively). This observation further supports the theory of an AIE 
process taking place, as the complexes are diluted with ionic liquid in the case of thin film 
samples.
196–200
 
 
 
Fig. 58 Solid state emission spectra of thin films of complexes with different cyclometallating 
ligands and btzpy as ancillary ligand. Composition: [Ir(C^N) 2(btzpy)][PF6]:[Bmim][PF6] 4:1. 
λexc = 320 nm. 
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Table 15 Solid state photophysical properties of powder samples and in thin film 
(complex:[Bmim][PF6] 4:1). Thin film of [Ir(ppy)2(tpybtz)][PF6] included 2 wt-% PMMA. 
Compound 
Powder samples Thin film 
λem
max 
[nm]
a
 
PLQY 
[%]
b 
τave [ns] 
(χ)c 
τ1 [ns] 
(A1) 
τ2 [ns] 
(A2) 
λem
max 
[nm]
d
 
PLQY 
[%]
d
 
[Ir(ppy)2(bozpy)][PF6] 616 9.7 236 (1.0) 
113 
(2466) 
253 
(7659) 
625 12 
[Ir(ppy)2(btzpybtz)][PF6] 648 3.1 185 (1.0) 
109 
(4892) 
229 
(4022) 
658 5.8 
[Ir(ppy)2(tpybtz)][PF6] 630 16 305 (1.1) 
224 
(5183) 
370 
(3953) 
642 18 
[Ir(ppy)2(ppybtz)][PF6] 638 8.5 214 (1.0) 
148 
(5424) 
266 
(3743) 
651 9.7 
[Ir(ppy)2(bbtz)][PF6] 656 17 565 (1.1) 
340 
(2834) 
613 
(7404) 
693 6.7 
[Ir(ppy)2(btzpy)][PF6] 630 8.6 277 (1.0) 
206 
(6796) 
397 
(2094) 
645 11 
[Ir(ppz)2(btzpy)][PF6] 612 11 337 (1.2) 
176 
(3291) 
379 
(5783) 
629 12 
[Ir(piq)2(btzpy)][PF6] 642 2.3 142 (1.1) 
111 
(8362) 
256 
(1006) 
659 3.3 
[Ir(tppy)2(btzpy)][PF6] 648 10 328 (1.0) 
175 
(5547) 
444 
(2858) 
666 5.1 
[Ir(pbtz)2(btzpy)][PF6] 614 33 730 (1.1) 
538 
(3936) 
808 
(6488) 
625 29 
a
 λexc = 280 nm. 
b
 For λexc, see Table 14. 
c
 λexc = 280 nm; 340 nm for [Ir(pbtz)2(btzpy)][PF6]. 
Biexponential fits were used for the excited state lifetime determination of all complexes, according to 
the equation τave=∑Aiτi/∑Ai (Ai = pre-exponential factor of the lifetime). 
d
 λexc = 320 nm. 
 
5. Electrochemical Properties 
Electrochemical data gained from cyclic voltammetry measurements in CH2Cl2 with both 
glassy carbon and Pt working electrodes are summarized in Table 16. For complexes with 
different cyclometallating ligands [Ir(C^N)2(btzpy)][PF6] (C^N = ppy, ppz, piq, tppy, pbtz), 
the reduction potentials lie in a close range (−1.52 to −1.57 V), as shown in Fig. 59. This is in 
accordance with the localization of the LUMO on the ancillary ligand (btzpy in our case) in 
this type of iridium complexes. Since the HOMO is localized mainly on the iridium centre 
and the phenyl ring of the cyclometallating ligand, the oxidation potential is sensitive to 
variation of the C^N ligand. With respect to [Ir(ppy)2(btzpy)][PF6] (E1/2
ox  = +0.93 V for glassy 
carbon and 0.94 V for Pt electrode), complex [Ir(tppy)2(btzpy)][PF6] is more readily oxidized. 
This observation is attributed to the electron-donating nature of the introduced tert-butyl 
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substituent. Replacing ppy by ppz or pbtz shifts the observed oxidation to higher potentials 
(by 0.09 to 0.18 V), due to a destabilization of the HOMO, leading to a larger HOMO-LUMO 
gap. Introducing the piq cyclometallating ligand has no influence on the oxidation potential. 
These observations correlate well with the photoluminescence maxima (vide supra), as a 
larger HOMO-LUMO gap leads to a blue-shift in the emission of [Ir(ppz)2(btzpy)][PF6] and 
[Ir(pbtz)2(btzpy)][PF6], whereas a red-shift can be assigned to a smaller energy gap of 
[Ir(tppy)2(btzpy)][PF6]. 
 
 
Fig. 59 Cyclic voltammograms of complexes with different cyclometallating ligands and btzpy 
ancillary ligand with respect to Fc/Fc
+
, measured in CH2Cl2 solution; Pt working and counter 
electrodes, Ag pseudo-reference electrode, 0.1 M TBAPF6 supporting electrolyte, scan rate = 
0.1 V s
−1
. The arrow indicates the initial scanning direction. 
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Table 16 Cyclic voltammetric data in de-aerated CH2Cl2 solutions with respect to Fc/Fc
+
, using 
Pt counter and Ag pseudo-reference electrodes and 0.1 M TBAPF6 supporting electrolyte. 
Measured at a scan rate of 0.1 V s
−1
. For each complex, the first row values correspond to 
measurements with glassy carbon, the second row values to Pt working electrode. ir = 
irreversible, qr = quasi-reversible. 
Compound E1/2
ox  [V] (Epa–Epc [mV]) E1/2
red [V] (Epc–Epa [mV]) ΔE1/2 [V] 
[Ir(ppy)2(bozpy)][PF6] 
+0.92 (132) 
+0.92 (114) 
−1.61 (123) 
−1.61 (104) 
2.53 
2.53 
[Ir(ppy)2(btzpybtz)][PF6] 
+0.99
ir
, +1.17
ir 
+0.99
ir
, +1.17
ir
 
−1.48 (113), −2.32ir 
−1.47 (86), −2.30ir 
2.47 
2.46 
[Ir(ppy)2(tpybtz)][PF6] 
+0.92 (125) 
+0.92 (95) 
−1.60 (118) 
−1.59 (89) 
2.52 
2.51 
[Ir(ppy)2(ppybtz)][PF6] 
+0.84 (148) 
+0.86 (126) 
−1.60 (105) 
−1.57 (95) 
2.44 
2.43 
[Ir(ppy)2(bbtz)][PF6] 
+1.01 (149) 
+1.01 (144) 
−1.28 (125), −2.05 (160) 
−1.27 (123), −2.03 (140) 
2.29 
2.28 
[Ir(ppy)2(btzpy)][PF6] 
+0.93 (102) 
+0.94 (92) 
−1.56 (85) 
−1.55 (83) 
2.49 
2.49 
[Ir(ppz)2(btzpy)][PF6] 
+1.02 (131) 
+1.02 (121) 
−1.57 (124) 
−1.57 (103) 
2.59 
2.59 
[Ir(piq)2(btzpy)][PF6] 
+0.93 (127) 
+0.92 (109) 
−1.56 (118) 
−1.56 (98) 
2.49 
2.48 
[Ir(tppy)2(btzpy)][PF6] 
+0.82 (133) 
+0.81 (113) 
−1.57 (125) 
−1.56 (100) 
2.39 
2.37 
[Ir(pbtz)2(btzpy)][PF6] 
+1.11 (113) 
+1.11 (113) 
−1.52 (104) 
−1.52 (91) 
2.63 
2.63 
 
Reduction potentials are also similar for complexes [Ir(ppy)2(btzpy)][PF6], 
[Ir(ppy)2(ppybtz)][PF6], [Ir(ppy)2(tpybtz)][PF6] and [Ir(ppy)2(bozpy)][PF6] (−1.55 to 
−1.61 V), indicating that reduction takes place mainly on the benzothiazole unit of the 
ancillary ligand and replacing benzothiazole by benzoxazole does not significantly influence 
the reduction potential. Both [Ir(ppy)2(bbtz)][PF6] and [Ir(ppy)2(btzpybtz)][PF6] are more 
readily reduced than [Ir(ppy)2(btzpy)][PF6], with E1/2
red shifted by 0.08 and 0.28 V, respectively. 
The introduction of a second benzothiazole moiety therefore has a pronounced stabilization 
effect on the LUMO, especially in bbtz, where the two benzothiazoles are directly linked. A 
second reduction peak is observed for both complexes, which is not seen for the remaining 
eight compounds within the accessible solvent window. Oxidation potentials are in a close 
range (+0.84 to +1.01 V), as expected for [Ir(ppy)2(N^N)][PF6] complexes in which the 
HOMO is located on the iridium centre and the cyclometallating ligand. For 
[Ir(ppy)2(bbtz)][PF6], oxidation is shifted to higher potential, which can be explained by the 
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extremely electron-deficient nature of the bbtz ligand, making oxidation of the iridium centre 
more difficult. The opposite trend is seen in [Ir(ppy)2(ppybtz)][PF6], where the introduction of 
a phenyl group on the ancillary ligand facilitates oxidation. In [Ir(ppy)2(btzpybtz)][PF6], two 
irreversible oxidation waves are observed, whereas all other complexes exhibit only one 
reversible to quasi-reversible oxidation. 
 
6. Electroluminescence and Device Data 
Light emitting electrochemical cells of all complexes in this series were prepared by Dr. Henk 
Bolink and his team at the University of Valencia. The device configuration used was 
ITO/PEDOT:PSS/[Ir(C^N)2(N^N)][PF6]:[Bmim][PF6] 4:1/Al. Block-wave pulsed current 
driving (frequency 1 kHz, 50% duty cycle, average current density 100 or 700 A m
−2
) was 
applied to evaluate the LEEC performance.
21,163
 Electroluminescence spectra obtained under 
these conditions are shown in Fig. 61 for complexes with different N^N ligands and Fig. 62 
for complexes containing different C^N ligands. Electroluminescence maxima and LEEC 
performance parameters are summarized in Table 17. Photographs of the LEEC devices in 
operation are presented in Fig. 60, showing the orange to red electroluminescence colours. 
 
    
[Ir(ppy)2(btzpy)][PF6] [Ir(ppy)2(ppybtz)][PF6] [Ir(ppy)2(tpybtz)][PF6] [Ir(ppy)2(bozpy)][PF6] 
    
[Ir(ppz)2(btzpy)][PF6] [Ir(piq)2(btzpy)][PF6] [Ir(tppy)2(btzpy)][PF6] [Ir(pbtz)2(btzpy)][PF6] 
Fig. 60 Photographs of LEEC devices in operation of selected iridium complexes, showing 
orange to red electroluminescence. 
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Fig. 61 Electroluminescence spectra of complexes with ppy cyclometallating ligands and 
different ancillary ligands. 
 
 
Fig. 62 Electroluminescence spectra of complexes with different cyclometallating ligands and 
btzpy ancillary ligand. 
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Luminescence maxima are retained or slightly blue-shifted (<9 nm) for most of the complexes 
with respect to photoluminescence maxima in thin film. A more pronounced blue-shift of over 
20 nm is observed for complexes [Ir(ppy)2(bozpy)][PF6], [Ir(ppz)2(btzpy)][PF6] and 
[Ir(pbtz)2(btzpy)][PF6]. In contrast, a small red-shift to the near-infrared region occurs for 
[Ir(ppy)2(bbtz)][PF6] on going from thin film photoluminescence (693 nm) to 
electroluminescence (699 nm). 
Luminance curves are plotted against time in Fig. 63 for [Ir(ppy)2(C^N)][PF6] with 
different N^N ligands and Fig. 64 for [Ir(C^N)2(btzpy)][PF6] with different C^N ligands. 
Device parameters are given in Table 17. Due to problems with film formation, it was not 
possible to obtain working LEECs with complex [Ir(ppy)2(bbtz)][PF6]. Complexes with ppy 
as cyclometallating ligand and different ancillary ligands were measured at an average current 
density of 100 A m
−2
. Under these conditions, the simplest complex [Ir(ppy)2(btzpy)][PF6] 
reaches a maximum luminance of 78 cd m
−2
 and shows high stability. The recorded lifetime 
of >1000 h is much longer than the longest lifetime for a red LEEC reported in the literature 
(compound Z-B(Mes)2, t1/2 = 73.6 h, see Table 13).
166
 However, the turn-on time is long 
(58 h) and the efficacy low (1.16 cd A
−1
). By adding a pendant phenyl ring to the ancillary 
ligand and thus allowing for intramolecular π-stacking interactions (complex 
[Ir(ppy)2(ppybtz)][PF6]), an increase in the maximum luminance is observed (119 cd m
−2
), 
together with an increase in efficacy (1.22 cd A
−1
). Furthermore, the turn-on time is 
significantly reduced to 17 h, while the stability is enhanced (t1/2 >4500 h). Introduction of a 
tert-butyl group on the benzothiazolyl-pyridine backbone further increases the lifetime to 
>6000 h, as observed for complex [Ir(ppy)2(tpybtz)][PF6]. Furthermore, both maximum 
luminance (200 cd m
−2
) and efficacy (1.5 cd A
−1
) are improved. The turn-on time becomes 
significantly longer (778 h), this is due to a very slow increase in luminance after reaching 
140 cd m
−2
 (see Fig. 63). A luminance level of 100 cd m
−2
 on the other hand is obtained after 
only 9 h. A pendant benzothiazolyl unit on the ancillary ligand does not have the same 
beneficial effect on device performance as does a phenyl ring. While stability is reasonable 
for [Ir(ppy)2(btzpybtz)][PF6], maximum luminance (9 cd m
−2
) and efficacy (0.094 cd A
−1
) are 
dramatically reduced. This is in accordance with the much lower PLQY in thin film. By 
replacing the benzothiazolyl-pyridine ancillary ligand by benzoxazolyl-pyridine, maximum 
luminance levels and efficacy are comparable: 97 cd m
−2
 and 0.97 cd A
−1
 for 
[Ir(ppy)2(bozpy)][PF6] compared to 78 cd m
−2
 and 1.16 cd A
−1
 for [Ir(ppy)2(btzpy)][PF6]. 
CHAPTER IV: RED EMITTERS – BENZOTHIAZOLE-BASED ANCILLARY LIGANDS 
 
 
 
 
- 137 - 
 
However, both turn-on time (0.84 h) and lifetime (9 h) decrease considerably for 
[Ir(ppy)2(bozpy)][PF6]. The high stability of LEECs containing the other complexes is 
therefore attributed to the benzothiazolyl moiety and is lost by changing the sulfur to oxygen. 
 
 
Fig. 63 Luminance vs. time curves of LEECs containing the complexes with ppy 
cyclometallating ligands and different ancillary ligands, measured under block-wave pulsed 
current conditions (50% duty cycle, frequency 1 kHz, average current density 100 A m
−2
).
21,163
 
Device configuration: ITO/PEDOT:PSS/[Ir(ppy)2(N^N)][PF6]:[Bmim][PF6] 4:1/Al. The active 
layer in the LEEC with [Ir(ppy)2(tpybtz)][PF6] contained 2 wt-% PMMA. 
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Fig. 64 Luminance plotted vs. time of devices containing complexes with different 
cyclometallating and btzpy ancillary ligand, measured applying block-wave pulsed current 
conditions (50% duty cycle, frequency 1 kHz, average current density 700 A m
−2
).
21,163
 LEEC 
configuration: ITO/PEDOT:PSS/[Ir(C^N)2(btzpy)][PF6]:[Bmim][PF6] 4:1/Al. 
 
Devices containing complexes [Ir(C^N)2(btzpy)][PF6] with different cyclometallating ligands 
were measured at an average current density of 700 A m
−2
. These conditions lead to an 
enhancement of the maximum luminance (861 cd m
−2
) and efficacy (1.23 cd A
−1
) of 
[Ir(ppy)2(btzpy)][PF6] with respect to the measurement at 100 A m
−2
. The turn-on time is 
reduced to 39 h, while the lifetime stays long (>1200 h). Replacing the ppy cyclometallating 
ligands by ppz or piq results in reduced maximum luminance levels (320 cd m
−2
 and 
84 cd m
−2
, respectively) and reduced efficacies (0.46 cd A
−1
 and 0.12 cd A
−1
, respectively). 
For [Ir(ppz)2(btzpy)][PF6], this finding is surprising, since the quantum yield in thin film is 
comparable to that of [Ir(ppy)2(btzpy)][PF6] (both between 11 and 12%). Turn-on times are 
also significantly reduced for [Ir(ppz)2(btzpy)][PF6] (3.88 h) and [Ir(piq)2(btzpy)][PF6] 
(3.3 min) with respect to [Ir(ppy)2(btzpy)][PF6] (39 h). While lifetimes are considerably lower 
for [Ir(ppz)2(btzpy)][PF6] (>200 h) and [Ir(piq)2(btzpy)][PF6] (250 h) compared to 
[Ir(ppy)2(btzpy)][PF6], they are still much longer than those reported in the literature for red 
emitters (cf. Table 13). Complex [Ir(tppy)2(btzpy)][PF6] shows similar stability, however, the 
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maximum luminance amounts only to 164 cd m
−2
 and the efficacy to 0.23 cd A
−1
. The highest 
maximum luminance level in this series is observed for [Ir(pbtz)2(btzpy)][PF6] (1049 cd m
−2
). 
With 1.49 cd A
−1
, the efficacy is also higher than for [Ir(ppy)2(btzpy)][PF6] (1.23 cd A
−1
). The 
measured lifetime of a LEEC containing [Ir(pbtz)2(btzpy)][PF6] is drastically decreased to 
26 h. In general, substitution of the ppy cyclometallating ligand does not lead to a better 
overall device performance and the stability is greatly reduced for complexes 
[Ir(C^N)2(btzpy)][PF6] with C^N = ppz, piq, tppy and pbtz. 
 
Table 17 Performance parameters of LEECs with benzothiazole-based iridium complexes, 
obtained under pulsed current driving conditions (frequency 1 kHz, 50% duty cycle, block-
wave).
21,163
 Device configuration: ITO/PEDOT:PSS/[Ir(C^N)2(N^N)][PF6]: [Bmim][PF6] 4:1/Al. 
For [Ir(ppy)2(tpybtz)][PF6], PMMA (2 wt-%) was added to the active layer. 
Compound 
ton 
[h] 
Lummax 
[cd m
–2
] 
t1/2 
[h] 
PCE 
[lm W
–1
] 
efficacy 
[cd A
−1
] 
λEL
max 
[nm] 
[Ir(ppy)2(bozpy)][PF6]
a
 0.84 97 9 0.54 0.97 598 
[Ir(ppy)2(btzpybtz)][PF6]
a
 3 9 >150 0.062 0.094 655 
[Ir(ppy)2(tpybtz)][PF6]
a
 778 200 >6000 1.02 1.5 642 
[Ir(ppy)2(ppybtz)][PF6]
a
 17.4 119 >4500 0.77 1.22 651 
[Ir(ppy)2(bbtz)][PF6]
a
 --- --- --- --- --- 699 
[Ir(ppy)2(btzpy)][PF6]
a
 58 78 >1000 0.88 1.16 636 
[Ir(ppy)2(btzpy)][PF6]
b
 38.7 861 >1200 0.54 1.23 636 
[Ir(ppz)2(btzpy)][PF6]
b
 3.88 320 >200 0.21 0.46 607 
[Ir(piq)2(btzpy)][PF6]
b
 0.055 84 250 0.057 0.12 654 
[Ir(tppy)2(btzpy)][PF6]
b
 18.5 164 >150 0.14 0.23 658 
[Ir(pbtz)2(btzpy)][PF6]
b
 3.8 1049 26 0.84 1.49 601 
a
 Average current density = 100 A m
−2
. 
b
 Average current density = 700 A m
−2
. 
 
7. Conclusions 
A series of benzothiazolyl- and in one case benzoxazolyl-containing iridium complexes was 
prepared and investigated. Starting from simple benzothiazolyl-pyridine, ancillary ligands 
with different functionalizations, such as tert-butyl or pendant phenyl and benzothiazole 
groups, were synthesized. The benzothiazolyl-pyridine ancillary ligand was also combined 
with different cyclometallating ligands. The influence of these functionalizations and ligand 
combinations on photophysics, electrochemistry and device performance was determined. 
CHAPTER IV: RED EMITTERS – BENZOTHIAZOLE-BASED ANCILLARY LIGANDS 
 
 
 
 
- 140 - 
 
 Single crystal structures were obtained for complexes [Ir(ppy)2(btzpy)][PF6], 
[Ir(ppy)2(bbtz)][PF6] and [Ir(ppy)2(bozpy)][PF6]. The expected chemical structure and 
coordination through the N atom of the benzothiazole or benzoxazole units was confirmed. 
 Introduction of the btzpy ligand leads to a 49 nm red-shift in the emission maximum 
of [Ir(ppy)2(btzpy)][PF6] in CH2Cl2 with respect to [Ir(ppy)2(bpy)][PF6]. All complexes in this 
series are dark orange to deep red emitters in solution (λem
max
 = 600–686 nm), as powder 
samples (λem
max
 = 612–656 nm) and in thin films (λem
max
 = 625–693 nm). The emission maximum 
depends strongly on the nature of the ancillary ligand as well as the cyclometallating ligand. 
Together with the mostly broad, featureless emission profiles, this suggests a large 
3
MLCT 
and/or 
3
LLCT character of the emissive triplet state. Electrochemical data follow the trends 
observed for photoluminescence maxima in solution. 
 Light emitting electrochemical cells were assembled with all complexes included in 
this series. Unfortunately, [Ir(ppy)2(bbtz)][PF6] yielded no working devices. 
Electroluminescence maxima range from 598 to 699 nm and are slightly blue-shifted for most 
complexes with respect to photoluminescence maxima in thin films. Highly stable red LEECs 
were obtained from [Ir(ppy)2(btzpy)][PF6] with lifetimes of over 1000 h, much longer than 
those reported so far for red light emitting electrochemical cells based on iridium complexes. 
By introducing a tert-butyl substituent or pendant phenyl ring on the ancillary ligand it was 
possible to further increase the lifetime as well as the maximum luminance level and the 
efficacy. The benzothiazole moiety seems to be crucial for device stability, since the lifetime 
is dramatically reduced for the benzoxazole-based complex. The same is true for the ppy 
cyclometallating ligand: for complexes containing different cyclometallating ligands, a 
decrease in device stability was observed. 
 Iridium complexes with benzothiazole-based ancillary ligands are a promising new 
class of materials for highly stable red light emitting electrochemical cells. Combining the 
beneficial effect on device performance of the tert-butyl group and the pendant phenyl ring 
could lead to devices with even higher efficiency and lifetimes. 
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8. Experimental 
8.1. General 
2-Bromo-6-phenylpyridine,
201
 2-(pyridin-2-yl)benzo[d]thiazole (btzpy),
178
 2,2'-
bibenzo[d]thiazole (bbtz),
176,202
 2-bromo-4-(tert-butyl)pyridine,
203
 2,6-bis(benzo[d]thiazol-2-
yl)pyridine (btzpybtz)
177
 and 1-phenylisoquinoline (piq)
180
 were synthesized according to 
literature procedures and their 
1
H NMR spectroscopic data matched those reported. 
Adaptation of the reported synthesis of 2-(pyridin-2-yl)benzo[d]thiazole (btzpy)
178
 gave 2-(4-
(tert-butyl)pyridin-2-yl)benzo[d]thiazole (tpybtz),
204
 2-(pyridin-2-yl)benzo[d]oxazole 
(bozpy)
205
 and 2-phenylbenzo[d]thiazole (pbtz)
206
 and their 
1
H NMR spectroscopic data were 
compared to those described in the literature. 1-Phenyl-1H-pyrazole (ppz) was synthesized 
adapting a literature procedure;
149
 
1
H NMR spectroscopic data matched those reported.
207
 
8.2. 2-(6-Phenylpyridin-2-yl)benzo[d]thiazole (ppybtz) 
2-(6-Phenylpyridin-2-yl)benzo[d]thiazole (ppybtz) was synthesized 
by adaptation of a literature procedure.
178
 Benzothiazole (110 μL, 
135 mg, 0.971 mmol), 2-bromo-6-phenylpyridine (455 mg, 
1.94 mmol), CuI (17.9 mg, 94.0 μmol), phenanthroline monohydrate 
(19.1 mg, 96.4 μmol), K3PO4 (412 mg, 1.94 mmol) and dry DMF (0.8 mL) were added to a 
microwave vial, purged with N2, sealed and heated at 120 °C overnight. The mixture was let 
to cool to room temperature. H2O (50 mL) and EtOAc (50 mL) were added to the mixture and 
the layers were separated. The aqueous layer was extracted with EtOAc (3 × 50 mL), the 
combined organic layers were washed with brine (100 mL), dried over Na2SO4 and the 
solvent was removed under reduced pressure. The crude product was purified by column 
chromatography (silica, cyclohexane/EtOAc 6:1), the solvent removed and the residue 
washed with n-pentane to yield 2-(6-phenylpyridin-2-yl)benzo[d]thiazole (ppybtz) as an off-
white solid (143 mg, 0.496 mmol, 51.1%). M.p. 129.3 °C. 
1
H NMR (500 MHz, CDCl3) δ/ppm 
8.31 (dd, J = 7.6, 1.0 Hz, 1H, H
E3
), 8.20–8.15 (m, 2H, HG2), 8.12 (pseudo-dt, J = 8.3, 0.9 Hz, 
1H, H
F4
), 7.97 (ddd, J = 8.0, 1.1, 0.6 Hz, 1H, H
F7
), 7.92 (pseudo-t, J = 7.7 Hz, 1H, H
E4
), 7.85 
(dd, J = 7.9, 1.0 Hz, 1H, H
E5
), 7.56–7.50 (overlapping m, 3H, HF5+G3), 7.50–7.45 (m, 1H, 
H
G4
), 7.43 (ddd, J = 8.2, 7.2, 1.2 Hz, 1H, H
F6
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 
170.4 (C
F2
), 157.1 (C
E6
), 154.5 (C
F3a
), 151.2 (C
E2
), 138.3 (C
G1
), 138.0 (C
E4
), 136.5 (C
F7a
), 
129.6 (C
G4
), 129.0 (C
G3
), 127.1 (C
G2
), 126.3 (C
F5
), 125.7 (C
F6
), 123.7 (C
F4
), 122.1 (C
F7
), 
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121.8 (C
E5
), 119.0 (C
E3
). IR (solid, ṽ/cm–1) 2982 (w), 1589 (w), 1566 (m), 1509 (w), 1447 (s), 
1435 (m), 1319 (m), 1270 (w), 1250 (w), 1237 (w), 1183 (w), 1155 (w), 1083 (m), 1028 (w), 
988 (m), 946 (w), 922 (w), 870 (w), 811 (m), 786 (w), 757 (s), 732 (s), 691 (s), 667 (m), 623 
(m), 587 (w), 574 (w), 531 (w), 486 (w), 432 (m). LC-ESI-MS m/z 289.0 [M+H]
+
 (calc. 
289.1). Found C 74.67, H 4.43, N 10.01; C18H12N2S requires C 74.97, H 4.19, N 9.71%. 
8.3. 2-(3-(tert-Butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
1-Bromo-3-tert-butylbenzene (0.24 mL, 300 mg, 1.38 mmol), 
bis(pinacolato)diboron (712 mg, 2.78 mmol), KOAc (406 mg, 4.14 mmol) and 
Pd(dppf)2Cl2·CH2Cl2 (56.6 mg, 69.3 μmol) were suspended in THF (dry, 20 mL) 
in a microwave vial, purged with N2 and the reaction mixture heated at 90 °C for 
1 h in a microwave reactor (4 bar). The resulting mixture was filtered over celite, 
washed with EtOAc (100 mL) and the filtrate was concentrated under reduced pressure. The 
crude product was purified by column chromatography (silica, cyclohexane–5% EtOAc) to 
yield 2-(3-(tert-butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane as a yellow oil which 
solidified upon standing (258 mg, 0.992 mmol, 71.9%). 
1
H NMR (500 MHz, CDCl3) δ/ppm 
7.83 (ddd, J = 1.9, 1.2, 0.6 Hz, 1H, H
2
), 7.64 (dt, J = 7.3, 1.2 Hz, 1H, H
6
), 7.50 (ddd, J = 7.9, 
2.3, 1.3 Hz, 1H, H
4
), 7.31 (ddd, J = 7.9, 7.2, 0.6 Hz, 1H, H
5
), 1.35 (s, 12H, H
BO2C2(CH3)4
), 1.35 
(s, 9H, H
C(CH3)3
). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 150.4 (C
3
), 132.2 (C
6
), 131.5 (C
2
), 
128.5 (C
4
), 127.6 (C
5
), 83.8 (C
BO2C2(CH3)4
), 34.8 (C
C(CH3)3
), 31.6 (C
C(CH3)3
), 25.0 (C
BO2C2(CH3)4
).
 
The signal for C
1
 was not resolved. 
11
B NMR (160 MHz, CDCl3) δ/ppm 31.25. 
8.4. 2-(3-(tert-Butyl)phenyl)pyridine (tppy) 
The synthesis of 2-(3-(tert-butyl)phenyl)pyridine (tppy) has been 
previously reported,
208
 but the following procedure gives a higher yield. 
2-(3-(tert-Butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(205 mg, 0.788 mmol), PdCl2(PPh3)2 (23.1 mg, 32.9 μmol), 2-
bromopyridine (63 μL, 104 mg, 0.658 mmol) and Na2CO3 (210 mg, 1.98 mmol) were 
suspended in THF (5 mL) and H2O (5 mL) in a microwave vial. The mixture was heated at 
100 °C for 30 min in a microwave reactor (7 bar), then poured into H2O (100 mL) and 
extracted with CH2Cl2 (3 × 60 mL). The combined organic layers were dried over Na2SO4 and 
the solvent was removed under reduced pressure. The crude product was purified by column 
chromatography (silica, cyclohexane–5% EtOAc) to yield 2-(3-(tert-butyl)phenyl)pyridine 
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(tppy) as a colourless oil (127 mg, 0.601 mmol, 91.3%). 
1
H NMR spectroscopic data matched 
those reported in the literature.
208
 
8.5. General procedure for the synthesis of chlorido-bridged iridium(III) dimers 
[Ir(ppy)2Cl]2, [Ir(ppz)2Cl]2, [Ir(piq)2Cl]2, [Ir(tppy)2Cl]2 and [Ir(pbtz)2Cl]2 were synthesized 
according to the standard method.
100,101
 The cyclometallating ligand was suspended in a 
mixture of 2-ethoxyethanol and H2O (3:1) and purged with N2. IrCl3·xH2O was added and the 
reaction mixture was heated at reflux overnight. After letting the mixture cool to room 
temperature, the precipitation was collected, washed with EtOH and Et2O and dried. The 
dimers were characterized by 
1
H NMR spectroscopy and used for subsequent reactions 
without further purification. 
1
H NMR spectroscopic data of [Ir(ppy)2Cl]2 matched those 
reported in the literature.
182
 
8.6. [Ir(ppz)2Cl]2 
IrCl3·xH2O (ca. 82% IrCl3, 564 mg, 1.55 mmol) and 1-phenyl-
1H-pyrazole (ppz) (447 mg, 3.10 mmol) in 28 mL solvent. 
[Ir(ppz)2Cl]2 was isolated as an off-white powder (733 mg, 
775 µmol, 92.0%). 
1
H NMR (400 MHz, acetone-d6) δ/ppm 
8.71 (dd, J = 2.9, 0.7 Hz, 4H), 7.81 (dd, J = 2.1, 0.7 Hz, 4H), 
7.40 (dd, J = 7.9, 1.3 Hz, 4H), 6.87 (dd, J = 2.9, 2.2 Hz, 4H), 6.75 (ddd, J = 7.8, 7.3, 1.3 Hz, 
4H), 6.48 (pseudo-td, J = 7.5, 1.3 Hz, 4H), 5.94 (dd, J = 7.6, 1.3 Hz, 4H). 
8.7. [Ir(piq)2Cl]2 
IrCl3·xH2O (ca. 82% IrCl3, 444 mg, 1.22 mmol) and 1-
phenylisoquinoline (piq) (501 mg, 2.44 mmol) in 20 mL 
solvent. [Ir(piq)2Cl]2 was isolated as a dark red powder 
(532 mg, 610 µmol, 68.5%). 
1
H NMR (400 MHz, CDCl3) 
δ/ppm 9.05 (d, J = 6.4 Hz, 4H), 8.99–8.95 (m, 4H), 8.15–8.11 
(m, 4H), 7.88–7.80 (overlapping m, 8H), 7.76 (ddd, J = 8.4, 
6.4, 2.0 Hz, 4H), 6.81 (ddd, J = 8.2, 7.1, 1.3 Hz, 4H), 6.55 (dd, 
J = 6.5, 0.8 Hz, 4H), 6.50 (ddd, J = 8.3, 7.1, 1.3 Hz, 4H), 6.03 (dd, J = 7.9, 1.2 Hz, 4H). 
1
H 
NMR spectroscopic data matched those reported in the literature.
183
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8.8. [Ir(tppy)2Cl]2 
IrCl3·xH2O (ca. 82% IrCl3, 772 mg, 2.12 mmol) and 
2-(3-(tert-butyl)phenyl)pyridine (tppy) (894 mg, 
4.23 mmol) in 40 mL solvent. [Ir(tppy)2Cl]2 was 
isolated as a yellow powder (905 mg, 1.06 mmol, 
65.9%). 
1
H NMR (400 MHz, CDCl3) δ/ppm 9.17 
(ddd, J = 5.8, 1.7, 0.7 Hz, 4H), 7.89–7.84 (m, 4H), 7.71 (ddd, J = 8.1, 7.4, 1.6 Hz, 4H), 7.48 
(d, J = 2.2 Hz, 4H), 6.73 (ddd, J = 7.3, 5.8, 1.4 Hz, 4H), 6.64 (dd, J = 8.2, 2.2 Hz, 4H), 5.93 
(d, J = 8.2 Hz, 4H), 1.17 (s, 36H). 
8.9. [Ir(pbtz)2Cl]2 
IrCl3·xH2O (ca. 82% IrCl3, 221 mg, 606 µmol) and 2-
phenylbenzo[d]thiazole (pbtz) (256 mg, 1.21 mmol) in 
10 mL solvent. [Ir(pbtz)2Cl]2 was isolated as an orange 
powder (323 mg, 249 µmol, 82.2%). 
1
H NMR (400 MHz, 
CDCl3) δ/ppm 8.76 (dd, J = 7.8, 1.7 Hz, 4H), 7.53 (dd, J = 
7.6, 1.5 Hz, 4H), 7.43–7.39 (m, 4H), 7.10–7.01 (overlapping 
m, 8H), 6.75 (pseudo-td, J = 7.4, 1.2 Hz, 4H), 6.42 (pseudo-td, J = 7.6, 1.5 Hz, 4H), 5.99 (d, J 
= 7.7 Hz, 4H). 
8.10. General procedure for the synthesis of iridium(III) complexes 
The iridium dimer and AgPF6 were suspended in MeOH (15–25 mL) and stirred at room 
temperature for 2–4 h. The mixture was filtered through Celite® and washed with MeOH. 
The filtrate was concentrated under reduced pressure to yield [Ir(C^N)2(MeOH)2][PF6] which 
was neither purified nor characterized. Ancillary ligand and MeOH (2–10 mL) were added 
immediately to the solvento intermediate and the mixture stirred at room temperature 
overnight. The resulting orange-red precipitate was filtered off, redissolved in CH2Cl2 and 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (silica) and solvent removed. The residue was dissolved in little CH2Cl2 and 
precipitated with Et2O and/or n-hexane. Where necessary, the complex was dissolved in little 
CH2Cl2, layered with toluene and n-hexane and kept in the refrigerator overnight. The 
resulting precipitation was filtered off and dried under vacuum. The reported yields (over two 
steps) were calculated based on the iridium dimer starting material. 
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8.11. [Ir(ppy)2(btzpy)][PF6] 
[Ir(ppy)2Cl]2 (100 mg, 93.3 μmol) and AgPF6 (51.4 mg, 
0.203 mmol) in MeOH (20 mL), 2 h 45 min at room 
temperature. Addition of 2-(pyridin-2-yl)benzo[d]thiazole 
(btzpy) (39.7 mg, 0.187 mmol) and MeOH (10 mL). 
Purification by column chromatography (silica, CH2Cl2 
changing to CH2Cl2–1% MeOH) and precipitation with Et2O. 
[Ir(ppy)2(btzpy)][PF6] was isolated as an orange solid (129 mg, 0.151 mmol, 80.6%). 
1
H 
NMR (500 MHz, CD3CN) δ/ppm 8.48 (pseudo-dt, J = 8.0, 1.1 Hz, 1H, H
E3
), 8.19–8.15 
(overlapping m, 2H, H
E4+F7
), 8.07 (pseudo-dt, J = 8.2, 1.2 Hz, 1H, H
D3
), 8.01 (pseudo-dt, J = 
8.2, 1.2 Hz, 1H, H
B3
), 7.97 (ddd, J = 5.5, 1.6, 0.8 Hz, 1H, H
E6
), 7.87–7.78 (overlapping m, 
4H, H
A3+B4+C3+D4
), 7.74 (ddd, J = 5.8, 1.5, 0.8 Hz, 1H, H
D6
), 7.59 (ddd, J = 5.8, 1.5, 0.8 Hz, 
1H, H
B6
), 7.57–7.51 (overlapping m, 2H, HE5+F6), 7.20 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H, HF5), 
7.11 (pseudo-td, J = 7.6, 1.2 Hz, 1H, H
A4
), 7.07 (ddd, J = 7.8, 7.4, 1.2 Hz, 1H, H
C4
), 7.02 
(ddd, J = 7.4, 5.8, 1.4 Hz, 1H, H
B5
), 7.00–6.91 (overlapping m, 4H, HA5+C5+D5+F4), 6.38 (dd, J 
= 7.5, 1.3 Hz, 1H, H
A6
), 6.22 (dd, J = 7.6, 1.1 Hz, 1H, H
C6
). 
13
C{
1
H} NMR (126 MHz, 
CD3CN) δ/ppm 171.4 (C
F2
), 168.4 (C
B2
), 167.9 (C
D2
), 152.6 (C
E2
), 151.8 (C
E6
), 151.5 (C
F3a
), 
151.4 (C
D6
), 150.5 (C
B6
), 148.5 (C
A1
), 148.3 (C
C1
), 145.5 (C
A2
), 145.0 (C
C2
), 140.8 (C
E4
), 
139.6 (C
D4
), 139.5 (C
B4
), 135.5 (C
F7a
), 133.1 (C
A6
), 131.9 (C
C6
), 131.4 (C
C5
), 131.1 (C
A5
), 
130.5 (C
E5
), 129.2 (C
F5
), 129.1 (C
F6
), 127.5 (C
E3
), 125.9 (C
C3
), 125.8 (C
A3
), 124.7 (C
D5
), 
124.5 (C
B5/F7
), 124.5 (C
B5/F7
), 123.9 (C
C4
), 123.6 (C
A4
), 123.0 (C
F4
), 120.9 (C
D3
), 120.5 (C
B3
). 
IR (solid, ṽ/cm–1) 3045 (w), 1608 (m), 1584 (m), 1563 (w), 1479 (s), 1458 (w), 1440 (m), 
1421 (m), 1323 (w), 1269 (m), 1229 (w), 1165 (m), 1065 (w), 1031 (m), 1008 (w), 835 (s), 
794 (m), 757 (s), 739 (s), 730 (s), 713 (m), 670 (m), 631 (m), 556 (s), 477 (w). UV/Vis 
(CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 255 (39 000), 295 sh (24 000), 330 
(21 000), 350 sh (17 000), 382 (8300), 410 sh (5600). Emission (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, 
λexc = 266 nm) λem
max
 = 644 nm. ESI-MS m/z 713.4 [M–PF6]
+
 (calc. 713.1). Found C 47.16, H 
2.97, N 6.76; C34H24F6IrN4PS·0.5H2O requires C 47.11, H 2.91, N 6.46%. 
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8.12. [Ir(ppy)2(bbtz)][PF6] 
[Ir(ppy)2Cl]2 (59.9 mg, 55.9 μmol) and AgPF6 (39.3 mg, 
0.155 mmol) in MeOH (15 mL), 3 h at room temperature. 
Addition of 2,2'-bibenzo[d]thiazole (bbtz) (30.0 mg, 
0.112 mmol) and MeOH (5 mL). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–2% 
MeOH) and precipitation with Et2O. [Ir(ppy)2(bbtz)][PF6] 
was isolated as an orange-red solid (83.7 mg, 92.0 μmol, 81.9%). 1H NMR (500 MHz, 
CD2Cl2) δ/ppm 8.12 (pseudo-dt, J = 8.2, 0.7 Hz, 2H, H
E7
), 7.95 (pseudo-dt, J = 8.1, 0.9 Hz, 
2H, H
B3
), 7.80–7.74 (overlapping m, 4H, HA3+B4), 7.63–7.55 (overlapping m, 4H, HB6+E6), 
7.28 (ddd, J = 8.4, 7.1, 1.2 Hz, 2H, H
E5
), 7.19 (pseudo-td, J = 7.6, 1.2 Hz, 2H, H
A4
), 7.02 
(pseudo-td, J = 7.5, 1.4 Hz, 2H, H
A5
), 6.96 (ddd, J = 7.4, 5.8, 1.4 Hz, 2H, H
B5
), 6.86 (pseudo-
dt, J = 8.9, 0.8 Hz, 2H, H
E4
), 6.34 (dd, J = 7.8, 1.1 Hz, 2H, H
A6
). 
13
C{
1
H} NMR (126 MHz, 
CD2Cl2) δ/ppm 168.1 (C
B2
), 163.3 (C
E2
), 151.0 (C
E3a
), 150.2 (C
B6
), 144.9 (C
A1
), 144.8 (C
A2
), 
139.0 (C
B4
), 136.1 (C
E7a
), 132.4 (C
A6
), 131.2 (C
A5
), 129.9 (C
E5
), 129.7 (C
E6
), 125.6 (C
A3
), 
124.2 (C
B5
), 124.00 (C
A4
), 123.97 (C
E7
), 123.6 (C
E4
), 120.5 (C
B3
). IR (solid, ṽ/cm–1) 3093 (w), 
1603 (m), 1587 (m), 1562 (w), 1477 (m), 1460 (m), 1441 (w), 1422 (m), 1409 (w), 1326 (m), 
1297 (w), 1271 (w), 1257 (m), 1163 (m), 1134 (w), 1085 (w), 1073 (w), 1025 (m), 870 (m), 
834 (s), 772 (s), 760 (s), 748 (s), 727 (m), 709 (m), 671 (m), 630 (w), 600 (w), 557 (s), 492 
(w), 419 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 254 (40 000), 
338 sh (19 000), 367 (29 000), 387 (30 000), 415 sh (9800), 445 sh (4800). Emission 
(CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, λexc = 259 nm) λem
max
 = 686 nm. ESI-MS m/z 769.1 [M–PF6]
+
 
(calc. 769.1). Found C 47.35, H 2.91, N 6.50; C36H24F6IrN4PS2 requires C 47.31, H 2.65, 
N 6.13%. 
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8.13. [Ir(ppy)2(ppybtz)][PF6] 
[Ir(ppy)2Cl]2 (100 mg, 93.3 μmol) and AgPF6 (62.1 mg, 
0.246 mmol) in MeOH (20 mL), 3 h 15 min at room 
temperature. Addition of 2-(6-phenylpyridin-2-
yl)benzo[d]thiazole (ppybtz) (55.5 mg, 0.192 mmol) and 
MeOH (10 mL). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–1% 
MeOH) and precipitation with Et2O. [Ir(ppy)2(ppybtz)][PF6] was isolated as an orange solid 
(152 mg, 0.163 mmol, 87.5%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 8.48 (dd, J = 7.9, 1.3 Hz, 
1H, H
E3
), 8.25 (pseudo-t, J = 7.8 Hz, 1H, H
E4
), 8.03 (ddd, J = 8.3, 1.1, 0.5 Hz, 1H, H
F7
), 7.92 
(pseudo-dt, J = 5.9, 1.1 Hz, 1H, H
B6
), 7.90–7.82 (overlapping m, 2H, HB3+B4), 7.77–7.70 
(overlapping m, 2H, H
D3+D4
), 7.53–7.45 (overlapping m, 3H, HC3+E5+F6), 7.42 (pseudo-dt, J = 
5.9, 1.1 Hz, 1H, H
D6
), 7.21 (dd, J = 7.8, 1.3 Hz, 1H, H
A3
), 7.16–7.07 (overlapping m, 2H, 
H
D5+F5
), 7.04–6.98 (overlapping m, 3H, HB5+C4+G4), 6.86 (pseudo-td, J = 7.5, 1.4 Hz, 1H, HC5), 
6.82–6.75 (overlapping m, 3H, HF4+G3), 6.62 (pseudo-td, J = 7.6, 1.2 Hz, 1H, HA4), 6.53 (br, 
2H, H
G2
), 6.41 (pseudo-td, J = 7.4, 1.3 Hz, 1H, H
A5
), 6.10 (dd, J = 7.8, 1.1 Hz, 1H, H
C6
), 5.59 
(dd, J = 7.7, 1.1 Hz, 1H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 171.5 (C
F2
), 169.1 
(C
B2
), 167.8 (C
D2
), 167.0 (C
E6
), 152.9 (C
E2
), 151.6 (C
F3a
), 150.4 (C
B6
), 149.4 (C
D6
), 148.3 
(C
A1
), 144.1 (2C, C
C1+C2
), 143.4 (C
A2
), 140.5 (C
E4
), 138.8 (C
D4
), 138.7 (C
B4
), 137.6 (C
G1
), 
134.7 (C
F7a
), 132.0 (C
E5
), 131.7 (C
C6
), 131.4 (C
A6
), 130.7 (C
C5
), 130.3 (C
A5
), 129.8 (C
G4
), 
128.8 (C
F5
), 128.6 (C
F6
), 128.5 (C
G3
), 127.8 (C
G2
), 126.0 (C
E3
), 125.4 (C
A3
), 125.1 (C
C3
), 
124.0 (C
D5
), 123.6 (C
C4
), 123.4 (C
F7
), 123.2 (C
F4
), 123.1 (C
B5
), 121.8 (C
A4
), 120.7 (C
B3
), 
120.2 (C
D3
). IR (solid, ṽ/cm–1) 3055 (w), 1608 (m), 1585 (m), 1563 (m), 1479 (m), 1459 (w), 
1440 (m), 1424 (m), 1326 (w), 1270 (w), 1228 (w), 1180 (w), 1165 (w), 1064 (w), 1031 (w), 
836 (s), 756 (s), 729 (s), 699 (m), 670 (m), 630 (m), 556 (s), 418 (m). UV/Vis (CH2Cl2, 1.0 × 
10
−5
 mol dm
−3
) λ/nm (ε/dm3 mol−1 cm−1) 261 (40 000), 271 sh (39 000), 340 (26 000), 355 sh 
(22 000), 420 sh (4500). Emission (CH2Cl2, 1.0 × 10
−5
 mol dm
−3
, λexc = 270 nm) λem
max
 = 642 
nm. ESI-MS m/z 789.1 [M−PF6]
+
 (calc. 789.2). Found C 51.03, H 3.33, N 6.32; 
C40H28F6IrN4PS·0.5H2O requires C 50.95, H 3.10, N 5.94%. 
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8.14. [Ir(ppy)2(tpybtz)][PF6] 
[Ir(ppy)2Cl]2 (100 mg, 93.3 μmol) and AgPF6 (51.9 mg, 
0.205 mmol) in MeOH (20 mL), 2 h at room temperature. 
Addition of 2-(4-(tert-butyl)pyridin-2-yl)benzo[d]thiazole 
(tpybtz) (50.1 mg, 0.187 mmol) and MeOH (10 mL). 
Purification by column chromatography (silica, CH2Cl2 
changing to CH2Cl2–1% MeOH) and precipitation with 
Et2O. [Ir(ppy)2(tpybtz)][PF6] was isolated as an orange solid (121 mg, 0.133 mmol, 70.9%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 8.26 (dd, J = 2.0, 0.6 Hz, 1H, H
E3
), 8.08 (pseudo-dt, J = 
8.2, 0.9 Hz, 1H, H
F7
), 7.98 (pseudo-dt, J = 8.3, 1.2 Hz, 1H, H
B3
), 7.93 (pseudo-dt, J = 8.0, 0.9 
Hz, 1H, H
D3
), 7.87 (dd, J = 5.9, 0.6 Hz, 1H, H
E6
), 7.80 (ddd, J = 8.3, 7.5, 1.5 Hz, 1H, H
B4
), 
7.78–7.73 (overlapping m, 3H, HA3+C3+D4), 7.62 (ddd, J = 5.8, 1.5, 0.7 Hz, 1H, HB6), 7.54 
(ddd, J = 8.3, 7.2, 1.1 Hz, 1H, H
F6
), 7.51–7.46 (overlapping m, 2H, HD6+E5), 7.24 (ddd, J = 
8.5, 7.2, 1.2 Hz, 1H, H
F5
), 7.14 (pseudo-td, J = 7.6, 1.2 Hz, 1H, H
C4
), 7.10 (pseudo-td, J = 7.6, 
1.2 Hz, 1H, H
A4
), 7.04–6.94 (overlapping m, 5H, HA5+B5+C5+D5+F4), 6.40 (dd, J = 7.7, 1.2 Hz, 
1H, H
C6
), 6.25 (dd, J = 7.6, 1.2 Hz, 1H, H
A6
), 1.43 (s, 9H, H
E4-tBu
). 
13
C{
1
H} NMR (126 MHz, 
CD2Cl2) δ/ppm 170.3 (C
F2
), 168.5 (C
D2
), 167.9 (C
B2
), 165.6 (C
E4
), 152.1 (C
E2
), 151.2 (C
F3a
), 
151.0 (C
E6
), 150.3 (C
B6
), 149.2 (C
D6
), 147.9 (C
C1
), 147.7 (C
A1
), 144.8 (C
C2
), 144.2 (C
A2
), 
138.84 (C
B4/D4
), 138.82 (C
B4/D4
), 134.6 (C
F7a
), 132.8 (C
C6
), 131.6 (C
A6
), 131.4 (C
A5
), 131.1 
(C
C5
), 129.3 (C
F5
), 129.0 (C
F6
), 127.3 (C
E5
), 125.51 (C
A3/C3
), 125.50 (C
A3/C3
), 124.1 (C
B5
), 
123.9 (C
D5
), 123.71 (C
E3
), 123.67 (C
F7
), 123.66 (C
A4
), 123.4 (C
C4
), 123.3 (C
F4
), 120.5 (C
B3
), 
120.3 (C
D3
), 36.3 (C
E4-C(CH3)3
), 30.5 (C
E4-C(CH3)3
). IR (solid, ṽ/cm–1) 2963 (w), 1609 (m), 1584 
(m), 1563 (w), 1479 (m), 1440 (w), 1423 (m), 1369 (w), 1326 (w), 1269 (w), 1247 (w), 1228 
(w), 1165 (w), 1065 (w), 1033 (m), 834 (s), 794 (m), 757 (s), 730 (m), 709 (w), 670 (w), 631 
(w), 556 (s), 462 (w), 418 (m). UV/Vis (CH2Cl2, 1.0 × 10
−5
 mol dm
−3
) λ/nm (ε/dm3 mol−1 
cm
−1
) 258 (45 000), 314 (26 000), 348 sh (20 000), 381 (9500), 410 sh (6300). Emission 
(CH2Cl2, 1.0 × 10
−5
 mol dm
−3
, λexc = 270 nm) λem
max
 = 638 nm. ESI-MS m/z 769.2 [M−PF6]
+
 
(calc. 769.2). Found C 49.41, H 3.72, N 6.39; C38H32F6IrN4PS·0.5H2O requires C 49.45, 
H 3.60, N 6.07%. 
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8.15. [Ir(ppy)2(btzpybtz)][PF6] 
[Ir(ppy)2Cl]2 (150 mg, 0.140 mmol) and AgPF6 
(88.1 mg, 0.348 mmol) in MeOH (25 mL), 2 h at 
room temperature. Addition of 2,6-
bis(benzo[d]thiazol-2-yl)pyridine (btzpybtz) 
(98.0 mg, 0.284 mmol) and MeOH (10 mL). 
Purification by column chromatography (silica, 
CH2Cl2 changing to CH2Cl2–1% MeOH), layering 
with toluene/n-hexane and subsequent precipitation with n-hexane from a CH2Cl2 solution. 
[Ir(ppy)2(btzpybtz)][PF6] was isolated as a dark red solid (136 mg, 0.137 mmol, 49.0%). 
1
H 
NMR (500 MHz, CD2Cl2) δ/ppm 8.66 (br, 1H, H
D6
), 8.60 (dd, J = 7.9, 1.2 Hz, 1H, H
E3
), 8.31 
(pseudo-t, J = 7.8 Hz, 1H, H
E4
), 8.10 (dd, J = 8.2, 1.0 Hz, 1H, H
F7
), 7.91–7.77 (overlapping 
m, 4H, H
B3+B4+D3+D4
), 7.75 (dd, J = 7.8, 1.1 Hz, 1H, H
E5
), 7.71 (d, J = 8.1 Hz, 1H, H
G4/G7
), 
7.68 (dd, J = 8.2, 1.1 Hz, 1H, H
G4/G7
), 7.64 (dd, J = 7.8, 1.4 Hz, 1H, H
C3
), 7.55–7.45 
(overlapping m, 3H, H
B6+F6+G5/G6
), 7.41 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H, H
G5/G6
), 7.24 (ddd, J = 
7.3, 5.8, 1.8 Hz, 1H, H
D5
), 7.18–7.06 (overlapping m, 2H, HA3+F5), 7.02 (pseudo-td, J = 7.5, 
1.2 Hz, 1H, H
C4
), 6.97 (pseudo-td, J = 6.3, 2.0 Hz, 1H, H
B5
), 6.79 (pseudo-td, J = 7.5, 1.4 Hz, 
1H, H
C5
), 6.66 (d, J = 8.6 Hz, 1H, H
F4
), 6.21 (pseudo-t, J = 7.5 Hz, 1H, H
A4
), 5.96 (dd, J = 
7.8, 1.1 Hz, 1H, H
C6
), 5.67 (pseudo-t, J = 7.2 Hz, 1H, H
A5
), 5.36 (d, J = 7.6 Hz, 1H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 170.6 (C
F2
), 168.6 (C
B2
), 167.3 (C
D2
), 162.9 (C
G2
), 
157.4 (C
E6
), 153.8 (C
E2
), 153.1 (C
G3a/G7a
), 151.7 (C
F3a
), 148.9 (C
B6
), 145.5 (C
A1
), 144.3 (C
C2
), 
143.4 (C
C1
), 142.9 (C
A2
), 141.1 (C
E4
), 138.90 (2C, C
B3/B4+D3/D4
), 138.88 (2C, C
B3/B4+D3/D4
), 
137.3 (C
G3a/G7a
), 134.9 (C
F7a
), 132.7 (C
A6
), 131.83 (C
C6/E5
), 131.81 (C
C6/E5
), 130.8 (C
C5
), 129.1 
(C
F5
), 129.0 (C
F6
), 128.9 (C
A5
), 127.6 (C
E3
), 127.1 (C
G5/G6
), 126.8 (C
G5/G6
), 125.2 (C
C3
), 124.6 
(C
G4/G7
), 124.0 (C
A3
), 123.62 (C
C4/F7
), 123.60 (C
C4/F7
), 123.43 (C
B5/F4
), 123.38 (C
B5/F4
), 123.3 
(C
D5
), 122.2 (C
G4/G7
), 121.4 (C
A4
), 120.3 (C
B3/B4
), 119.8 (C
D3/D4
). IR (solid, ṽ/cm–1) 3058 (w), 
1608 (m), 1584 (m), 1564 (w), 1480 (m), 1459 (w), 1439 (w), 1423 (m), 1319 (w), 1270 (w), 
1230 (w), 1180 (w), 1165 (w), 1119 (w), 1063 (w), 1031 (w), 983 (w), 835 (s), 756 (s), 728 
(s), 669 (m), 630 (m), 556 (s), 420 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 
mol
–1
 cm
–1
) 255 (41 000), 261 sh (40 000), 300 sh (30 000), 340 (25 000), 365 sh (19 000), 
420 sh (4100). Emission (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, λexc = 265 nm) λem
max
 = 652 nm. ESI-MS 
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m/z 846.0 [M–PF6]
+
 (calc. 846.1). HR ESI-MS m/z 846.1340 (calc. 846.1332). Satisfactory 
elemental analysis could not be obtained. 
8.16. [Ir(ppy)2(bozpy)][PF6] 
[Ir(ppy)2Cl]2 (149 mg, 0.139 mmol) and AgPF6 (91.6 mg, 
0.362 mmol) in MeOH (25 mL), 3.5 h at room temperature. 
Addition of 2-(pyridin-2-yl)benzo[d]oxazole (bozpy) 
(56.6 mg, 0.288 mmol) and MeOH (10 mL). Purification by 
column chromatography (silica, CH2Cl2 changing to CH2Cl2–
1% MeOH) and precipitation with Et2O. 
[Ir(ppy)2(bozpy)][PF6] was isolated as an orange solid 
(184 mg, 0.219 mmol, 78.6%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 8.52 (pseudo-dt, J = 7.9, 
1.0 Hz, 1H, H
E3
), 8.25 (pseudo-td, J = 7.8, 1.5 Hz, 1H, H
E4
), 8.05 (pseudo-dt, J = 5.4, 1.1 Hz, 
1H, H
E6
), 7.99 (pseudo-dt, J = 8.3, 1.1 Hz, 1H, H
B3
), 7.93 (pseudo-dt, J = 8.3, 1.0 Hz, 1H, 
H
D3
), 7.86–7.81 (overlapping m, 2H, HB4+F7), 7.80–7.75 (overlapping m, 4H, HA3+B6+C3+D4), 
7.64 (ddd, J = 7.8, 5.4, 1.3 Hz, 1H, H
E5
), 7.58 (ddd, J = 8.7, 7.5, 1.2 Hz, 1H, H
F6
), 7.54 
(pseudo-dt, J = 5.8, 1.1 Hz, 1H, H
D6
), 7.26 (ddd, J = 8.4, 7.5, 1.0 Hz, 1H, H
F5
), 7.16 (pseudo-
td, J = 7.5, 1.2 Hz, 1H, H
C4
), 7.12 (pseudo-td, J = 7.6, 1.2 Hz, 1H, H
A4
), 7.05 (ddd, J = 7.4, 
5.9, 1.4 Hz, 1H, H
D5
), 7.02–6.96 (overlapping m, 3H, HA5+B5+C5), 6.46 (dd, J = 7.7, 1.3 Hz, 
1H, H
C6
), 6.39 (pseudo-dt, J = 8.1, 0.9 Hz, 1H, H
F4
), 6.37 (dd, J = 7.7, 1.2 Hz, 1H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 168.4 (C
D2
), 168.1 (C
B2
), 166.8 (C
F2
), 152.3 (C
E6
), 
152.1 (C
F7a
), 150.2 (C
B6
), 149.5 (C
D6
), 148.3 (C
A1
), 145.0 (C
C2
), 144.53 (C
C1
), 144.46 (C
A2
), 
144.0 (C
E2
), 140.6 (C
E4
), 139.01 (C
B4
), 138.98 (C
D4
), 137.9 (C
F3a
), 132.9 (C
C6
), 132.1 (C
A6
), 
131.3 (C
A5
), 131.0 (C
E5
), 130.8 (C
C5
), 129.6 (C
F6
), 128.1 (C
F5
), 126.8 (C
E3
), 125.6 (C
C3
), 
125.2 (C
A3
), 124.17 (C
B5/D5
), 124.15 (C
5/D5
), 123.7 (2C, C
A4+C4
), 120.5 (C
B3
), 120.2 (C
D3
), 
119.4 (C
F4
), 113.2 (C
F7
). IR (solid, ṽ/cm–1) 3054 (w), 1608 (m), 1584 (m), 1565 (w), 1542 
(w), 1479 (m), 1439 (m), 1423 (m), 1393 (m), 1304 (w), 1269 (w), 1229 (w), 1164 (w), 1142 
(w), 1108 (w), 1093 (w), 1065 (w), 1032 (w), 1019 (w), 836 (s), 792 (m), 755 (s), 698 (w), 
670 (w), 646 (w), 631 (w), 556 (s), 494 (w), 434 (w), 418 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 
mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 254 (42 000), 266 (41 000), 295 sh (31 000), 317 
(29 000), 335 sh (21 000), 378 (9100), 410 sh (5700). Emission (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, 
λexc = 270 nm) λem
max
 = 636 nm. ESI-MS m/z 697.1 [M–PF6]
+
 (calc. 697.2). Found C 48.19, 
H 3.26, N 6.89; C34H24F6IrN4OP·0.5H2O requires C 48.00, H 2.96, N 6.59%. 
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8.17. [Ir(ppz)2(btzpy)][PF6] 
[Ir(ppz)2Cl]2 (101 mg, 98.2 μmol) and AgPF6 (57.6 mg, 0.228 
mmol) in MeOH (20 mL), 4 h at room temperature. Addition 
of 2-(pyridin-2-yl)benzo[d]thiazole (btzpy) (31.0 mg, 
0.198 mmol) and MeOH (2 mL). Purification by column 
chromatography (silica, CH2Cl2 changing to CH2Cl2–1% 
MeOH) and precipitation with Et2O. [Ir(ppz)2(btzpy)][PF6] 
was isolated as an orange solid (79.8 mg, 95.0 μmol, 48.7%). 1H NMR (500 MHz, CD2Cl2) 
δ/ppm 8.42 (pseudo-dt, J = 8.1, 1.0 Hz, 1H, HE3), 8.24–8.15 (overlapping m, 3H, HB3+E4+E6), 
8.13 (d, J = 2.9 Hz, 1H, H
D3
), 8.08 (dd, J = 8.2, 0.9 Hz, 1H, H
F7
), 7.59–7.52 (overlapping m, 
2H, H
E5+F6
), 7.37 (dd, J = 8.1, 1.1 Hz, 2H, H
A3+C3
), 7.28 (ddd, J = 8.5, 7.2, 1.2 Hz, 1H, H
F5
), 
7.18–7.10 (overlapping m, 3H, HA4+C4+F4), 6.99–6.88 (overlapping m, 3H, HA5+B5+C5), 6.87 (d, 
J = 2.2 Hz, 1H, H
D5
), 6.55 (pseudo-t, J = 2.6 Hz, 2H, H
B4+D4
), 6.38 (dd, J = 7.6, 1.3 Hz, 1H, 
H
C6
), 6.28 (dd, J = 7.5, 1.3 Hz, 1H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 170.5 
(C
F2
), 152.8 (C
E2
), 151.9 (C
F3a
), 151.8 (C
E6
), 143.6 (C
C2
), 143.3 (C
A2
), 140.6 (C
E4
), 139.8 
(C
B5
), 138.8 (C
D5
), 134.5 (C
C6
), 134.3 (C
F7a
), 133.4 (C
A6
), 129.8 (C
A1
), 129.5 (C
E5
), 129.31 
(C
F5
), 129.28 (C
C1
), 129.0 (C
F6
), 127.9 (C
B3
), 127.7 (C
D3
), 127.6 (C
A5
), 127.2 (C
C5
), 126.5 
(C
E3
), 124.4 (C
A4
), 124.2 (C
C4
), 123.7 (C
F7
), 123.2 (C
F4
), 112.5 (C
A3
), 112.4 (C
C3
), 109.0 
(C
B4
), 108.8 (C
D4
). IR (solid, ṽ/cm–1) 3147 (w), 1589 (w), 1482 (m), 1459 (w), 1446 (m), 1413 
(m), 1338 (m), 1325 (m), 1277 (m), 1248 (w), 1163 (w), 1111 (w), 1075 (m), 1058 (m), 1032 
(m), 1010 (w), 968 (w), 918 (w), 836 (s), 751 (s), 730 (m), 703 (m), 656 (m), 610 (m), 557 (s), 
477 (m), 457 (m), 437 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 
255 (35 000), 330 (23 000), 350 sh (18 000), 380 sh (5500), 410 sh (3000). Emission 
(CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, λexc = 261 nm) λem
max
 = 607 nm. ESI-MS m/z 691.1 [M–PF6]
+
 
(calc. 691.1). Found C 42.66, H 3.03, N 10.29; C30H22F6IrN6PS·0.5H2O requires C 42.65, 
H 2.74, N 9.95%. 
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8.18. [Ir(piq)2(btzpy)][PF6] 
[Ir(piq)2Cl]2 (151 mg, 0.119 mmol) and AgPF6 (77.4 mg, 
0.306 mmol) in MeOH (25 mL), 3 h at room temperature. 
Addition of 2-(pyridin-2-yl)benzo[d]thiazole (btzpy) 
(50.8 mg, 0.239 mmol) and MeOH (10 mL). Purification by 
column chromatography (silica, CH2Cl2 changing to CH2Cl2–
2% MeOH), layering with toluene/n-hexane and subsequent 
precipitation with n-hexane from a CH2Cl2 solution. 
[Ir(piq)2(btzpy)][PF6] was isolated as a dark orange solid 
(180 mg, 0.188 mmol, 78.9%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 9.04–8.97 (overlapping 
m, 1H, H
B8
), 8.94 (pseudo-dt, J = 7.1, 3.5 Hz, 1H, H
D8
), 8.49 (d, J = 7.9 Hz, 1H, H
E3
), 8.36 
(pseudo-dt, J = 8.2, 1.5 Hz, 2H, H
A3+C3
), 8.19 (pseudo-td, J = 7.9, 1.5 Hz, 1H, H
E4
), 8.06 (dd, 
J = 8.3, 0.9 Hz, 1H, H
F7
), 7.95–7.88 (overlapping m, 2H, HB5+D5), 7.85–7.80 (overlapping m, 
3H, H
B6+B7+E6
), 7.80–7.75 (overlapping m, 2H, HD6+D7), 7.54 (d, J = 6.4 Hz, 1H, HB3), 7.52–
7.47 (overlapping m, 2H, H
E5+F6
), 7.37 (s, 2H, H
D3+D4
), 7.32 (d, J = 6.4 Hz, 1H, H
B4
), 7.25 
(ddd, J = 8.2, 7.3, 1.3 Hz, 1H, H
C4
), 7.22–7.16 (overlapping m, 2H, HA4+F5), 7.00–6.90 
(overlapping m, 2H, H
A5+C5
), 6.68 (d, J = 8.4 Hz, 1H, H
F4
), 6.43 (dd, J = 7.8, 1.2 Hz, 1H, 
H
C6
), 6.27 (dd, J = 7.6, 1.2 Hz, 1H, H
A6
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 170.0 
(C
F2
), 169.6 (C
D1
), 169.0 (C
B1
), 152.1 (C
E2
), 151.5 (C
E6
), 151.1 (C
F3a
), 150.9 (C
C1
), 150.8 
(C
A1
), 146.7 (C
C2
), 146.0 (C
A2
), 141.8 (C
B3
), 140.7 (C
D3
), 140.5 (C
E4
), 137.7 (C
B4a
), 137.6 
(C
D4a
), 134.8 (C
F7a
), 133.3 (C
C6
), 132.54 (C
B6
), 132.45 (C
D6
), 132.2 (C
A6
), 131.5 (C
A5
), 131.42 
(C
A3/C3
), 131.39 (C
A3/C3
), 131.0 (C
C5
), 129.9 (C
E5
), 129.6 (C
B7
), 129.4 (C
D7
), 129.2 (C
F5
), 
128.9 (C
F6
), 128.1 (C
B5
), 128.0 (C
D5
), 127.4 (C
D8
), 127.3 (C
B8
), 126.99 (C
B8a
), 126.95 (C
E3
), 
126.8 (C
D8a
), 123.7 (C
F7
), 123.4 (C
A4
), 123.2 (C
F4
), 123.1 (C
C4
), 122.8 (C
B4
), 122.5 (C
D4
). IR 
(solid, ṽ/cm–1) 3046 (w), 1576 (m), 1541 (m), 1502 (w), 1485 (w), 1448 (m), 1434 (m), 1382 
(m), 1352 (m), 1324 (m), 1298 (w), 1272 (m), 1159 (m), 1049 (w), 1030 (w), 1009 (w), 
836 (s), 757 (s), 741 (s), 731 (s), 712 (m), 676 (m), 664 (m), 628 (m), 581 (m), 556 (s), 516 
(m), 499 (m), 481 (w), 439 (m), 407 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 
mol
–1
 cm
–1
) 293 (46 000), 335 (35 000), 350 sh (31 000), 380 sh (14 000), 433 (8900), 465 sh 
(4600). Emission (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, λexc = 293 nm) λem
max
 = 642 nm. ESI-MS m/z 
813.1 [M–PF6]
+
 (calc. 813.2). HRMS m/z 813.1665 (calc. 813.1658). Found C 50.71, H 3.52, 
N 5.82; C42H28F6IrN4PS·2H2O requires C 50.75, H 3.25, N 5.64%. 
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8.19. [Ir(tppy)2(btzpy)][PF6] 
[Ir(tppy)2Cl]2 (151 mg, 0.116 mmol) and AgPF6 (83.3 mg, 
0.329 mmol) in MeOH (25 mL), 3.5 h at room 
temperature. Addition of 2-(pyridin-2-yl)benzo[d]thiazole 
(btzpy) (49.3 mg, 0.232 mmol) and MeOH (5 mL). 
Purification by column chromatography (silica, CH2Cl2 
changing to CH2Cl2–2% MeOH) and precipitation with 
Et2O/n-hexane. [Ir(tppy)2(btzpy)][PF6] was isolated as a red solid (180 mg, 0.186 mmol, 
80.0%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 8.43 (pseudo-dt, J = 8.0, 1.1 Hz, 1H, H
E3
), 8.19 
(pseudo-td, J = 7.9, 1.5 Hz, 1H, H
E4
), 8.06 (pseudo-dt, J = 8.4, 0.8 Hz, 1H, H
F7
), 8.02–7.98 
(overlapping m, 2H, H
B3+E6
), 7.93 (pseudo-dt, J = 8.3, 1.0 Hz, 1H, H
D3
), 7.83–7.71 
(overlapping m, 4H, H
A3+B4+C3+D4
), 7.61 (ddd, J = 5.8, 1.6, 0.8 Hz, 1H, H
B6
), 7.57–7.49 
(overlapping m, 2H, H
E5+F6
), 7.47 (pseudo-dt, J = 5.8, 1.2 Hz, 1H, H
D6
), 7.16 (ddd, J = 8.4, 
7.1, 1.2 Hz, 1H, H
F5
), 7.12 (dd, J = 8.0, 2.1 Hz, 1H, H
C5
), 7.07 (dd, J = 8.0, 2.1 Hz, 1H, H
A5
), 
6.99 (ddd, J = 7.3, 5.8, 1.4 Hz, 1H, H
D5
), 6.93 (ddd, J = 7.3, 5.8, 1.4 Hz, 1H, H
B5
), 6.79 (dd, J 
= 8.5, 0.8 Hz, 1H, H
F4
), 6.35 (d, J = 8.0 Hz, 1H, H
C6
), 6.20 (d, J = 8.0 Hz, 1H, H
A6
), 1.38 (s, 
9H, H
C4-tBu
), 1.35 (s, 9H, H
A4-tBu
). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 170.0 (C
F2
), 
168.8 (C
D2
), 168.2 (C
B2
), 152.3 (C
E2
), 151.5 (C
E6
), 151.2 (C
F3a
), 150.3 (C
B6
), 149.2 (C
D6
), 
146.8 (C
C4
), 146.6 (C
A4
), 144.5 (C
C2
), 143.8 (C
C1
), 143.7 (C
A2
), 143.6 (C
A1
), 140.4 (C
E4
), 
138.7 (C
B4/D4
), 138.6 (C
B4/D4
), 134.9 (C
F7a
), 132.6 (C
C6
), 131.3 (C
A6
), 129.9 (C
E5
), 129.10 
(C
A5/F5
), 129.08 (C
A5/F5
), 128.9 (C
F6
), 128.6 (C
C5
), 126.8 (C
E3
), 123.9 (C
B5
), 123.8 (C
D5
), 
123.6 (C
F7
), 123.4 (C
F4
), 122.4 (C
A3
), 122.2 (C
C3
), 120.4 (C
B3
), 120.2 (C
D3
), 34.84 (C
C4-
C(CH3)3
), 34.80 (C
A4-C(CH3)3
), 31.8 (C
C4-C(CH3)3
), 31.7 (C
A4-C(CH3)3
). IR (solid, ṽ/cm–1) 2953 (w), 
2865 (w), 1608 (w), 1561 (w), 1537 (w), 1479 (m), 1429 (m), 1362 (w), 1323 (w), 1297 (w), 
1269 (w), 1254 (m), 1202 (w), 1161 (w), 1114 (w), 1070 (w), 1029 (w), 1007 (w), 876 (w), 
834 (s), 780 (s), 754 (s), 729 (m), 709 (m), 644 (m), 623 (m), 556 (s), 477 (w), 436 (w), 
416 (w). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 257 (47 000), 270 
sh (44 000), 335 (24 000), 350 sh (19 000), 387 (9200), 412 (7400). Emission (CH2Cl2, 1.0 × 
10
–5
 mol dm
–3
, λexc = 268 nm) λem
max
 = 660 nm. ESI-MS m/z 825.2 [M–PF6]
+
 (calc. 825.3). 
Found C 51.84, H 4.34, N 6.03; C42H40F6IrN4PS requires C 52.00, H 4.16, N 5.78%. 
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8.20. [Ir(pbtz)2(btzpy)][PF6] 
[Ir(pbtz)2Cl]2 (151 mg, 0.116 mmol) and AgPF6 (73.8 mg, 
0.292 mmol) in MeOH (25 mL), 2.5 h at room temperature. 
Addition of 2-(pyridin-2-yl)benzo[d]thiazole (btzpy) 
(49.1 mg, 0.134 mmol) and MeOH (10 mL). Purification 
by column chromatography (silica, CH2Cl2 changing to 
CH2Cl2–2% MeOH) and precipitation with Et2O/n-hexane. 
[Ir(pbtz)2(btzpy)][PF6] was isolated as a bright orange solid 
(130 mg, 0.134 mmol, 57.8%). 
1
H NMR (500 MHz, CD2Cl2) δ/ppm 8.40 (pseudo-dt, J = 8.1, 
1.1 Hz, 1H, H
E3
), 8.23 (pseudo-td, J = 7.8, 1.5 Hz, 1H, H
E4
), 8.11 (pseudo-dt, J = 5.5, 1.0 Hz, 
1H, H
E6
), 8.08 (pseudo-dt, J = 8.4, 0.9 Hz, 1H, H
F7
), 7.93–7.85 (overlapping m, 4H, 
H
A3+B7+C3+D7
), 7.64–7.55 (overlapping m, 2H, HE5+F6), 7.39–7.32 (overlapping m, 2H, HB6+D6), 
7.28 (ddd, J = 8.5, 7.3, 1.2 Hz, 1H, H
F5
), 7.22–7.14 (overlapping m, 2H, HA4+C4), 7.11 (ddd, J 
= 8.5, 7.3, 1.2 Hz, 1H, H
D5
), 7.00–6.89 (overlapping m, 4H, HA5+B5+C5+F4), 6.52 (dd, J = 7.8, 
1.0 Hz, 1H, H
C6
), 6.40–6.33 (overlapping m, 2H, HA6+B4), 6.01 (d, J = 8.4 Hz, 1H, HD4). 
13
C{
1
H} NMR (126 MHz, CD2Cl2) δ/ppm 182.3 (C
D2
), 181.5 (C
B2
), 170.3 (C
F2
), 153.1 (C
E2
), 
151.8 (C
E6
), 151.6 (C
F3a
), 149.7 (C
D3a
), 149.5 (C
B3a
), 147.4 (C
C1
), 147.3 (C
A1
), 141.4 (C
C2
), 
141.0 (C
E4
), 140.6 (C
A2
), 134.4 (C
F7a
), 134.3 (C
C6
), 133.2 (C
A6
), 132.9 (C
A5
), 132.7 (C
C5
), 
132.08 (C
B7a/D7a
), 132.05 (C
B7a/D7a
), 130.1 (C
E5
), 129.7 (C
F5
), 129.2 (C
F6
), 128.72 (C
B5/D5
), 
128.69 (C
B5/D5
), 127.37 (C
A3/C3
), 127.36 (C
A3/C3
), 126.73 (C
B6/D6/E3
), 126.69 (C
B6/D6/E3
), 126.5 
(C
B6/D6
), 124.3 (C
A4
), 124.2 (C
D7
), 124.14 (C
B7
), 124.08 (C
C4
), 124.0 (C
F7
), 123.1 (C
F4
), 118.3 
(C
B4
), 117.7 (C
D4
). IR (solid, ṽ/cm–1) 3059 (w), 1581 (w), 1552 (w), 1485 (w), 1470 (w), 1459 
(w), 1448 (m), 1439 (m), 1408 (m), 1324 (w), 1299 (w), 1267 (m), 1162 (w), 1126 (w), 1078 
(w), 1053 (w), 1028 (w), 997 (w), 836 (s), 754 (s), 741 (m), 725 (m), 712 (m), 685 (w), 657 
(w), 646 (w), 583 (w), 557 (s), 509 (w), 480 (w), 449 (m). UV/Vis (CH2Cl2, 1.0 × 10
–5
 mol 
dm
–3
) λ/nm (ε/dm3 mol–1 cm–1) 253 (32 000), 270 (28 000), 279 (27 000), 290 (26 000), 324 
(46 000), 409 (9200), 435 sh (6300). Emission (CH2Cl2, 1.0 × 10
–5
 mol dm
–3
, λexc = 326 nm) 
λem
max
 = 600 nm. ESI-MS m/z 825.0 [M–PF6]
+
 (calc. 825.1). Found C 46.88, H 2.79, N 6.16; 
C38H24F6IrN4PS3 requires C 47.05, H 2.49, N 5.78%. 
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8.21. Crystallography 
Solvent molecules were severely disordered in [Ir(ppy)2(btzpy)][PF6] and the SQUEEZE
188
 
procedure was used; residual electron density corresponds to 1.5 CH2Cl2 per formula unit. 
[Ir(ppy)2(btzpy)][PF6]·1.5CH2Cl2. C35.50H27Cl3F6Ir1N4P1S1, M = 985.24, yellow block, 
monoclinic, space group P21/c, a = 14.4951(15), b = 13.7676(14), c = 18.7348(19) Å, β 
= 106.359(3)°, U = 3587.4(6) Å
3
, Z = 4, Dc = 1.82 Mg m
–3
, µ(Cu-Kα) = 10.8 mm
−1
, T = 
123 K. Total 33781 reflections, 6209 unique, Rint = 0.022. Refinement of 6169 reflections 
(424 parameters) with I >2σ (I) converged at final R1 = 0.0243 (R1 all data = 0.0244), wR2 = 
0.0546 (wR2 all data = 0.0547), gof = 0.9999. CCDC 1062206. 
[Ir(ppy)2(bbtz)][PF6]. C34H24F6Ir1N6P1S2, M = 917.92, red block, orthorhombic, space group 
Fdd2, a = 12.2991(19), b = 13.340(2), c = 40.350(7) Å, U = 6620.3(18) Å
3
, Z = 8, Dc = 1.842 
Mg m
–3
, µ(Cu-Kα) = 10.068 mm
−1
, T = 123 K. Total 10929 reflections, 2564 unique, Rint = 
0.030. Refinement of 2553 reflections (228 parameters) with I >2σ (I) converged at final R1 = 
0.0170 (R1 all data = 0.0171), wR2 = 0.0405 (wR2 all data = 0.0405), gof = 0.9244. 
[Ir(ppy)2(bozpy)][PF6]·CH2Cl2. C35H26Cl2F6Ir1N4O1P1, M = 926.70, red block, monoclinic, 
space group P21/n, a = 14.6181(15), b = 13.8956(14), c = 16.9244(17) Å, β = 107.448(2)°, U 
= 3279.6(6) Å
3
, Z = 4, Dc = 1.877 Mg m
–3
, µ(Cu-Kα) = 10.478 mm
−1
, T = 123 K. Total 19957 
reflections, 5966 unique, Rint = 0.022. Refinement of 5956 reflections (451 parameters) with I 
>2σ (I) converged at final R1 = 0.0256 (R1 all data = 0.0257), wR2 = 0.0556 (wR2 all data = 
0.0556), gof = 0.9994. 
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CHAPTER V: GLYCOSYLATED IRIDIUM COMPLEXES 
 
1. Introduction 
Carbohydrates play a vital role in living organisms. They form part of essential biomolecules, 
such as starch, adenosine triphosphate (ATP), ribonucleic acid (RNA) and deoxyribonucleic 
acid (DNA), and are important for recognition within cells.
209–212
 
 Few examples exist in which iridium complexes were functionalized with glycosyl 
moieties: these include application as sensors,
209
 phosphorescent labels in cells,
210–212
 water-
soluble drugs
213
 and catalysts,
213–215
 as well as for analytical purposes.
216
 
 In this chapter, ongoing work in the field of iridium(III) complexes containing sugar 
moieties either on the ancillary or on the cyclometallating ligand is presented. 
 
2. Synthesis and NMR Spectroscopic Characterization 
2.1. Ligand synthesis 
Bpy glycoside ligand 12 was synthesized according to a procedure reported in the 
literature.
217
 In the first step, β-D-ribofuranose 1,2,3,5-tetraacetate (10) was reacted with 2-
bromoethanol in the presence of Lewis acidic SnCl4 to an anomeric mixture of bromo-
substituted ribofuranose 11 in moderate yield.
217,218
 Separation of the anomers was 
challenging and was achieved by repeated column chromatography, resulting in a relatively 
low yield of the pure β-anomer. 4,4'-Dihydroxy-2,2'-bipyridine was treated with glycoside 
donor 11 to give bpy ligand 12 in good yield (Scheme 23). 
1
H NMR spectroscopic data of 
ligand 12 were compared with literature data.
217
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Scheme 23 Synthesis of glycosylated bpy ligand 12. Reaction conditions: a) SnCl4, 2-
bromoethanol, CH2Cl2/CH3CN, room temperature, 1 h 45 min, N2; b) K2CO3, KI, DMF, 75 °C, 
overnight, N2.
 
 
Glycosylated cyclometallating ligand 14 was prepared according to Scheme 24. 2-(4-
Hydroxyphenyl)pyridine (13) was obtained in excellent yield by a literature known Suzuki 
coupling reaction of 4-hydroxyphenylboronic acid with 2-bromopyridine, catalysed by 
Pd(OAc)2.
219
 By adaptation of the reported literature procedure,
217
 the functionalized Hppy 
ligand 14 was synthesized in good yield from 2-(4-hydroxyphenyl)pyridine (13) and 
glycoside 11 via an in situ halogen exchange of 11 using the Finkelstein reaction followed by 
an SN2 reaction. Cyclometallating ligand 14 was characterized by 
1
H NMR, 
13
C NMR and IR 
spectroscopies, LC-ESI mass spectrometry and elemental analysis. 
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Scheme 24 Synthetic route to glycosylated phenylpyridine ligand 14. Reaction conditions: a) 
Pd(OAc)2, K3PO4, ethylene glycol, 80 °C, 2 h; b) K2CO3, KI, DMF, 75 °C, overnight, N2.
 
 
2.2. Synthesis of [Ir(C^N)2Cl]2 dimer 
 
 
Scheme 25 Synthetic pathway to iridium dimer 15. Reaction conditions: a) [Ir(cod)Cl]2, 2-
ethoxyethanol, 130 °C, 2 d.
 
 
With the glycosylated cyclometallating ligand 14 in hand, two different routes to obtain 
iridium dimer 15 were tested: using IrCl3·xH2O in 2-ethoxyethanol/H2O (3:1)
100,101
 or 
[Ir(cod)Cl]2 in 2-ethoxyethanol (Scheme 25).
102
 For both methods, the ligand was dissolved in 
solvent, iridium source added and the mixture heated at reflux overnight. In the case of 
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IrCl3·xH2O as starting material, no cyclometallation occurred, as determined by 
1
H NMR 
spectroscopy (Fig. 65). However, starting ligand 14 was not recovered either, suggesting a 
degradation reaction of the ligand. When cyclometallation takes place, the NMR signal of the 
proton ortho to the Ir–C bond is shifted upfield in a distinctive and significant manner. This is 
seen for the product of the reaction with [Ir(cod)Cl]2 (bottom spectrum, Fig. 65). Negligible 
impurities were observed in the 
1
H NMR spectrum of dimer 15, which was therefore used for 
subsequent transformations without purification. 
 
 
Fig. 65 
1
H NMR spectra of ligand 14 (top) and products of the reactions of ligand 14 with 
IrCl3·xH2O (middle) and [Ir(cod)Cl]2 (bottom) in CDCl3. The proton in ortho position to the Ir–
C bond is marked in red; upon cyclometallation, a significant upfield shift takes place (bottom 
spectrum). Scale: δ/ppm. 
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2.3. Synthesis of [Ir(C^N)2(N^N)][PF6] complexes 
Treatment of iridium dimer [Ir(ppy)2Cl]2 with bpy glycoside 12 under reflux conditions in 
MeOH followed by anion exchange with an excess of solid NH4PF6 led to acetyl-protected 
complex 16. Deprotection was performed with sodium methoxide in MeOH and subsequent 
neutralization with acidic DOWEX 50WX4 resin, according to a procedure described in the 
literature.
209
 Deprotected glycosyl complex 17 was obtained as the [PF6]
−
 salt in good yield 
and was fully characterized (Scheme 26). 
 
 
Scheme 26 Synthetic route to iridium complex 17. Reaction conditions: a) MeOH, reflux, 
overnight, then NH4PF6; b) NaOMe, MeOH, room temperature, 4.5 h, then DOWEX 50WX4.
 
 
In order to enhance the solubility in H2O, the chloride salt analogue of complex 17 was 
prepared. In the first step, [Ir(ppy)2Cl]2 was again reacted with glycosylated ligand 12, this 
time without anion metathesis (Scheme 27). This gave protected complex 18 in excellent 
yield, which was fully characterized by 
1
H NMR, 
13
C NMR and IR spectroscopies, ESI mass 
spectrometry and elemental analysis. Subsequent deprotection should be carried out 
analogously to the reaction described for complex 17. 
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Scheme 27 Synthesis of iridium complex 18. Reaction conditions: a) MeOH, reflux, overnight.
 
 
Starting from glycosylated dimer 15, complex 19 was obtained in excellent yield from the 
reflux reaction with bpy in MeOH (Scheme 28). This reaction should be repeated on a larger 
scale and then deprotection carried out according to the procedure described for complex 17. 
This appears to be the first report of an iridium complex of the type [Ir(C^N)2(N^N)]
+
 
containing sugar substituents on the cyclometallating ligand, rather than the ancillary ligand. 
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Scheme 28 Synthetic route to iridium complex 19. Reaction conditions: a) bpy, MeOH, reflux, 
overnight.
 
 
2.4. Addition of phenylboronic acid to complex 17 
 
 
Scheme 29 Addition of phenylboronic acid to deprotected glycosyl complex 17, leading to 
binding of the boronic acid to the cis-diol of the furanose unit (phenylboronic acid part shown 
in red).
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Boronic acids easily condense with a cis-diol moiety of sugars in the fashion shown in 
Scheme 29.
220
 To investigate whether this reaction also takes place with deprotected iridium 
complex 17, an excess of solid phenylboronic acid was added to the NMR tube containing 
complex 17 dissolved in DMSO-d6. By integration of the obtained 
1
H NMR spectra taken 
before and after the addition (Fig. 66), it was possible to show that ester formation indeed 
occurs. Going from the top to bottom spectrum, the signals of four OH protons disappear, in 
accordance with the reaction shown in Scheme 29. Photographs were taken of the NMR tube 
under 366 nm UV light irradiation before and after the addition of phenylboronic acid (Fig. 
66). No emission colour change is visible by eye. 
 
 
Fig. 66 500 MHz 
1
H NMR spectra of glycosyl complex 17 in DMSO-d6 before (top) and after 
(bottom) the addition of phenylboronic acid to the NMR tube. Due to binding of the 
phenylboronic acid to the furanose moieties, four proton signals in the alkyl region disappear. 
The photographs of the NMR tube under 366 nm light irradiation before (top) and after (bottom) 
the addition of phenylboronic acid show that no emission colour change is visible by eye. 
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3. Conclusions and Outlook 
The synthesis of iridium(III) complexes containing glycosyl moieties either on the ancillary or 
on the cyclometallating ligand is reported. First, a complex containing ribose-
functionalizations on the bpy ancillary ligand was prepared as the [PF6]
−
 salt and deprotected 
to give the free hydroxyl groups. The ribose unit attached to the ligands of the iridium 
complex readily allows late stage modifications, which can be useful in many fields in which 
iridium complexes are used. As a proof-of-principle, it was shown that condensation of 
phenylboronic acid to the cis-diol domains of the ribose takes place. As many diverse boronic 
acids are commercially available, this transformation can be a powerful tool for derivatisation 
of iridium complexes. Furthermore, the OH group at C-5 position stays unprotected, which 
allows this position to act as a linker (e.g. for the addition of a second iridium complex) or 
allows transformation into the azide for click chemistry. To improve the solubility in aqueous 
media, the analogous chloride salt of the complex was prepared and should be deprotected in 
the next step. Synthesis of the iridium dimer containing glycosylated ppy cyclometallating 
ligands was followed by cleavage of the chlorido-bridged dimer with bpy to give the 
corresponding complex, which needs to be deprotected in the next step. This is the first 
example of an iridium complex containing glycosyl moieties on the cyclometallating, rather 
than the ancillary ligand. 
 In the future, scaling up of the reactions will need to be carried out in order to allow 
for complete characterization and investigation of the photophysical and electrochemical 
properties. 
 
4. Experimental 
4.1. General 
[Ir(cod)Cl]2
128
 and [Ir(ppy)2Cl]2
101
 were synthesized according to literature procedures. 4,4'-
Dihydroxy-2,2'-bipyridine was obtained from Dr. Steffen Müller. 
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4.2. Brominated ribofuranose 11 
β-D-Ribofuranose 1,2,3,5-tetraacetate (10) (986 mg, 3.10 mmol) was 
dissolved in dry CH3CN (5 mL) under N2 atmosphere and a solution of 
SnCl4 (370 µL, 824 mg, 3.16 mmol) in dry CH2Cl2 (3 mL) was added 
dropwise. The solution was stirred for 15 min at room temperature, then a 
solution of 2-bromoethanol (220 µL, 387 mg, 3.1 mmol) in dry CH3CN (5 mL) was added 
dropwise during 1 h and the mixture was stirred for another 30 min at room temperature. 
Saturated aq. NaHCO3 solution was added to the mixture at 0 °C, the resulting suspension 
was filtered over Celite and washed with hot CHCl3 (300 mL). The combined filtrates were 
washed with H2O (200 mL) and brine (200 mL), dried over Na2SO4 and the solvent was 
removed under reduced pressure. The crude product was purified by column chromatography 
(SiO2, CH2Cl2–1% MeOH). The mixed fractions were combined and again purified by 
column chromatography (SiO2, cyclohexane/EtOAc 2:1). The pure fractions were combined 
to yield ribofuranose 11 as colourless oil (455 mg, 1.19 mmol, 38.3%). 
1
H NMR (400 MHz, 
CDCl3) δ/ppm 5.34 (dd, J = 7.0, 4.7 Hz, 1H), 5.28 (d, J = 4.8 Hz, 1H), 5.06 (s, 1H), 4.37–4.28 
(m, 2H), 4.22–4.10 (m, 1H), 4.01 (dt, J = 10.9, 6.1 Hz, 1H), 3.77 (dt, J = 10.9, 6.3 Hz, 1H), 
3.52–3.40 (m, 2H), 2.12 (s, 3H), 2.10 (s, 3H), 2.06 (s, 3H). 
4.3. Glycosylated bpy ligand 12 
4,4'-Dihydroxy-2,2'-bipyridine (24.6 mg, 
130 µmol) and K2CO3 (110 mg, 796 µmol) 
were suspended in dry DMF (2 mL) under 
N2 atmosphere and heated at 75 °C for 45 min. A solution of ribofuranose 11 (99.7 mg, 
260 µmol) in dry DMF (2 mL) and KI (45.0 mg, 271 µmol) were added and the mixture was 
stirred overnight. The mixture was let to cool to room temperature and the solvent was 
evaporated under reduced pressure. The residue was suspended in H2O and extracted with 
CHCl3 (3 × 20 mL). The combined organic layers were dried over Na2SO4 and the solvent 
was removed under reduced pressure. The crude product was purified by column 
chromatography (SiO2, CH2Cl2–8% MeOH) to yield ligand 12 as a colourless solid (66.2 mg, 
84.0 µmol, 64.0%). 
1
H NMR (400 MHz, CDCl3) δ/ppm 8.47 (d, J = 5.7 Hz, 2H), 7.97 (d, J = 
2.5 Hz, 2H), 6.87 (dd, J = 5.7, 2.6 Hz, 2H), 5.35 (dd, J = 6.5, 4.9 Hz, 2H), 5.31–5.28 (m, 2H), 
5.13 (s, 2H), 4.40–4.27 (overlapping m, 8H), 4.22–4.14 (m, 2H), 4.13–4.05 (m, 2H), 3.91–
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3.83 (m, 2H), 2.11 (s, 6H), 2.08 (s, 6H), 2.06 (s, 6H). 
1
H NMR spectroscopic data matched 
those reported in the literature.
217
 
4.4. 2-(4-Hydroxyphenyl)pyridine (13) 
Pd(OAc)2 (4.43 mg, 19.7 µmol), 4-hydroxyphenylboronic acid (405 mg, 
2.94 mmol) and K3PO4 (825 mg, 3.89 mmol) were suspended in ethylene 
glycol (12 mL). 2-bromopyridine (190 µL, 314 mg, 1.98 mmol) was added 
and the mixture was heated at 80 °C for 2 h, after which the mixture was let to cool to room 
temperature. The mixture was poured into H2O (100 mL) and brine (100 mL) and the 
resulting suspension was stirred for 30 min at room temperature. The mixture was filtered. 
The filtrate was extracted with CH2Cl2 (2 × 200 mL) and the combined organic layers were 
dried over Na2SO4. The solid which was collected by filtration was washed with H2O and 
redissolved with CH2Cl2. The solutions were combined and the solvent was removed under 
reduced pressure. The residue was purified by column chromatography (SiO2, 
cyclohexane/EtOAc 1:1) to yield 2-(4-hydroxyphenyl)pyridine (13) as an off-white solid 
(300 mg, 1.75 mmol, 88.3%). 
1
H NMR (400 MHz, CDCl3) δ/ppm 8.64 (ddd, J = 4.9, 1.9, 
1.0 Hz, 1H), 7.89–7.82 (m, 2H), 7.73 (ddd, J = 8.0, 7.4, 1.8 Hz, 1H), 7.66 (dt, J = 8.0, 1.1 Hz, 
1H), 7.19 (ddd, J = 7.4, 4.9, 1.2 Hz, 1H), 6.92–6.84 (m, 2H), 6.15 (s, 1H). 1H NMR 
spectroscopic data matched those reported in the literature.
219
 
4.5. Glycosylated ppy ligand 14 
2-(4-Hydroxyphenyl)pyridine (13) (44.5 mg, 260 µmol) and 
K2CO3 (109 mg, 785 µmol) were suspended in dry DMF (2 mL) 
under N2 atmosphere and heated at 75 °C for 45 min. A solution 
of glycoside 11 (101 mg, 263 µmol) in dry DMF (2 mL) was 
added and the mixture was stirred for 2 h at 75 °C. KI (43.4 mg, 
261 µmol) was added and the mixture was stirred overnight at 75 °C. The mixture was let to 
cool to room temperature and the solvent was evaporated under reduced pressure. The residue 
was suspended in H2O and extracted with CHCl3 (3 × 20 mL). The combined organic layers 
were dried over Na2SO4 and the solvent was removed under reduced pressure. The crude 
product was purified by column chromatography (SiO2, EtOAc/cyclohexane 1:1) to yield 
ligand 14 as brownish oil (93.3 mg, 197 µmol, 75.8%). 
1
H NMR (500 MHz, CDCl3) δ/ppm 
8.64 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H), 7.97–7.91 (m, 2H), 7.71 (ddd, J = 8.1, 7.3, 1.8 Hz, 1H), 
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7.66 (dt, J = 8.1, 1.2 Hz, 1H), 7.17 (ddd, J = 7.2, 4.8, 1.3 Hz, 1H), 7.02–6.97 (m, 2H), 5.36 
(dd, J = 6.7, 4.9 Hz, 1H), 5.31 (dd, J = 4.9, 0.9 Hz, 1H), 5.13 (d, J = 0.9 Hz, 1H), 4.39–4.30 
(m, 2H), 4.21–4.14 (m, 3H), 4.07 (dt, J = 11.1, 4.5 Hz, 1H), 3.85 (dt, J = 11.0, 4.8 Hz, 1H), 
2.11 (s, 3H), 2.08 (s, 3H), 2.05 (s, 3H). 
13
C{
1
H} NMR (126 MHz, CDCl3) δ/ppm 170.8, 
169.80, 169.75, 159.6, 157.2, 149.7, 136.8, 132.5, 128.3, 121.6, 120.0, 114.9, 105.6, 78.9, 
74.9, 71.7, 67.1, 66.5, 64.9, 21.0, 20.8, 20.7. IR (solid, ṽ/cm–1) 2935 (w), 1743 (s), 1607 (w), 
1587 (w), 1564 (w), 1515 (w), 1467 (m), 1436 (m), 1369 (m), 1216 (s), 1178 (m), 1094 (s), 
1043 (s), 988 (m), 961 (m), 925 (m), 899 (m), 841 (m), 781 (s), 744 (w), 719 (w), 638 (w), 
604 (m), 555 (w), 498 (w). LC-ESI-MS m/z 474.2 [M+H]
+
 (calc. 474.2). Found C 60.18, H 
5.84, N 2.88; C24H27NO9·0.5H2O requires C 59.74, H 5.84, N 2.90%. 
4.6. Iridium dimer 15 
Glycosylated ligand 14 
(30.0 mg, 63.4 µmol) and 
[Ir(cod)Cl]2 (10.6 mg, 
158 µmol) were suspended 
in 2-ethoxyethanol in a 
microwave vial, sealed and 
heated at 130 °C for 2 d. The 
mixture was let to cool to room temperature and a few drops of H2O were added. The 
resulting precipitate was filtered off and washed with EtOH. The solid was redissolved with 
CH2Cl2 and the solvent was removed under reduced pressure to yield dimer 15 as an orange 
solid (13.4 mg, 6.0 µmol, 72.1%). 
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4.7. Protected ribose complex 16 
[Ir(ppy)2Cl]2 (42.3 mg, 39.5 µmol) and ligand 12 (62.4 mg, 
78.7 µmol) were suspended in MeOH (5 mL) and heated at reflux 
overnight. The suspension was let to cool to room temperature, 
filtered through Celite
®
, washed with MeOH and the filtrate was 
concentrated under reduced pressure. The residue was dissolved in 
little MeOH, an excess of solid NH4PF6 was added and the mixture 
was stirred at room temperature for 15 min. H2O was added until 
precipitation was observed and the suspension was stirred for 
another 15 min at room temperature. The precipitate was filtered 
off, washed with H2O and MeOH and redissolved with CH2Cl2. The 
solvent was removed under reduced pressure. The residue was purified by column 
chromatography (SiO2, CH2Cl2–2% MeOH changing to CH2Cl2–4% MeOH) to yield complex 
16 as a yellow solid (101 mg, 70.0 µmol, 89.0%). 
1
H NMR (250 MHz, CD3CN) δ/ppm 8.13–
7.98 (m, 4H), 7.90–7.74 (m, 4H), 7.72 (d, J = 6.4 Hz, 2H), 7.70–7.62 (m, 2H), 7.10–6.96 (m, 
6H), 6.89 (td, J = 7.4, 1.4 Hz, 2H), 6.27 (dd, J = 7.6, 1.3 Hz, 2H), 5.21–5.11 (m, 4H), 5.11–
5.05 (m, 2H), 4.39–4.22 (m, 8H), 4.16–3.98 (m, 4H), 3.84 (dt, J = 11.7, 4.4 Hz, 2H), 2.05 (s, 
3H), 2.05 (s, 3H), 2.00 (s, 6H), 1.98 (s, 3H), 1.96 (s, 3H). 
4.8. Deprotected ribose complex 17 
NaOMe (3.28 mg, 59.5 µmol) was added to a solution of complex 
16 (85.9 mg, 59.7 µmol) in MeOH (7 mL). The mixture was stirred 
at room temperature for 4.5 h. DOWEX 50WX4 (washed 
subsequently with H2O, 1 M HCl, H2O and MeOH) was added to 
neutralize the mixture. The DOWEX was removed by filtration and 
the filtrate was concentrated under reduced pressure. The residue 
was suspended in CH3CN, filtered over Celite
®
 and the filtrate was 
concentrated under reduced pressure to yield complex 17 as a 
yellow solid (55.6 mg, 47.0 µmol, 78.5%). 
1
H NMR (500 MHz, 
dmso-d6) δ/ppm 8.51–8.44 (m, 2H), 8.25 (dt, J = 8.5, 1.0 Hz, 2H), 
7.97–7.85 (m, 4H), 7.70–7.62 (m, 2H), 7.59 (d, J = 6.4 Hz, 2H), 7.28 (dd, J = 6.5, 2.6 Hz, 
2H), 7.18 (ddd, J = 7.4, 5.8, 1.4 Hz, 2H), 6.99 (td, J = 7.5, 1.2 Hz, 2H), 6.87 (td, J = 7.4, 1.3 
Hz, 2H), 6.19 (dd, J = 7.6, 1.2 Hz, 2H), 5.06 (dd, J = 4.5, 1.7 Hz, 2H), 4.87 (d, J = 6.7 Hz, 
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2H), 4.83 (t, J = 1.1 Hz, 2H), 4.61 (td, J = 5.7, 1.3 Hz, 2H), 4.42–4.31 (m, 4H), 3.96 (ddd, J = 
11.7, 5.4, 3.2 Hz, 2H), 3.83 (ddd, J = 11.2, 6.5, 4.8 Hz, 2H), 3.80–3.67 (m, 6H), 3.51 (ddt, J = 
11.7, 5.6, 3.7 Hz, 2H), 3.33 (s, 2H). IR (solid, ṽ/cm–1) 3373 (w), 2927 (w), 1608 (m), 1583 
(w), 1558 (w), 1478 (m), 1439 (m), 1420 (m), 1330 (m), 1315 (m), 1268 (m), 1250 (m), 1222 
(m), 1165 (w), 1098 (m), 1030 (s), 949 (m), 831 (s), 757 (s), 738 (s), 669 (m), 630 (m), 556 
(s). ESI-MS m/z 1041.6 [M−PF6]
+
 (calc. 1041.3). Found C 43.53, H 4.34, N 4.13; 
C46H48F6IrN4O12P·0.5H2O requires C 43.60, H 4.53, N 4.42%. 
4.9. Protected ribose complex 18 
[Ir(ppy)2Cl]2 (44.6 mg, 41.6 µmol) and ligand 12 (65.7 mg, 
82.9 µmol) were suspended in MeOH (5 mL) and heated at reflux 
overnight. The suspension was let to cool to room temperature, 
filtered through cotton, washed with MeOH and the filtrate was 
concentrated under reduced pressure. The crude product was 
purified by column chromatography (SiO2, CH2Cl2–10% MeOH) to 
yield complex 18 as a yellow powder (101 mg, 76.0 µmol, 91.4%). 
1
H NMR (500 MHz, CD3CN) δ/ppm 8.31 (s, 2H), 8.05 (dt, J = 8.2, 
1.0 Hz, 2H), 7.86–7.80 (m, 2H), 7.78 (dd, J = 8.0, 1.3 Hz, 2H), 7.70 
(d, J = 6.4 Hz, 2H), 7.69–7.67 (m, 2H), 7.05 (ddd, J = 7.4, 5.8, 1.4 
Hz, 2H), 7.00 (td, J = 6.9, 1.9 Hz, 4H), 6.88 (td, J = 7.4, 1.3 Hz, 2H), 6.27 (dd, J = 7.6, 1.2 
Hz, 2H), 5.17 (dd, J = 6.5, 4.7 Hz, 2H), 5.14–5.09 (m, 4H), 4.50–4.40 (m, 4H), 4.31–4.25 (m, 
4H), 4.12–4.07 (m, 2H), 4.07–4.00 (m, 2H), 3.87–3.80 (m, 2H), 2.05 (s, 3H), 2.04 (s, 3H), 
2.00 (s, 6H), 1.98 (s, 3H), 1.97 (s, 3H). 
13
C{
1
H} NMR (126 MHz, CD3CN) δ/ppm 171.50, 
171.49, 170.8, 170.64, 170.63, 168.4, 168.0, 158.4, 152.2, 151.8, 150.0, 145.1, 139.2, 132.5, 
131.2, 125.7, 124.3, 123.2, 120.6, 115.4, 112.81, 112.79, 106.01, 105.97, 79.4, 75.1, 72.6, 
69.8, 66.5, 66.4, 65.60, 65.57, 21.0, 20.73, 20.66. IR (solid, ṽ/cm–1) 2935 (w), 1740 (s), 1607 
(s), 1583 (w), 1556 (w), 1478 (m), 1437 (m), 1369 (m), 1337 (w), 1218 (s), 1164 (m), 1036 
(s), 961 (m), 897 (m), 796 (w), 761 (s), 738 (s), 669 (m), 630 (m), 603 (m). ESI-MS m/z 
1293.8 [M−PF6]
+
 (calc. 1293.4). Found C 50.76, H 4.90, N 4.24; C58H60ClIrN4O18·2H2O 
requires C 51.04, H 4.73, N 4.11%. 
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4.10. Protected ribose complex 19 
Dimer 15 (13.4 mg, 5.71 µmol) and bpy (1.78 mg, 11.4 µmol) 
were suspended in MeOH (2 mL) and heated at reflux 
overnight. The solution was let to cool to room temperature, 
filtered through cotton, washed with MeOH and the filtrate 
was concentrated under reduced pressure. The crude product 
was purified by column chromatography (SiO2, CH2Cl2–
10% MeOH changing to CH2Cl2–20% MeOH) to yield 
complex 19 as a yellow solid (14.0 mg, 11.0 µmol, 92.3%). 
1
H NMR (500 MHz, CD3CN) 
δ/ppm 8.59 (d, J = 8.2 Hz, 2H), 8.13 (td, J = 7.9, 1.6 Hz, 2H), 8.07–8.01 (m, 2H), 7.93 (dt, J = 
8.3, 0.9 Hz, 2H), 7.81–7.72 (m, 4H), 7.51 (ddd, J = 7.7, 5.6, 1.1 Hz, 4H), 6.93 (dddd, J = 7.4, 
5.9, 2.3, 1.4 Hz, 2H), 6.64 (ddd, J = 8.6, 2.6, 0.8 Hz, 2H), 5.72 (dd, J = 2.5, 1.1 Hz, 2H), 5.15 
(ddd, J = 6.9, 4.9, 2.3 Hz, 2H), 5.09 (dd, J = 4.9, 0.9 Hz, 2H), 5.00 (d, J = 1.0 Hz, 2H), 4.29–
4.20 (m, 4H), 4.04–3.97 (m, 2H), 3.94–3.80 (m, 4H), 3.68–3.59 (m, 2H), 2.05 (s, 3H), 2.04 (s, 
3H), 2.00 (s, 3H), 2.00 (s, 3H), 1.96 (s, 3H), 1.94 (s, 3H). 
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CONCLUSIONS AND OUTLOOK 
 
Sulfur-functionalizations were introduced to the cyclometallating and ancillary ligands of 
iridium(III) complexes to achieve emission colour tuning over the whole visible region, from 
blue to red. 
By placing thioether and sulfone substituents on the cyclometallating ligands it was 
possible to obtain yellow and green emitters. This highlights the potential of electron-
withdrawing sulfone groups to replace the widely used fluorine substituents in iridium 
complexes to reach blue-shifted emission. Different alkyl substituents on the sulfur moieties 
were investigated; these had no or negligible influences on photoluminescence maxima and 
electrochemical properties. High solution quantum yields of 64 and 74% were observed for 
complexes containing sulfone-functionalized C^N ligands. The most promising candidates 
from this series were tested in light-emitting electrochemical cells, resulting in yellow-green 
electroluminescence. Unfortunately, low luminance levels and device efficiencies were 
observed, together with short lifetimes of less than 69 min. 
In the above described series of complexes, substituents were placed exclusively in 5-
position of the cyclometallating ligands, meta to the Ir–C bond. Thus, as a next step, the 
influence of the substitution position on photophysical, electrochemical and device properties 
was investigated. For this, a series of regioisomeric iridium complexes containing a 
methylsulfonyl group in 3-, 4- or 5-position of the C^N ligands was prepared. Within this 
series, the two complexes containing the substituent in meta position to the Ir–C bond (3- and 
5-position) showed similar properties in terms of quantum yields, excited state lifetimes and 
structured emission spectra in solution. Substitution in 4-position (para to the Ir–C bond) 
resulted in enhanced quantum yields both in solution (92%) and powder (27%) compared to 
the other two complexes. Furthermore, a broad, featureless photoluminescence spectrum was 
observed in solution. This indicates that for the complex containing the sulfone group in 4-
position, the charge transfer character of the emissive triplet state is higher than for the 
complexes containing the substituent in meta position to the Ir–C bond. All compounds are 
green emitters in solution and yellow emitters as powder samples. In LEECs, the 4-substituted 
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complex yielded the best performance with respect to maximum luminance (940 cd m
−2
) and 
efficiency (EQE = 2.6%). However, device stability is limited for all complexes in this series 
(t1/2 ≤ 69 min). 
In order to shift the emission further to the blue, electron-deficient sulfone-
functionalized cyclometallating ligands were combined with electron-rich ancillary ligands. 
Pyrazolylpyridines were chosen as N^N ligands; together, this should lead to a stabilization of 
the HOMO and destabilization of the LUMO and thus a widening of the energy gap. In fact, 
the synthesized complexes are green or blue emitters in solution, depending on the 
substitution position of the methylsulfonyl group. In LEEC devices, all complexes exhibit 
green electroluminescence, low efficiencies (EQE = 0.2–0.4%) and lifetimes in the order of a 
few minutes. 
The use of ancillary ligands containing benzothiazole units gave complexes with dark 
orange to deep red photoluminescence (in CH2Cl2 solution, thin film and as powder samples) 
and electroluminescence. Based on the simple benzothiazolylpyridine (btzpy), different 
functionalizations were introduced to the N^N ligand and the device properties of the 
corresponding complexes with 2-phenylpyridine (ppy) as cyclometallating ligand 
investigated. In a second series, different C^N ligands were combined with btzpy. For 
complex [Ir(ppy)2(btzpy)][PF6], excellent device stability was observed when operated under 
average current densities of both 100 and 700 A m
−2
 (t1/2 >1000 h). Addition of a tert-butyl 
group or a pendant phenyl ring on the ancillary ligand leads to complexes with further 
enhanced lifetimes of over 4500 h. Moreover, luminance and efficiency levels are increased. 
Both the ppy cyclometallating ligand and the benzothiazole moiety seem to be crucial for long 
LEEC lifetimes. Replacing either ppy by another C^N ligand or benzothiazole by 
benzoxazole leads to significantly reduced device stability. The lifetimes reported for this 
series are by far the longest reported for iridium-based red light emitting electrochemical 
cells. 
It was possible to highlight the potential of sulfone groups to act as an alternative to 
the widely used fluorine substituents in order to shift the emission to the blue. Whereas blue 
emission was observed in solution, all complexes showed green electroluminescence in 
device configuration. The introduction of a second sulfone group on the cyclometallating 
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ligand might lead to a blue-shift in the electroluminescence maximum. Unfortunately, the 
LEEC stability of all sulfone-containing complexes was poor, with lifetimes ranging from a 
few minutes to approximately an hour. This observation leads to the assumption that either the 
sulfone group is unstable under driving conditions (similar to fluorine substituents) or that 
instability is an inherent feature of iridium complexes with a large HOMO-LUMO energy 
gap. To enhance stability, modifications can be made to the ligands; for example, by placing 
bulky groups or a π-stacking phenyl ring on the ancillary ligand. Another possibility is the 
introduction of steric hindrance to the cyclometallating ligands, shielding the sulfone group 
from degradation. Combined with the idea of two sulfone substituents on the C^N ligand, it 
might be interesting to investigate the effect of connecting these two groups; this goal can be 
achieved for example by the use of a thianthrene tetraoxide core. 
As for the benzothiazole-based red emitters, it might be possible to further enhance 
LEEC performance by a combination of the beneficial effects of a tert-butyl substituent and a 
pendant phenyl ring on the ancillary ligand. In addition, the use of other cyclometallating 
ligands might also result in an increased device performance. 
Glycosylated iridium complexes are a promising field of research, for they can be 
applied as phosphorescent labels, sensors, drugs, catalysts, etc. By a condensation reaction, 
ribofuranose-functionalized complexes can be easily modified with boronic acids, making 
these glycosyl compounds highly versatile intermediates. In the future, the potential of such 
transformations in addition to the photophysical and electrochemical properties of such 
iridium(III) complexes will be investigated. 
  
REFERENCES 
 
 
 
 
 - 177 -  
 
REFERENCES 
 
1 APEX2, version 2 User Manual, M86-E01078, Bruker Analytical X-ray Systems, Inc., 
Madison, WI, 2006. 
2 G. M. Sheldrick, Acta Crystallogr. Sect. A Found. Crystallogr., 2008, A64, 112–122. 
3 P. W. Betteridge, J. P. Carruthers, R. I. Cooper, K. Prout and D. J. Watkin, J. Appl. 
Crystallogr., 2003, 36, 1487. 
4 M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. 
Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. 
Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. 
Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr, J. E. 
Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. 
Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. 
S. Iyengar, J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene, J. E. Knox, J. B. 
Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, 
A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. 
G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg, S. Dapprich, A. D. Daniels, 
O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox, Gaussian 09, 
Revision D.01, Gaussian, Inc., Wallingford, CT, 2009. 
5 A. D. Becke, J. Chem. Phys., 1993, 98, 5648–5652. 
6 C. Lee, W. Yang and R. G. Parr, Phys. Rev. B, 1988, 37, 785–789. 
7 M. M. Francl, W. J. Pietro, W. J. Hehre, J. S. Binkley, M. S. Gordon, D. J. DeFrees and 
J. A. Pople, J. Chem. Phys., 1982, 77, 3654–3665. 
8 P. J. Hay and W. R. Wadt, J. Chem. Phys., 1985, 82, 299–310. 
9 J. Tomasi, B. Mennucci and R. Cammi, Chem. Rev., 2005, 105, 2999–3093. 
10 J. Tomasi and M. Persico, Chem. Rev., 1994, 94, 2027–2094. 
11 C. S. Cramer and D. G. Truhlar, in Solvent Effects and Chemical Reactivity, Kluwer, 
Dordrecht, 1996, pp. 1–80. 
12 M. Petersilka, U. J. Gossmann and E. K. U. Gross, Phys. Rev. Lett., 1996, 76, 1212–
1215. 
REFERENCES 
 
 
 
 
 - 178 -  
 
13 M. E. Casida, C. Jamorski, K. C. Casida and D. R. Salahub, J. Chem. Phys., 1998, 108, 
4439–4449. 
14 C. Jamorski, M. E. Casida and D. R. Salahub, J. Chem. Phys., 1996, 104, 5134–5147. 
15 http://www.light2015.org/Home.html, 05.02.2016. 
16 C. E. Housecroft and A. G. Sharpe, Inorganic Chemistry, Pearson, Essex, 3
rd
 ed., 2008. 
17 P. W. Atkins and J. de Paula, Physikalische Chemie, Wiley-VCH, Weinheim, 4
th
 ed., 
2006. 
18 C. E. Housecroft and E. C. Constable, Chem. Soc. Rev., 2015, 44, 8386–8398. 
19 J. Clayden, N. Greeves, S. Warren and P. Wothers, Organic Chemistry, Oxford 
University Press, Oxford, 1
st
 ed., 2001. 
20 N. Armaroli and V. Balzani, Energy Environ. Sci., 2011, 4, 3193–3222. 
21 R. D. Costa, E. Ortí, H. J. Bolink, F. Monti, G. Accorsi and N. Armaroli, Angew. 
Chem. Int. Ed., 2012, 51, 8178–8211. 
22 http://www.theskepticsguide.org/humans-seeing-infrared-light-kind-of, 04.02.2016. 
23 http://www.centennialbulb.org/, 06.02.2016. 
24 M. Krajewski, IEEE Spectr., 2014, 51, 56–61. 
25 https://commons.wikimedia.org/wiki/File:Livermore_Centennial_Light_Bulb.jpg, 
06.02.2016. 
26 E. J. Gago, T. Muneer, M. Knez and H. Köster, Renew. Sustain. Energy Rev., 2015, 41, 
1–13. 
27 B. Bowers, IEEE Spectr., 2011, 48, 44–52. 
28 http://www.tagesanzeiger.ch/leben/rat-und-tipps/Grosses-Lichterlschen-fr-die-
Glhbirnen/story/25999013, 06.02.2016. 
29 http://www.reuters.com/article/us-lightbulbs-env-idUSN2529253520070425, 
06.02.2016. 
30 C.-C. Lin, K.-J. Chen, D.-W. Lin, H.-V. Han, W.-C. Lai, J.-J. Huang, T.-C. Lu, S.-J. 
Chang and H.-C. Kuo, Top. Appl. Phys., 2015, 129, 337–354. 
31 P. Pust, P. J. Schmidt and W. Schnick, Nat. Mater., 2015, 14, 454–458. 
REFERENCES 
 
 
 
 
 - 179 -  
 
32 ‘The Nobel Prize Phys. 2014’. Nobelprize.org. Nobel Media AB 2014. Web. 
01.02.2016. <http//www.nobelprize.org/nobel_prizes/physics/laureates/2014/>. 
33 S. Nakamura, Angew. Chem. Int. Ed., 2015, 54, 7770–7788. 
34 H. Amano, Angew. Chem. Int. Ed., 2015, 54, 7764–7769. 
35 I. Akasaki, Angew. Chem. Int. Ed., 2015, 54, 7750–7763. 
36 J. Godlewski and M. Obarowska, Opto-Electronics Rev., 2007, 15, 179–183. 
37 O. Nuyken, S. Jungermann, V. Wiederhirn, E. Bacher and K. Meerholz, Monatshefte 
für Chemie - Chem. Mon., 2006, 137, 811–824. 
38 A. Bergh, G. Craford, A. Duggal and R. Haitz, Phys. Today, 2001, 54, 42. 
39 Q. Pei, G. Yu, C. Zhang, Y. Yang and A. J. Heeger, Science, 1995, 269, 1086–1088. 
40 K. M. Maness, R. H. Terrill, T. J. Meyer, R. W. Murray and R. M. Wightman, J. Am. 
Chem. Soc., 1996, 118, 10609–10616. 
41 J.-K. Lee, D. S. Yoo, E. S. Handy and M. F. Rubner, Appl. Phys. Lett., 1996, 69, 1686–
1688. 
42 J.-C. Leprêtre, A. Deronzier and O. Stéphan, Synth. Met., 2002, 131, 175–183. 
43 S. Bernhard, J. A. Barron, P. L. Houston, H. D. Abruña, J. L. Ruglovksy, X. Gao and 
G. G. Malliaras, J. Am. Chem. Soc., 2002, 124, 13624–13628. 
44 M. Buda, G. Kalyuzhny and A. J. Bard, J. Am. Chem. Soc., 2002, 124, 6090–6098. 
45 H. Rudmann, S. Shimada and M. F. Rubner, J. Am. Chem. Soc., 2002, 124, 4918–4921. 
46 H. Rudmann and M. F. Rubner, J. Appl. Phys., 2001, 90, 4338–4345. 
47 F. G. Gao and A. J. Bard, J. Am. Chem. Soc., 2000, 122, 7426–7427. 
48 C. M. Elliott, F. Pichot, C. J. Bloom and L. S. Rider, J. Am. Chem. Soc., 1998, 120, 
6781–6784. 
49 S. Bernhard, X. Gao, G. G. Malliaras and H. D. Abruña, Adv. Mater., 2002, 14, 433–
436. 
50 F. G. Gao and A. J. Bard, Chem. Mater., 2002, 14, 3465–3470. 
 
REFERENCES 
 
 
 
 
 - 180 -  
 
51 J. D. Slinker, A. A. Gorodetsky, M. S. Lowry, J. Wang, S. Parker, R. Rohl, S. Bernhard 
and G. G. Malliaras, J. Am. Chem. Soc., 2004, 126, 2763–2767. 
52 M. Lenes, G. Garcia-Belmonte, D. Tordera, A. Pertegás, J. Bisquert and H. J. Bolink, 
Adv. Funct. Mater., 2011, 21, 1581–1586. 
53 D. Tordera, S. Meier, M. Lenes, R. D. Costa, E. Ortí, W. Sarfert and H. J. Bolink, Adv. 
Mater., 2012, 24, 897–900. 
54 M. V. Werrett, G. S. Huff, S. Muzzioli, V. Fiorini, S. Zacchini, B. W. Skelton, A. 
Maggiore, J. M. Malicka, M. Cocchi, K. C. Gordon, S. Stagni and M. Massi, Dalton 
Trans., 2015, 44, 8379–8393. 
55 O. Moudam, A. C. Tsipis, S. Kommanaboyina, P. N. Horton and S. J. Coles, RSC Adv., 
2015, 5, 95047–95053. 
56 N. Armaroli, G. Accorsi, M. Holler, O. Moudam, J.-F. Nierengarten, Z. Zhou, R. T. 
Wegh and R. Welter, Adv. Mater., 2006, 18, 1313–1316. 
57 R. D. Costa, D. Tordera, E. Ortí, H. J. Bolink, J. Schönle, S. Graber, C. E. Housecroft, 
E. C. Constable and J. A. Zampese, J. Mater. Chem., 2011, 21, 16108–16118. 
58 S. Keller, E. C. Constable, C. E. Housecroft, M. Neuburger, A. Prescimone, G. Longo, 
A. Pertegás, M. Sessolo and H. J. Bolink, Dalton Trans., 2014, 43, 16593–16596. 
59 S. Keller, A. Pertegás, G. Longo, L. Martínez, J. Cerdá, J. M. Junquera-Hernández, A. 
Prescimone, E. C. Constable, C. E. Housecroft, E. Ortí and H. J. Bolink, J. Mater. 
Chem. C, 2016. 
60 O. Moudam, A. Kaeser, B. Delavaux-Nicot, C. Duhayon, M. Holler, G. Accorsi, N. 
Armaroli, I. Séguy, J. Navarro, P. Destruel and J.-F. Nierengarten, Chem. Commun., 
2007, 3077–3079. 
61 Q. Zhang, Q. Zhou, Y. Cheng, L. Wang, D. Ma, X. Jing and F. Wang, Adv. Funct. 
Mater., 2006, 16, 1203–1208. 
62 A. Pertegás, D. Tordera, J. J. Serrano-Pérez, E. Ortí and H. J. Bolink, J. Am. Chem. 
Soc., 2013, 135, 18008–18011. 
63 M. Y. Wong, G. J. Hedley, G. Xie, L. S. Kölln, I. D. W. Samuel, A. Pertegás, H. J. 
Bolink and E. Zysman-Colman, Chem. Mater., 2015, 27, 6535–6542. 
64 M. S. Lowry and S. Bernhard, Chem. Eur. J., 2006, 12, 7970–7977. 
65 Y. You and S. Y. Park, Dalton Trans., 2009, 9226, 1267. 
REFERENCES 
 
 
 
 
 - 181 -  
 
66 R. D. Costa, E. Ortí and H. J. Bolink, Pure Appl. Chem., 2011, 1. 
67 C. Ulbricht, B. Beyer, C. Friebe, A. Winter and U. S. Schubert, Adv. Mater., 2009, 21, 
4418–4441. 
68 L. Flamigni, A. Barbieri, C. Sabatini, B. Ventura and F. Barigelletti, Top. Curr. Chem., 
2007, 281, 143–203. 
69 E. Zysman-Colman, J. D. Slinker, J. B. Parker, G. G. Malharas and S. Bernhard, Chem. 
Mater., 2008, 20, 388–396. 
70 S. Graber, K. Doyle, M. Neuburger, C. E. Housecroft, E. C. Constable, R. D. Costa, E. 
Ortí, D. Repetto and H. J. Bolink, J. Am. Chem. Soc., 2008, 130, 14944–14945. 
71 H. J. Bolink, E. Coronado, R. D. Costa, E. Ortí, M. Sessolo, S. Graber, K. Doyle, M. 
Neuburger, C. E. Housecroft and E. C. Constable, Adv. Mater., 2008, 20, 3910–3913. 
72 R. D. Costa, E. Ortí, H. J. Bolink, S. Graber, C. E. Housecroft and E. C. Constable, 
Adv. Funct. Mater., 2010, 20, 1511–1520. 
73 A. M. Bünzli, E. C. Constable, C. E. Housecroft, A. Prescimone, J. A. Zampese, G. 
Longo, L. Gil-Escrig, A. Pertegás, E. Ortí and H. J. Bolink, Chem. Sci., 2015, 6, 2843–
2852. 
74 R. D. Costa, E. Ortí, H. J. Bolink, S. Graber, C. E. Housecroft, M. Neuburger, S. 
Schaffner and E. C. Constable, Chem. Commun., 2009, 2029–2031. 
75 H.-C. Su, H.-F. Chen, F.-C. Fang, C.-C. Liu, C.-C. Wu, K.-T. Wong, Y.-H. Liu and S.-
M. Peng, J. Am. Chem. Soc., 2008, 130, 3413–3419. 
76 L. He, J. Qiao, L. Duan, G. Dong, D. Zhang, L. Wang and Y. Qiu, Adv. Funct. Mater., 
2009, 19, 2950–2960. 
77 H.-C. Su, H.-F. Chen, Y.-C. Shen, C.-T. Liao and K.-T. Wong, J. Mater. Chem., 2011, 
21, 9653–9660. 
78 L. He, L. Duan, J. Qiao, R. Wang, P. Wei, L. Wang and Y. Qiu, Adv. Funct. Mater., 
2008, 18, 2123–2131. 
79 F. De Angelis, S. Fantacci, N. Evans, C. Klein, S. M. Zakeeruddin, J.-E. Moser, K. 
Kalyanasundaram, H. J. Bolink, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 
2007, 46, 5989–6001. 
80 E. Baranoff, H. J. Bolink, E. C. Constable, M. Delgado, D. Häussinger, C. E. 
Housecroft, M. K. Nazeeruddin, M. Neuburger, E. Ortí, G. E. Schneider, D. Tordera, 
R. M. Walliser and J. A. Zampese, Dalton Trans., 2013, 42, 1073–1087. 
REFERENCES 
 
 
 
 
 - 182 -  
 
81 S. Schmidbauer, A. Hohenleutner and B. König, Adv. Mater., 2013, 25, 2114–2129. 
82 D. Tordera, J. J. Serrano-Pérez, A. Pertegás, E. Ortí, H. J. Bolink, E. Baranoff, M. K. 
Nazeeruddin and J. Frey, Chem. Mater., 2013, 25, 3391–3397. 
83 C. Hansch, A. Leo and R. W. Taft, Chem. Rev., 1991, 91, 165–195. 
84 D. H. McDaniel and H. C. Brown, J. Org. Chem., 1958, 23, 420–427. 
85 M. Tavasli, S. Bettington, I. F. Perepichka, A. S. Batsanov, M. R. Bryce, C. Rothe and 
A. P. Monkman, Eur. J. Inorg. Chem., 2007, 4808–4814. 
86 G. Zhou, C.-L. Ho, W.-Y. Wong, Q. Wang, D. Ma, L. Wang, Z. Lin, T. B. Marder and 
A. Beeby, Adv. Funct. Mater., 2008, 18, 499–511. 
87 G. Zhou, X. Yang, W.-Y. Wong, Q. Wang, S. Suo, D. Ma, J. Feng and L. Wang, 
ChemPhysChem, 2011, 12, 2836–2843. 
88 X. Xu, X. Yang, J. Dang, G. Zhou, Y. Wu, H. Li and W.-Y. Wong, Chem. Commun., 
2014, 50, 2473–2476. 
89 J. Zhao, Y. Yu, X. Yang, X. Yan, H. Zhang, X. Xu, G. Zhou, Z. Wu, Y. Ren and W.-Y. 
Wong, ACS Appl. Mater. Interfaces, 2015, 7, 24703–24714. 
90 R. Ragni, E. Orselli, G. S. Kottas, O. H. Omar, F. Babudri, A. Pedone, F. Naso, G. M. 
Farinola and L. De Cola, Chem. Eur. J., 2009, 15, 136–148. 
91 C. Fan, Y. Li, C. Yang, H. Wu, J. Qin and Y. Cao, Chem. Mater., 2012, 24, 4581–
4587. 
92 Y. Hisamatsu and S. Aoki, Eur. J. Inorg. Chem., 2011, 5360–5369. 
93 D. Tordera, A. M. Bünzli, A. Pertegás, J. M. Junquera-Hernández, E. C. Constable, J. a 
Zampese, C. E. Housecroft, E. Ortí and H. J. Bolink, Chem. Eur. J., 2013, 19, 8597–
609. 
94 G. E. Schneider, H. J. Bolink, E. C. Constable, C. D. Ertl, C. E. Housecroft, A. 
Pertegás, J. A. Zampese, A. Kanitz, F. Kessler and S. B. Meier, Dalton Trans., 2014, 
43, 1961–1964. 
95 E. C. Constable, C. D. Ertl, C. E. Housecroft and J. A. Zampese, Dalton Trans., 2014, 
43, 5343–5356. 
96 C. Liu, Q. Ni, P. Hu and J. Qiu, Org. Biomol. Chem., 2011, 9, 1054–60. 
 
REFERENCES 
 
 
 
 
 - 183 -  
 
97 Y. Harrak, G. Casula, J. Basset, G. Rosell, S. Plescia, D. Raffa, M. G. Cusimano, R. 
Pouplana and M. D. Pujol, J. Med. Chem., 2010, 53, 6560–6571. 
98 S. Clavier, O. Rist, S. Hansen, L.-O. Gerlach, T. Högberg and J. Bergman, Org. 
Biomol. Chem., 2003, 1, 4248–53. 
99 A. B. Charette, C. Berthelette and D. St-Martin, Tetrahedron Lett., 2001, 42, 5149–
5153. 
100 F. O. Garces, K. A. King and R. J. Watts, Inorg. Chem., 1988, 27, 3464–3471. 
101 S. Sprouse, K. A. King, P. J. Spellane and R. J. Watts, J. Am. Chem. Soc., 1984, 106, 
6647–6653. 
102 E. Baranoff, B. F. E. Curchod, J. Frey, R. Scopelliti, F. Kessler, I. Tavernelli, U. 
Rothlisberger, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 2012, 51, 215–224. 
103 R. D. Costa, E. Ortí, D. Tordera, A. Pertegás, H. J. Bolink, S. Graber, C. E. Housecroft, 
L. Sachno, M. Neuburger and E. C. Constable, Adv. Energy Mater., 2011, 1, 282–290. 
104 F. Neve, A. Crispini, S. Campagna and S. Serroni, Inorg. Chem., 1999, 38, 2250–2258. 
105 F. A. M. Rudolph, A. L. Fuller, A. M. Z. Slawin, M. Bühl, R. A. Aitken and J. D. 
Woollins, J. Chem. Crystallogr., 2010, 40, 253–265. 
106 C. Glidewell, W. T. A. Harrison, J. N. Low, J. G. Sime and J. L. Wardell, Acta 
Crystallogr. Sect. B, 2001, 57, 190–200. 
107 S. Evariste, M. Sandroni, T. W. Rees, C. Roldán-Carmona, L. Gil-Escrig, H. J. Bolink, 
E. Baranoff and E. Zysman-Colman, J. Mater. Chem. C, 2014, 2, 5793. 
108 H. J. Bolink, E. Coronado, R. D. Costa, N. Lardiés and E. Ortí, Inorg. Chem., 2008, 47, 
9149–9151. 
109 H.-C. Su, F.-C. Fang, T.-Y. Hwu, H.-H. Hsieh, H.-F. Chen, G.-H. Lee, S.-M. Peng, K.-
T. Wong and C.-C. Wu, Adv. Funct. Mater., 2007, 17, 1019–1027. 
110 M. S. Lowry, J. I. Goldsmith, J. D. Slinker, R. Rohl, R. A. Pascal, G. G. Malliaras and 
S. Bernhard, Chem. Mater., 2005, 17, 5712–5719. 
111 M. Marigo, N. Marsich and E. Farnetti, J. Mol. Catal. A Chem., 2002, 187, 169–177. 
112 N. M. Shavaleev, F. Monti, R. D. Costa, R. Scopelliti, H. J. Bolink, E. Ortí, G. Accorsi, 
N. Armaroli, E. Baranoff, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 2012, 51, 
2263–2271. 
REFERENCES 
 
 
 
 
 - 184 -  
 
113 N. M. Shavaleev, G. Xie, S. Varghese, D. B. Cordes, A. M. Z. Slawin, C. Momblona, 
E. Ortí, H. J. Bolink, I. D. W. Samuel and E. Zysman-Colman, Inorg. Chem., 2015, 54, 
5907–5914. 
114 D. L. Davies, M. P. Lowe, K. S. Ryder, K. Singh and S. Singh, Dalton Trans., 2011, 
40, 1028–1030. 
115 J. Nishida, H. Echizen, T. Iwata and Y. Yamashita, Chem. Lett., 2005, 34, 1378–1379. 
116 V. V. Grushin, N. Herron, D. D. LeCloux, W. J. Marshall, V. A. Petrov and Y. Wang, 
Chem. Commun., 2001, 1494–1495. 
117 T.-H. Kwon, H. S. Cho, M. K. Kim, J.-W. Kim, J.-J. Kim, K. H. Lee, S. J. Park, I.-S. 
Shin, H. Kim, D. M. Shin, Y. K. Chung and J.-I. Hong, Organometallics, 2005, 24, 
1578–1585. 
118 Q.-L. Xu, C.-C. Wang, T.-Y. Li, M.-Y. Teng, S. Zhang, Y.-M. Jing, X. Yang, W.-N. 
Li, C. Lin, Y.-X. Zheng, J.-L. Zuo and X.-Z. You, Inorg. Chem., 2013, 52, 4916–4925. 
119 G. Sarada, J. Yoon, W. Cho, M. Cho, D. W. Cho, S. O. Kang, Y. Nam, J. Y. Lee and 
S.-H. Jin, J. Mater. Chem. C, 2016, 4, 113–120. 
120 B. J. Coe, M. Helliwell, J. Raftery, S. Sánchez, M. K. Peers and N. S. Scrutton, Dalton 
Trans., 2015, 44, 20392–20405. 
121 H. A. Bronstein, C. E. Finlayson, K. R. Kirov, R. H. Friend and C. K. Williams, 
Organometallics, 2008, 27, 2980–2989. 
122 N. Ishida, T. Moriya, T. Goya and M. Murakami, J. Org. Chem., 2010, 75, 8709–8712. 
123 L. Niu, H. Yang, D. Yang and H. Fu, Adv. Synth. Catal., 2012, 354, 2211–2217. 
124 C. Glidewell, W. T. A. Harrison, J. N. Low, J. G. Sime and J. L. Wardell, Acta 
Crystallogr. Sect. B Struct. Sci., 2001, 57, 190–200. 
125 N. M. Shavaleev, R. Scopelliti, M. Grätzel, M. K. Nazeeruddin, A. Pertegás, C. 
Roldán-Carmona, D. Tordera and H. J. Bolink, J. Mater. Chem. C, 2013, 1, 2241–
2248. 
126 C. D. Ertl, J. Cerdá, J. M. Junquera-Hernández, A. Pertegás, H. J. Bolink, E. C. 
Constable, M. Neuburger, E. Ortí and C. E. Housecroft, RSC Adv., 2015, 5, 42815–
42827. 
127 E. C. Constable, C. D. Ertl, C. E. Housecroft and J. A. Zampese, Dalton Trans., 2014, 
43, 5343–5356. 
REFERENCES 
 
 
 
 
 - 185 -  
 
128 M. Marigo, N. Marsich and E. Farnetti, J. Mol. Catal. A Chem., 2002, 187, 169–177. 
129 C. O’Brien, M. Y. Wong, D. B. Cordes, A. M. Z. Slawin and E. Zysman-Colman, 
Organometallics, 2015, 34, 13–22. 
130 J. Xu, G. Cheng, D. Su, Y. Liu, X. Wang and Y. Hu, Chem. Eur. J., 2009, 15, 13105–
13110. 
131 M. Mydlak, C. Bizzarri, D. Hartmann, W. Sarfert, G. Schmid and L. De Cola, Adv. 
Funct. Mater., 2010, 20, 1812–1820. 
132 N. M. Shavaleev, R. Scopelliti, E. Baranoff, M. Grätzel and M. K. Nazeeruddin, Inorg. 
Chim. Acta, 2012, 383, 316–319. 
133 A. B. Tamayo, S. Garon, T. Sajoto, P. I. Djurovich, I. M. Tsyba, R. Bau and M. E. 
Thompson, Inorg. Chem., 2005, 44, 8723–8732. 
134 S. Ladouceur, K. N. Swanick, S. Gallagher-Duval, Z. Ding and E. Zysman-Colman, 
Eur. J. Inorg. Chem., 2013, 5329–5343. 
135 M. K. Nazeeruddin, R. T. Wegh, Z. Zhou, C. Klein, Q. Wang, F. De Angelis, S. 
Fantacci and M. Grätzel, Inorg. Chem., 2006, 45, 9245–9250. 
136 C. S. Chin, M.-S. Eum, S. Y. Kim, C. Kim and S. K. Kang, Eur. J. Inorg. Chem., 2007, 
372–375. 
137 B. Chen, Y. Li, W. Yang, W. Luo and H. Wu, Org. Electron., 2011, 12, 766–773. 
138 C. D. Sunesh, G. Mathai and Y. Choe, Org. Electron., 2014, 15, 667–674. 
139 F. Zhang, D. Ma, L. Duan, J. Qiao, G. Dong, L. Wang and Y. Qiu, Inorg. Chem., 2014, 
53, 6596–6606. 
140 S. B. Meier, W. Sarfert, J. M. Junquera-Hernández, M. Delgado, D. Tordera, E. Ortí, 
H. J. Bolink, F. Kessler, R. Scopelliti, M. Grätzel, M. K. Nazeeruddin and E. Baranoff, 
J. Mater. Chem. C, 2013, 1, 58–68. 
141 T. Hu, L. Duan, J. Qiao, L. He, D. Zhang, R. Wang, L. Wang and Y. Qiu, Org. 
Electron., 2012, 13, 1948–1955. 
142 F. Monti, A. Baschieri, I. Gualandi, J. J. Serrano-Pérez, J. M. Junquera-Hernández, D. 
Tonelli, A. Mazzanti, S. Muzzioli, S. Stagni, C. Roldán-Carmona, A. Pertegás, H. J. 
Bolink, E. Ortí, L. Sambri and N. Armaroli, Inorg. Chem., 2014, 53, 7709–7721. 
143 L. He, L. Duan, J. Qiao, D. Zhang, G. Dong, L. Wang and Y. Qiu, Org. Electron., 
2009, 10, 152–157. 
REFERENCES 
 
 
 
 
 - 186 -  
 
144 L. He, L. Duan, J. Qiao, D. Zhang, L. Wang and Y. Qiu, Appl. Phys. A, 2010, 100, 
1035–1040. 
145 L. He, L. Duan, J. Qiao, D. Zhang, L. Wang and Y. Qiu, Chem. Commun., 2011, 47, 
6467–6469. 
146 L. He, L. Duan, J. Qiao, D. Zhang, L. Wang and Y. Qiu, Org. Electron., 2010, 11, 
1185–1191. 
147 T. Hu, L. Duan, J. Qiao, L. He, D. Zhang, L. Wang and Y. Qiu, Synth. Met., 2013, 163, 
33–37. 
148 N. M. Shavaleev, R. Scopelliti, M. Grätzel and M. K. Nazeeruddin, Inorg. Chim. Acta, 
2013, 404, 210–214. 
149 H. Zhang, Q. Cai and D. Ma, J. Org. Chem., 2005, 70, 5164–5173. 
150 Y.-C. Teo, F.-F. Yong and S. Sim, Tetrahedron, 2013, 69, 7279–7284. 
151 H.-Y. Liu, Z.-T. Yu, Y.-J. Yuan, T. Yu and Z.-G. Zou, Tetrahedron, 2010, 66, 9141–
9144. 
152 A. Baschieri, S. Muzzioli, V. Fiorini, E. Matteucci, M. Massi, L. Sambri and S. Stagni, 
Organometallics, 2014, 33, 6154–6164. 
153 F. Monti, M. G. I. La Placa, N. Armaroli, R. Scopelliti, M. Grätzel, M. K. Nazeeruddin 
and F. Kessler, Inorg. Chem., 2015, 54, 3031–3042. 
154 P. Pla, J. M. Junquera-Hernández, H. J. Bolink and E. Ortí, Dalton Trans., 2015. 
155 J. Wang, S. Tang, A. Sandström and L. Edman, ACS Appl. Mater. Interfaces, 2015, 7, 
2784–2789. 
156 W.-L. Jia, Y.-F. Hu, J. Gao and S. Wang, Dalton Trans., 2006, 1721–1728. 
157 A. Breivogel, M. Park, D. Lee, S. Klassen, A. Kühnle, C. Lee, K. Char and K. Heinze, 
Eur. J. Inorg. Chem., 2014, 288–295. 
158 P. Dreyse, B. Loeb, M. Soto-Arriaza, D. Tordera, E. Ortí, J. J. Serrano-Pérez and H. J. 
Bolink, Dalton Trans., 2013, 42, 15502–15513. 
159 H. J. Bolink, L. Cappelli, E. Coronado and P. Gaviña, Inorg. Chem., 2005, 44, 5966–
5968. 
160 H. J. Bolink, E. Coronado, R. D. Costa, P. Gaviña, E. Ortí and S. Tatay, Inorg. Chem., 
2009, 48, 3907–3909. 
REFERENCES 
 
 
 
 
 - 187 -  
 
161 J. L. Rodríguez-Redondo, R. D. Costa, E. Ortí, A. Sastre-Santos, H. J. Bolink and F. 
Fernández-Lázaro, Dalton Trans., 2009, 9787–9793. 
162 H.-F. Chen, K.-T. Wong, Y.-H. Liu, Y. Wang, Y.-M. Cheng, M.-W. Chung, P.-T. 
Chou and H.-C. Su, J. Mater. Chem., 2011, 21, 768–774. 
163 E. C. Constable, C. E. Housecroft, G. E. Schneider, J. A. Zampese, H. J. Bolink, A. 
Pertegás and C. Roldan-Carmona, Dalton Trans., 2014, 43, 4653–4667. 
164 J. Zhang, L. Zhou, H. A. Al-Attar, K. Shao, L. Wang, D. Zhu, Z. Su, M. R. Bryce and 
A. P. Monkman, Adv. Funct. Mater., 2013, 23, 4667–4677. 
165 K. Hasan, A. K. Bansal, I. D. W. Samuel, C. Roldán-Carmona, H. J. Bolink and E. 
Zysman-Colman, Sci. Rep., 2015, 5, 12325. 
166 W.-J. Xu, S.-J. Liu, T.-C. Ma, Q. Zhao, A. Pertegás, D. Tordera, H. J. Bolink, S.-H. 
Ye, X.-M. Liu, S. Sun and W. Huang, J. Mater. Chem., 2011, 21, 13999–14007. 
167 R. D. Costa, F. J. Céspedes-Guirao, H. J. Bolink, Á. Sastre-Santos, E. Ortí and J. 
Gierschner, J. Phys. Chem. C, 2009, 113, 19292–19297. 
168 R. D. Costa, F. J. Céspedes-Guirao, E. Ortí, H. J. Bolink, J. Gierschner, F. Fernández-
Lázaro and A. Sastre-Santos, Chem. Commun., 2009, 3886–3888. 
169 C.-T. Liao, H.-F. Chen, H.-C. Su and K.-T. Wong, Phys. Chem. Chem. Phys., 2012, 14, 
1262–1269. 
170 Y.-J. Yuan, Z.-T. Yu, X.-Y. Chen, J.-Y. Zhang and Z.-G. Zou, Chem. Eur. J., 2011, 17, 
12891–12895. 
171 K. K.-W. Lo, C.-K. Li and J. S.-Y. Lau, Organometallics, 2005, 24, 4594–4601. 
172 K. K.-W. Lo, S.-K. Leung and C.-Y. Pan, Inorg. Chim. Acta, 2012, 380, 343–349. 
173 C. K. Choudhary, R. K. Choudhary and L. K. Mishra, J. Indian Chem. Soc., 2002, 79, 
761–762. 
174 C. Richardson, F. R. Keene and P. J. Steel, Aust. J. Chem., 2008, 61, 183–188. 
175 F. Gärtner, D. Cozzula, S. Losse, A. Boddien, G. Anilkumar, H. Junge, T. Schulz, N. 
Marquet, A. Spannenberg, S. Gladiali and M. Beller, Chem. Eur. J., 2011, 17, 6998–
7006. 
176 C. Rai and J. B. Braunwarth, J. Org. Chem., 1961, 26, 3434–3436. 
 
REFERENCES 
 
 
 
 
 - 188 -  
 
177 L. J. Carlson, J. Welby, K. A. Zebrowski, M. M. Wilk, R. Giroux, N. Ciancio, J. M. 
Tanski, A. Bradley and L. A. Tyler, Inorg. Chim. Acta, 2011, 365, 159–166. 
178 H.-Q. Do, R. M. Kashif Khan and O. Daugulis, J. Am. Chem. Soc., 2008, 130, 15185–
15192. 
179 L. Vandromme, H.-U. Reißig, S. Gröper and J. P. Rabe, Eur. J. Org. Chem., 2008, 
2008, 2049–2055. 
180 F.-F. Zhuo, W.-W. Xie, Y.-X. Yang, L. Zhang, P. Wang, R. Yuan and C.-S. Da, J. Org. 
Chem., 2013, 78, 3243–3249. 
181 F. Brunner, Synthesis and Investigation of Cyclometalated Ruthenium Complexes with 
Various Anchoring Groups for use in p-type Dye-Sensitized Solar Cells, Master Thesis, 
University of Basel, 2015. 
182 A. A. Rachford, R. Ziessel, T. Bura, P. Retailleau and F. N. Castellano, Inorg. Chem., 
2010, 49, 3730–3736. 
183 M. Lepeltier, F. Dumur, J. Marrot, E. Contal, D. Bertin, D. Gigmes and C. R. Mayer, 
Dalton Trans., 2013, 42, 4479–86. 
184 L. Donato, P. Abel and E. Zysman-Colman, Dalton Trans., 2013, 42, 8402–8412. 
185 F. Riblet, G. Novitchi, R. Scopelliti, L. Helm, A. Gulea and A. E. Merbach, Inorg. 
Chem., 2010, 49, 4194–4211. 
186 J. C. Bailar, J. Inorg. Nucl. Chem., 1958, 8, 165–175. 
187 A. Rodger and B. F. G. Johnson, Inorg. Chem., 1988, 27, 3062–3064. 
188 A. L. Spek, Acta Crystallogr. Sect. D, 2009, 65, 148–155. 
189 Q. Zhao, S. Liu, M. Shi, C. Wang, M. Yu, L. Li, F. Li, T. Yi and C. Huang, Inorg. 
Chem., 2006, 45, 6152–6160. 
190 S.-J. Liu, Q. Zhao, Q.-L. Fan and W. Huang, Eur. J. Inorg. Chem., 2008, 2177–2185. 
191 Z. Li, P. Cui, C. Wang, S. Kilina and W. Sun, J. Phys. Chem. C, 2014, 118, 28764–
28775. 
192 Y. Wu, H. Jing, Z. Dong, Q. Zhao, H. Wu and F. Li, Inorg. Chem., 2011, 50, 7412–
7420. 
193 J. H. Vella, A. Parthasarathy and K. S. Schanze, J. Phys. Chem. A, 2013, 117, 7818–
7822. 
REFERENCES 
 
 
 
 
 - 189 -  
 
194 F. Gärtner, S. Denurra, S. Losse, A. Neubauer, A. Boddien, A. Gopinathan, A. 
Spannenberg, H. Junge, S. Lochbrunner, M. Blug, S. Hoch, J. Busse, S. Gladiali and 
M. Beller, Chem. Eur. J., 2012, 18, 3220–3225. 
195 E. C. Constable, M. Neuburger, P. Rösel, G. E. Schneider, J. A. Zampese, C. E. 
Housecroft, F. Monti, N. Armaroli, R. D. Costa and E. Ortí, Inorg. Chem., 2013, 52, 
885–897. 
196 Y. Hong, J. W. Y. Lam and B. Z. Tang, Chem. Soc. Rev., 2011, 40, 5361–5388. 
197 Q. Zhao, L. Li, F. Li, M. Yu, Z. Liu, T. Yi and C. Huang, Chem. Commun., 2008, 685–
687. 
198 Y. You, H. S. Huh, K. S. Kim, S. W. Lee, D. Kim and S. Y. Park, Chem. Commun., 
2008, 3998–4000. 
199 K. Huang, H. Wu, M. Shi, F. Li, T. Yi and C. Huang, Chem. Commun., 2009, 2, 1243–
1245. 
200 A. J. Howarth, R. Patia, D. L. Davies, F. Lelj, M. O. Wolf and K. Singh, Eur. J. Inorg. 
Chem., 2014, 3657–3664. 
201 L. Vandromme, H.-U. Reißig, S. Gröper and J. P. Rabe, Eur. J. Org. Chem., 2008, 
2049–2055. 
202 M. Zhu, K. Fujita and R. Yamaguchi, Chem. Commun., 2011, 47, 12876–12878. 
203 M. Peters and R. Breinbauer, Tetrahedron Lett., 2010, 51, 6622–6625. 
204 S. O. Ojwach, G. Westman and J. Darkwa, Polyhedron, 2007, 26, 5544–5552. 
205 M. Wu, X. Hu, J. Liu, Y. Liao and G.-J. Deng, Org. Lett., 2012, 14, 2722–2725. 
206 S. M. Khake, V. Soni, R. G. Gonnade and B. Punji, Dalton Trans., 2014, 43, 16084–
16096. 
207 D. Toummini, A. Tlili, J. Bergès, F. Ouazzani and M. Taillefer, Chem. Eur. J., 2014, 
20, 14619–14623. 
208 A. Singh, K. Teegardin, M. Kelly, K. S. Prasad, S. Krishnan and J. D. Weaver, J. 
Organomet. Chem., 2015, 776, 51–59. 
209 S. Mandal, R. Das, P. Gupta and B. Mukhopadhyay, Tetrahedron Lett., 2012, 53, 
3915–3918. 
 
REFERENCES 
 
 
 
 
 - 190 -  
 
210 A. Maity, J.-S. Choi, T. S. Teets, N. Deligonul, A. J. Berdis and T. G. Gray, Chem. 
Eur. J., 2013, 19, 15924–15932. 
211 H.-W. Liu, K. Y. Zhang, W. H.-T. Law and K. K.-W. Lo, Organometallics, 2010, 29, 
3474–3476. 
212 W. H.-T. Law, L. C.-C. Lee, M.-W. Louie, H.-W. Liu, T. W.-H. Ang and K. K.-W. Lo, 
Inorg. Chem., 2013, 52, 13029–13041. 
213 T. Nishioka, T. Shibata and I. Kinoshita, Organometallics, 2007, 26, 1126–1128. 
214 T. Shibata, H. Hashimoto, I. Kinoshita, S. Yano and T. Nishioka, Dalton Trans., 2011, 
40, 4826–4829. 
215 O. Pàmies, M. Diéguez, G. Net, A. Ruiz and C. Claver, J. Chem. Soc. Dalt. Trans., 
1999, 3439–3444. 
216 M.-J. Li, P. Jiao, M. Lin, W. He, G.-N. Chen and X. Chen, Analyst, 2011, 136, 205–
210. 
217 E. C. Constable, R. Frantz, C. E. Housecroft, J. Lacour and A. Mahmood, Inorg. 
Chem., 2004, 43, 4817–4819. 
218 E. C. Constable, C. E. Housecroft and A. Mahmood, Carbohydr. Res., 2008, 343, 
2567–2575. 
219 J. S. Ward, J. M. Lynam, J. W. B. Moir, D. E. Sanin, A. P. Mountford and I. J. S. 
Fairlamb, Dalton Trans., 2012, 41, 10514–10517. 
220 S. Mundwiler, Metal complexes of biomolecules: Supramolecular chemistry of 
2,2':6',2''-terpyridine bound peptides, carbohydrates and phospholipids, PhD Thesis, 
University of Basel, 2000. 
 
 
